Publications

This is a list of all ARCN publications.

ARCN scientists (with PI status) are shown in bold letters, DZL sites in brackets.

We publish preferably open access. Nonetheless it might be that you can’t gain full text access via the links given, if you or your institution didn’t subscribe to the respective journal.

2022, until march

West HJ, McCleland M, Cappuzzo F, Reck M, Mok TSK, Jotte RM, Nishio M, Kim E, Morris S, Zou W, Shames D, Das Thakur M, Shankar G, Socinski MA (2022) Clinical efficacy of atezolizumab plus bevacizumab and chemotherapy in KRAS-mutated non-small cell lung cancer with STK11, KEAP1, or TP53 comutations: subgroup results from the phase III IMpower150 trial. Journal for ImmunoTherapy of Cancer 10: e003027 (ARCN) https://doi.org/10.1136/jitc-2021-003027

Uchino J, Goldmann T, Kimura H (2022) Editorial: Treatment for Non-Small Cell Lung Cancer in Distinct Patient Populations. Front Oncol 12: 838570 (ARCN) https://doi.org/10.3389/fonc.2022.838570  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828902/pdf/fonc-12-838570.pdf

Spigel DR, Faivre-Finn C, Gray JE, Vicente D, Planchard D, Paz-Ares L, Vansteenkiste JF, Garassino MC, Hui R, Quantin X, Rimner A, Wu Y-L, Özgüroğlu M, Lee KH, Kato T, de Wit M, Kurata T, Reck M, Cho BC, Senan S, Naidoo J, Mann H, Newton M, Thiyagarajah P, Antonia SJ (2022) Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer. J Clin Oncol: Jco2101308 (ARCN) https://doi.org/10.1200/jco.21.01308

Santos Junior NG, Lima RM, Athanazio RA, Carvalho Pinto RM, Rabe K, Cukier A, Stelmach R (2022) Changes after 12 years of follow-up severe asthma patients cohort: higher obstruction and comorbidities, but significant better quality of life. J Asthma: 1-10 (ARCN) https://doi.org/10.1080/02770903.2022.2045311 https://www.tandfonline.com/doi/full/10.1080/02770903.2022.2045311

Röckendorf N, Nehls C, Gutsmann T (2022) Design of Membrane Active Peptides Considering Multi-Objective Optimization for Biomedical Application. Membranes 12: 180 (ARCN) https://doi.org/10.3390/membranes12020180 https://mdpi-res.com/d_attachment/membranes/membranes-12-00180/article_deploy/membranes-12-00180-v2.pdf

Remon J, Lacas B, Herbst R, Reck M, Garon EB, Scagliotti GV, Ramlau R, Hanna N, Vansteenkiste J, Yoh K, Groen HJM, Heymach JV, Mandrekar SJ, Okamoto I, Neal JW, Heist RS, Planchard D, Pignon J-P, Besse B, Besse B, Lacas B, Pignon JP, Remon J, Berghmans T, Dahlberg S, Felip E, Berghmans T, Besse B, Dahlberg S, Felip E, Garon E, Groen HJM, Hanna N, Heist RS, Herbst R, Heymach JV, Lacas B, Adjei AA, Heist R, Mandrekar SJ, Neal JW, Okamoto I, Pignon J-P, Ramlau R, Remon J, Reck M, Scagliotti GV, Vansteenkiste J, Yoh K (2022) ANtiangiogenic Second-line Lung cancer Meta-Analysis on individual patient data in non-small cell lung cancer: ANSELMA. Eur J Cancer 166: 112-125 (ARCN) https://doi.org/10.1016/j.ejca.2022.02.002 https://www.ejcancer.com/article/S0959-8049(22)00075-2/fulltext

Reck M, Remon J, Hellmann MD (2022) First-Line Immunotherapy for Non-Small-Cell Lung Cancer. J Clin Oncol: Jco2101497 (ARCN) https://doi.org/10.1200/jco.21.01497

Quellhorst L, Barten-Neiner G, de Roux A, Diel R, Mertsch P, Pink I, Rademacher J, Sutharsan S, Welte T, Zurawski A, Ringshausen FC (2022) Psychometric Validation of the German Translation of the Quality of Life Questionnaire-Bronchiectasis (QOL-B)—Data from the German Bronchiectasis Registry PROGNOSIS. Journal of Clinical Medicine 11: 441 (ARCN, BREATH, CPC-M) https://doi.org/10.3390/jcm11020441 https://mdpi-res.com/d_attachment/jcm/jcm-11-00441/article_deploy/jcm-11-00441-v2.pdf

Petersen EL, Goßling A, Adam G, Aepfelbacher M, Behrendt C-A, Cavus E, Cheng B, Fischer N, Gallinat J, Kühn S, Gerloff C, Koch-Gromus U, Härter M, Hanning U, Huber TB, Kluge S, Knobloch JK, Kuta P, Schmidt-Lauber C, Lütgehetmann M, Magnussen C, Mayer C, Muellerleile K, Münch J, Nägele FL, Petersen M, Renné T, Riedl KA, Rimmele DL, Schäfer I, Schulz H, Tahir E, Waschki B, Wenzel J-P, Zeller T, Ziegler A, Thomalla G, Twerenbold R, Blankenberg S (2022) Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: The Hamburg City Health Study COVID programme. Eur Heart J (ARCN) https://doi.org/10.1093/eurheartj/ehab914

Palusińska-Szysz M, Jurak M, Gisch N, Waldow F, Zehethofer N, Nehls C, Schwudke D, Koper P, Mazur A (2022) The human LL-37 peptide exerts antimicrobial activity against Legionella micdadei interacting with membrane phospholipids. Biochim Biophys Acta: 159138 (ARCN) https://doi.org/10.1016/j.bbalip.2022.159138 https://www.sciencedirect.com/science/article/abs/pii/S1388198122000282?via%3Dihub

Nogami N, Barlesi F, Socinski MA, Reck M, Thomas CA, Cappuzzo F, Mok TSK, Finley G, Aerts JG, Orlandi F, Moro-Sibilot D, Jotte RM, Stroyakovskiy D, Villaruz LC, Rodríguez-Abreu D, Wan-Teck Lim D, Merritt D, Coleman S, Lee A, Shankar G, Yu W, Bara I, Nishio M (2022) IMpower150 Final Exploratory Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in Key NSCLC Patient Subgroups With EGFR Mutations or Metastases in the Liver or Brain. J Thorac Oncol 17: 309-323 (ARCN) https://doi.org/10.1016/j.jtho.2021.09.014 https://www.jto.org/article/S1556-0864(21)03217-2/pdf

Nissen G, Ben-Meir E, Kopp M, Shaw M, Ratjen F, Grasemann H (2022) Interleukin-1 beta is a potential mediator of airway nitric oxide deficiency in cystic fibrosis. Journal of Cystic Fibrosis (ARCN) https://doi.org/10.1016/j.jcf.2022.02.017 https://www.cysticfibrosisjournal.com/article/S1569-1993(22)00049-2/fulltext

Maison N, Omony J, Illi S, Thiele D, Skevaki C, Dittrich A-M, Bahmer T, Rabe KF, Weckmann M, Happle C, Schaub B, Meier M, Foth S, Rietschel E, Renz H, Hansen G, Kopp MV, von Mutius E, Grychtol R (2022) T-high asthma phenotypes across life span. Eur Respir J: 2102288 (ARCN, BREATH, CPC-M, UGMLC) https://doi.org/10.1183/13993003.02288-2021 https://erj.ersjournals.com/content/early/2022/02/10/13993003.02288-2021

Lommatzsch M, Speer T, Herr C, Jörres RA, Watz H, Müller A, Welte T, Vogelmeier CF, Bals R (2022) IgE is associated with exacerbations and lung function decline in COPD. Respir Res 23: 1 (ARCN. BREATH, CPC-M, UGMLC) https://doi.org/10.1186/s12931-021-01847-0 https://respiratory-research.biomedcentral.com/track/pdf/10.1186/s12931-021-01847-0.pdf

Kraft M, Richardson M, Hallmark B, Billheimer D, Van den Berge M, Fabbri LM, Van der Molen T, Nicolini G, Papi A, Rabe KF, Singh D, Brightling C, Siddiqui S, Pizzichini E, Cukier A, Stelmach R, Olivenstein R, Zhang Q, Badorrek P, Gessner C, Scichilone N, Chetta A, Paggiaro P, Milleri S, D’Amato M, Spanevello A, Foschino MP, Boersma WG, Broeders M, Vroegop JS, Plaza Moral V, Djukanovic R, Usmani O, Schilz R, Martin R, Hanania N (2022) The role of small airway dysfunction in asthma control and exacerbations: a longitudinal, observational analysis using data from the ATLANTIS study. The Lancet Respiratory Medicine (ARCN) https://doi.org/10.1016/s2213-2600(21)00536-1 https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00536-1/fulltext

Kopp MV, Weckmann M, Nissen G, Ricklefs I, Härtel C (2022) Two Beer(s) or Not Two Beer(s): The eNose as an Instrument to Pacify the World. Klin Padiatr (ARCN) https://doi.org/10.1055/a-1714-8895 https://www.thieme-connect.de/products/ejournals/pdf/10.1055/a-1714-8895.pdf

Kopp MV, Muche-Borowski C, Abou-Dakn M, Ahrens B, Beyer K, Blümchen K, Bubel P, Chaker A, Cremer M, Ensenauer R, Gerstlauer M, Gieler U, Hübner I-M, Horak F, Klimek L, Koletzko BV, Koletzko S, Lau S, Lob-Corzilius T, Nemat K, Peters EMJ, Pizzulli A, Reese I, Rolinck-Werninghaus C, Rouw E, Schaub B, Schmidt S, Steiß J-O, Striegel AK, Szépfalusi Z, Schlembach D, Spindler T, Taube C, Trendelenburg V, Treudler R, Umpfenbach U, Vogelberg C, Wagenmann M, Weißenborn A, Werfel T, Worm M, Sitter H, Hamelmann E (2022) S3 guideline Allergy Prevention. Allergologie select 6: 61-97 (ARCN, CPC-M) https://doi.org/10.5414/alx02303e https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905073/pdf/allergologieselect-6-061.pdf

Koopman M, Franssen FME, Gaffron S, Watz H, Troosters T, Garcia-Aymerich J, Paggiaro P, Molins E, Moya M, van Burk L, Maier D, Garcia Gil E, Wouters EFM, Vanfleteren LEGW, Spruit MA (2022) Differential Outcomes Following 4 Weeks of Aclidinium/Formoterol in Patients with COPD: A Reanalysis of the ACTIVATE Study. Int J Chron Obstruct Pulmon Dis Volume 17: 517-533 (ARCN) https://doi.org/10.2147/copd.S308600 https://www.dovepress.com/getfile.php?fileID=78904

Kahnert K, Andreas S, Kellerer C, Lutter JI, Lucke T, Yildirim Ö, Lehmann M, Seissler J, Behr J, Frankenberger M, Bals R, Watz H, Welte T, Trudzinski FC, Vogelmeier CF, Alter P, Jörres RA, Andreas S, Bals R, Behr J, Kahnert K, Bahmer T, Bewig B, Ewert R, Stubbe B, Ficker JH, Grohé C, Held M, Henke M, Herth F, Kirsten A-M, Watz H, Koczulla R, Kronsbein J, Kropf-Sanchen C, Herzmann C, Pfeifer M, Randerath WJ, Seeger W, Studnicka M, Taube C, Timmermann H, Alter P, Schmeck B, Vogelmeier C, Welte T, Wirtz H (2022) Reduced decline of lung diffusing capacity in COPD patients with diabetes and metformin treatment. Sci Rep 12: 1435 (ARCN, BREATH, CPC-M, TLRC, UGMLC) https://doi.org/10.1038/s41598-022-05276-x https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792053/pdf/41598_2022_Article_5276.pdf

Janning M, Süptitz J, Albers-Leischner C, Delpy P, Tufman A, Velthaus-Rusik JL, Reck M, Jung A, Kauffmann-Guerrero D, Bonzheim I, Brändlein S, Hummel HD, Wiesweg M, Schildhaus HU, Stratmann JA, Sebastian M, Alt J, Buth J, Esposito I, Berger J, Tögel L, Saalfeld FC, Wermke M, Merkelbach-Bruse S, Hillmer AM, Klauschen F, Bokemeyer C, Buettner R, Wolf J, Loges S (2022) Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM). Ann Oncol (ARCN, CPC-M) https://doi.org/10.1016/j.annonc.2022.02.225 https://www.annalsofoncology.org/article/S0923-7534(22)00361-1/pdf

Jabbour SK, Keller SM, Reck M (2022) Analysis of Outcomes With Addition of Immunotherapy to Chemoradiation Therapy for Non–Small Cell Lung Cancer—Reply. JAMA Oncology 8: 168 (ARCN) https://doi.org/10.1001/jamaoncol.2021.5611 https://jamanetwork.com/journals/jamaoncology/article-abstract/2785695

Huck BC, Thiyagarajan D, Bali A, Boese A, Besecke KFW, Hozsa C, Gieseler RK, Furch M, Carvalho‐Wodarz C, Waldow F, Schwudke D, Metelkina O, Titz A, Huwer H, Schwarzkopf K, Hoppstädter J, Kiemer AK, Koch M, Loretz B, Lehr CM (2022) Nano‐in‐Microparticles for Aerosol Delivery of Antibiotic‐loaded, Fucose‐derivatized and Macrophage‐targeted Liposomes to Combat Mycobacterial Infections: In Vitro deposition, Pulmonary Barrier Interactions and Targeted Delivery. Advanced Healthcare Materials: 2102117 (ARCN) https://doi.org/10.1002/adhm.202102117 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/adhm.202102117?download=true

Hendriks LEL, Remon J, Reck M (2022) Chemotherapy + PD-1/PD-L1 Blockade Should Not Be the Preferred Option in the Neoadjuvant Therapy of NSCLC. J Thorac Oncol 17: 499-502 (ARCN) https://doi.org/10.1016/j.jtho.2021.11.024 https://www.jto.org/article/S1556-0864(21)03399-2/pdf

Günes Günsel G, Conlon TM, Jeridi A, Kim R, Ertüz Z, Lang NJ, Ansari M, Novikova M, Jiang D, Strunz M, Gaianova M, Hollauer C, Gabriel C, Angelidis I, Doll S, Pestoni JC, Edelmann SL, Kohlhepp MS, Guillot A, Bassler K, Van Eeckhoutte HP, Kayalar Ö, Konyalilar N, Kanashova T, Rodius S, Ballester-López C, Genes Robles CM, Smirnova N, Rehberg M, Agarwal C, Krikki I, Piavaux B, Verleden SE, Vanaudenaerde B, Königshoff M, Dittmar G, Bracke KR, Schultze JL, Watz H, Eickelberg O, Stoeger T, Burgstaller G, Tacke F, Heissmeyer V, Rinkevich Y, Bayram H, Schiller HB, Conrad M, Schneider R, Yildirim AÖ (2022) The arginine methyltransferase PRMT7 promotes extravasation of monocytes resulting in tissue injury in COPD. Nature Communications 13: 1303 (ARCN, CPC-M) https://doi.org/10.1038/s41467-022-28809-4 https://www.nature.com/articles/s41467-022-28809-4.pdf

Gridelli C, Peters S, Mok T, Forde PM, Reck M, Attili I, de Marinis F (2022) First-line immunotherapy in advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an International Expert Panel Meeting by the Italian Association of Thoracic Oncology. ESMO Open 7: 100355 (ARCN) https://doi.org/10.1016/j.esmoop.2021.100355

Gerster T, Wröbel M, Hofstaedter CE, Schwudke D, Ernst RK, Ranf S, Gisch N (2022) Remodeling of Lipid A in Pseudomonas syringae pv. phaseolicola In Vitro. Int J Mol Sci 23: 1996 (ARCN) https://doi.org/10.3390/ijms23041996 https://mdpi-res.com/d_attachment/ijms/ijms-23-01996/article_deploy/ijms-23-01996-v2.pdf

Föh B, Buhre JS, Lunding HB, Moreno-Fernandez ME, König P, Sina C, Divanovic S, Ehlers M (2022) Microbial metabolite butyrate promotes induction of IL-10+IgM+ plasma cells. PLoS One 17: e0266071 (ARCN) https://doi.org/10.1371/journal.pone.0266071 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956175/pdf/pone.0266071.pdf

Elmas H, Biancosino C, Önal B, Schmitt F, Buyucek S, Nordholt G, Sauter G, Welker L (2022) Combination of Biochemical and Cytological Findings for Better Diagnosis in Pleural Effusions. Adv Exp Med Biol (ARCN) https://doi.org/10.1007/5584_2021_703 https://link.springer.com/chapter/10.1007/5584_2021_703

Andreas S, Testa M, Boyer L, Brusselle G, Janssens W, Kerwin E, Papi A, Pek B, Puente-Maestu L, Saralaya D, Watz H, Wilkinson TMA, Casula D, Di Maro G, Lattanzi M, Moraschini L, Schoonbroodt S, Tasciotti A, Arora AK, Maltais F, Brusselle G, Corhay J-L, Janssens E, Janssens W, Leys M, Ferguson M, Fitzgerald M, Maltais F, Mayers I, McNeil S, Pek B, Bourdin A, Boyer L, Couturaud F, Dussart L, Andreas S, Illies G, Eich A, Ludwig-Sengpiel A, Watz H, Blasi F, Centanni S, Papi A, Pomari C, Echave-Sustaeta JM, Llorca Martínez E, Narejos Pérez S, Pascual-Guardia S, Pérez Vera M, Puente-Maestu L, Terns Riera M, Anderson W, Choudhury G, De-Soyza A, Saralaya D, Wilkinson TMA, Boscia Iii J, Chinsky K, Dunn L, Erb D, Fogarty C, Downey HJ, Kerwin E, Kunz C, Poling T, Sellman R, Sigal B, Southard J, Spangenthal S, Tannous Z, Testa M, Casula D, Di Maro G, Lattanzi M, Moraschini L, Schoonbroodt S, Tasciotti A, Arora AK (2022) Non-typeable Haemophilus influenzae–Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease: a multicentre, randomised, placebo-controlled, observer-blinded, proof-of-concept, phase 2b trial. The Lancet Respiratory Medicine (ARCN ) https://doi.org/10.1016/s2213-2600(21)00502-6 https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00502-6/fulltext

Abdo M, Pedersen F, Kirsten A-M, Veith V, Biller H, Trinkmann F, von Mutius E, Kopp M, Hansen G, Rabe KF, Bahmer T, Watz H (2022) Longitudinal Impact of Sputum Inflammatory Phenotypes on Small Airway Dysfunction and Disease Outcomes in Asthma. The Journal of Allergy and Clinical Immunology: In Practice (ARCN, BREATH, CPC-M, TLRC) https://doi.org/10.1016/j.jaip.2022.02.020 https://www.jaci-inpractice.org/article/S2213-2198(22)00221-5/pdf

 

2021

Zillikens H, Kasprick A, Osterloh C, Gross N, Radziewitz M, Hass C, Hartmann V, Behnen-Härer M, Ernst N, Boch K, Vidarsson G, Visser R, Laskay T, Yu X, Petersen F, Ludwig RJ, Bieber K (2021) Topical Application of the PI3Kβ-Selective Small Molecule Inhibitor TGX-221 Is an Effective Treatment Option for Experimental Epidermolysis Bullosa Acquisita. Frontiers in Medicine 8: 713312 (ARCN) https://doi.org/10.3389/fmed.2021.713312 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452940/pdf/fmed-08-713312.pdf

Zamyatina A, Heine H (2021) Corrigendum: Lipopolysaccharide Recognition in the Crossroads of TLR4 and Caspase-4/11 Mediated Inflammatory Pathways. Front Immunol 12: 649442 (ARCN) https://doi.org/10.3389/fimmu.2021.649442 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876549/pdf/fimmu-12-649442.pdf

Yue X, Petersen F, Shu Y, Kasper B, Magatsin JDT, Ahmadi M, Yin J, Wax J, Wang X, Heidecke H, Lamprecht P, Müller A, Yu X, Riemekasten G (2021) Transfer of PBMC From SSc Patients Induces Autoantibodies and Systemic Inflammation in Rag2-/-/IL2rg-/- Mice. Front Immunol 12: 677970 (ARCN) https://doi.org/10.3389/fimmu.2021.677970 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261241/pdf/fimmu-12-677970.pdf

Yue X, Deng F, Chen J, Yin J, Zheng J, Chen Y, Huang Q, Gao X, Liu Z, Luo J, Müller A, Heidecke H, Riemekasten G, Petersen F, Yu X (2021) Autoantibodies against C5aR1, C3aR1, CXCR3, and CXCR4 are decreased in primary Sjogren’s syndrome. Mol Immunol (ARCN) https://doi.org/10.1016/j.molimm.2020.12.027 https://www.sciencedirect.com/science/article/abs/pii/S0161589020305940?via%3Dihub

Yin J, Ibrahim S, Petersen F, Yu X (2021) Autoimmunomic Signatures of Aging and Age-Related Neurodegenerative Diseases Are Associated With Brain Function and Ribosomal Proteins. Front Aging Neurosci 13: 679688 (ARCN) https://doi.org/10.3389/fnagi.2021.679688 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192960/pdf/fnagi-13-679688.pdf

Xue P, Bai Y, Rottwinkel G, Averbukh E, Ma Y, Roeder T, Scheerer P, Krauß N, Lamparter T (2021) Phytochrome Mediated Responses in Agrobacterium fabrum: Growth, Motility and Plant Infection. Curr Microbiol (ARCN) https://doi.org/10.1007/s00284-021-02526-5 https://link.springer.com/content/pdf/10.1007/s00284-021-02526-5.pdf

Worm M, Reese I, Ballmer-Weber B, Beyer K, Bischoff SC, Bohle B, Brockow K, Claßen M, Fischer PJ, Hamelmann E, Jappe U, Kleine-Tebbe J, Klimek L, Koletzko B, Lange L, Lau S, Lepp U, Mahler V, Nemat K, Raithel M, Saloga J, Schäfer C, Schnadt S, Schreiber J, Szépfalusi Z, Treudler R, Wagenmann M, Werfel T, Zuberbier T (2021) Update of the S2k guideline on the management of IgE-mediated food allergies. Allergologie select 5: 195-243 (ARCN) https://doi.org/10.5414/alx02257e

Wenzel J, Lampe J, Müller-Fielitz H, Schuster R, Zille M, Müller K, Krohn M, Körbelin J, Zhang L, Özorhan Ü, Neve V, Wagner JUG, Bojkova D, Shumliakivska M, Jiang Y, Fähnrich A, Ott F, Sencio V, Robil C, Pfefferle S, Sauve F, Coêlho CFF, Franz J, Spiecker F, Lembrich B, Binder S, Feller N, König P, Busch H, Collin L, Villaseñor R, Jöhren O, Altmeppen HC, Pasparakis M, Dimmeler S, Cinatl J, Püschel K, Zelic M, Ofengeim D, Stadelmann C, Trottein F, Nogueiras R, Hilgenfeld R, Glatzel M, Prevot V, Schwaninger M (2021) The SARS-CoV-2 main protease Mpro causes microvascular brain pathology by cleaving NEMO in brain endothelial cells. Nat Neurosci 24: 1522-1533 (ARCN) https://doi.org/10.1038/s41593-021-00926-1 https://doi.org/10.1038/s41593-021-00926-1

Wen L, Dong X, Li Q, Schramm G, Zhang B, Zillikens D, Ludwig RJ, Petersen F, Yu X (2021) Preventive but Not Therapeutic Topical Application of Local Anesthetics Can Inhibit Experimental Epidermolysis Bullosa Acquisita in Mice. Front Immunol 12: 750160 (ARCN) https://doi.org/10.3389/fimmu.2021.750160 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546209/pdf/fimmu-12-750160.pdf

Weckmann M, Bahmer T, Sand JM, Rank Rønnow S, Pech M, Vermeulen C, Faiz A, Leeming DJ, Karsdal MA, Lunding L, Oliver BGG, Wegmann M, Ulrich-Merzenich G, Juergens UR, Duhn J, Laumonnier Y, Danov O, Sewald K, Zissler U, Jonker M, König I, Hansen G, von Mutius E, Fuchs O, Dittrich A-M, Schaub B, Happle C, Rabe KF, van de Berge M, Burgess JK, Kopp MV (2021) COL4A3 is degraded in allergic asthma and degradation predicts response to anti-IgE therapy. Eur Respir J 58: 2003969 (ARCN, BREATH, CPC-M) https://doi.org/10.1183/13993003.03969-2020 https://erj.ersjournals.com/content/early/2021/05/06/13993003.03969-2020

Wechsler ME, Ruddy MK, Pavord ID, Israel E, Rabe KF, Ford LB, Maspero JF, Abdulai RM, Hu C-C, Martincova R, Jessel A, Nivens MC, Amin N, Weinreich DM, Yancopoulos GD, Goulaouic H (2021) Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma. New England Journal of Medicine 385: 1656-1668 (ARCN) https://doi.org/10.1056/NEJMoa2024257 https://www.nejm.org/doi/pdf/10.1056/NEJMoa2024257?articleTools=true

Wechsler ME, Ford LB, Maspero JF, Pavord ID, Papi A, Bourdin A, Watz H, Castro M, Nenasheva NM, Tohda Y, Langton D, Cardona G, Domingo C, Park HS, Chapman KR, Mao X, Zhang Y, Khan AH, Deniz Y, Rowe PJ, Kapoor U, Khokhar FA, Mannent LP, Ruddy M, Laws E, Amin N, Hardin M (2021) Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study. The Lancet Respiratory Medicine (ARCN) https://doi.org/10.1016/s2213-2600(21)00322-2 https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00322-2/fulltext

Watz H, Barile S, Guastalla D, Topole E, Cocconi D, Mignot B, Belmans D, Duman D, Poli G, Fabbri LM (2021) Targeting the Small Airways with Inhaled Corticosteroid/Long-Acting Beta Agonist Dry Powder Inhalers: A Functional Respiratory Imaging Study. J Aerosol Med Pulm Drug Deliv (ARCN) https://doi.org/10.1089/jamp.2020.1618 https://www.liebertpub.com/doi/10.1089/jamp.2020.1618

Watz H (2021) Inhalative Therapie der COPD – alle Patienten auf „fixed triple“? DMW – Deutsche Medizinische Wochenschrift 146: 471-473 (ARCN) https://doi.org/10.1055/a-1219-0708 https://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-1219-0708

Walter K, Kokesch-Himmelreich J, Treu A, Waldow F, Hillemann D, Jakobs N, Lemm A-K, Schwudke D, Römpp A, Hölscher C (2021) Interleukin-13 overexpressing mice represent an advanced pre-clinical model for detecting the distribution of anti-mycobacterial drugs within centrally necrotizing granulomas. Antimicrob Agents Chemother: Aac0158821 (ARCN) https://doi.org/10.1128/aac.01588-21 https://journals.asm.org/doi/pdf/10.1128/AAC.01588-21?download=true

Wagner C, Uliczka K, Bossen J, Niu X, Fink C, Thiedmann M, Knop M, Vock C, Abdelsadik A, Zissler UM, Isermann K, Garn H, Pieper M, Wegmann M, Koczulla AR, Vogelmeier CF, Schmidt-Weber CB, Fehrenbach H, König P, Silverman N, Renz H, Pfefferle P, Heine H, Roeder T (2021) Constitutive immune activity promotes JNK- and FoxO-dependent remodeling of Drosophila airways. Cell Rep 35: 108956 (ARCN, CPC-M, UGMLC) https://doi.org/10.1016/j.celrep.2021.108956

Voigt GM, Thiele D, Wetzke M, Weidemann J, Parpatt PM, Welte T, Seidenberg J, Vogelberg C, Koster H, Rohde GGU, Härtel C, Hansen G, Kopp MV (2021) Interobserver agreement in interpretation of chest radiographs for pediatric community acquired pneumonia: Findings of the pedCAPNETZ‐cohort. Pediatr Pulmonol 56: 2676-2685 (ARCN, BREATH) https://doi.org/10.1002/ppul.25528 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ppul.25528?download=true

Twisselmann N, Pagel J, Künstner A, Weckmann M, Hartz A, Glaser K, Hilgendorff A, Göpel W, Busch H, Herting E, Weinberg JB, Härtel C (2021) Hyperoxia/Hypoxia Exposure Primes a Sustained Pro-Inflammatory Profile of Preterm Infant Macrophages Upon LPS Stimulation. Front Immunol 12: 762789 (ARCN, CPC-M) https://doi.org/10.3389/fimmu.2021.762789 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637891/pdf/fimmu-12-762789.pdf

Trudzinski FC, Kellerer C, Jörres RA, Alter P, Lutter JI, Trinkmann F, Herth FJF, Frankenberger M, Watz H, Vogelmeier CF, Kauczor HU, Welte T, Behr J, Bals R, Kahnert K (2021) Gender-specific differences in COPD symptoms and their impact for the diagnosis of cardiac comorbidities. Clin Res Cardiol (ARCN, BREATH, CPC-M, TLRC, UGMLC) https://doi.org/10.1007/s00392-021-01915-x https://link.springer.com/content/pdf/10.1007/s00392-021-01915-x.pdf

Tischer C, Karvonen AM, Kirjavainen PV, Flexeder C, Roponen M, Hyvärinen A, Renz H, Frey U, Fuchs O, Pekkanen J (2021) Early age exposure to moisture and mould is related to FeNO at the age of 6 years. Pediatr Allergy Immunol (ARCN, UGMLC) https://doi.org/10.1111/pai.13526 https://onlinelibrary.wiley.com/doi/10.1111/pai.13526

Svanes C, Bertelsen RJ, Accordini S, Holloway JW, Júlíusson P, Boateng E, Krauss-Etchmann S, Schlünssen V, Gómez-Real F, Skulstad SM (2021) Exposures during the prepuberty period and future offspring’s health: evidence from human cohort studies†. Biol Reprod 105: 667-680 (ARCN) https://doi.org/10.1093/biolre/ioab158 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444705/pdf/ioab158.pdf

Svanes C, Bertelsen RJ, Accordini S, Holloway JW, Juliusson P, Boateng E, Krauss-Eschmann S, Schlünssen V, Gomez-Real F, Skulstad SM (2021) Exposures during the pre-puberty period and future offspring health: Evidence from human cohort studies. Biol Reprod (ARCN) https://doi.org/10.1093/biolre/ioab158

Stoffel L, Agyeman PKA, Keitel K, Barbani MT, Duppenthaler A, Kopp MV, Aebi C (2021) Striking Decrease of Enteroviral Meningitis in Children During the COVID-19 Pandemic. Open Forum Infectious Diseases 8: ofab115 (ARCN) https://doi.org/10.1093/ofid/ofab115 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083471/pdf/ofab115.pdf

Stellmacher F, Perner S (2021) Histopathologie der Lungentuberkulose. Der Pathologe ((ARCN)) https://doi.org/10.1007/s00292-021-00910-3 https://link.springer.com/content/pdf/10.1007/s00292-021-00910-3.pdf

Stellmacher F, Perner S (2021) Übersicht: Granulomatöse Erkrankungen der Lunge. Der Pathologe ((ARCN)) https://doi.org/10.1007/s00292-020-00893-7 https://link.springer.com/article/10.1007%2Fs00292-020-00893-7

Spigel DR, Vicente D, Ciuleanu TE, Gettinger S, Peters S, Horn L, Audigier-Valette C, Aranda NP, Juan-Vidal O, Cheng Y, Zhang H, Shi M, Luft A, Wolf J, Antonia S, Nakagawa K, Fairchild J, Baudelet C, Pandya D, Doshi P, Chang H, Reck M (2021) Second-Line Nivolumab in Relapsed Small-Cell Lung Cancer: CheckMate 331. Ann Oncol (ARCN) https://doi.org/10.1016/j.annonc.2021.01.071 https://www.annalsofoncology.org/article/S0923-7534(21)00099-5/fulltext

Socinski MA, Nishio M, Jotte RM, Cappuzzo F, Orlandi F, Stroyakovskiy D, Nogami N, Rodríguez-Abreu D, Moro-Sibilot D, Thomas CA, Barlesi F, Finley G, Kong S, Lee A, Coleman S, Zou W, McCleland M, Shankar G, Reck M (2021) IMpower150 final overall survival analyses for atezolizumab plus bevacizumab and chemotherapy in first-line metastatic nonsquamous non-small cell lung cancer. J Thorac Oncol (ARCN) https://doi.org/10.1016/j.jtho.2021.07.009

Skevaki C, Tafo P, Eiringhaus K, Timmesfeld N, Weckmann M, Happle C, Nelson PP, Maison N, Schaub B, Ricklefs I, Fuchs O, von Mutius E, Kopp MV, Renz H, Hansen G, Dittrich AM, Roesler B, Welchering N, Kohistani‐Greif N, Kurz J, Landgraf‐Rauf K, Laubhahn K, Liebl C, Ege M, Illi S, Hose A, Zeitlmann E, Berbig M, Marzi C, Schauberger C, Zissler U, Schmidt‐Weber C, Diekmann G, Liboschik L, Voigt G, Sultansei L, Nissen G, König IR, Thiele D, Bahmer T, Kirsten AM, Pedersen F, Watz H, Waschki B, Rabe KF, Herzmann C, Abdo M, Biller H, Gaede KI, Bovermann X, Steinmetz A, Liselotte Husstedt B, Nitsche C, Veith V, Szewczyk M, Brinkmann F, Grychtol R, Malik A, Schwerk N, Dopfer C, Price M, Chari A, Habener A, DeLuca DS, Gaedcke S, Liu B, Calvero MR, Weber S, Foth S, Meyer M, Schildberg T, Rietschel E, van Koningsbruggen‐Rietschel S, Alcazar M (2021) Allergen extract‐ and component‐based diagnostics in children of the ALLIANCE asthma cohort. Clin Exp Allergy (ARCN, BREATH, CPC-M, UGMLC) https://doi.org/10.1111/cea.13964 https://onlinelibrary.wiley.com/doi/10.1111/cea.13964

Sicklinger F, Meyer IS, Li X, Radtke D, Dicks S, Kornadt MP, Mertens C, Meier JK, Lavine KJ, Zhang Y, Kuhn TC, Terzer T, Patel J, Boerries M, Schramm G, Frey N, Katus HA, Voehringer D, Leuschner F (2021) Basophils balance healing after myocardial infarction via IL-4/IL-13. J Clin Invest 131 (ARCN) https://doi.org/10.1172/jci136778 https://dm5migu4zj3pb.cloudfront.net/manuscripts/136000/136778/JCI136778.v1.pdf

Shu Y, He D, Ma X, Li J, Wu H, Chen C, Lu Z, Petersen F, Qiu W, Yu X (2021) Infiltration of plasma cells in colorectal adenocarcinoma associated with autoimmune encephalitis. Annals of Clinical and Translational Neurology (ARCN) https://doi.org/10.1002/acn3.51283 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51283?download=true

Shang Y, Chen F, Li S, Song L, Gao Y, Yu X, Zheng J (2021) Investigation of Interaction between the Spike Protein of SARS-CoV-2 and ACE2-Expressing Cells Using an In Vitro Cell Capturing System. Biol Proced Online 23: 16 (ARCN) https://doi.org/10.1186/s12575-021-00153-9 https://biologicalproceduresonline.biomedcentral.com/track/pdf/10.1186/s12575-021-00153-9.pdf

Schunk SJ, Beisswenger C, Ritzmann F, Herr C, Wagner M, Triem S, Hütter G, Schmit D, Zewinger S, Sarakpi T, Honecker A, Mahadevan P, Boor P, Wagenpfeil S, Jörres R, Watz H, Welte T, Vogelmeier CF, Gröne H-J, Fliser D, Speer T, Bals R (2021) Measurement of urinary Dickkopf-3 uncovered silent progressive kidney injury in patients with chronic obstructive pulmonary disease. Kidney Int (ARCN, BREATH, CPC-M, UGMLC) https://doi.org/10.1016/j.kint.2021.06.029 https://www.kidney-international.org/article/S0085-2538(21)00663-3/fulltext

https://www.sciencedirect.com/science/article/abs/pii/S0085253821006633?via%3Dihub

Schröder A, Lunding LP, Zissler UM, Vock C, Webering S, Ehlers JC, Orinska Z, Chaker A, Schmidt‐Weber CB, Lang NJ, Schiller HB, Mall MA, Fehrenbach H, Dinarello CA, Wegmann M (2021) IL‐37 regulates allergic inflammation by counterbalancing pro‐inflammatory IL‐1 and IL‐33. Allergy (ARCN, CPC-M, (BIH)) https://doi.org/10.1111/all.15072 https://onlinelibrary.wiley.com/doi/10.1111/all.15072

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/all.15072?download=true

Schoenfeld AJ, Antonia SJ, Awad MM, Felip E, Gainor J, Gettinger SN, Hodi FS, Johnson ML, Leighl NB, Lovly CM, Mok T, Perol M, Reck M, Solomon B, Soria JC, Tan DSW, Peters S, Hellmann MD (2021) Clinical definition of acquired resistance to immunotherapy in patients with metastatic non-small cell lung cancer. Ann Oncol (ARCN) https://doi.org/10.1016/j.annonc.2021.08.2151 https://www.annalsofoncology.org/article/S0923-7534(21)04455-0/fulltext

Schocker F, Fehrenbach H, Schromm AB (2021) Mission impossible? EMBO reports 22: e52334 (ARCN) https://doi.org/10.15252/embr.202052334 https://www.embopress.org/doi/full/10.15252/embr.202052334

Schneider E, Winzer R, Rissiek A, Ricklefs I, Meyer-Schwesinger C, Ricklefs FL, Bauche A, Behrends J, Reimer R, Brenna S, Wasielewski H, Lauten M, Rissiek B, Puig B, Cortesi F, Magnus T, Fliegert R, Müller CE, Gagliani N, Tolosa E (2021) CD73-mediated adenosine production by CD8 T cell-derived extracellular vesicles constitutes an intrinsic mechanism of immune suppression. Nature Communications 12: 5911 ((ARCN)) https://doi.org/10.1038/s41467-021-26134-w https://www.nature.com/articles/s41467-021-26134-w.pdf

Santos-Valente E, Buntrock-Döpke H, Abou Taam R, Arasi S, Bakirtas A, Lozano Blasco J, Bønnelykke K, Craiu M, Cutrera R, Deschildre A, Elnazir B, Fleming L, Frey U, Gappa M, Nieto García A, Skamstrup Hansen K, Hanssens L, Jahnz-Rozyk K, Jesenak M, Kerzel S, Kopp MV, Koppelman GH, Krivec U, MacLeod KA, Mäkelä M, Melén E, Mezei G, Moeller A, Moreira A, Pohunek P, Minić P, Rutjes NWP, Sammut P, Schwerk N, Szépfalusi Z, Turkalj M, Tzotcheva I, Ulmeanu A, Verhulst S, Xepapadaki P, Niggel J, Vijverberg S, Maitland-van der Zee AH, Potočnik U, Reinartz SM, van Drunen CM, Kabesch M (2021) Biologicals in childhood severe asthma: the European PERMEABLE survey on the status quo. ERJ Open Research 7: 00143-02021 (ARCN, (BREATH)) https://doi.org/10.1183/23120541.00143-2021 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365152/pdf/00143-2021.pdf

Rodríguez-Abreu D, Powell SF, Hochmair MJ, Gadgeel S, Esteban E, Felip E, Speranza G, De Angelis F, Dómine M, Cheng SY, Bischoff HG, Peled N, Reck M, Hui R, Garon EB, Boyer M, Kurata T, Yang J, Pietanza MC, Souza F, Garassino MC (2021) Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189. Ann Oncol 32: 881-895 (ARCN) https://doi.org/10.1016/j.annonc.2021.04.008 https://doi.org/10.1016/j.annonc.2021.04.008

https://www.annalsofoncology.org/article/S0923-7534(21)01146-7/pdf

Rodríguez-Abreu D, Powell SF, Hochmair MJ, Gadgeel S, Esteban E, Felip E, Speranza G, De Angelis F, Dómine M, Cheng SY, Bischoff HG, Peled N, Reck M, Hui R, Garon EB, Boyer M, Kurata T, Yang J, Pietanza MC, Souza F, Garassino MC (2021) Pemetrexed Plus Platinum With or Without Pembrolizumab in Patients With Previously Untreated Metastatic Nonsquamous NSCLC: Protocol-Specified Final Analysis From KEYNOTE-189. Ann Oncol (ARCN) https://doi.org/10.1016/j.annonc.2021.04.008 https://www.annalsofoncology.org/article/S0923-7534(21)01146-7/fulltext

Remon J, Aldea M, Besse B, Planchard D, Reck M, Giaccone G, Soria JC (2021) Small cell lung cancer: a slightly less orphan disease after immunotherapy. Ann Oncol (ARCN) https://doi.org/10.1016/j.annonc.2021.02.025 https://www.annalsofoncology.org/article/S0923-7534(21)00877-2/fulltext

Reck M, Rodríguez-Abreu D, Robinson AG, Hui R, Csőszi T, Fülöp A, Gottfried M, Peled N, Tafreshi A, Cuffe S, O’Brien M, Rao S, Hotta K, Leal TA, Riess JW, Jensen E, Zhao B, Pietanza MC, Brahmer JR (2021) Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%. J Clin Oncol 0: JCO.21.00174 (ARCN) https://doi.org/10.1200/jco.21.00174 https://ascopubs.org/doi/abs/10.1200/JCO.21.00174

Reck M, Ciuleanu TE, Cobo M, Schenker M, Zurawski B, Menezes J, Richardet E, Bennouna J, Felip E, Juan-Vidal O, Alexandru A, Sakai H, Lingua A, Reyes F, Souquet PJ, De Marchi P, Martin C, Pérol M, Scherpereel A, Lu S, Paz-Ares L, Carbone DP, Memaj A, Marimuthu S, Zhang X, Tran P, John T (2021) Corrigendum to ‘First-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus chemotherapy alone (4 cycles) in advanced non-small cell lung cancer: CheckMate 9LA 2-year update’. ESMO Open 6: 100345 (ARCN) https://doi.org/10.1016/j.esmoop.2021.100345 https://www.esmoopen.com/article/S2059-7029(21)00307-0/pdf

Reck M, Ciuleanu TE, Cobo M, Schenker M, Zurawski B, Menezes J, Richardet E, Bennouna J, Felip E, Juan-Vidal O, Alexandru A, Sakai H, Lingua A, Reyes F, Souquet PJ, De Marchi P, Martin C, Pérol M, Scherpereel A, Lu S, Paz-Ares L, Carbone DP, Memaj A, Marimuthu S, Zhang X, Tran P, John T (2021) First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year update. ESMO Open 6: 100273 (ARCN) https://doi.org/10.1016/j.esmoop.2021.100273 https://www.esmoopen.com/article/S2059-7029(21)00235-0/pdf

Reck M, Ciuleanu T-E, Lee J-S, Schenker M, Audigier-Valette C, Zurawski B, Linardou H, Otterson GA, Salman P, Nishio M, de la Mora Jimenez E, Lesniewski-Kmak K, Albert I, Ahmed S, Syrigos K, Penrod JR, Yuan Y, Blum SI, Nathan FE, Sun X, Moreno-Koehler A, Taylor F, O’Byrne KJ (2021) First-Line Nivolumab Plus Ipilimumab vs Chemotherapy in Advanced Non-Small Cell Lung Cancer With Tumor PD-L1 ≥ 1%: Patient-Reported Outcomes From CheckMate 227 Part 1. J Thorac Oncol (ARCN) https://doi.org/10.1016/j.jtho.2020.12.019 https://www.jto.org/article/S1556-0864(21)00041-1/pdf

Reck M, Carbone DP, Garassino M, Barlesi F (2021) Targeting KRAS in non–small cell lung cancer: recent progress and new approaches. Ann Oncol (ARCN) https://doi.org/10.1016/j.annonc.2021.06.001 https://www.annalsofoncology.org/article/S0923-7534(21)02045-7/pdf

Ramakrishnan S, Janssens W, Burgel P-R, Contoli M, Franssen FME, Greening NJ, Greulich T, Gyselinck I, Halner A, Huerta A, Morgan RL, Quint JK, Vanfleteren LEGW, Vermeersch K, Watz H, Bafadhel M (2021) Standardisation of Clinical Assessment, Management and Follow-Up of Acute Hospitalised Exacerbation of COPD: A Europe-Wide Consensus. Int J Chron Obstruct Pulmon Dis Volume 16: 321-332 (ARCN, UGMLC) https://doi.org/10.2147/copd.S287705 https://www.dovepress.com/front_end/cr_data/cache/pdf/download_1614697244_603e531c395f5/copd-287705-standardisation-of-clinical-assessment-management-and-follo.pdf

Rabe KF, Martinez FJ, Singh D, Trivedi R, Jenkins M, Darken P, Aurivillius M, Dorinsky P (2021) Improvements in lung function with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler versus dual therapies in patients with COPD: a sub-study of the ETHOS trial. Ther Adv Respir Dis 15: 175346662110343 (ARCN) https://doi.org/10.1177/17534666211034329 https://journals.sagepub.com/doi/pdf/10.1177/17534666211034329

Rabe KF, Celli BR, Wechsler ME, Abdulai RM, Luo X, Boomsma MM, Staudinger H, Horowitz JE, Baras A, Ferreira MA, Ruddy MK, Nivens MC, Amin N, Weinreich DM, Yancopoulos GD, Goulaouic H (2021) Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial. The Lancet Respiratory Medicine (ARCN) https://doi.org/10.1016/s2213-2600(21)00167-3 https://www.sciencedirect.com/science/article/abs/pii/S2213260021001673?via%3Dihub

Raacke M, Kerr A, Dörpinghaus M, Brehmer J, Wu Y, Lorenzen S, Fink C, Jacobs T, Roeder T, Sellau J, Bachmann A, Metwally NG, Bruchhaus I (2021) Altered Cytokine Response of Human Brain Endothelial Cells after Stimulation with Malaria Patient Plasma. Cells 10: 1656 (ARCN) https://doi.org/10.3390/cells10071656 https://res.mdpi.com/d_attachment/cells/cells-10-01656/article_deploy/cells-10-01656-v2.pdf

Proske A, Bossen J, von Frieling J, Roeder T (2021) Low-protein diet applied as part of combination therapy or stand-alone normalizes lifespan and tumor proliferation in a model of intestinal cancer. Aging 13 (ARCN) https://doi.org/10.18632/aging.203692

Popat S, Baas P, Faivre-Finn C, Girard N, Nicholson AG, Nowak AK, Opitz I, Scherpereel A, Reck M (2021) Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (ARCN) https://doi.org/10.1016/j.annonc.2021.11.005 https://www.annalsofoncology.org/article/S0923-7534(21)04820-1/pdf

Ponce Aix S, Novello S, Garon EB, Nakagawa K, Nadal E, Moro-Sibilot D, Alonso Garcia M, Fabre E, Frimodt-Moller B, Zimmermann AH, Visseren-Grul CM, Reck M (2021) RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in patients with untreated, EGFR-mutated, metastatic non-small cell lung cancer: Europe/United States subset analysis. Cancer Treatment and Research Communications 27: 100378 (ARCN) https://doi.org/10.1016/j.ctarc.2021.100378

Platts‐Mills TA, Hilger C, Jappe U, Hage M, Gadermaier G, Spillner E, JonasLidholm, Keshavarz B, Aalberse RC, Van Ree R, Goodman RE, Pomés A (2021) Carbohydrate Epitopes Currently Recognized as Targets for IgE Antibodies. Allergy (ARCN) https://doi.org/10.1111/all.14802 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/all.14802?download=true

Pillai RN, Ramalingam SS, Thayu M, Lorenzini P, Alvarez Arias DA, Moy C, Hutnick N, Knoblauch R, Feng H, Kane C, Horn L, Reck M, Ponce S (2021) Daratumumab Plus Atezolizumab in Previously Treated Advanced or Metastatic NSCLC: Brief Report on a Randomized, Open-Label, Phase 1b/2 Study (LUC2001 JNJ-54767414). JTO Clinical and Research Reports 2: 100104 (ARCN) https://doi.org/10.1016/j.jtocrr.2020.100104 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474375/pdf/main.pdf

Pfeiffer S, Herzmann C, Gaede KI, Kovacevic D, Krauss-Etschmann S, Schloter M (2021) Different responses of the oral, nasal and lung microbiomes to cigarette smoke. Thorax: thoraxjnl-2020-216153 (ARCN, CPC-M) https://doi.org/10.1136/thoraxjnl-2020-216153 https://thorax.bmj.com/content/thoraxjnl/early/2021/08/13/thoraxjnl-2020-216153.full.pdf

Pfaar O, Blumchen K, Boateng E, Hamelmann E, Iinuma T, Jakob T, Krauss-Etschmann S, Nagase H, Nakajima S, Nakano T, Renz H, Sato S, Taube C, Wagenmann M, Werfel T, Worm M, Izuhara K (2021) Precision medicine reaching out to the patients in allergology – a German-Japanese workshop report. Allergologie select 5: 162-179 (ARCN, UGMLC) https://doi.org/10.5414/alx02234e https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167740/pdf/allergologieselect-5-162.pdf

Peters S, Pujol JL, Dafni U, Dómine M, Popat S, Reck M, Andrade J, Becker A, Moro-Sibilot D, Curioni-Fontecedro A, Molinier O, Nackaerts K, Mollá AI, Gervais R, Vivanco GL, Madelaine J, Mazieres J, Faehling M, Griesinger F, Majem M, Larriba JLG, Pulla MP, Vervita K, Roschitzki-Voser H, Ruepp B, Mitchell P, Stahel RA, Le Pechoux C, De Ruysscher D (2021) Consolidation nivolumab and ipilimumab versus observation in limited-disease small cell lung cancer after chemo-radiotherapy – Results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial. Ann Oncol (ARCN) https://doi.org/10.1016/j.annonc.2021.09.011 https://www.annalsofoncology.org/article/S0923-7534(21)04490-2/fulltext

Peters S, Galle PR, Bernaards CA, Ballinger M, Bruno R, Quarmby V, Ruppel J, Vilimovskij A, Wu B, Sternheim N, Reck M (2021) Evaluation of atezolizumab immunogenicity: Efficacy and safety (Part 2). Clin Transl Sci (ARCN) https://doi.org/10.1111/cts.13149 https://ascpt.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.13149?download=true

Perner S, Stellmacher F (2021) Nicht-neoplastische Lungenerkrankungen. Der Pathologe 42: 2-3 ((ARCN)) https://doi.org/10.1007/s00292-021-00909-w https://link.springer.com/content/pdf/10.1007/s00292-021-00909-w.pdf

Peñate Medina T, Kolb JP, Hüttmann G, Huber R, Peñate Medina O, Ha L, Ulloa P, Larsen N, Ferrari A, Rafecas M, Ellrichmann M, Pravdivtseva MS, Anikeeva M, Humbert J, Both M, Hundt JE, Hövener J-B (2021) Imaging Inflammation – From Whole Body Imaging to Cellular Resolution. Front Immunol 12: 692222 (ARCN) https://doi.org/10.3389/fimmu.2021.692222 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264453/pdf/fimmu-12-692222.pdf

Pedersen F, Trinkmann F, Abdo M, Kirsten A-M, Rabe KF, Watz H, Baraldo S, Saetta M, Hohlfeld JM, Holz O (2021) Influence of Cell Quality on Inflammatory Biomarkers in COPD Sputum Supernatant. Int J Chron Obstruct Pulmon Dis Volume 16: 487-493 (ARCN, BREATH, TLRC) https://doi.org/10.2147/copd.S284938 https://www.dovepress.com/front_end/cr_data/cache/pdf/download_1615902919_6050b8c747dbc/copd-284938-influence-of-cell-quality-on-inflammatory-biomarkers-in-copd.pdf

Paz-Ares LG, Ramalingam SS, Ciuleanu T-E, Lee J-S, Urban L, Caro RB, Park K, Sakai H, Ohe Y, Nishio M, Audigier-Valette C, Burgers JA, Pluzanski A, Sangha R, Gallardo C, Takeda M, Linardou H, Lupinacci L, Lee KH, Caserta C, Provencio M, Carcereny E, Otterson GA, Schenker M, Zurawski B, Alexandru A, Vergnenegre A, Raimbourg J, Feeney K, Kim S-W, Borghaei H, O’Byrne KJ, Hellmann MD, Memaj A, Nathan FE, Bushong J, Tran P, Brahmer JR, Reck M (2021) First-Line Nivolumab Plus Ipilimumab in Advanced Non-Small Cell Lung Cancer: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial. J Thorac Oncol (ARCN) https://doi.org/10.1016/j.jtho.2021.09.010 https://www.jto.org/article/S1556-0864(21)03207-X/pdf

Paz-Ares L, Ciuleanu T-E, Cobo M, Schenker M, Zurawski B, Menezes J, Richardet E, Bennouna J, Felip E, Juan-Vidal O, Alexandru A, Sakai H, Lingua A, Salman P, Souquet P-J, De Marchi P, Martin C, Pérol M, Scherpereel A, Lu S, John T, Carbone DP, Meadows-Shropshire S, Agrawal S, Oukessou A, Yan J, Reck M (2021) First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial. The Lancet Oncology (ARCN) https://doi.org/10.1016/s1470-2045(20)30641-0 https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(20)30641-0/fulltext

Pasternack H, Kuempers C, Deng M, Watermann I, Olchers T, Kuehnel M, Jonigk D, Kugler C, Stellmacher F, Goldmann T, Kirfel J, Ammerpohl O, Perner S, Reck M (2021) Identification of molecular signatures associated with early relapse after complete resection of lung adenocarcinomas. Sci Rep 11: 9532 (ARCN, BREATH) https://doi.org/10.1038/s41598-021-89030-9 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099905/pdf/41598_2021_Article_89030.pdf

Papi A, Fabbri LM, Kerstjens HAM, Rogliani P, Watz H, Singh D (2021) Inhaled long-acting muscarinic antagonists in asthma – A narrative review. Eur J Intern Med (ARCN) https://doi.org/10.1016/j.ejim.2021.01.027 https://www.ejinme.com/article/S0953-6205(21)00033-9/pdf

Owonikoko TK, Park K, Govindan R, Ready N, Reck M, Peters S, Dakhil SR, Navarro A, Rodríguez-Cid J, Schenker M, Lee J-S, Gutierrez V, Percent I, Morgensztern D, Barrios CH, Greillier L, Baka S, Patel M, Lin WH, Selvaggi G, Baudelet C, Baden J, Pandya D, Doshi P, Kim HR (2021) Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451. J Clin Oncol: JCO.20.02212 (ARCN) https://doi.org/10.1200/jco.20.02212

Nogami N, Barlesi F, Socinski MA, Reck M, Thomas CA, Cappuzzo F, Mok TSK, Finley G, Aerts JG, Orlandi F, Moro-Sibilot D, Jotte RM, Stroyakovskiy D, Villaruz LC, Rodríguez-Abreu D, Lim DW-T, Merritt D, Coleman S, Lee A, Shankar G, Yu W, Bara I, Nishio M (2021) IMpower150 Final Exploratory Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in Key NSCLC Patient Subgroups With EGFR Mutations or Metastases in the Liver or Brain. J Thorac Oncol (ARCN) https://doi.org/10.1016/j.jtho.2021.09.014 https://www.jto.org/article/S1556-0864(21)03217-2/pdf

Nishio K, Seto T, Nishio M, Reck M, Garon EB, Sakai K, Goto K, Kato T, Nakanishi Y, Takahashi T, Yamamoto N, Kiura K, Ohe Y, Tamura T, Visseren-Grul C, Frimodt-Moller B, Hozak RR, Wijayawardana SR, Zimmermann A, Homma G, Enatsu S, Nakagawa K (2021) Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Untreated Metastatic EGFR-Mutated NSCLC: RELAY Japanese Subset. JTO Clinical and Research Reports 2: 100171 (ARCN) https://doi.org/10.1016/j.jtocrr.2021.100171 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474372/pdf/main.pdf

Niemi MEK, Karjalainen J, Liao RG, Neale BM, Daly M, Ganna A, Pathak GA, Andrews SJ, Kanai M, Veerapen K, Fernandez-Cadenas I, Schulte EC, Striano P, Marttila M, Minica C, Marouli E, Karim MA, Wendt FR, Savage J, Sloofman L, Butler-Laporte G, Kim H-N, Kanoni S, Okada Y, Byun J, Han Y, Uddin MJ, Smith GD, Willer CJ, Buxbaum JD, Mehtonen J, Finucane H, Cordioli M, Martin AR, Zhou W, Pasaniuc B, Julienne H, Aschard H, Shi H, Yengo L, Polimanti R, Ghoussaini M, Schwartzentruber J, Dunham I, Chwialkowska K, Francescatto M, Trankiem A, Balaconis MK, Davis L, Lee S, Priest J, Renieri A, Sankaran VG, van Heel D, Deelen P, Richards JB, Nakanishi T, Biesecker L, Kerchberger VE, Baillie JK, Mari F, Bernasconi A, Baillie SC, Canakoglu A, Wolford B, Faucon A, Dutta AK, Schurmann C, Harry E, Birney E, Nguyen H, Nasir J, Kaunisto M, Solomonson M, Dueker N, Vadgama N, Limou S, Rahmouni S, Mbarek H, Darwish D, Uddin MM, Albertos R, Pérez-Tur J, Li R, Folkersen L, Moltke I, Koelling N, Teumer A, Kousathanas A, Utrilla A, Verdugo RA, Zárate R, Medina-Gómez C, Gómez-Cabrero D, Carnero-Montoro E, Cadilla CL, Moreno-Estrada A, Garmendia A, Moya L, Sedaghati-Khayat B, Boua PR, Favé M-J, Francioli L, Lemaçon A, Migeotte I, Patel S, Varnai R, Szentpeteri JL, Sipeky C, Colombo F, von Hohenstaufen K, Lio P, Vallerga C, Wang Q, Tanigawa Y, Im H, Han C, Song H, Lim J, Lee Y, Kim S, Im S, Atanasovska B, Ahmad HF, Boer C, Jansen P, Franke L, Kaja E, Pasko D, Kennis-Szilagyi I, Kornilov SA, Prijatelj V, Prokić I, Sivanadhan I, Perumal S, Esmaeeli S, Pearson NM, Auton A, Shelton JF, Shastri AJ, Filshtein-Sonmez T, Coker D, Symons A, Esparza-Gordillo J, Aslibekyan S, O’Connell J, Ye C, Weldon CH, Perera M, O’Leary K, Tuck M, O’Brien T, Meltzer D, O’Donnell P, Nutescu E, Yang G, Alarcon C, Herrmann S, Mazurek S, Banagan J, Hamidi Z, Barbour A, Raffat N, Moreno D, Friedman P, Ferwerda B, van de Beek D, Brouwer MC, Vlaar APJ, Wiersinga WJ, Posthuma D, Tissink E, Koos Zwinderman AH, Uffelmann E, van Agtmael M, Algera AG, van Baarle F, Bax D, Beudel M, Jan Bogaard H, Bomers M, Bonta PI, Bos L, Botta M, de Brabander J, de Bree G, de Bruin S, Bugiani M, Bulle E, Chouchane O, Cloherty A, Dongelmans D, Elbers P, Fleuren L, Geerlings S, Geerts B, Geijtenbeek T, Girbes A, Goorhuis B, Grobusch MP, Hafkamp F, Hagens L, Hamann J, Harris V, Hemke R, Hermans SM, Heunks L, Hollmann M, Horn J, Hovius JW, de Jong MD, Koning R, van Mourik N, Nellen J, Nossent EJ, Paulus F, Peters E, van der Poll T, Preckel B, Prins JM, Raasveld J, Reijnders T, Schinkel M, Schultz MJ, Schuurman A, Sigaloff K, Smit M, Stijnis CS, Stilma W, Teunissen C, Thoral P, Tsonas A, van der Valk M, Veelo D, de Vries H, van Vugt M, Wouters D, Minnaar RP, Kromhout A, van Uffelen KWJ, Wolterman RA, Roberts G, Park D, Ball CA, Coignet M, McCurdy S, Knight S, Partha R, Rhead B, Zhang M, Berkowitz N, Gaddis M, Noto K, Ruiz L, Pavlovic M, Hong EL, Rand K, Girshick A, Guturu H, Baltzell AH, Rahmouni S, Guntz J, Beguin Y, Pigazzini S, Nkambule L, Bouysran Y, Busson A, Peyrassol X, Wilkin F, Pichon B, Smits G, Vandernoot I, Goffard J-C, Georges M, Moutschen M, Misset B, Darcis G, Guiot J, Jadot L, Azarzar S, Dellot P, Gofflot S, Claassen S, Bertrand A, Parzibut G, Clarinval M, Moermans C, Malaise O, El Kandoussi K, Thonon R, Huynen P, Mesdagh A, Melo S, Jacques N, Di Valentin E, Giroule F, Collignon A, Radermecker C, Lebrun M, Perée H, Latour S, Barada O, Sanchez J, Josse C, Boujemla B, Meunier M, Mariavelle E, Anania S, Gazon H, Juszczak D, Fadeur M, Camby S, Meuris C, Thys M, Jacques J, Henket M, Léonard P, Frippiat F, Giot J-B, Sauvage A-S, Von Frenckell C, Mni M, Wéry M, Staderoli A, Belhaj Y, Lambermont B, Morrison DR, Mooser V, Forgetta V, Li R, Ghosh B, Laurent L, Belisle A, Henry D, Abdullah T, Adeleye O, Mamlouk N, Kimchi N, Afrasiabi Z, Rezk N, Vulesevic B, Bouab M, Guzman C, Petitjean L, Tselios C, Xue X, Afilalo J, Afilalo M, Oliveira M, Brenner B, Brassard N, Durand M, Schurr E, Lepage P, Ragoussis J, Auld D, Chassé M, Kaufmann DE, Lathrop GM, Adra D, Davis LK, Cox NJ, Below JE, Sealock JM, Faucon AB, Shuey MM, Polikowsky HG, Petty LE, Shaw DM, Chen H-H, Zhu W, Ludwig KU, Schröder J, Maj C, Rolker S, Nöthen MM, Fazaal J, Keitel V, Jensen B-EO, Feldt T, Kurth I, Marx N, Dreher M, Pink I, Cornberg M, Illig T, Lehmann C, Schommers P, Augustin M, Rybniker J, Knopp L, Eggermann T, Volland S, Altmüller J, Berger MM, Brenner T, Hinney A, Witzke O, Bals R, Herr C, Ludwig N, Walter J, Fuchsberger C, Pattaro C, De Grandi A, Pramstaller P, Emmert D, Melotti R, Foco L, Mascalzoni D, Gögele M, Domingues F, Hicks A, Gignoux CR, Wicks SJ, Crooks K, Barnes KC, Daya M, Shortt J, Rafaels N, Chavan S, Goldstein DB, Kiryluk K, Sengupta S, Chung W, Reilly MP, Khan A, Wang C, Povysil G, Bhardwaj N, Gharavi AG, Ionita-Laza I, Shang N, O’Byrne SM, Nandakumar R, Menon A, So YS, Hod E, Pendrick D, Kim H-N, Park S-K, Kim H-L, Kang CK, Lee H-J, Song K-H, Jae Yoon K, Paik N-J, Seok W, Yoon H, Joo E-J, Chang Y, Ryu S, Park WB, Su Park J, Un Park K, Ham SY, Jung J, Kim ES, Kim HB, Ellinghaus D, Degenhardt F, Cáceres M, Juzenas S, Lenz TL, Albillos A, Julià A, Heidecker B, Garcia F, Kurth F, Tran F, Hanses F, Zoller H, Holter JC, Fernández J, Sander LE, Rosenstiel P, Koehler P, de Cid R, Asselta R, Schreiber S, Hehr U, Prati D, Baselli G, Valenti L, Bujanda L, Banales JM, Duga S, D’Amato M, Romero-Gómez M, Buti M, Invernizzi P, Franke A, Hov JR, Karlsen TH, Folseraas T, Maya-Miles D, Teles A, Azuure C, Wacker EM, Uellendahl-Werth F, ElAbd H, Arora J, Lerga-Jaso J, Wienbrandt L, Rühlemann MC, Wendorff M, Vadla MS, Lenning OB, Özer O, Myhre R, Raychaudhuri S, Tanck A, Gassner C, Hemmrich-Stanisak G, Kässens J, Figuera Basso ME, Schulzky M, Wittig M, Braun N, Wesse T, Albrecht W, Yi X, Ortiz AB, Chercoles AG, Ruiz A, Mantovani A, Holten AR, Mayer A, Cherubini A, Protti A, Aghemo A, Gerussi A, Ramirez A, Braun A, Barreira A, Lleo A, Kildal AB, Glück A, Nolla AC, Latiano A, Dyrhol-Riise AM, Muscatello A, Voza A, Rando-Segura A, Solier A, Karina B, Cortes B, Mateos B, Nafria-Jimenez B, Schaefer B, Bellinghausen C, Ferrando C, Quereda C, Skurk C, Thibeault C, Spinner CD, Lange C, Hu C, Cappadona C, Bianco C, Sancho C, Lihaug Hoff DA, Galimberti D, Jiménez D, Pestaña D, Toapanta D, Azzolini E, Scarpini E, Helbig ET, Urrechaga E, Paraboschi EM, Pontali E, Reverter E, Navas E, Arana E, Sánchez FG, Ceriotti F, Malvestiti F, Mesonero F, Pezzoli G, Lamorte G, Neb H, My I, Hernández I, de Rojas I, Galván-Femenia I, Heyckendorf J, Rybniker J, Badia JR, Schneider J, Goikoetxea J, Kraft J, Müller KE, Gaede KI, Garcia-Etxebarria K, Tonby K, Heggelund L, Izquierdo-Sanchez L, Sumoy L, Lippert LJ, Terranova L, Garbarino L, Téllez L, Roade L, Ostadreza M, Intxausti M, Kogevinas M, Gutiérrez-Stampa MA, Vehreschild MJGT, Marquié M, Castoldi M, Cecconi M, Boada M, Seilmaier MJ, Mazzocco M, Rodríguez-Gandía M, Ayo NI, Blay N, Martínez N, Cornely OA, Palmieri O, Tentorio P, Rodrigues PM, España PP, Hoffmann P, Bacher P, Suwalski P, de Pablo R, Nieto R, Badalamenti S, Ciesek S, Bombace S, Wilfling S, Brunak S, Heilmann-Heimbach S, Ripke S, Bahmer T, Landmesser U, Protzer U, Rimoldi V, Skogen V, Andrade V, Moreno V, Poller W, Farre X, Wang X, Khodamoradi Y, Karadeniz Z, de Salazar A, Palom A, Garcia-Fernandez A-E, Blanco-Grau A, Zanella A, Bandera A, Nebel A, Biondi A, Caballero-Garralda A, Gori A, Lind A, Fracanzani AL, Peschuck A, Pesenti A, de la Horra C, Milani C, Paccapelo C, Angelini C, Cea C, Muñiz-Diaz E, Sandoval E, Calderón EJ, Solligård E, Aziz F, Martinelli-Boneschi F, Peyvandi F, Blasi F, Medrano FJ, Rodriguez-Frias F, Müller F, Grasselli G, Costantino G, Cardamone G, Foti G, Matullo G, Kurihara H, Afset JE, Damås JK, Ampuero J, Martín J, Erdmann J, Bergan J, Goerg S, Ferrusquía-Acosta J, Quero JH, Delgado J, Guerrero JM, Risnes K, Bettini LR, Moreira L, Gustad LT, Santoro L, Scudeller L, Riveiro-Barciela M, Schaefer M, Carrabba M, Valsecchi MG, Hernandez-Tejero M, Acosta-Herrera M, D’Angiò M, Baldini M, Cazzaniga M, Ciccarelli M, Bocciolone M, Miozzo M, Chueca N, Montano N, Faverio P, Preatoni P, Bonfanti P, Omodei P, Castro P, Ferrer R, Gualtierotti R, Gallego-Durán R, Morilla R, Haider S, Marsal S, Aneli S, Pelusi S, Bosari S, Aliberti S, Dudman S, Zheng T, Pumarola T, Cejudo TG, Monzani V, Friaza V, Peter W, Dopazo X, Duga S, May S, Grimsrud MM, Gudbjartsson DF, Stefansson K, Sulem P, Sveinbjornsson G, Melsted P, Norddahl G, Swerford Moore KH, Thorsteinsdottir U, Holm H, Alarcón-Riquelme ME, Bernardo D, Martínez-Bueno M, Rello SR, Magi R, Milani L, Metspalu A, Laisk T, Läll K, Lepamets M, Esko T, Reimann E, Naaber P, Laane E, Pesukova J, Peterson P, Kisand K, Tabri J, Allos R, Hensen K, Starkopf J, Ringmets I, Tamm A, Kallaste A, Alavere H, Metsalu K, Puusepp M, Kristiansson K, Koskelainen S, Perola M, Donner K, Kivinen K, Palotie A, Palotie A, Rivolta C, Bochud P-Y, Bibert S, Boillat N, Nussle SG, Albrich W, Quinodoz M, Kamdar D, Suh N, Neofytos D, Erard V, Voide C, Bochud PY, Rivolta C, Bibert S, Quinodoz M, Kamdar D, Neofytos D, Erard V, Voide C, Friolet R, Vollenweider P, Pagani JL, Oddo M, zu Bentrup FM, Conen A, Clerc O, Marchetti O, Guillet A, Guyat-Jacques C, Foucras S, Rime M, Chassot J, Jaquet M, Viollet RM, Lannepoudenx Y, Portopena L, Desgranges F, Filippidis P, Guéry B, Haefliger D, Kampouri EE, Manuel O, Munting A, Papadimitriou-Olivgeris M, Regina J, Rochat-Stettler L, Suttels V, Tadini E, Tschopp J, Van Singer M, Viala B, Boillat-Blanco N, Brahier T, Hügli O, Meuwly JY, Pantet O, Nussle SG, Bochud M, D’Acremont V, Younes SE, Albrich WC, Suh N, Cerny A, O’Mahony L, von Mering C, Bochud PY, Frischknecht M, Kleger GR, Filipovic M, Kahlert CR, Wozniak H, Negro TR, Pugin J, Bouras K, Knapp C, Egger T, Perret A, Montillier P, di Bartolomeo C, Barda B, de Cid R, Carreras A, Moreno V, Galván-Femenía I, Blay N, Farré X, Sumoy L, Cortés B, Mercader JM, Guindo-Martinez M, Torrents D, Garcia-Aymerich J, Castaño-Vinyals G, Dobaño C, Gori M, Renieri A, Mondelli MU, Castelli F, Vaghi M, Rusconi S, Montagnani F, Bargagli E, Franchi F, Mazzei MA, Cantarini L, Tacconi D, Feri M, Scala R, Spargi G, Nencioni C, Bandini M, Caldarelli GP, Spagnesi M, Canaccini A, Ognibene A, D’Arminio Monforte A, Girardis M, Antinori A, Francisci D, Schiaroli E, Scotton PG, Panese S, Scaggiante R, Monica MD, Capasso M, Fiorentino G, Castori M, Aucella F, Di Biagio A, Masucci L, Valente S, Mandalà M, Zucchi P, Giannattasio F, Coviello DA, Mussini C, Bosio G, Tavecchia L, Crotti L, Rizzi M, La Rovere MT, Sarzi-Braga S, Bussotti M, Ravaglia S, Artuso R, Perrella A, Romani D, Bergomi P, Catena E, Vincenti A, Ferri C, Grassi D, Pessina G, Tumbarello M, Di Pietro M, Sabrina R, Luchi S, Barbieri C, Acquilini D, Andreucci E, Paciosi F, Segala FV, Tiseo G, Falcone M, Lista M, Poscente M, De Vivo O, Petrocelli P, Guarnaccia A, Baroni S, Perticaroli V, Furini S, Dei S, Benetti E, Picchiotti N, Sanarico M, Ceri S, Pinoli P, Raimondi F, Biscarini F, Stella A, Bergomi M, Zguro K, Capitani K, Tanfoni M, Fallerini C, Daga S, Baldassarri M, Fava F, Frullanti E, Valentino F, Doddato G, Giliberti A, Tita R, Amitrano S, Bruttini M, Croci S, Meloni I, Mencarelli MA, Lo Rizzo C, Pinto AM, Beligni G, Tommasi A, Di Sarno L, Palmieri M, Carriero ML, Alaverdian D, Iuso N, Inchingolo G, Busani S, Bruno R, Vecchia M, Belli MA, Mantovani S, Ludovisi S, Quiros-Roldan E, Antoni MD, Zanella I, Siano M, Emiliozzi A, Fabbiani M, Rossetti B, Zanelli G, Bergantini L, D’Alessandro M, Cameli P, Bennet D, Anedda F, Marcantonio S, Scolletta S, Guerrini S, Conticini E, Frediani B, Spertilli C, Donati A, Guidelli L, Corridi M, Croci L, Piacentini P, Desanctis E, Cappelli S, Verzuri A, Anemoli V, Pancrazi A, Lorubbio M, Merlini E, Miraglia FG, Venturelli S, Cossarizza A, Vergori A, Gabrieli A, Riva A, Paciosi F, Andretta F, Gatti F, Parisi SG, Baratti S, Piscopo C, Russo R, Andolfo I, Iolascon A, Carella M, Merla G, Squeo GM, Raggi P, Marciano C, Perna R, Bassetti M, Sanguinetti M, Giorli A, Salerni L, Parravicini P, Menatti E, Trotta T, Coiro G, Lena F, Martinelli E, Mancarella S, Gabbi C, Maggiolo F, Ripamonti D, Bachetti T, Suardi C, Parati G, Bottà G, Di Domenico P, Rancan I, Bianchi F, Colombo R, van Heel DA, Hunt KA, Trembath RC, Huang QQ, Martin HC, Mason D, Trivedi B, Wright J, Finer S, Griffiths CJ, Akhtar S, Anwar M, Arciero E, Ashraf S, Breen G, Chung R, Curtis CJ, Chowdhury M, Colligan G, Deloukas P, Durham C, Finer S, Griffiths C, Huang QQ, Hurles M, Hunt KA, Hussain S, Islam K, Khan A, Khan A, Lavery C, Lee SH, Lerner R, MacArthur D, MacLaughlin B, Martin H, Mason D, Miah S, Newman B, Safa N, Tahmasebi F, Trembath RC, Trivedi B, van Heel DA, Wright J, Smith AV, Boughton AP, Li KW, LeFaive J, Annis A, Jannes CE, Krieger JE, Pereira AC, Velho M, Marques E, Lima IR, Tada MT, Valino K, McCarthy M, Rosenberger C, Lee JE, Chang D, Hammer C, Hunkapiller J, Mahajan A, Pendergrass S, Sucheston-Campbell L, Yaspan B, Lee HS, Shin E, Jang HY, Kim S, Kym S, Kim Y-S, Jeong H, Kwon KT, Kim S-W, Kim JY, Jang YR, Kim Ha, Lee JY, Lee JE, Lee S, Choe K-W, Kang YM, Jee SH, Jung KJ, Parikh V, Ashley E, Wheeler M, Rivas M, Bustamante C, Pinksy B, Febbo P, Farh K, Schroth GP, deSouza F, Dalton K, Christle J, Deboever C, Szalma S, Tanigawa Y, Rubinacci S, Delaneau O, Gorzynski J, de Jong H, Sutton S, Youlton N, Joshi R, Jimenez-Morales D, Hughes C, Amar D, Ioannidis A, Hershman S, Kirillova A, Seo K, Huang Y, Shoura M, Hammond N, Watson N, Raja A, Huang C, Sahoo M, Wang H, Zhen J, Rakitko A, Ilinsky V, Yermakovich D, Popov I, Chernitsov A, Kovalenko E, Krasnenko A, Plotnikov N, Stetsenko I, Kim A, Cirulli ET, Schiabor Barrett KM, Bolze A, White S, Washington NL, Lu JT, Riffle S, Tanudjaja F, Wang X, Ramirez JM, Leonetti N, Sandoval E, Neveux I, Dabe S, Grzymski JJ, Esteban Miñano JI, Aguirre LA, López-Collazo E, de la Mata Pazos M, Cerrato L, Folkersen L, Lozano-Rodríguez R, Avendaño-Ortiz J, Arcos VT, Montalbán-Hernández KM, Quiroga JV, Pascual-Iglesias A, Maroun-Eid C, Martín-Quirós A, Namkoong H, Okada Y, Imoto S, Katayama K, Fukunaga K, Kitagawa Y, Sato T, Hasegawa N, Kumanogoh A, Kimura A, Ai M, Tokunaga K, Kanai T, Miyano S, Ogawa S, Edahiro R, Sonehara K, Shirai Y, Kanai M, Ishii M, Kabata H, Masaki K, Kamata H, Ikemura S, Chubachi S, Okamori S, Terai H, Tanaka H, Morita A, Lee H, Asakura T, Sasaki J, Morisaki H, Uwamino Y, Nanki K, Mikami Y, Tomono K, Kato K, Matsuda F, Takahashi M, Hizawa N, Takeda Y, Hirata H, Shiroyama T, Miyawaki S, Suzuki K, Maeda Y, Nii T, Noda Y, Niitsu T, Adachi Y, Enomoto T, Amiya S, Hara R, Takahashi K, Anzai T, Hasegawa T, Ito S, Koike R, Endo A, Uchimura Y, Miyazaki Y, Honda T, Tateishi T, Tohda S, Ichimura N, Sonobe K, Sassa C, Nakajima J, Nannya Y, Omae Y, Takahashi K, Harada N, Hiki M, Takagi H, Nakamura A, Tagaya E, Kawana M, Arimura K, Ishiguro T, Takayanagi N, Isono T, Takaku Y, Takano K, Anan R, Nakajima Y, Nakano Y, Nishio K, Ueda S, Hayashi R, Tateno H, Hase I, Yoshida S, Suzuki S, Mitamura K, Saito F, Ueda T, Azuma M, Nagasaki T, Yasui Y, Hasegawa Y, Mutoh Y, Yoshiyama T, Shoko T, Kojima M, Adachi T, Ishikawa M, Takahashi K, Watanabe K, Manabe T, Ito F, Fukui T, Funatsu Y, Koh H, Hirai Y, Kawashima H, Narita A, Niwa K, Sekikawa Y, Saito F, Yoshiya K, Yoshihara T, Suzuki Y, Nakayama S, Masuzawa K, Nishi K, Nishitsuji M, Tani M, Inoue T, Hirano T, Kobayashi K, Miyazawa N, Kimura Y, Sado R, Ogura T, Kitamura H, Murohashi K, Nakachi I, Baba R, Arai D, Fuke S, Saito H, Kuwahara N, Fujiwara A, Okada T, Baba T, Noda J, Mashimo S, Yagi K, Shiomi T, Hashiguchi M, Odani T, Mochimaru T, Oyamada Y, Mori N, Izumi N, Nagata K, Taki R, Murakami K, Yamada M, Sugiura H, Hayashi K, Shimizu T, Gon Y, Fujitani S, Tsuchida T, Yoshida T, Kagaya T, Kita T, Sakagami S, Kimizuka Y, Kawana A, Nakamura Y, Ishikura H, Takata T, Kikuchi T, Taniyama D, Nakamura M, Kodama N, Kaneyama Y, Maeda S, Nagasaki Y, Okamoto M, Ishihara S, Ito A, Chihara Y, Takeuchi M, Onoi K, Hashimoto N, Wakahara K, Ando A, Masuda M, Wakabayashi A, Watanabe H, Sageshima H, Nakada T-A, Abe R, Shimada T, Kawamura K, Ichikado K, Nishiyama K, Yamasaki M, Hashimoto S, Kusaka Y, Ohba T, Isogai S, Takada M, Kanda H, Komase Y, Sano F, Asano K, Oguma T, Harada M, Takahashi T, Shibusawa T, Abe S, Kono Y, Togashi Y, Izumo T, Inomata M, Awano N, Ogawa S, Ogata T, Ishihara S, Kanehiro A, Ozaki S, Fuchimoto Y, Kitagawa Y, Yoshida S, Ogura S, Nishiyama K, Yoshida K, Beppu S, Fukuyama S, Eriguchi Y, Yonekawa A, Inoue Y, Yamagata K, Chiba S, Narumoto O, Nagai H, Ooshima N, Motegi M, Sagara H, Tanaka A, Ohta S, Shibata Y, Tanino Y, Sato Y, Yamada Y, Hashino T, Shinoki M, Iwagoe H, Imamura T, Umeda A, Shimada H, Endo M, Hayashi S, Takahashi M, Nakano S, Yatomi M, Maeno T, Ishii T, Utsugi M, Ono A, Kanaoka K, Ihara S, Komuta K, Franke L, Boezen M, Claringbould A, Lopera E, Warmerdam R, Vonk JM, van Blokland I, Lanting P, Ori APS, Obeidat Me, Hernández Cordero AI, Sin DD, Bossé Y, Joubert P, Hao K, Nickle D, Timens W, van den Berge M, Feng Y-CA, Mercader J, Weiss ST, Karlson EW, Smoller JW, Murphy SN, Meigs JB, Woolley AE, Green RC, Perez EF, Wolford B, Zöllner S, Wang J, Beck A, Sloofman LG, Ascolillo S, Sebra RP, Collins BL, Levy T, Sealfon SC, Jordan DM, Thompson RC, Gettler K, Chaudhary K, Belbin GM, Preuss M, Hoggart C, Choi S, Underwood SJ, Salib I, Britvan B, Keller K, Tang L, Peruggia M, Hiester LL, Niblo K, Aksentijevich A, Labkowsky A, Karp A, Zlatopolsky M, Zyndorf M, Charney AW, Beckmann ND, Schadt EE, Abul-Husn NS, Cho JH, Itan Y, Kenny EE, Loos RJF, Nadkarni GN, Do R, O’Reilly P, Huckins LM, Ferreira MAR, Abecasis GR, Leader JB, Cantor MN, Justice AE, Carey DJ, Chittoor G, Josyula NS, Kosmicki JA, Horowitz JE, Baras A, Gass MC, Yadav A, Mirshahi T, Jan Hottenga J, Bartels M, de Geus EJC, Nivard MG, Verma A, Ritchie MD, Rader D, Li B, Verma SS, Lucas A, Bradford Y, Zara F, Salpietro V, Scala M, Iacomino M, Scudieri P, Bocciardi R, Minetti C, Riva A, Vari MS, Rahier J-F, Giorgio E, Carli D, Louis E, Bulik CM, Landén M, Brusco A, Ferrero GB, Madia F, Fundín B, Ismail SI, Saad C, Al-Sarraj Y, Badji RM, Al-Muftah W, Al Thani A, Afifi N, Klovins J, Rovite V, Rescenko R, Peculis R, Ustinova M, Zeberg H, Frithiof R, Hultström M, Lipcsey M, Johnson R, Geschwind DH, Freimer N, Butte MJ, Geschwind DH, Pasaniuc B, Ding Y, Chiu A, Chang TS, Boutros P, Moutsianas L, Caulfield MJ, Scott RH, Walker S, Stuckey A, Odhams CA, Rhodes D, Fowler T, Rendon A, Chan G, Arumugam P, Karczewski KJ, Wilson DJ, Spencer CA, Crook DW, Wyllie DH, O’Connell AM, Atkinson EG, Kanai M, Tsuo K, Baya N, Turley P, Gupta R, Walters RK, Palmer DS, Sarma G, Solomonson M, Cheng N, Lu W, Churchhouse C, Goldstein JI, King D, Seed C, Daly MJ, Neale BM, Bryant S, Satterstrom FK, Band G, Earle SG, Lin S-K, Arning N, Armstrong J, Rudkin JK, Callier S, Bryant S, Cusick C, Soranzo N, Zhao JH, Danesh J, Di Angelantonio E, Butterworth AS, Sun YV, Huffman JE, Cho K, O’Donnell CJ, Tsao P, Gaziano JM, Peloso G, Ho Y-L, Mian M, Scaggiante F, Chang X, Glessner JR, Hakonarson H, McGuigan PJ, Prockter Moore LS, Vizcaychipi MP, Hall K, Campbell A, Nichol A, Ward G, Page VJ, Semple MG, Adeniji K, Agranoff D, Agwuh K, Ail D, Aldera EL, Alegria A, Angus B, Ashish A, Atkinson D, Bari S, Barlow G, Barnass S, Barrett N, Bassford C, Basude S, Baxter D, Beadsworth M, Bernatoniene J, Berridge J, Best N, Bothma P, Chadwick D, Brittain-Long R, Bulteel N, Burden T, Burtenshaw A, Caruth V, Chambler D, Chee N, Child J, Chukkambotla S, Clark T, Collini P, Cosgrove C, Cupitt J, Cutino-Moguel M-T, Dark P, Dawson C, Dervisevic S, Donnison P, Douthwaite S, Drummond A, DuRand I, Dushianthan A, Dyer T, Evans C, Eziefula C, Fegan C, Finn A, Fullerton D, Garg S, Garg A, Gkrania-Klotsas E, Godden J, Goldsmith A, Graham C, Hardy E, Hartshorn S, Harvey D, Havalda P, Hawcutt DB, Hobrok M, Hodgson L, Hormis A, Jacobs M, Jain S, Jennings P, Kaliappan A, Kasipandian V, Kegg S, Kelsey M, Kendall J, Kerrison C, Kerslake I, Koch O, Koduri G, Koshy G, Laha S, Laird S, Larkin S, Leiner T, Lillie P, Limb J, Linnett V, Little J, Lyttle M, MacMahon M, MacNaughton E, Mankregod R, Masson H, Matovu E, McCullough K, McEwen R, Meda M, Mills GH, Minton J, Ward K, Mirfenderesky M, Mohandas K, Mok Q, Moon J, Moore E, Morgan P, Morris C, Mortimore K, Moses S, Mpenge M, Mulla R, Murphy M, Nagel M, Nagarajan T, Nelson M, O’Shea MK, Otahal I, Ostermann M, Pais M, Panchatsharam S, Papakonstantinou D, Paraiso H, Patel B, Pattison N, Pepperell J, Peters M, Phull M, Pintus S, Pooni JS, Post F, Price D, Prout R, Rae N, Reschreiter H, Reynolds T, Richardson N, Roberts M, Roberts D, Rose A, Rousseau G, Ryan B, Saluja T, Shah A, Shanmuga P, Sharma A, Shawcross A, Sizer J, Shankar-Hari M, Smith R, Snelson C, Spittle N, Staines N, Stambach T, Stewart R, Subudhi P, Szakmany T, Tatham K, Thomas J, Thompson C, Thompson R, Tridente A, Tupper-Carey D, Twagira M, Ustianowski A, Vallotton N, Vincent-Smith L, Visuvanathan S, Vuylsteke A, Waddy S, Wake R, Walden A, Welters I, Whitehouse T, Whittaker P, Whittington A, Papineni P, Wijesinghe M, Williams M, Wilson L, Cole S, Winchester S, Wiselka M, Wolverson A, Wooton DG, Workman A, Yates B, Young P, Beale R, Bretherick AD, Clohisey S, Fourman MH, Furniss J, Gountouna E, Grimes G, Haley C, Harrison D, Hayward C, Keating S, Klaric L, Klenerman P, Law A, Meynert AM, Millar J, Pairo-Castineira E, Parkinson N, Ponting CP, Porteous DJ, Rawlik K, Richmond A, Rowan K, Russell CD, Scott RH, Shen X, Shih B, Tenesa A, Vitart V, Wang B, Wilson JF, Wu Y, Yang J, Yang Z, Zechner M, Zhai R, Zheng C, Norman L, Pius R, Drake TM, Fairfield CJ, Knight SR, McLean KA, Murphy D, Shaw CA, Dalton J, Girvan M, Saviciute E, Roberts S, Harrison J, Marsh L, Connor M, Halpin S, Jackson C, Gamble C, Leeming G, Law A, Wham M, Hendry R, Scott-Brown J, Begg C, Hinds C, Wai Ho AY, Horby PW, Knight J, Ling L, Maslove D, McAuley D, Montgomery H, Nichol A, Openshaw PJM, Semple MG, Shankar-Hari M, Summers C, Walsh T, Armstrong L, Bates H, Dooks E, Farquhar F, Hairsine B, McParland C, Packham S, Alldis Z, Astin-Chamberlain R, Bibi F, Biddle J, Blow S, Bolton M, Borra C, Bowles R, Burton M, Choudhury Y, Collier D, Cox A, Easthope A, Ebano P, Fotiadis S, Gurasashvili J, Halls R, Hartridge P, Kallon D, Kassam J, Lancoma-Malcolm I, Matharu M, May P, Mitchelmore O, Newman T, Patel M, Pheby J, Pinzuti I, Prime Z, Prysyazhna O, Shiel J, Taylor M, Tierney C, Wood S, Zak A, Zongo O, Forsey M, Kaliappan A, Nicholson A, Riches J, Vertue M, Wasson C, Finn S, Green J, Collins E, King B, Grauslyte L, Hussain M, Phull M, Pogreban T, Rosaroso L, Salciute E, Franke G, Wong J, George A, Akeroyd L, Bano S, Bromley M, Gurr L, Lawton T, Morgan J, Sellick K, Warren D, Wilkinson B, McGowan J, Ledgard C, Stacey A, Pye K, Bellwood R, Bentley M, Hobrok M, Loosley R, McGuinness H, Tench H, Wolf-Roberts R, Gibson S, Lyle A, McNeela F, Radhakrishnan J, Hughes A, Ali A, Brady M, Dale S, Dance A, Gledhill L, Greig J, Hanson K, Holdroyd K, Home M, Kelly D, Kitson R, Matapure L, Melia D, Mellor S, Nortcliffe T, Pinnell J, Robinson M, Shaw L, Shaw R, Thomis L, Wilson A, Wood T, Bayo L-A, Merwaha E, Ishaq T, Hanley S, Antcliffe D, Banach D, Brett S, Coghlan P, Fernandez Z, Gordon A, Rojo R, Arias SS, Templeton M, Jha R, Krishnamurthy V, Lim L, Bi R, Scholefield B, Ashton L, Williams A, Cheyne C, Saunderson A, Allan A, Anderson F, Kaye C, Liew J, Medhora J, Scott T, Trumper E, Botello A, Polgarova P, Stroud K, Meaney E, Jones M, Ng A, Agrawal S, Pathan N, White D, Daubney E, Elston K, Parker R, Reddy A, Turner-Bone I, Wilding L, Harding P, Jacob R, Jones C, Denmade C, Croft M, White I, Lim L, Griffin D, Muchenje N, Mupudzi M, Partridge R, Conyngham J-A, Thomas R, Wright M, Corral MA, Bastion V, Clarke D, David B, Kent H, Lorusso R, Lubimbi G, Murdoch S, Penacerrada M, Thomas A, Valentine J, Vochin A, Wulandari R, Djeugam B, Dawson J, Garrioch S, Tolson M, Aldridge J, de Almeida Martins LG, Carungcong J, Beavis S, Dale K, Gascoyne R, Hawes J, Pritchard K, Stevenson L, Whileman A, Cowley A, Highgate J, Crawley R, Crew A, Cunningham M, Daniels A, Harrison L, Hope S, Inweregbu K, Jones S, Lancaster N, Matthews J, Nicholson A, Wray G, Benham L, Bradshaw Z, Brown J, Caswell M, Cupitt J, Melling S, Preston S, Slawson N, Stoddard E, Warden S, Combes E, Joefield T, Monnery S, Beech V, Trotman S, Hopkins B, Scriven J, Thrasyvoulou L, Willis H, Anderson S, Birch J, Collins E, Hammerton K, O’Leary R, Abernathy C, Foster L, Gratrix A, Martinson V, Parkinson P, Stones E, Carbral-Ortega L, Kapoor R, Loader D, Castle K, Brandwood C, Smith L, Clark R, Birchall K, Kolakaluri L, Baines D, Sukumaran A, Mapfunde I, Meredith M, Morris L, Ryan L, Clark A, Sampson J, Peters C, Dent M, Langley M, Ashraf S, Wei S, Andrew A, Chablani M, Kirkby A, Netherton K, Bates M, Dasgin J, Gill J, Nilsson A, Scriven J, Apetri E, Basikolo C, Blackledge B, Catlow L, Charles B, Dark P, Doonan R, Harris J, Harvey A, Horner D, Knowles K, Lee S, Lomas D, Lyons C, Marsden T, McLaughlan D, McMorrow L, Pendlebury J, Perez J, Poulaka M, Proudfoot N, Slaughter M, Slevin K, Taylor M, Thomas V, Walker D, Michael A, Collis M, Clark M, Coulding M, Jude E, McCormick J, Mercer O, Potla D, Rehman H, Savill H, Turner V, Davey M, Golden D, Seaman R, Hunt J, Dearden J, Dobson E, Mulcahy M, Munt S, O’Connor G, Philbin J, Rishton C, Tully R, Winnard S, Cagova L, Fofano A, Garner L, Holcombe H, Mepham S, Mitchell AM, Mwaura L, Praman K, Vuylsteke A, Zamikula J, Bercades G, Brealey D, Hass I, MacCallum N, Martir G, Raith E, Reyes A, Smyth D, Taylor A, Hughes RA, Thomas H, Rees A, Duskova M, Phipps J, Brooks S, Edwards M, Alexander P, Allen S, Bradley-Potts J, Brantwood C, Egan J, Felton T, Padden G, Ward L, Moss S, Glasgow S, Beesley K, Board S, Kubisz-Pudelko A, Lewis A, Perry J, Pippard L, Wood D, Buckley C, Brown A, Gregory J, O’Connell S, Smith T, Belagodu Z, Fuller B, Gherman A, Olufuwa O, Paramsothy R, Stuart C, Oakley N, Kamundi C, Tyl D, Collins K, Silva P, Taylor J, King L, Coates C, Crowley M, Wakefield P, Beadle J, Johnson L, Sargeant J, Anderson M, Jardine C, Williams D, Parris V, Quaid S, Watson E, Melville J, Naisbitt J, Joseph R, Lazo M, Walton O, Neal A, Hill M, Kannan T, Wild L, Allan E, Darlington K, Davies F, Easton J, Kumar S, Lean R, Menzies D, Pugh R, Qiu X, Davies L, Williams H, Scanlon J, Davies G, Mackay C, Lewis J, Rees S, Coetzee S, Gales A, Otahal I, Raj M, Sell C, Langton H, Prout R, Watters M, Novis C, Arbane G, Bociek A, Campos S, Grau N, Jones TO, Lim R, Marotti M, Ostermann M, Shankar-Hari M, Whitton C, Barron A, Collins C, Kaul S, Passmore H, Prendergast C, Reed A, Rogers P, Shokkar R, Woodruff M, Middleton H, Polgar O, Nolan C, Thwaites V, Mahay K, Sri-Chandana C, Scherewode J, Stephenson L, Marsh S, Bancroft H, Bellamy M, Carmody M, Daglish J, Moore F, Rhodes J, Sangombe M, Kadiri S, Scriven J, Ayers A, Harrison W, North J, Cavazza A, Cockrell M, Corcoran E, Depante M, Finney C, Jerome E, McPhail M, Nayak M, Noble H, O’Reilly K, Pappa E, Saha R, Saha S, Smith J, Knighton A, Gill M, Paul P, Ratnam V, Shelton S, Wynter I, Baptista D, Crowe R, Fernandes R, Herdman-Grant R, Joseph A, Loveridge A, McKenley I, Morino E, Naranjo A, Simms R, Sollesta K, Swain A, Venkatesh H, Khera J, Fox J, Barber R, Hewitt C, Hilldrith A, Jackson-Lawrence K, Shepardson S, Wills M, Butler S, Tavares S, Cunningham A, Hindale J, Arif S, George L, Twiss S, Wright D, Holland M, Keenan N, Lyons M, Wassall H, Marsh C, Mahenthran M, Carter E, Kong T, Adanini O, Bhatia N, Msiska M, Mew L, Mwaura E, Stewart R, Williams F, Wren L, Sutherland S-B, Battle C, Brinkworth E, Harford R, Murphy C, Newey L, Rees T, Williams M, Arnold S, Brealey D, Hardy J, Houlden H, Moncur E, Raith E, Tariq A, Tucci A, Convery K, Fottrell-Gould D, Hudig L, Keshet-Price J, Randell G, Stammers K, Abdelrazik M, Bakthavatsalam D, Elhassan M, Ganesan A, Haldeos A, Moreno-Cuesta J, Purohit D, Vincent R, Xavier K, Rohit K, Alasdair F, Saleem M, David C, Jenkins S, Lamond Z, Wall A, Yates B, Reynolds J, Campbell H, Thompsom M, Dodds S, Duffy S, Butcher D, O’Sullivan S, Butterworth-Cowin N, Deacon B, Hibbert M, Pothecary C, Tetla D, Woodford C, Durga L, Kennard-Holden G, de Gordoa LO-R, Peasgood E, Phillips C, Skinner D, Gaylard J, Mullan D, Newman J, Davies E, Roche L, Sathe S, Brimfield L, Daly Z, Pogson D, Rose S, Collins A, Khaliq W, Gude ET, Allen L, Beranova E, Crisp N, Deery J, Hazelton T, Knight A, Price C, Tilbey S, Turki S, Turney S, Giles J, Booth S, Bell G, English K, Katary A, Wilcox L, Campbell R, Clarke N, Whiteside J, Mascarenhas M, Donaldson A, Matheson J, Barrett F, O’Hara M, O’Keefe L, Bradley C, Collier D, Hormis A, Walker R, Maynard V, Patel T, Smith M, Chukkambotla S, Kazi A, Hartley J, Dykes J, Hijazi M, Keith S, Khan M, Ryan-Smith J, Springle P, Thomas J, Truman N, Saad S, Coleman D, Fine C, Matt R, Gay B, Dalziel J, Ali S, Goodchild D, Harling R, Bhatterjee R, Goddard W, Davison C, Duberly S, Hargreaves J, Bolton R, Laha S, Verlander M, Williams A, Blackman H, Creagh-Brown B, Donlon S, Michalak-Glinska N, Mtuwa S, Pristopan V, Salberg A, Smith E, Stone S, Piercy C, Verula J, Burda D, Montaser R, Harden L, Mayangao I, Marriott C, Bradley P, Harris C, Cooper J, Finch C, Liderth S, Quinn A, Waddington N, Fidler K, Tagliavini E, Donnelly K, Abel L, Brett M, Digby B, Gemmell L, Hornsby J, MacGoey P, O’Neil P, Price R, Rodden N, Rooney K, Sundaram R, Thomson N, Flanagan R, Hughes G, Latham S, McKenna E, Anderson J, Hull R, Rhead K, Branney D, Frankham J, Pitts S, White N, Cristiano D, Dormand N, Farzad Z, Gummadi M, Liyanage K, Patel BV, Salmi S, Sloane G, Thwaites V, Varghese M, Zborowski AC, Bean S, Burt K, Spivey M, Eastgate-Jackson C, Filipe H, Martin D, Maharajh A, Garcia SM, De Neef M, Deacon B, Lynch C, Pothecary C, Roche L, Howe GS, Singh J, Turner K, Ellis H, Stroud N, Cherian S, Cutler S, Heron AE, Roynon-Reed A, Szakmany T, Williams G, Richards O, Cheema Y, Ahmad N, Barker J, Bauchmuller K, Bird S, Cawthron K, Harrington K, Jackson Y, Kibutu F, Lenagh B, Masuko S, Mills GH, Raithatha A, Wiles M, Willson J, Newell H, Lye A, Nwafor L, Jarman C, Rowland-Jones S, Foote D, Cole J, Thompson R, Watson J, Hesseldon L, Macharia I, Chetam L, Smith J, Ford A, Anderson S, Birchall K, Housley K, Walker S, Milner L, Hanratty H, Trower H, Phillips P, Oxspring S, Donne B, Bevan E, Martin J, Trodd D, Watson G, Brown CW, Bunni L, Jennings C, Latif M, Marshall R, Subramanian G, Bandla N, Gellamucho M, Davies M, Thompson C, Trim F, Eapen B, Ahmed C, Baines B, Clamp S, Colley J, Haq R, Hayes A, Hulme J, Hussain S, Joseph S, Kumar R, Maqsood Z, Purewal M, Chandler B, Elliott K, Mallinson J, Turnbull A, Dent K, Horsley E, Akhtar MN, Pearson S, Potoczna D, Spencer S, Blakemore H, Borislavova B, Faulkner B, Gendall E, Goff E, Hayes K, Thomas M, Worner R, Smith K, Stephens D, Delgado CC, Dawson D, Ding L, Durrant G, Ezeobu O, Farnell-Ward S, Harrison A, Kanu R, Leaver S, Maccacari E, Manna S, Saluzzio RP, Queiroz J, Samakomva T, Sicat C, Texeira J, Da Gloria EF, Lisboa A, Rawlins J, Mathew J, Kinch A, Hurt WJ, Shah N, Clark V, Thanasi M, Yun N, Patel K, Crickmore V, Debreceni G, Wilkins J, Nicol L, Burn I, Hambrook G, Manso K, Penn R, Shanmugasundaram P, Tebbutt J, Thornton D, Rostron A, Roy A, Woods L, Cornell S, Wakinshaw F, Rogerson K, Jarmain J, Anderson P, Archer K, Austin K, Davis C, Durie A, Kelsall O, Thrush J, Vigurs C, Wild L, Wood H-L, Tranter H, Harrison A, Cowley N, McAlindon M, Burtenshaw A, Digby S, Low E, Morgan A, Cother N, Rankin T, Clayton S, McCurdy A, Allibone S, Mary-Genetu R, Kasipandian V, Patel A, Mac A, Murphy A, Mahjoob P, Nazari R, Worsley L, Fagan A, Mohamed Ali IA, Beaumont K, Blunt M, Coton Z, Curgenven H, Elsaadany M, Fernandes K, Ally SM, Rangarajan H, Sarathy V, Selvanayagam S, Vedage D, White M, Fernandez-Roman J, Hamilton DO, Johnson E, Johnston B, Martinez ML, Mulla S, Shaw D, Waite AAC, Waugh V, Welters ID, Williams K, Bemand T, Black E, Rosa AD, Howle R, Jhanji S, Baikady RR, Tatham KC, Thomas B, Halkes M, Mercer P, Thornton L, West J, Baird T, Ruddy J, Reece-Anthony R, Birt M, Cowton A, Kay A, Kent M, Potts K, Wilkinson A, Naylor S, Brown E, Clark M, Purvis S, Cole J, Davies M, Davies R, Duffin D, Hill H, Player B, Thomas E, Williams A, Beith CM, Black K, Clements S, Morrison A, Strachan D, Taylor M, Clarkson M, D’Sylva S, Norman K, Coventry T, Fowler S, MacMahon M, McGregor A, Brady A, Chan R, Little J, McIvor S, Prady H, Whittle H, Mathew B, Clapham M, Harper R, Poultney U, Rice P, Smith T, Mutch R, Baird Y, Butler A, Chadbourn I, Folkes L, Fox H, Gardner A, Gomez R, Hobden G, Hodgson L, King K, Margarson M, Martindale T, Meadows E, Raynard D, Thirlwall Y, Helm D, Margalef J, Greer S, Shuker K, Tridente A, Smuts S, Duffield J, Smith O, Mallon L, Claire W, Birkinshaw I, Carter J, Howard K, Ingham J, Joy R, Pearson H, Roche S, Scott Z, Knights E, Price A, Thomas A, Thorpe C, Abraheem A, Bamford P, Cawley K, Dunmore C, Faulkner M, Girach R, Jeffrey H, Jones R, London E, Nagra I, Nasir F, Sainsbury H, Smedley C, Khade R, Sundar A, Tsinaslanidis G, Behan T, Burnett C, Hatton J, Heeney E, Mitra A, Newton M, Pollard R, Stead R, Birch J, Bough L, Goodsell J, Tutton R, Williams P, Williams S, Winter-Goodwin B, Auld F, Donnachie J, Edmond I, Prentice L, Runciman N, Salutous D, Symon L, Todd A, Turner P, Short A, Sweeney L, Murdoch E, Senaratne D, Burns K, Higham A, Anderson T, Hawcutt D, O’Malley L, Rad L, Rogers N, Saunderson P, Allison KS, Afolabi D, Whitbread J, Jones D, Dore R, Lankester L, Nikitas N, Wells C, Stowe B, Spencer K, Cathcart S, Duffy K, Puxty A, Puxty K, Turner L, Ireland J, Semple G, Barry P, Hilltout P, Evitts J, Tyler A, Waldron J, Irvine V, Shelley B, Akinkugbe O, Bamford A, Beech E, Belfield H, Bell M, Davies C, Jones GAL, McHugh T, Meghari H, O’Neill L, Peters MJ, Ray S, Tomas AL, Easthope A, Gorman C, Gupta A, Timlick E, Brady R, Bonner S, Hugill K, Jones J, Liggett S, Bashyal A, Davidson N, Hutton P, McKechnie S, Wilson J, Flint N, Rekha P, Hales D, Cruz C, Pattison N, Gopal S, Harris N, Lake V, Metherell S, Radford E, Clement I, Patel B, Gulati A, Hays C, Webster K, Hudson A, Webster A, Stephenson E, McCormack L, Slater V, Nixon R, Hanson H, Fearby M, Kelly S, Bridgett V, Robinson P, Almaden-Boyle C, Austin P, Cabrelli L, Cole S, Casey M, Chapman S, Whyte C, Brayne A, Fisher E, Hunt J, Jackson P, Kaye D, Love N, Parkin J, Tuckey V, van Koutrik L, Carter S, Andrew B, Findlay L, Adams K, Bruce M, Connolly K, Duncan T, T.-Michael H, Lindergard G, Hey S, Fox C, Alfonso J, Durrans LJ, Guerin J, Blackledge B, Harris J, Hruska M, Eltayeb A, Lamb T, Hodgkiss T, Cooper L, Rothwell J, Dennis C, McGregor A, Parris V, Srikaran S, Sukha A, Davies K, O’Brien L, Omar Z, Otahal I, Perkins E, Lewis T, Sutherland I, Brooke H, Buckley S, Suarez JC, Charlesworth R, Hansson K, Norris J, Poole A, Rose A, Sandhu R, Sloan B, Smithson E, Thirumaran M, Wagstaff V, Metcalfe A, Camsooksai J, Humphrey C, Jenkins S, Reschreiter H, Wadams B, DeAth Y, Adams C, Agasou A, Arden T, Bowes A, Boyle P, Beekes M, Button H, Capps N, Carnahan M, Carter A, Childs D, Donaldson D, Hard K, Hurford F, Hussain Y, Javaid A, Jones J, Jose S, Leigh M, Martin T, Millward H, Motherwell N, Rikunenko R, Stickley J, Summers J, Ting L, Tivenan H, Tonks L, Wilcox R, Bokhari M, Linnett V, Lucas R, McCormick W, Ritzema J, Sanderson A, Wild H, Baxter N, Henderson S, Kennedy-Hay S, McParland C, Rooney L, Sim M, McCreath G, Brunton M, Caterson J, Coles H, Frise M, Rai SG, Jacques N, Keating L, Tilney E, Bartley S, Bhuie P, Downes C, Holding K, Riches K, Hilton M, Hayman M, Subramanian D, Daniel P, Zitter L, Benyon S, Marriott S, Park L, Keenan S, Gordon E, Quinn H, Baines K, Andrew G, Baillie JK, Barclay L, Callaghan M, Campbell R, Clark S, Hope D, Marshall L, McCulloch C, Briton K, Singleton J, Birch S, Higham A, Simpson K, Craig J, Demetriou C, Eckbad C, Hierons S, Howie L, Mitchard S, Ramos L, Serrano-Ruiz A, White K, Kelly F, Amin V, Anastasescu E, Anumakonda V, Karthik K, Kausar R, Reid K, Smith J, Imeson-Wood J, Bellini A, Bryant J, Mayer A, Pickard A, Roe N, Sowter J, Howlett A, Criste K, Cusack R, Golder K, Golding H, Jones O, Leggett S, Male M, Marani M, Prager K, Williams T, Roberts B, Salmon K, Gondo P, Hadebe B, Kayani A, Masunda B, Ahmed A, Morris A, Jakkula S, Long K, Whiteley S, Wilby E, Ogg B, Moultrie S, Odam M, Bewley J, Garland Z, Grimmer L, Gumbrill B, Johnson R, Sweet K, Webster D, Efford G, Bennett S, Goodwin E, Jackson M, Kent A, Tibke C, Woodyatt W, Zaki A, Daniel A, Finn J, Saha R, Staines N, Easthope A, Bremmer P, Allan J, Geary T, Houston G, Meikle A, O’Brien P, Bell D, Boyle R, Douglas K, Glass L, Lee E, Lennon L, Rattray A, Charnock R, McFarland D, Cosgrove D, Attwood B, Parsons P, Carmody S, Oblak M, Popescu M, Thankachen M, Baruah R, Morris S, Ferguson S, Shepherd A, Altabaibeh A, Alvaro A, Gilbert K, Ma L, Mostoles L, Parmar C, Simpson K, Jetha C, Booker L, Pratley A, Cosier T, Millen G, Richardson N, Schumacher N, Weston H, Rand J, Alex B, Bach B, Barclay WS, Bogaert D, Chand M, Cooke GS, Docherty AB, Dunning J, da Silva Filipe A, Fletcher T, Green CA, Harrison EM, Hiscox JA, Ijaz S, Khoo S, Klenerman P, Lim WS, Mentzer AJ, Merson L, Noursadeghi M, Moore SC, Palmarini M, Paxton WA, Pollakis G, Price N, Rambaut A, Robertson DL, Russell CD, Sancho-Shimizu V, Scott JT, de Silva T, Sigfrid L, Solomon T, Sriskandan S, Stuart D, Tedder RS, Thomson EC, Roger Thompson AA, Thwaites RS, Turtle LCW, Gupta RK, Palmieri C, Swann OV, Zambon M, Dumas M-E, Griffin JL, Takats Z, Chechi K, Andrikopoulos P, Osagie A, Olanipekun M, Liggi S, Lewis MR, Correia GdS, Sands CJ, Takis P, Maslen L, Greenhalf W, Shaw V, McDonald SE, Keating S, Ahmed KA, Armstrong JA, Ashworth M, Asiimwe IG, Bakshi S, Barlow SL, Booth L, Brennan B, Bullock K, Catterall BWA, Clark JJ, Clarke EA, Cooper L, Cox H, Davis C, Dincarslan O, Dunn C, Dyer P, Elliott A, Evans A, Finch L, Fisher LWS, Foster T, Garcia-Dorival I, Greenhalf W, Gunning P, Hartley C, Jensen RL, Jones CB, Jones TR, Khandaker S, King K, Kiy RT, Koukorava C, Lake A, Lant S, Latawiec D, Lavelle-Langham L, Lefteri D, Lett L, Livoti LA, Mancini M, McDonald S, McEvoy L, McLauchlan J, Metelmann S, Miah NS, Middleton J, Mitchell J, Moore SC, Murphy EG, Penrice-Randal R, Pilgrim J, Prince T, Reynolds W, Ridley PM, Sales D, Shaw VE, Shears RK, Small B, Subramaniam KS, Szemiel A, Taggart A, Tanianis-Hughes J, Thomas J, Trochu E, van Tonder L, Wilcock E, Zhang JE, Flaherty L, Maziere N, Cass E, Carracedo AD, Carlucci N, Holmes A, Massey H, Murphy L, Wrobel N, McCafferty S, Morrice K, MacLean A, Armstrong R, Boz C, Brown A, Clark R, Coutts A, Cullum L, Day N, Donnelly L, Duncan E, Fawkes A, Finernan P, Gilchrist T, Golightly A, Hafezi K, Law D, Law R, Law S, Macgillivray L, Maclean A, Mal H, McCafferty S, McMaster E, Meikle J, Moore SC, Morrice K, Murphy L, Oosthuyzen W, Paterson T, Stenhouse A, Swets M, Szoor-McElhinney H, Taneski F, Wackett T, Ward M, Weaver J, Wrobel N, Coyle J, Gallagher B, Lidstone-Scott R, Hamilton D, Schon K, Furlong A, Biggs H, Griffiths F, Andrews E, Brickell K, Smyth M, Murphy L, Carson G, Hardwick H, Donohue C (2021) Mapping the human genetic architecture of COVID-19. Nature 600: 472-477 (ARCN) https://doi.org/10.1038/s41586-021-03767-x https://www.nature.com/articles/s41586-021-03767-x.pdf

Nemani SSP, Vermeulen CJ, Pech M, Faiz A, Oliver BGG, van den Berge M, Burgess JK, Kopp MV, Weckmann M (2021) COL4A3 expression in asthmatic epithelium depends on intronic methylation and ZNF263 binding. ERJ Open Res 7 (ARCN) https://doi.org/10.1183/23120541.00802-2020 https://openres.ersjournals.com/content/erjor/7/2/00802-2020.full.pdf

Nakagawa K, Nadal E, Garon EB, Nishio M, Seto T, Yamamoto N, Park K, Shih J-Y, Paz-Ares L, Frimodt-Moller B, Zimmermann AH, Wijayawardana S, Visseren-Grul C, Reck M (2021) RELAY Subgroup Analyses by EGFR Ex19del and Ex21L858R Mutations for Ramucirumab Plus Erlotinib in Metastatic Non-small Cell Lung Cancer. Clinical Cancer Research: clincanres.0273.2021 (ARCN) https://doi.org/10.1158/1078-0432.Ccr-21-0273 https://clincancerres.aacrjournals.org/content/clincanres/early/2021/07/21/1078-0432.CCR-21-0273.full.pdf

Nadal E, Horinouchi H, Shih J-Y, Nakagawa K, Reck M, Garon EB, Wei Y-F, Kollmeier J, Frimodt-Moller B, Barrett E, Lipkovich O, Visseren-Grul C, Novello S (2021) RELAY, Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients with Untreated, Epidermal Growth Factor Receptor Mutation-Positive, Metastatic Non-Small-Cell Lung Cancer: Safety Profile and Manageability. Drug Saf (ARCN) https://doi.org/10.1007/s40264-021-01127-2 https://link.springer.com/content/pdf/10.1007/s40264-021-01127-2.pdf

Münter M, Pieper M, Kohlfaerber T, Bodenstorfer E, Ahrens M, Winter C, Huber R, König P, Hüttmann G, Schulz-Hildebrandt H (2021) Microscopic optical coherence tomography (mOCT) at 600 kHz for 4D volumetric imaging and dynamic contrast. Biomedical Optics Express 12: 6024 (ARCN) https://doi.org/10.1364/boe.425001 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547980/pdf/boe-12-10-6024.pdf

Mountzios G, Samantas E, Senghas K, Zervas E, Krisam J, Samitas K, Bozorgmehr F, Kuon J, Agelaki S, Baka S, Athanasiadis I, Gaissmaier L, Elshiaty M, Daniello L, Christopoulou A, Pentheroudakis G, Lianos E, Linardou H, Kriegsmann K, Kosmidis P, El Shafie R, Kriegsmann M, Psyrri A, Andreadis C, Fountzilas E, Heussel CP, Herth FJ, Winter H, Emmanouilides C, Oikonomopoulos G, Meister M, Muley T, Bischoff H, Saridaki Z, Razis E, Perdikouri EI, Stenzinger A, Boukovinas I, Reck M, Syrigos K, Thomas M, Christopoulos P (2021) Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancer. ESMO Open 6: 100254 (ARCN) https://doi.org/10.1016/j.esmoop.2021.100254 https://www.esmoopen.com/article/S2059-7029(21)00216-7/pdf

Morgensztern D, Dols MC, Ponce Aix S, Postmus PE, Bennouna J, Fischer JR, Juan-Vidal O, Stewart DJ, Ardizzoni A, Bhore R, Wolfsteiner M, Reck M, Talbot D, Govindan R, Ong TJ (2021) nab-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+). Front Oncol 10 (ARCN) https://doi.org/10.3389/fonc.2020.569715 https://www.frontiersin.org/article/10.3389/fonc.2020.569715

https://fjfsdata01prod.blob.core.windows.net/articles/files/569715/pubmed-zip/.versions/2/.package-entries/fonc-10-569715-r1/fonc-10-569715.pdf?sv=2018-03-28&sr=b&sig=GWgxOCQ%2F5WOIr5h4frkzS4hV%2B%2Fw8RTQcjOFqv540Q8Y%3D&se=2021-03-02T15%3A21%3A47Z&sp=r&rscd=attachment%3B%20filename%2A%3DUTF-8%27%27fonc-10-569715.pdf

Mikus MS, Kolmert J, Andersson LI, Östling J, Knowles RG, Gómez C, Ericsson M, Thörngren J-O, Khoonsari PE, Dahlén B, Kupczyk M, De Meulder B, Auffray C, Bakke PS, Beghe B, Bel EH, Caruso M, Chanez P, Chawes B, Fowler SJ, Gaga M, Geiser T, Gjomarkaj M, Horváth I, Howarth PH, Johnston SL, Joos G, Krug N, Montuschi P, Musial J, Niżankowska-Mogilnicka E, Olsson HK, Papi A, Rabe KF, Sandström T, Shaw DE, Siafakas NM, Uhlen M, Riley JH, Bates S, Middelveld RJM, Wheelock CE, Chung KF, Adcock IM, Sterk PJ, Djukanovic R, Nilsson P, Dahlén S-E, James A (2021) Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation. Eur Respir J: 2100142 (ARCN, BREATH) https://doi.org/10.1183/13993003.00142-2021 https://erj.ersjournals.com/content/erj/early/2021/07/01/13993003.00142-2021.full.pdf

Mayerhofer B, Jörres RA, Lutter JI, Waschki B, Kauffmann-Guerrero D, Alter P, Trudzinski FC, Herth FJF, Holle R, Behr J, Bals R, Welte T, Watz H, Vogelmeier CF, Kahnert K (2021) Deterioration and Mortality Risk of COPD Patients Not Fitting into Standard GOLD Categories: Results of the COSYCONET Cohort. Respiration: 1-10 (ARCN, BREATH, CPC-M, TLRC, UGMLC) https://doi.org/10.1159/000513010 https://www.karger.com/Article/Abstract/513010

Marwitz S, Ballesteros-Merino C, Jensen SM, Reck M, Kugler C, Perner S, Drömann D, Goldmann T, Fox BA (2021) Phosphorylation of SMAD3 in immune cells predicts survival of patients with early stage non-small cell lung cancer. J Immunother Cancer 9 (ARCN) https://doi.org/10.1136/jitc-2020-001469 https://jitc.bmj.com/content/jitc/9/2/e001469.full.pdf

Martinez FJ, Rabe KF, Ferguson GT, Wedzicha JA, Trivedi R, Jenkins M, Darken P, Aurivillius M, Dorinsky P (2021) Benefits of budesonide/glycopyrrolate/formoterol fumarate (BGF) on symptoms and quality of life in patients with COPD in the ETHOS trial. Respir Med 185: 106509 (ARCN) https://doi.org/10.1016/j.rmed.2021.106509 https://www.resmedjournal.com/article/S0954-6111(21)00215-8/fulltext

Martinez FJ, Agusti A, Celli BR, Han MK, Allinson J, Bhatt SP, Calverley P, Chotirmall SH, Chowdhury B, Darken P, Da Silva CA, Donaldson G, Dorinsky P, Dransfield M, Faner R, Halpin DM, Jones P, Krishnan JA, Locantore N, Martinez FD, Mullerova H, Price D, Rabe KF, Reisner C, Singh D, Vestbo J, Vogelmeier CF, Wise RA, Tal-Singer R, Wedzicha JA (2021) Treatment Trials in Young Patients with COPD and Pre-COPD Patients: Time to Move Forward. American Journal of Respiratory and Critical Care Medicine (ARCN, UGMLC) https://doi.org/10.1164/rccm.202107-1663SO

Maqhuzu PN, Kreuter M, Bahmer T, Kahn N, Claussen M, Holle R, Schwarzkopf L (2021) Cost drivers in the pharmacological treatment of interstitial lung disease. Respir Res 22: 218 (ARCN, CPC-M, TLRC) https://doi.org/10.1186/s12931-021-01807-8 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335870/pdf/12931_2021_Article_1807.pdf

Mansfield AS, Herbst RS, de Castro G, Hui R, Peled N, Kim D-W, Novello S, Satouchi M, Wu Y-L, Garon EB, Reck M, Robinson AG, Samkari A, Piperdi B, Ebiana V, Lin J, Mok TSK (2021) Outcomes With Pembrolizumab Monotherapy in Patients With Programmed Death-Ligand 1–Positive NSCLC With Brain Metastases: Pooled Analysis of KEYNOTE-001, 010, 024, and 042. JTO Clinical and Research Reports 2: 100205 (ARCN) https://doi.org/10.1016/j.jtocrr.2021.100205 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474394/pdf/main.pdf

Malin JJ, Spinner CD, Janssens U, Welte T, Weber-Carstens S, Schälte G, Gastmeier P, Langer F, Wepler M, Westhoff M, Pfeifer M, Rabe KF, Hoffmann F, Böttiger BW, Weinmann-Menke J, Kersten A, Berlit P, Krawczyk M, Nehls W, Fichtner F, Laudi S, Stegemann M, Skoetz N, Nothacker M, Marx G, Karagiannidis C, Kluge S (2021) Correction to: Key summary of German national treatment guidance for hospitalized COVID19 patients. Infection: 1-2 (ARCN, BREATH) https://doi.org/10.1007/s15010-021-01665-y https://link.springer.com/content/pdf/10.1007/s15010-021-01665-y.pdf

Malin JJ, Spinner CD, Janssens U, Welte T, Weber-Carstens S, Schälte G, Gastmeier P, Langer F, Wepler M, Westhoff M, Pfeifer M, Rabe KF, Hoffmann F, Böttiger BW, Weinmann-Menke J, Kersten A, Berlit P, Krawczyk M, Nehls W, Fichtner F, Laudi S, Stegemann M, Skoetz N, Nothacker M, Marx G, Karagiannidis C, Kluge S (2021) Key summary of German national treatment guidance for hospitalized COVID-19 patients Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021). Infection: 1-14 (ARCN, BREATH) https://doi.org/10.1007/s15010-021-01645-2 https://link.springer.com/content/pdf/10.1007/s15010-021-01645-2.pdf

Malik M, Kunze A-C, Bahmer T, Herget-Rosenthal S, Kunze T (2021) SARS-CoV-2: Viral Loads of Exhaled Breath and Oronasopharyngeal Specimens in Hospitalized Patients with COVID-19. Int J Infect Dis 110: 105-110 (ARCN) https://doi.org/10.1016/j.ijid.2021.07.012 https://www.ijidonline.com/article/S1201-9712(21)00567-1/pdf

Maison N, Herbrüggen H, Schaub B, Schauberger C, Foth S, Grychtol R, Abdo M, Watz H, Nikolaizik W, Rabe KF, Kopp MV, Hansen G, von Mutius E, Bahmer T, Omony J (2021) Impact of imposed social isolation and use of face masks on asthma course and mental health in pediatric and adult patients with recurrent wheeze and asthma. Allergy Asthma Clin Immunol 17: 93 (ARCN, BREATH, CPC-M, UGMLC) https://doi.org/10.1186/s13223-021-00592-9 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444172/pdf/13223_2021_Article_592.pdf

Mahler DA, Ludwig-Sengpiel A, Ferguson GT, de la Hoz A, Ritz J, Shaikh A, Watz H (2021) TRONARTO: A Randomized, Placebo-Controlled Study of Tiotropium/Olodaterol Delivered via Soft Mist Inhaler in COPD Patients Stratified by Peak Inspiratory Flow. Int J Chron Obstruct Pulmon Dis Volume 16: 2455-2465 (ARCN) https://doi.org/10.2147/copd.S324467 https://www.dovepress.com/getfile.php?fileID=73084

Magnussen H, Lucas S, Lapperre T, Quint JK, Dandurand RJ, Roche N, Papi A, Price D, Miravitlles M (2021) Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study. Respir Res 22: 25 ((ARCN)) https://doi.org/10.1186/s12931-021-01615-0 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818945/pdf/12931_2021_Article_1615.pdf

Ma A, Zhang L, Ye X, Chen J, Yu J, Zhuang L, Weng C, Petersen F, Wang Z, Yu X (2021) High Levels of Circulating IL-8 and Soluble IL-2R Are Associated With Prolonged Illness in Patients With Severe COVID-19. Front Immunol 12: 626235 (ARCN) https://doi.org/10.3389/fimmu.2021.626235 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878368/pdf/fimmu-12-626235.pdf

Lutter JI, Jörres RA, Trudzinski FC, Alter P, Kellerer C, Watz H, Welte T, Bals R, Kauffmann-Guerrero D, Behr J, Holle R, Vogelmeier CF, Kahnert K (2021) Treatment of COPD Groups GOLD A and B with Inhaled Corticosteroids in the COSYCONET Cohort – Determinants and Consequences. Int J Chron Obstruct Pulmon Dis Volume 16: 987-998 (ARCN, BREATH, CPC-M, TLRC, UGMLC) https://doi.org/10.2147/copd.S304532 https://www.dovepress.com/front_end/cr_data/cache/pdf/download_1619430664_60868d086055b/copd-304532-treatment-of-copd-groups-gold-a-and-b-with-inhaled-corticost.pdf

Lunding LP, Skouras DB, Vock C, Dinarello CA, Wegmann M (2021) The NLRP3 Inflammasome Inhibitor, OLT1177®, Ameliorates Experimental Allergic Asthma in Mice. Allergy (ARCN) https://doi.org/10.1111/all.15164 https://onlinelibrary.wiley.com/doi/10.1111/all.15164

Lunding LP, Krause D, Stichtenoth G, Stamme C, Lauterbach N, Hegermann J, Ochs M, Schuster B, Sedlacek R, Saftig P, Schwudke D, Wegmann M, Damme M (2021) LAMP3 deficiency affects surfactant homeostasis in mice. PLoS Genet 17: e1009619 (ARCN, BREATH) https://doi.org/10.1371/journal.pgen.1009619

López-Cervantes JP, Lønnebotn M, Jogi NO, Calciano L, Kuiper IN, Darby MG, Dharmage SC, Gómez-Real F, Hammer B, Bertelsen RJ, Johannessen A, Würtz AML, Mørkve Knudsen T, Koplin J, Pape K, Skulstad SM, Timm S, Tjalvin G, Krauss-Etschmann S, Accordini S, Schlünssen V, Kirkeleit J, Svanes C (2021) The Exposome Approach in Allergies and Lung Diseases: Is It Time to Define a Preconception Exposome? International Journal of Environmental Research and Public Health 18: 12684 (ARCN) https://doi.org/10.3390/ijerph182312684 https://mdpi-res.com/d_attachment/ijerph/ijerph-18-12684/article_deploy/ijerph-18-12684.pdf

Liu SV, Reck M, Mansfield AS, Mok T, Scherpereel A, Reinmuth N, Garassino MC, De Castro Carpeno J, Califano R, Nishio M, Orlandi F, Alatorre-Alexander J, Leal T, Cheng Y, Lee J-S, Lam S, McCleland M, Deng Y, Phan S, Horn L (2021) Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133). J Clin Oncol: JCO.20.01055 (ARCN, CPC-M) https://doi.org/10.1200/jco.20.01055

Li C, Duda KA, Elverdal PL, Skovsted IC, Kjeldsen C, Teze D, Duus JØ (2021) Structural, biosynthetic and serological cross-reactive elucidation of capsular polysaccharides from Streptococcus pneumoniae serogroup 28. Carbohydrate Polymers 254: 117323 (ARCN) https://doi.org/10.1016/j.carbpol.2020.117323 https://www.sciencedirect.com/science/article/abs/pii/S014486172031496X?via%3Dihub

Le X, Nilsson M, Goldman J, Reck M, Nakagawa K, Kato T, Ares LP, Frimodt-Moller B, Wolff K, Visseren-Grul C, Heymach JV, Garon EB (2021) Dual EGFR-VEGF Pathway Inhibition: A Promising Strategy for Patients With EGFR-Mutant NSCLC. J Thorac Oncol 16: 205-215 (ARCN) https://doi.org/10.1016/j.jtho.2020.10.006 https://www.jto.org/article/S1556-0864(20)30814-5/pdf

Lazzari C, Mirabile A, Bulotta A, Viganó MG, Ogliari FR, Ippati S, DellOca I, Santarpia M, Lorusso V, Reck M, Gregorc V (2021) History of Extensive Disease Small Cell Lung Cancer Treatment: Time to Raise the Bar? A Review of the Literature. Cancers (Basel) 13: 998 (ARCN) https://doi.org/10.3390/cancers13050998 https://res.mdpi.com/d_attachment/cancers/cancers-13-00998/article_deploy/cancers-13-00998-v2.pdf

Kutschera A, Schombel U, Schwudke D, Ranf S, Gisch N (2021) Analysis of the Structure and Biosynthesis of the Lipopolysaccharide Core Oligosaccharide of Pseudomonas syringae pv. tomato DC3000. Int J Mol Sci 22: 3250 (ARCN) https://doi.org/10.3390/ijms22063250 https://res.mdpi.com/d_attachment/ijms/ijms-22-03250/article_deploy/ijms-22-03250-v2.pdf

Kümpers C, Tharun L, Stellmacher F, Greinert U, May K, Perner S (2021) IgG4-assoziierte Lungenerkrankung mit granulomatösen Läsionen. Der Pathologe ((ARCN)) https://doi.org/10.1007/s00292-020-00904-7 https://link.springer.com/article/10.1007%2Fs00292-020-00904-7

Kuempers C, Jagomast T, Krupar R, Paulsen F-O, Heidel C, Ribbat-Idel J, Idel C, Märkl B, Anlauf M, Berezowska S, Tiemann M, Bösmüller H, Fend F, Kalsdorf B, Bohnet S, Dreyer E, Sailer V, Kirfel J, Perner S (2021) Delta-Like Protein 3 Expression in Paired Chemonaive and Chemorelapsed Small Cell Lung Cancer Samples. Frontiers in Medicine 8: 734901 (ARCN) https://doi.org/10.3389/fmed.2021.734901 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531433/pdf/fmed-08-734901.pdf

Krupar R, Kümpers C, Haenel A, Perner S, Stellmacher F (2021) Kryptogen organisierende Pneumonie versus sekundäre organisierende Pneumonie. Der Pathologe: 1-9 ((ARCN)) https://doi.org/10.1007/s00292-020-00903-8 https://link.springer.com/content/pdf/10.1007/s00292-020-00903-8.pdf

Kraft M, Dölle-Bierke S, Renaudin J-M, Ruëff F, Hofmeier KS, Treudler R, Pföhler C, Hawranek T, Poziomkowska-Gęsicka I, Jappe U, Christoff G, Müller S, Fernandez-Rivas M, García BE, De Vicente Jiménez TM, Cardona V, Kleinheinz A, Kreft B, Bauer A, Wagner N, Wedi B, Wenzel M, Bilò MB, Worm M (2021) Wheat anaphylaxis in adults differs from reactions to other types of food. The Journal of Allergy and Clinical Immunology: In Practice (ARCN) https://doi.org/10.1016/j.jaip.2021.03.037 https://www.sciencedirect.com/science/article/abs/pii/S2213219821003822?via%3Dihub

König C, Honecker B, Wilson IW, Weedall GD, Hall N, Roeder T, Metwally NG, Bruchhaus I (2021) Taxon-Specific Proteins of the Pathogenic Entamoeba Species E. histolytica and E. nuttalli. Frontiers in Cellular and Infection Microbiology 11: 641472 (ARCN) https://doi.org/10.3389/fcimb.2021.641472 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017271/pdf/fcimb-11-641472.pdf

Köfeler HC, Eichmann TO, Ahrends R, Bowden JA, Danne-Rasche N, Dennis EA, Fedorova M, Griffiths WJ, Han X, Hartler J, Holčapek M, Jirásko R, Koelmel JP, Ejsing CS, Liebisch G, Ni Z, O’Donnell VB, Quehenberger O, Schwudke D, Shevchenko A, Wakelam MJO, Wenk MR, Wolrab D, Ekroos K (2021) Quality control requirements for the correct annotation of lipidomics data. Nature Communications 12: 4771 (ARCN) https://doi.org/10.1038/s41467-021-24984-y https://www.nature.com/articles/s41467-021-24984-y.pdf

Koczulla AR, Ankermann T, Behrends U, Berlit P, Böing S, Brinkmann F, Franke C, Glöckl R, Gogoll C, Hummel T, Kronsbein J, Maibaum T, Peters EMJ, Pfeifer M, Platz T, Pletz M, Pongratz G, Powitz F, Rabe KF, Scheibenbogen C, Stallmach A, Stegbauer M, Wagner HO, Waller C, Wirtz H, Zeiher A, Zwick RH (2021) S1-Leitlinie Post-COVID/Long-COVID. Pneumologie (ARCN, UGMLC) https://doi.org/10.1055/a-1551-9734 https://www.thieme-connect.de/products/ejournals/abstract/10.1055/a-1551-9734

Kirfel J, Kümpers CC, Fähnrich A, Heidel C, Jokic M, Vlasic I, Marwitz S, Goldmann T, Pasternack H, Bohnet S, Jonigk D, Kühnel MP, Offermann A, Busch H, Perner S (2021) PD-L1 Dependent Immunogenic Landscape in Hot Lung Adenocarcinomas Identified by Transcriptome Analysis. Cancers (Basel) 13: 4562 (ARCN, BREATH) https://doi.org/10.3390/cancers13184562 https://mdpi-res.com/d_attachment/cancers/cancers-13-04562/article_deploy/cancers-13-04562-v3.pdf

Kirchner M, Kluck K, Brandt R, Volckmar AL, Penzel R, Kazdal D, Endris V, Neumann O, Seker-Cin H, Goldschmid H, Glade J, Allgäuer M, Kriegsmann M, Winter H, Muley T, Perner S, Frost N, Reck M, Fröhling S, Schirmacher P, Thomas M, Budczies J, Christopoulos P, Stenzinger A (2021) The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinoma. ESMO Open 6: 100253 (ARCN, TLRC) https://doi.org/10.1016/j.esmoop.2021.100253 https://www.esmoopen.com/article/S2059-7029(21)00214-3/pdf

Kellerer C, Kahnert K, Trudzinski FC, Lutter J, Berschneider K, Speicher T, Watz H, Bals R, Welte T, Vogelmeier CF, Jörres RA, Alter P (2021) COPD maintenance medication is linked to left atrial size: Results from the COSYCONET cohort. Respir Med 185: 106461 (ARCN, BREATH, CPC-M, TLRC, UGMLC) https://doi.org/10.1016/j.rmed.2021.106461 https://www.resmedjournal.com/article/S0954-6111(21)00167-0/pdf

Kellerer C, Jörres RA, Schneider A, Alter P, Kauczor H-U, Jobst B, Biederer J, Bals R, Watz H, Behr J, Kauffmann-Guerrero D, Lutter J, Hapfelmeier A, Magnussen H, Trudzinski FC, Welte T, Vogelmeier CF, Kahnert K (2021) Prediction of lung emphysema in COPD by spirometry and clinical symptoms: results from COSYCONET. Respir Res 22: 242 (ARCN, BREATH, CPC-M, TLRC, UGMLC) https://doi.org/10.1186/s12931-021-01837-2 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427948/pdf/12931_2021_Article_1837.pdf

Kazdal D, Rempel E, Oliveira C, Allgäuer M, Harms A, Singer K, Kohlwes E, Ormanns S, Fink L, Kriegsmann J, Leichsenring M, Kriegsmann K, Stögbauer F, Tavernar L, Leichsenring J, Volckmar A-L, Longuespée R, Winter H, Eichhorn M, Heußel CP, Herth F, Christopoulos P, Reck M, Muley T, Weichert W, Budczies J, Thomas M, Peters S, Warth A, Schirmacher P, Stenzinger A, Kriegsmann M (2021) Conventional and semi-automatic histopathological analysis of tumor cell content for multigene sequencing of lung adenocarcinoma. Translational Lung Cancer Research 10: 1666-1678 (ARCN, TLRC) https://doi.org/10.21037/tlcr-20-1168 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107748/pdf/tlcr-10-04-1666.pdf

Kammerl IE, Flexeder C, Karrasch S, Thorand B, Heier M, Peters A, Schulz H, Meiners S (2021) Blood Immunoproteasome Activity Is Regulated by Sex, Age and in Chronic Inflammatory Diseases: A First Population-Based Study. Cells 10: 3336 (ARCN, CPC-M) https://doi.org/10.3390/cells10123336

Kahnert K, Lutter JI, Welte T, Alter P, Behr J, Herth F, Kauczor H-U, Söhler S, Pfeifer M, Watz H, Vogelmeier CF, Bals R, Jörres RA, Trudzinski FC (2021) Impact of the COVID-19 pandemic on the behaviour and health status of patients with COPD: results from the German COPD cohort COSYCONET. ERJ Open Research 7: 00242-02021 (ARCN, BREATH, CPC-M, TLRC, UMGLC) https://doi.org/10.1183/23120541.00242-2021 https://openres.ersjournals.com/content/erjor/7/3/00242-2021.full.pdf

Kahnert K, Jörres RA, Lucke T, Trudzinski FC, Mertsch P, Bickert C, Ficker JH, Behr J, Bals R, Watz H, Welte T, Vogelmeier CF, Alter P (2021) Lower Prevalence of Osteoporosis in Patients with COPD Taking Anti-Inflammatory Compounds for the Treatment of Diabetes: Results from COSYCONET. Int J Chron Obstruct Pulmon Dis Volume 16: 3189-3199 (ARCN, BREATH, CPC-M, TLRC, UGMLC) https://doi.org/10.2147/copd.S335029 https://www.dovepress.com/getfile.php?fileID=76113

Jappe U, Karstedt A, Warneke D, Hellmig S, Böttger M, Riffelmann FW, Treudler R, Lange L, Abraham S, Dölle-Bierke S, Worm M, Wagner N, Ruëff F, Reese G, Knulst AC, Becker W-M (2021) Identification and Purification of Novel Low-Molecular-Weight Lupine Allergens as Components for Personalized Diagnostics. Nutrients 13: 409 (ARCN) https://doi.org/10.3390/nu13020409 https://res.mdpi.com/d_attachment/nutrients/nutrients-13-00409/article_deploy/nutrients-13-00409.pdf

Jappe U, Beckert H, Bergmann K-C, Gülsen A, Klimek L, Philipp S, Pickert J, Rauber-Ellinghaus MM, Renz H, Taube C, Treudler R, Wagenmann M, Werfel T, Worm M, Zuberbier T (2021) Biologics for atopic diseases: Indication, side effect management, and new developments. Allergologie select 5: 1-25 (ARCN, UGMLC) https://doi.org/10.5414/alx02197e

Jankrift N, Kellerer C, Magnussen H, Nowak D, Jörres RA, Schneider A (2021) The role of clinical signs and spirometry in the diagnosis of obstructive airway diseases: a systematic analysis adapted to general practice settings. J Thorac Dis 13: 3369-3382 ((ARCN), CPC-M) https://doi.org/10.21037/jtd-20-3539 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264721/pdf/jtd-13-06-3369.pdf

Jakwerth CA, Chaker AM, Guerth F, Oelsner M, Pechtold L, zur Bonsen LS, Ullmann JT, Krauss‐Etschmann S, Erb A, Kau J, Plaschke M, Winkler M, Kurz A, Kloss A, Esser‐von Bieren J, Schmidt‐Weber CB, Zissler UM (2021) Sputum microRNA‐screening reveals Prostaglandin EP3 receptor as selective target in allergen‐specific immunotherapy. Clin Exp Allergy (ARCN, CPC-M) https://doi.org/10.1111/cea.14013 https://onlinelibrary.wiley.com/doi/10.1111/cea.14013

Jacobsen H, Walendy-Gnirß K, Tekin-Bubenheim N, Kouassi NM, Ben-Batalla I, Berenbrok N, Wolff M, dos Reis VP, Zickler M, Scholl L, Gries A, Jania H, Kloetgen A, Düsedau A, Pilnitz-Stolze G, Jeridi A, Yildirim AÖ, Fuchs H, Gailus-Durner V, Stoeger C, de Angelis MH, Manuylova T, Klingel K, Culley FJ, Behrends J, Loges S, Schneider B, Krauss-Etschmann S, Openshaw P, Gabriel G (2021) Offspring born to influenza A virus infected pregnant mice have increased susceptibility to viral and bacterial infections in early life. Nature Communications 12: 4957 (ARCN, CPC-M) https://doi.org/10.1038/s41467-021-25220-3 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8368105/pdf/41467_2021_Article_25220.pdf

Jäckle S, Lange A, García‐Vázquez V, Eixmann T, Matysiak F, Sieren MM, Horn M, Schulz‐Hildebrandt H, Hüttmann G, Ernst F, Heldmann S, Pätz T, Preusser T (2021) Instrument Localization for Endovascular Aneurysm Repair – Comparison of two methods based on Tracking Systems or using Imaging. The International Journal of Medical Robotics and Computer Assisted Surgery: e2327 (ARCN) https://doi.org/10.1002/rcs.2327 https://onlinelibrary.wiley.com/doi/10.1002/rcs.2327

Jabbour SK, Lee KH, Frost N, Breder V, Kowalski DM, Pollock T, Levchenko E, Reguart N, Martinez-Marti A, Houghton B, Paoli J-B, Safina S, Park K, Komiya T, Sanford A, Boolell V, Liu H, Samkari A, Keller SM, Reck M (2021) Pembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non–Small Cell Lung Cancer. JAMA Oncology 7: 1351 (ARCN) https://doi.org/10.1001/jamaoncol.2021.2301 https://jamanetwork.com/journals/jamaoncology/articlepdf/2780855/jamaoncology_jabbour_2021_oi_210037_1623084652.92292.pdf

Jabbour SK, Lee KH, Frost N, Breder V, Kowalski D, Alawin I, Levchenko E, Reguart N, Martinez-Marti A, Houghton B, Paoli JB, Safina S, Park K, Komiya T, Sanford A, Boolell V, Liu H, Samkari A, Keller S, Reck M (2021) Pembrolizumab Plus Platinum Chemotherapy and Radiotherapy for Unresectable, Locally Advanced, Stage 3 NSCLC: KEYNOTE-799. International Journal of Radiation Oncology*Biology*Physics 111: S9-S10 (ARCN) https://doi.org/10.1016/j.ijrobp.2021.07.054 https://www.redjournal.org/article/S0360-3016(21)00924-X/pdf

Jabbour SK, Cho BC, Bria E, Kato T, Bhosle J, Gainor JF, Reguart N, Wang L, Morgensztern D, Gurary EB, Ashraf TB, Lara-Guerra H, Reck M (2021) KEYLYNK-012: A Phase 3 Study of Pembrolizumab With Concurrent Chemoradiation Therapy (CCRT) Followed by Pembrolizumab With or Without Olaparib vs. CCRT Followed by Durvalumab in Unresectable, Locally Advanced, Stage III Non‒Small-Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics 111: e440-e441 (ARCN) https://doi.org/10.1016/j.ijrobp.2021.07.1246 https://www.redjournal.org/article/S0360-3016(21)02116-7/pdf

Horn L, Wang Z, Wu G, Poddubskaya E, Mok T, Reck M, Wakelee H, Chiappori AA, Lee DH, Breder V, Orlov S, Cicin I, Cheng Y, Liu Y, Fan Y, Whisenant JG, Zhou Y, Oertel V, Harrow K, Liang C, Mao L, Selvaggi G, Wu Y-L (2021) Ensartinib vs Crizotinib for Patients With Anaplastic Lymphoma Kinase−Positive Non–Small Cell Lung Cancer. JAMA Oncology (ARCN) https://doi.org/10.1001/jamaoncol.2021.3523 https://jamanetwork.com/journals/jamaoncology/articlepdf/2783490/jamaoncology_horn_2021_oi_210053_1629480185.83888.pdf

Horn A, Krist L, Lieb W, Montellano FA, Kohls M, Haas K, Gelbrich G, Bolay-Gehrig SJ, Morbach C, Reese JP, Störk S, Fricke J, Zoller T, Schmidt S, Triller P, Kretzler L, Rönnefarth M, Von Kalle C, Willich SN, Kurth F, Steinbeis F, Witzenrath M, Bahmer T, Hermes A, Krawczak M, Reinke L, Maetzler C, Franzenburg J, Enderle J, Flinspach A, Vehreschild J, Schons M, Illig T, Anton G, Ungethüm K, Finkenberg BC, Gehrig MT, Savaskan N, Heuschmann PU, Keil T, Schreiber S (2021) Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP). Infection (ARCN, BREATH) https://doi.org/10.1007/s15010-021-01707-5 https://link.springer.com/content/pdf/10.1007/s15010-021-01707-5.pdf

Holz O, Waschki B, Watz H, Kirsten A, Abdo M, Pedersen F, Weckmann M, Fuchs O, Dittrich A-M, Hansen G, Kopp MV, von Mutius E, Rabe KF, Hohlfeld JM, Bahmer T (2021) Breath volatile organic compounds and inflammatory markers in adult asthma patients: negative results from the ALLIANCE cohort. Eur Respir J 57: 2002127 (ARCN, BREATH, CPC-M) https://doi.org/10.1183/13993003.02127-2020 https://erj.ersjournals.com/content/erj/early/2020/09/09/13993003.02127-2020.full.pdf

Hinke CF, Jörres RA, Alter P, Bals R, Bornitz F, Kreuter M, Herth FJF, Kahnert K, Kellerer C, Watz H, Budweiser S, Trudzinski FC (2021) Prognostic Value of Oxygenated Hemoglobin Assessed during Acute Exacerbations of Chronic Pulmonary Disease. Respiration: 1-8 (ARCN, CPC-M, TLRC) https://doi.org/10.1159/000513440 https://www.karger.com/Article/Abstract/513440

Heymach JV, Mitsudomi T, Harpole D, Aperghis M, Jones S, Mann H, Fouad TM, Reck M (2021) Design and Rationale for a Phase III, Double-Blind, Placebo-Controlled Study of Neoadjuvant Durvalumab + Chemotherapy Followed by Adjuvant Durvalumab for the Treatment of Patients With Resectable Stages II and III non-small-cell Lung Cancer: The AEGEAN Trial. Clin Lung Cancer (ARCN) https://doi.org/10.1016/j.cllc.2021.09.010 https://www.clinical-lung-cancer.com/article/S1525-7304(21)00265-5/pdf

Heyckendorf J, Reimann M, Marwitz S, Lange C, Avsar K, DiNardo AR, Günther G, Hoelscher M, Ibraim E, Kalsdorf B, Kaufmann SHE, Kontsevaya I, van Leth F, Mandalakas AM, Maurer F, Müller M, Nitschkowski D, Olaru ID, Popa C, Rachow A, Rolling T, Rybniker J, Salzer HJF, Sanchez-Carballo P, Schuhmann M, Schaub D, Spinu V, Suárez I, Terhalle E, Unnewehr M, Weiner J, Goldmann T (2021) Pathogen-free diagnosis of tuberculosis. The Lancet Infectious Diseases 21: 1066 (ARCN) https://doi.org/10.1016/s1473-3099(21)00337-6 https://www.sciencedirect.com/science/article/abs/pii/S1473309921003376?via%3Dihub

Heyckendorf J, Marwitz S, Reimann M, Avsar K, DiNardo A, Günther G, Hoelscher M, Ibraim E, Kalsdorf B, Kaufmann SHE, Kontsevaya I, van Leth F, Mandalakas AM, Maurer FP, Müller M, Nitschkowski D, Olaru ID, Popa C, Rachow A, Rolling T, Rybniker J, Salzer HJF, Sanchez-Carballo P, Schuhmann M, Schaub D, Spinu V, Suárez I, Terhalle E, Unnewehr M, Weiner J, Goldmann T, Lange C (2021) Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model. Eur Respir J: 2003492 (ARCN) https://doi.org/10.1183/13993003.03492-2020 https://erj.ersjournals.com/content/early/2021/01/28/13993003.03492-2020

Herkenrath SD, Dreher M, Gompelmann D, Held M, Koczulla AR, Köhnlein T, Rohde G, Wälscher J, Watz H, Randerath WJ (2021) Technical Innovations in Pneumology: E-Health, Screening, Diagnostics, and Therapy. Respiration: 1-7 (ARCN, UGMLC) https://doi.org/10.1159/000516335 https://www.karger.com/Article/Abstract/516335

Heine H, Adanitsch F, Peternelj TT, Haegman M, Kasper C, Ittig S, Beyaert R, Jerala R, Zamyatina A (2021) Tailored Modulation of Cellular Pro-inflammatory Responses With Disaccharide Lipid A Mimetics. Front Immunol 12: 631797 (ARCN) https://doi.org/10.3389/fimmu.2021.631797 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012497/pdf/fimmu-12-631797.pdf

Harbaum L, Hennigs JK, Simon M, Oqueka T, Watz H, Klose H (2021) Genetic evidence for a causative effect of airflow obstruction on left ventricular filling: a Mendelian randomisation study. Respir Res 22: 199 (ARCN) https://doi.org/10.1186/s12931-021-01795-9 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261939/pdf/12931_2021_Article_1795.pdf

Hammer B, Kadalayil L, Boateng E, Buschmann D, Rezwan FI, Wolff M, Reuter S, Bartel S, Knudsen TM, Svanes C, Holloway JW, Krauss-Etschmann S (2021) Preconceptional smoking alters spermatozoal miRNAs of murine fathers and affects offspring’s body weight. International Journal of Obesity 45: 1623-1627 (ARCN) https://doi.org/10.1038/s41366-021-00798-2 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236406/pdf/41366_2021_Article_798.pdf

Gülsen A, Ruëff F, Jappe U (2021) Omalizumab ensures compatibility to bee venom immunotherapy (VIT) after VIT-induced anaphylaxis in a patient with systemic mastocytosis. Allergologie select 5: 128-132 (ARCN) https://doi.org/10.5414/alx02196e

Gülsen A, König IR, Jappe U, Drömann D (2021) Effect of comorbid pulmonary disease on the severity of COVID‐19: A systematic review and meta‐analysis. Respirology (ARCN) https://doi.org/10.1111/resp.14049 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/resp.14049?download=true

Griesinger F, Eberhardt W, Nusch A, Reiser M, Zahn M-O, Maintz C, Bernhardt C, Losem C, Stenzinger A, Heukamp LC, Büttner R, Marschner N, Jänicke M, Fleitz A, Spring L, Sahlmann J, Karatas A, Hipper A, Weichert W, Heilmann M, Sadjadian P, Gleiber W, Grah C, Waller CF, Reck M, Rittmeyer A, Christopoulos P, Sebastian M, Thomas M (2021) Corrigendum to “Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP registry (AIO-TRK-0315)” [Lung Cancer 152 (2021) 174–184]. Lung Cancer 157: 167 (ARCN, TLRC ) https://doi.org/10.1016/j.lungcan.2021.05.005 https://www.lungcancerjournal.info/article/S0169-5002(21)00173-2/pdf

Goldmann T, Schmitt B, Müller J, Kröger M, Scheufele S, Marwitz S, Nitschkowski D, Schneider MA, Meister M, Muley T, Thomas M, Kugler C, Rabe KF, Siebert R, Reck M, Ammerpohl O (2021) DNA methylation profiles of bronchoscopic biopsies for the diagnosis of lung cancer. Clin Epigenetics 13: 38 (ARCN, TLRC) https://doi.org/10.1186/s13148-021-01024-6 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890863/pdf/13148_2021_Article_1024.pdf

Goldmann T, Marwitz S, Nitschkowski D, Krupar R, Backman M, Elfving H, Thurfjell V, Lindberg A, Brunnström H, La Fleur L, Mezheyeuski A, Mattsson JSM, Botling J, Micke P, Strell C (2021) PD-L1 amplification is associated with an immune cell rich phenotype in squamous cell cancer of the lung. Cancer Immunology, Immunotherapy (ARCN) https://doi.org/10.1007/s00262-020-02825-z https://link.springer.com/content/pdf/10.1007/s00262-020-02825-z.pdf

Glöckner M, Marwitz S, Rohmann K, Watz H, Nitschkowski D, Rupp J, Dalhoff K, Goldmann T, Drömann D (2021) Haemophilus influenzae causes cellular trans-differentiation in human bronchial epithelia. Innate Immun: 175342592199490 (ARCN) https://doi.org/10.1177/1753425921994906 https://journals.sagepub.com/doi/pdf/10.1177/1753425921994906

Gisch N, Peters K, Thomsen S, Vollmer W, Schwudke D, Denapaite D (2021) Commensal Streptococcus mitis produces two different lipoteichoic acids of type I and type IV. Glycobiology (ARCN) https://doi.org/10.1093/glycob/cwab079 https://academic.oup.com/glycob/advance-article-abstract/doi/10.1093/glycob/cwab079/6328614?redirectedFrom=fulltext

Gandara D, Reck M, Moro-Sibilot D, Mazieres J, Gadgeel S, Morris S, Cardona A, Mendus D, Ballinger M, Rittmeyer A, Peters S (2021) Fast progression in non–small cell lung cancer: results from the randomized phase III OAK study evaluating second-line atezolizumab versus docetaxel. Journal for ImmunoTherapy of Cancer 9: e001882 (ARCN) https://doi.org/10.1136/jitc-2020-001882 https://jitc.bmj.com/content/jitc/9/3/e001882.full.pdf

Frye BC, Gaede KI, Saltini C, Rossman MD, Monos DS, Rosenman KD, Schuler CR, Weston A, Wegner R, Noth R, Zissel G, Schreiber S, Nothnagel M, Müller-Quernheim J (2021) Analysis of single nucleotide polymorphisms in chronic beryllium disease. Respir Res 22: 107 (ARCN) https://doi.org/10.1186/s12931-021-01691-2 https://respiratory-research.biomedcentral.com/track/pdf/10.1186/s12931-021-01691-2.pdf

Freundt K, Herzmann C, Biedziak D, Scheffzük C, Gaede KI, Stamme C (2021) Surfactant protein A enhances the degradation of LPS-induced TLR4 in primary alveolar macrophages involving Rab7, β-arrestin2, and mTORC1. Infection and Immunity: Iai0025021 (ARCN) https://doi.org/10.1128/iai.00250-21 https://journals.asm.org/doi/10.1128/IAI.00250-21

Franzen KF, Meusel M, Engel J, Röcker T, Drömann D, Sayk F (2021) Differential Effects of Angiotensin-II Compared to Phenylephrine on Arterial Stiffness and Hemodynamics: A Placebo-Controlled Study in Healthy Humans. Cells 10: 1108 (ARCN) https://doi.org/10.3390/cells10051108 https://res.mdpi.com/d_attachment/cells/cells-10-01108/article_deploy/cells-10-01108.pdf

Finetti L, Tiedemann L, Zhang X, Civolani S, Bernacchia G, Roeder T (2021) Monoterpenes alter TAR1-driven physiology in Drosophila species. The Journal of Experimental Biology 224: jeb232116 (ARCN) https://doi.org/10.1242/jeb.232116 https://jeb.biologists.org/content/early/2020/11/23/jeb.232116

Finetti L, Roeder T, Calò G, Bernacchia G (2021) The Insect Type 1 Tyramine Receptors: From Structure to Behavior. Insects 12: 315 (ARCN) https://doi.org/10.3390/insects12040315 https://res.mdpi.com/d_attachment/insects/insects-12-00315/article_deploy/insects-12-00315.pdf

Faivre-Finn C, Vicente D, Kurata T, Planchard D, Paz-Ares L, Vansteenkiste JF, Spigel DR, Garassino MC, Reck M, Senan S, Naidoo J, Rimner A, Wu YL, Gray JE, Özgüroğlu M, Lee KH, Cho BC, Kato T, de Wit M, Newton M, Wang L, Thiyagarajah P, Antonia SJ (2021) Brief report: Four-year survival with durvalumab after chemoradiotherapy in Stage III NSCLC – an update from the PACIFIC trial. J Thorac Oncol (ARCN) https://doi.org/10.1016/j.jtho.2020.12.015

Elmas H, Diel R, Önal B, Sauter G, Stellmacher F, Welker L (2021) Recommendations for immunocytochemistry in lung cancer typing: An update on the resource‐efficient approach with large‐scale comparative Bayesian analysis. Cytopathology (ARCN) https://doi.org/10.1111/cyt.13051 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cyt.13051?download=true

Ellrichmann M, Bethge J, Boesenkoetter J, Conrad C, Noth R, Bahmer T, Nikolaus S, Aden K, Zeissig S, Schreiber S (2021) Subclinical pulmonary involvement in active IBD responds to biological therapy. Journal of Crohn’s and Colitis (ARCN) https://doi.org/10.1093/ecco-jcc/jjab024

El-Merhie N, Krüger A, Uliczka K, Papenmeier S, Roeder T, Rabe KF, Wagner C, Angstmann H, Krauss-Etschmann S (2021) Sex dependent effect of maternal e-nicotine on F1 Drosophila development and airways. Sci Rep 11: 4441 (ARCN) https://doi.org/10.1038/s41598-021-81607-8 https://doi.org/10.1038/s41598-021-81607-8

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904947/pdf/41598_2021_Article_81607.pdf

Du X, Larsen J, Li M, Walter A, Slavetinsky C, Both A, Sanchez Carballo PM, Stegger M, Lehmann E, Liu Y, Liu J, Slavetinsky J, Duda KA, Krismer B, Heilbronner S, Weidenmaier C, Mayer C, Rohde H, Winstel V, Peschel A (2021) Staphylococcus epidermidis clones express Staphylococcus aureus-type wall teichoic acid to shift from a commensal to pathogen lifestyle. Nature Microbiology 6: 757-768 (ARCN) https://doi.org/10.1038/s41564-021-00913-z https://www.nature.com/articles/s41564-021-00913-z

Dingemans AC, Früh M, Ardizzoni A, Besse B, Faivre-Finn C, Hendriks LE, Lantuejoul S, Peters S, Reguart N, Rudin CM, De Ruysscher D, Van Schil PE, Vansteenkiste J, Reck M (2021) Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up(†). Ann Oncol (ARCN) https://doi.org/10.1016/j.annonc.2021.03.207

Diel R, Sotgiu G, Andres S, Hillemann D, Maurer FP (2021) Cost of multidrug resistant tuberculosis in Germany—An update. Int J Infect Dis 103: 102-109 (ARCN) https://doi.org/10.1016/j.ijid.2020.10.084

Diel R, Schaberg T, Nienhaus A, Otto-Knapp R, Kneitz C, Krause A, Fabri M, Mrowietz U, Bauer T, Häcker B (2021) Joint Statement (DZK, DGRh, DDG) on the Tuberculosis Risk with Treatment Using Novel Non-TNF-Alpha Biologicals. Pneumologie (ARCN) https://doi.org/10.1055/a-1294-1580 https://www.thieme-connect.de/products/ejournals/abstract/10.1055/a-1294-1580

Diel R, Nienhaus A (2021) Point-of-care COVID-19 antigen testing in German emergency rooms – a cost-benefit analysis. Pulmonology (ARCN) https://doi.org/10.1016/j.pulmoe.2021.06.009

Diel R, Hittel N, Nienhaus A (2021) Point-of-Care COVID-19 Antigen Testing in Exposed German Healthcare Workers—A Cost Model. International Journal of Environmental Research and Public Health 18: 10767 (ARCN) https://doi.org/10.3390/ijerph182010767 https://mdpi-res.com/d_attachment/ijerph/ijerph-18-10767/article_deploy/ijerph-18-10767.pdf

Dempke WCM, Reck M (2021) KEAP1/NRF2 (NFE2L2) mutations in NSCLC – Fuel for a superresistant phenotype? Lung Cancer 159: 10-17 (ARCN) https://doi.org/10.1016/j.lungcan.2021.07.006 https://www.lungcancerjournal.info/article/S0169-5002(21)00469-4/fulltext

Demeyer H, Mohan D, Burtin C, Vaes A, Heasley M, Bowler R, Casaburi R, Cooper CB, Corriol-Rohou S, Frei A, Hamilton A, Hopkinson NS, Karlsson N, Man WDC, Moy ML, Pitta F, Polkey MI, Puhan M, Rennard SI, Rochester CL, Rossiter HB, Sciurba F, Singh S, Tal-Singer R, Vogiatzis I, Watz H, Lummel RV, Wyatt J, Merrill DD, Spruit MA, Garcia-Aymerich J, Troosters T (2021) Objectively Measured Physical Activity in Patients with COPD: Recommendations from an International Task Force on Physical Activity. Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation (ARCN) https://doi.org/10.15326/jcopdf.2021.0213

Delgado-Eckert E, James A, Meier-Girard D, Kupczyk M, Andersson LI, Bossios A, Mikus M, Ono J, Izuhara K, Middelveld R, Dahlén B, Gaga M, Siafakas NM, Papi A, Beghe B, Joos G, Rabe KF, Sterk PJ, Bel EH, Johnston SL, Chanez P, Gjomarkaj M, Howarth PH, Niżankowska-Mogilnicka E, Dahlén S-E, Frey U (2021) Lung function fluctuation patterns unveil asthma and COPD phenotypes unrelated to type 2 inflammation. Journal of Allergy and Clinical Immunology 148: 407-419 (ARCN) https://doi.org/10.1016/j.jaci.2020.12.652 https://www.jacionline.org/article/S0091-6749(21)00162-7/fulltext

Dalton JP, Takaki KK, Roca FJ, Schramm G, Wilbers RHP, Ittiprasert W, Brindley PJ, Rinaldi G, Berriman M, Ramakrishnan L, Pagán AJ (2021) Tumor Necrosis Factor and Schistosoma mansoni egg antigen omega-1 shape distinct aspects of the early egg-induced granulomatous response. PLoS Negl Trop Dis 15: e0008814 ((ARCN)) https://doi.org/10.1371/journal.pntd.0008814

Crapo J, Gupta A, Lynch DA, Vogel-Claussen J, Watz H, Turner AM, Mroz RM, Janssens W, Ludwig-Sengpiel A, Beck M, Langellier B, Ittrich C, Risse F, Diefenbach C (2021) FOOTPRINTS study protocol: rationale and methodology of a 3-year longitudinal observational study to phenotype patients with COPD. BMJ Open 11: e042526 (ARCN, BREATH) https://doi.org/10.1136/bmjopen-2020-042526 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986686/pdf/bmjopen-2020-042526.pdf

Clauder A-K, Kordowski A, Bartsch YC, Köhl G, Lilienthal G-M, Almeida LN, Lindemann T, Petry J, Rau CN, Gramalla-Schmitz A, Dühring L, Elbracht C, Kenno S, Tillmann J, Wuhrer M, Ludwig RJ, Ibrahim SM, Bieber K, Köhl J, Ehlers M, Manz RA (2021) IgG Fc N-Glycosylation Translates MHCII Haplotype into Autoimmune Skin Disease. J Invest Dermatol 141: 285-294 (ARCN) https://doi.org/10.1016/j.jid.2020.06.022 https://www.jidonline.org/article/S0022-202X(20)31832-7/pdf

Chapman KR, Watz H, Singh D, Hohlfeld JM, Diamant Z, Jones I, Tillmann H-C, Nikolaev I (2021) Lung Function Normalisation with Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate in Patients with Asthma. Clin Drug Investig (ARCN, BREATH) https://doi.org/10.1007/s40261-021-01033-6 https://link.springer.com/content/pdf/10.1007/s40261-021-01033-6.pdf

Catar R, Herse-Naether M, Zhu N, Wagner P, Wischnewski O, Kusch A, Kamhieh-Milz J, Eisenreich A, Rauch U, Hegner B, Heidecke H, Kill A, Riemekasten G, Kleinau G, Scheerer P, Dragun D, Philippe A (2021) Autoantibodies Targeting AT1- and ETA-Receptors Link Endothelial Proliferation and Coagulation via Ets-1 Transcription Factor. Int J Mol Sci 23: 244 ((ARCN)) https://doi.org/10.3390/ijms23010244 https://mdpi-res.com/d_attachment/ijms/ijms-23-00244/article_deploy/ijms-23-00244.pdf

Busse WW, Kraft M, Rabe KF, Deniz Y, Rowe PJ, Ruddy M, Castro M (2021) Understanding the key issues in the treatment of uncontrolled persistent asthma with type 2 inflammation. Eur Respir J 58: 2003393 (ARCN) https://doi.org/10.1183/13993003.03393-2020 https://erj.ersjournals.com/content/erj/58/2/2003393.full.pdf

Busse WW, Kraft M, Rabe KF, Deniz Y, Rowe P, Ruddy M, Castro M (2021) Understanding the key issues in the treatment of uncontrolled persistent asthma with type 2 inflammation. Eur Respir J: 2003393 (ARCN) https://doi.org/10.1183/13993003.03393-2020 https://erj.ersjournals.com/content/erj/early/2021/01/08/13993003.03393-2020.full.pdf

Burtin C, Mohan D, Troosters T, Watz H, Hopkinson NS, Garcia-Aymerich J, Moy ML, Vogiatzis I, Rossiter HB, Singh S, Merrill DD, Hamilton A, Rennard SI, Fageras M, Petruzzelli S, Tal-Singer R, Tomaszewski E, Corriol-Rohou S, Rochester CL, Sciurba FC, Casaburi R, D-C Man W, Van Lummel RC, Cooper CB, Demeyer H, Spruit MA, Vaes A (2021) Objectively measured physical activity as a COPD clinical trial outcome. Chest (ARCN) https://doi.org/10.1016/j.chest.2021.06.044 https://journal.chestnet.org/article/S0012-3692(21)01274-5/pdf

Budczies J, Kirchner M, Kluck K, Kazdal D, Glade J, Allgäuer M, Kriegsmann M, Heußel C-P, Herth FJ, Winter H, Meister M, Muley T, Goldmann T, Fröhling S, Wermke M, Waller CF, Tufman A, Reck M, Peters S, Schirmacher P, Thomas M, Christopoulos P, Stenzinger A (2021) Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma. Cancer Immunology, Immunotherapy (ARCN, CPC-M, TLRC) https://doi.org/10.1007/s00262-021-02981-w

Brueckl WM, Reck M, Rittmeyer A, Kollmeier J, Wesseler C, Wiest GH, Christopoulos P, Stenzinger A, Tufman A, Hoffknecht P, Ulm B, Reich F, Ficker JH, Laack E (2021) Efficacy of docetaxel plus ramucirumab as palliative second-line therapy following first-line chemotherapy plus immune-checkpoint-inhibitor combination treatment in patients with non-small cell lung cancer (NSCLC) UICC stage IV. Translational Lung Cancer Research 10: 3093-3105 (ARCN, CPC-M, TLRC) https://doi.org/10.21037/tlcr-21-197 https://tlcr.amegroups.com/article/viewFile/53632/pdf

Brückl WM, Reck M, Griesinger F, Schäfer H, Kortsik C, Gaska T, Rawluk J, Krüger S, Kokowski K, Budweiser S, Ficker JH, Hoffmann C, Schüler A, Laack E (2021) Afatinib as first-line treatment in patients with EGFR-mutated non-small cell lung cancer in routine clinical practice. Ther Adv Med Oncol 13: 175883592110123 (ARCN) https://doi.org/10.1177/17588359211012361 https://journals.sagepub.com/doi/pdf/10.1177/17588359211012361

Brandenburg J, Marwitz S, Tazoll SC, Waldow F, Kalsdorf B, Vierbuchen T, Scholzen T, Gross A, Goldenbaum S, Hölscher A, Hein M, Linnemann L, Reimann M, Kispert A, Leitges M, Rupp J, Lange C, Niemann S, Behrends J, Goldmann T, Heine H, Schaible UE, Hölscher C, Schwudke D, Reiling N (2021) WNT6/ACC2-induced storage of triacylglycerols in macrophages is exploited by Mycobacterium tuberculosis. J Clin Invest 131 (ARCN) https://doi.org/10.1172/jci141833 https://dm5migu4zj3pb.cloudfront.net/manuscripts/141000/141833/JCI141833.v2.pdf

Boyer M, Şendur MAN, Rodríguez-Abreu D, Park K, Lee DH, Çiçin I, Yumuk PF, Orlandi FJ, Leal TA, Molinier O, Soparattanapaisam N, Langleben A, Califano R, Medgyasszay B, Hsia T-C, Otterson GA, Xu L, Piperdi B, Samkari A, Reck M (2021) Pembrolizumab Plus Ipilimumab or Placebo for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%: Randomized, Double-Blind Phase III KEYNOTE-598 Study. J Clin Oncol: JCO.20.03579 (ARCN) https://doi.org/10.1200/jco.20.03579

Bovermann X, Ricklefs I, Vogelberg C, Klimek L, Kopp MV (2021) Accelerated Dose Escalation with 3 Injections of an Aluminum Hydroxide-Adsorbed Allergoid Preparation of 6 Grasses Is Safe for Children and Adolescents with Moderate to Severe Allergic Rhinitis. International Archives of Allergy and Immunology: 1-11 (ARCN) https://doi.org/10.1159/000512561 https://www.karger.com/Article/Pdf/512561

Biancosino C, van der Linde LIS, Krüger M, Hussam S, Stellmacher F, Welker L (2021) Frozen Section or Intraoperative Cytology: Are We Ready for a Paradigm Shift in Thoracic Surgery? Adv Exp Med Biol (ARCN) https://doi.org/10.1007/5584_2021_696

Beier J, Watz H, Diamant Z, Hohlfeld JM, Singh D, Pinot P, Jones I, Tillmann H-C (2021) Lung function improvements following inhaled indacaterol/glycopyrronium/mometasone furoate are independent of dosing time in asthma patients: a randomised trial. ERJ Open Research 7: 00425-02020 (ARCN, BREATH) https://doi.org/10.1183/23120541.00425-2020 https://openres.ersjournals.com/content/erjor/7/2/00425-2020.full.pdf

Behrends J, Schwager C, Hein M, Scholzen T, Kull S, Jappe U (2021) Innovative robust basophil activation test using a novel gating strategy reliably diagnosing allergy with full automation. Allergy (ARCN) https://doi.org/10.1111/all.14900 https://onlinelibrary.wiley.com/doi/10.1111/all.14900

Bahmer T, Wälscher J, Fisser C, Groth EE, Schreiber T, Koch M, Raspe M (2021) Pneumologischer Nachwuchs in Deutschland. Pneumologie (ARCN) https://doi.org/10.1055/a-1397-6275 https://www.thieme-connect.de/products/ejournals/abstract/10.1055/a-1397-6275

Bahmer T, Krauss‐Etschmann S, Buschmann D, Behrends J, Watz H, Kirsten AM, Pedersen F, Waschki B, Fuchs O, Pfaffl MW, Mutius E, Rabe KF, Hansen G, Kopp MV, König IR, Bartel S (2021) RNA‐seq–based profiling of extracellular vesicles in plasma reveals a potential role of miR‐122‐5p in asthma. Allergy 76: 366-371 (ARCN, BREATH, CPC-M) https://doi.org/10.1111/all.14486 https://onlinelibrary.wiley.com/doi/abs/10.1111/all.14486

Bahmer T (2021) Daily, Once-Weekly, or No Asthma Controller Therapy At All: The Annoying Issue with Disease Remission in Clinical Asthma Trials. American Journal of Respiratory and Critical Care Medicine 203: 273-275 (ARCN) https://doi.org/10.1164/rccm.202008-3161ED https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874318/pdf/rccm.202008-3161ED.pdf

Auth K, Bohnet S, Borck C, Drömann D, Franzen KF (2021) Synonyms and Symptoms of COVID-19 and Individual and Official Actions against the Disease—A Brief Online Survey 6 Months into the Pandemic and on the Threshold of the Second Wave in Germany. International Journal of Environmental Research and Public Health 19: 169 (ARCN) https://doi.org/10.3390/ijerph19010169 https://mdpi-res.com/d_attachment/ijerph/ijerph-19-00169/article_deploy/ijerph-19-00169.pdf

Angeles AK, Christopoulos P, Yuan Z, Bauer S, Janke F, Ogrodnik SJ, Reck M, Schlesner M, Meister M, Schneider MA, Dietz S, Stenzinger A, Thomas M, Sültmann H (2021) Early identification of disease progression in ALK-rearranged lung cancer using circulating tumor DNA analysis. npj Precision Oncology 5: 100 (ARCN, TLRC) https://doi.org/10.1038/s41698-021-00239-3 https://www.nature.com/articles/s41698-021-00239-3.pdf

Alhamdan F, Marsh LM, Pedersen F, Alhamwe BA, Thölken C, Pfefferle PI, Bahmer T, Greulich T, Potaczek DP, Garn H (2021) Differential Regulation of Interferon Signaling Pathways in CD4+ T Cells of the Low Type-2 Obesity-Associated Asthma Phenotype. Int J Mol Sci 22: 10144 (ARCN, UGMLC) https://doi.org/10.3390/ijms221810144 https://mdpi-res.com/d_attachment/ijms/ijms-22-10144/article_deploy/ijms-22-10144-v3.pdf

Adeloye D, Agarwal D, Barnes PJ, Bonay M, van Boven JF, Bryant J, Caramori G, Dockrell D, D’Urzo A, Ekström M, Erhabor G, Esteban C, Greene CM, Hurst J, Juvekar S, Khoo EM, Ko FW, Lipworth B, López-Campos JL, Maddocks M, Mannino DM, Martinez FJ, Martinez-Garcia MA, McNamara RJ, Miravitlles M, Pinnock H, Pooler A, Quint JK, Schwarz P, Slavich GM, Song P, Tai A, Watz H, Wedzicha JA, Williams MC, Campbell H, Sheikh A, Rudan I (2021) Research priorities to address the global burden of chronic obstructive pulmonary disease (COPD) in the next decade. Journal of Global Health 11: 15003 (ARCN) https://doi.org/10.7189/jogh.11.15003 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542376/pdf/jogh-11-15003.pdf

Abdo M, Waschki B, Kirsten A-M, Trinkmann F, Biller H, Herzmann C, von Mutius E, Kopp M, Hansen G, Rabe KF, Bahmer T, Watz H (2021) Persistent Uncontrolled Asthma: Long-Term Impact on Physical Activity and Body Composition. J Asthma Allergy Volume 14: 229-240 (ARCN, BREATH, CPC-M, TLRC) https://doi.org/10.2147/jaa.S299756 https://www.dovepress.com/front_end/cr_data/cache/pdf/download_1616404947_605861d33e570/jaa-299756-persistent-uncontrolled-asthma-long-term-impact-on-physical.pdf

Abdo M, Uddin M, Goldmann T, Marwitz S, Bahmer T, Holz O, Kirsten A-M, Trinkmann F, von Mutius E, Kopp M, Hansen G, Rabe KF, Watz H, Pedersen F (2021) Raised sputum extracellular DNA confers lung function impairment and poor symptom control in an exacerbation-susceptible phenotype of neutrophilic asthma. Respir Res 22: 167 (ARCN, BREATH, CPC-M, TLRC) https://doi.org/10.1186/s12931-021-01759-z https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173872/pdf/12931_2021_Article_1759.pdf

Abdo M, Trinkmann F, Kirsten AM, Pedersen F, Herzmann C, von Mutius E, Kopp MV, Hansen G, Waschki B, Rabe KF, Watz H, Bahmer T (2021) Small Airway Dysfunction Links Asthma Severity with Physical Activity and Symptom Control. J Allergy Clin Immunol Pract (ARCN, BREATH, CPC-M, TLRC) https://doi.org/10.1016/j.jaip.2021.04.035

Abdo M, Trinkmann F, Kirsten AM, Biller H, Pedersen F, Waschki B, Von Mutius E, Kopp M, Hansen G, Rabe KF, Bahmer T, Watz H (2021) The Relevance of Small Airway Dysfunction in Asthma with Nocturnal Symptoms. J Asthma Allergy 14: 897-905 (ARCN, BREATH, CPC-M) https://doi.org/10.2147/jaa.S313572 https://www.dovepress.com/getfile.php?fileID=71646

 

2020

Zazara DE, Wegmann M, Giannou AD, Hierweger AM, Alawi M, Thiele K, Huber S, Pincus M, Muntau AC, Solano ME, Arck PC (2020) A prenatally disrupted airway epithelium orchestrates the fetal origin of asthma in mice. Journal of Allergy and Clinical Immunology 145: 1641-1654 (ARCN) https://doi.org/10.1016/j.jaci.2020.01.050

Zamyatina A, Heine H (2020) Lipopolysaccharide Recognition in the Crossroads of TLR4 and Caspase-4/11 Mediated Inflammatory Pathways. Front Immunol 11: 585146 (ARCN) https://doi.org/10.3389/fimmu.2020.585146 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732686/pdf/fimmu-11-585146.pdf

Yoh K, Atagi S, Reck M, Garon EB, Ponce Aix S, Moro-Sibilot D, Winfree KB, Frimodt-Moller B, Zimmermann A, Visseren-Grul C, Nakagawa K (2020) Patient-reported outcomes in RELAY, a phase 3 trial of ramucirumab plus erlotinib versus placebo plus erlotinib in untreated EGFR-mutated metastatic non-small-cell lung cancer. Curr Med Res Opin 36: 1667-1675 (ARCN) https://doi.org/10.1080/03007995.2020.1808781 https://doi.org/10.1080/03007995.2020.1808781

Yoh K, Atagi S, Reck M, Garon EB, Ponce Aix S, Moro-Sibilot D, Winfree KB, Frimodt-Moller B, Zimmermann A, Visseren-Grul C, Nakagawa K (2020) Patient-reported outcomes in RELAY, a Phase 3 trial of ramucirumab plus erlotinib versus placebo plus erlotinib in untreated EGFR-mutated metastatic NSCLC. Curr Med Res Opin: 1 (ARCN) https://doi.org/10.1080/03007995.2020.1808781 https://www.tandfonline.com/doi/pdf/10.1080/03007995.2020.1808781?needAccess=true

Yin J, Kasper B, Petersen F, Yu X (2020) Association of Cigarette Smoking, COPD, and Lung Cancer With Expression of SARS-CoV-2 Entry Genes in Human Airway Epithelial Cells. Frontiers in Medicine 7 (ARCN) https://doi.org/10.3389/fmed.2020.619453 https://www.frontiersin.org/article/10.3389/fmed.2020.619453

Yao C, Rudnitzki F, He Y, Zhang Z, Hüttmann G, Rahmanzadeh R (2020) Cancer cell‐specific protein delivery by optoporation with laser‐irradiated gold nanorods. Journal of Biophotonics 13 (ARCN) https://doi.org/10.1002/jbio.202000017 https://onlinelibrary.wiley.com/doi/abs/10.1002/jbio.202000017

Worth H, Bock R, Frisch M, Göhl O, Grünig E, Glöckl R, Limbach M, Schultz K, Spielmanns M, Taube K, Teschler S, Watz H (2020) Ambulanter Lungensport und körperliches Training bei Patienten mit Atemwegs- und Lungenkrankheiten. Pneumologie 75: 44-56 (ARCN, TLRC) https://doi.org/10.1055/a-1224-6024 https://www.thieme-connect.de/products/ejournals/abstract/10.1055/a-1224-6024

Worth H, Bock R, Frisch M, Göhl O, Grünig E, Glöckl R, Limbach M, Schultz K, Spielmanns M, Taube K, Teschler S, Watz H (2020) Ambulanter Lungensport und körperliches Training bei Patienten mit Atemwegs- und Lungenkrankheiten. Pneumologie (ARCN, TLRC) https://doi.org/10.1055/a-1310-2400 https://www.thieme-connect.de/products/ejournals/abstract/10.1055/a-1310-2400

Wessels S, Muley T, Christopoulos P, Meister M, Heinzmann-Groth I, Warth A, Herpel E, Hummler S, Klingmüller U, Kuon J, Heussel C-P, Eberhardt R, Herth FJF, Winter H, Bischoff H, Stenzinger A, Reck M, Huber RM, Thomas M, Schneider MA (2020) Comprehensive serial biobanking in advanced NSCLC: feasibility, challenges and perspectives. Translational Lung Cancer Research 9: 1000-1014 (ARCN, CPC-M, TLRC) https://doi.org/10.21037/tlcr-20-137 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481602/pdf/tlcr-09-04-1000.pdf

Weidner J, Bartel S, Kılıç A, Zissler UM, Renz H, Schwarze J, Schmidt‐Weber CB, Maes T, Rebane A, Krauss‐Etschmann S, Rådinger M (2020) Spotlight on microRNAs in allergy and asthma. Allergy n/a (ARCN, CPC-M, UGMLC) https://doi.org/10.1111/all.14646 https://onlinelibrary.wiley.com/doi/abs/10.1111/all.14646

Weckmann MD, Bahmer T, Sandi JM, Ronnow S, Leeming DJ, Karsdal M, Lunding L, Wegmann M, Oliver B, Duhn J, Laumonnier Y, Danov O, Sewald K, Zissler U, Jonker M, Konig I, Hansen G, von Mutius E, Fuchs O, Dittrich A, Schaub B, Happle C, Rabe KF, Berge MV, Burgess JK, Kopp MV (2020) COL4A3 Degradation Is Increased in Severe, Type 2 Exacerbating Asthmatics. American Journal of Respiratory and Critical Care Medicine 201 (ARCN, BREATH, CPC-M) <Go to ISI>://WOS:000556622801584

Weckmann MD, Bahmer T, Sand JM, Ronnow S, Leeming DJ, Karsdal M, Lunding L, Wegmann M, Oliver B, Ulrich-Merzenich G, Juergens UR, Zissler U, Jonker M, Konig I, Hansen G, von Mutius E, Fuchs O, Dittrich A, Schaub B, Happle C, Rabe KF, Berge MV, Burgess JK, Kopp MV, DZL GCLR (2020) COL4A3 Degradation Predicts Anti-IgE Treatment Response in Severe Asthma. American Journal of Respiratory and Critical Care Medicine 201 (ARCN, BREATH, CPC-M) <Go to ISI>://WOS:000556622801586

Weckmann M, Thiele D, Liboschik L, Bahmer T, Pech M, Dittrich AM, Fuchs O, Happle C, Schaub B, Ricklefs I, Rabe KF, Mutius E, Hansen G, König IR, Kopp MV, Roesler B, Welchering N, Kohistani‐Greif N, Landgraf‐Rauf K, Laubhahn K, Schaub B, Ege M, Liebl C, Mutius E, Kurz J, Fuchs O, Ricklefs I, Diekmann G, Sultansei L, Weckmann M, Nissen G, Kopp MV, Liboschik L, Bovermann X, Steinmetz A, Voigt G, Husstedt B, Nitsche C, König IR, Thiele D, Brinkmann F, Dittrich AM, Happle C, Malik A, Schwerk N, Dopfer C, Price M, Grychtol R, Hansen G, Zemlin M, Müller M, Rietschel E, Koningsbruggen‐Rietschel S, Bahmer T, Kirsten AM, Pedersen F, Watz H, Waschki B, Rabe KF, Herzmann C, Opitz A, Gaede KI, Zabel P (2020) Cytokine levels in children and adults with wheezing and asthma show specific patterns of variability over time. Clin Exp Immunol (ARCN, BREATH, CPC-M) https://doi.org/10.1111/cei.13550 https://onlinelibrary.wiley.com/doi/10.1111/cei.13550

Wechsler M, Ruddy MK, Pavord ID, Israel E, Rabe KF, Abdulai RM, Hu C, Martincova R, Nivens C, Amin N, Weinreich D, Yancopoulos G, Goulaouic H (2020) SAR440340, An Anti-IL-33 Monoclonal Antibody, Demonstrated a Significant Reduction of LOAC Events and Improved Pre-BD FEV1 in Patients with Moderate to Severe Asthma: Results from the Phase 2 Proof of Concept Study. American Journal of Respiratory and Critical Care Medicine 201 (ARCN) <Go to ISI>://WOS:000556393505251

Watz H, Rickard K, Rheault T, Bengtsson T, Singh D (2020) <p>Symptom Improvement Following Treatment with the Inhaled Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine in Patients with Moderate to Severe COPD – A Detailed Analysis</p>. Int J Chron Obstruct Pulmon Dis Volume 15: 2199-2206 (ARCN) https://doi.org/10.2147/copd.S263025 https://www.dovepress.com/front_end/cr_data/cache/pdf/download_1601467402_5f74740a360d5/copd-263025-symptom-improvement-following-treatment-with-the-inhaled-dua.pdf

Watz H, Hohlfeld JM, Singh D, Beier J, Diamant Z, Liu J, Hua S, Abd-Elaziz K, Pinot P, Jones I, Tillmann H-C (2020) Letter to the editor: indacaterol/glycopyrronium/mometasone furoate compared with salmeterol/fluticasone propionate in patients with asthma: a randomized controlled cross-over study. Respir Res 21: 87 (ARCN, BREATH) https://doi.org/10.1186/s12931-020-01349-5 https://respiratory-research.biomedcentral.com/track/pdf/10.1186/s12931-020-01349-5

Waschki B, Alter P, Zeller T, Magnussen C, Neumann JT, Twerenbold R, Sinning C, Herr C, Kahnert K, Fähndrich S, Blankenberg S, Rabe KF, Welte T, Jörres RA, Vogelmeier CF, Bals R, Watz H (2020) High-sensitivity troponin I and all-cause mortality in patients with stable COPD: an analysis of the COSYCONET study. Eur Respir J 55: 1901314 (ARCN, BREATH, CPC-M, UGMLC) https://doi.org/10.1183/13993003.01314-2019 https://www.ncbi.nlm.nih.gov/pubmed/31831579

Wanka L, Jappe U (2020) Trained immunity and allergy: State of the art and future perspectives. Allergy 76: 1265-1267 (ARCN) https://doi.org/10.1111/all.14617 https://onlinelibrary.wiley.com/doi/10.1111/all.14617

Wang Z, Minarsch E-ML, Kublik S, Heine H, Schloter M, Foesel BU, Dennehy JJ (2020) Complete Genome Sequence of Lactococcus lactis subsp. lactis G121, an Isolate with Allergy-Protective Features Derived from a Farming Environment. Microbiology Resource Announcements 9 (ARCN, CPC-M) https://doi.org/10.1128/mra.00777-20 https://mra.asm.org/content/ga/9/41/e00777-20.full.pdf

Voß F, van Beek LF, Schwudke D, Ederveen THA, van Opzeeland FJ, Thalheim D, Werner S, de Jonge MI, Hammerschmidt S (2020) Lipidation of Pneumococcal Antigens Leads to Improved Immunogenicity and Protection. Vaccines 8: 310 (ARCN) https://doi.org/10.3390/vaccines8020310 https://res.mdpi.com/d_attachment/vaccines/vaccines-08-00310/article_deploy/vaccines-08-00310.pdf

Vermeulen CJ, Xu C-J, Vonk JM, ten Hacken NHT, Timens W, Heijink IH, Nawijn MC, Boekhoudt J, van Oosterhout AJ, Affleck K, Weckmann M, Koppelman GH, van den Berge M (2020) Differential DNA methylation in bronchial biopsies between persistent asthma and asthma in remission. Eur Respir J 55: 1901280 (ARCN) https://doi.org/10.1183/13993003.01280-2019 https://pubmed.ncbi.nlm.nih.gov/31699840

Vella G, Lunding L, Ritzmann F, Honecker A, Herr C, Wegmann M, Bals R, Beisswenger C (2020) The IL-17 receptor IL-17RE mediates polyIC-induced exacerbation of experimental allergic asthma. Respir Res 21: 176 (ARCN) https://doi.org/10.1186/s12931-020-01434-9 https://respiratory-research.biomedcentral.com/track/pdf/10.1186/s12931-020-01434-9

van der Linde LIS, Shuaib H, Stellmacher F, Rabe KF, Welker L (2020) Beitrag der intraoperativen Zytologie zur Schnell-Diagnostik thoraxchirurgisch gewonnener Proben. Pneumologie 74: S75-S75 (ARCN) https://doi.org/10.1055/s-0039-3403224 <Go to ISI>://WOS:000588631500166

Ubags ND, Baker J, Boots A, Costa R, El-Merhie N, Fabre A, Faiz A, Heijink IH, Hiemstra PS, Lehmann M, Meiners S, Rolandsson Enes S, Bartel S (2020) ERS International Congress, Madrid, 2019: highlights from the Basic and Translational Science Assembly. ERJ Open Research 6: 00350-02019 ((ARCN), CPC-M) https://doi.org/10.1183/23120541.00350-2019 https://pubmed.ncbi.nlm.nih.gov/32154289

Trudzinski FC, Jörres RA, Alter P, Kahnert K, Waschki B, Herr C, Kellerer C, Omlor A, Vogelmeier CF, Fähndrich S, Watz H, Welte T, Jany B, Söhler S, Biertz F, Herth F, Kauczor HU, Bals R (2020) Associations of oxygenated hemoglobin with disease burden and prognosis in stable COPD: Results from COSYCONET. Sci Rep 10: 10544 (ARCN, BREATH, CPC-M, TLRC, UGMLC) https://doi.org/10.1038/s41598-020-67197-x https://www.nature.com/articles/s41598-020-67197-x.pdf

Trinkmann F, Watz H, Herth FJF (2020) Why do we still cling to spirometry for assessing small airway function? Eur Respir J 56: 2001071 (ARCN, TLRC) https://doi.org/10.1183/13993003.01071-2020 https://erj.ersjournals.com/content/56/1/2001071.long

Teleman AA, von Frieling J, Faisal MN, Sporn F, Pfefferkorn R, Nolte SS, Sommer F, Rosenstiel P, Roeder T (2020) A high-fat diet induces a microbiota-dependent increase in stem cell activity in the Drosophila intestine. PLoS Genet 16: e1008789 (ARCN) https://doi.org/10.1371/journal.pgen.1008789 https://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.1008789&type=printable

Stüssel P, Schulze Dieckhoff K, Künzel S, Hartmann V, Gupta Y, Kaiser G, Veldkamp W, Vidarsson G, Visser R, Ghorbanalipoor S, Matsumoto K, Krause M, Petersen F, Kalies K, Ludwig RJ, Bieber K (2020) Propranolol Is an Effective Topical and Systemic Treatment Option for Experimental Epidermolysis Bullosa Acquisita. J Invest Dermatol 140: 2408-2420 (ARCN) https://doi.org/10.1016/j.jid.2020.04.025 https://doi.org/10.1016/j.jid.2020.04.025

Stahl M, Joachim C, Kirsch I, Uselmann T, Yu Y, Alfeis N, Berger C, Minso R, Rudolf I, Stolpe C, Bovermann X, Liboschik L, Steinmetz A, Tennhardt D, Dörfler F, Röhmel J, Unorji-Frank K, Rückes-Nilges C, von Stoutz B, Naehrlich L, Kopp MV, Dittrich A-M, Sommerburg O, Mall MA (2020) Multicentre feasibility of multiple-breath washout in preschool children with cystic fibrosis and other lung diseases. ERJ Open Research 6: 00408-02020 (ARCN, BREATH, TLRC, UGMLC) https://doi.org/10.1183/23120541.00408-2020 https://openres.ersjournals.com/content/erjor/6/4/00408-2020.full.pdf

Skevaki C, Weckmann M (2020) Activation of Group 2 Innate Lymphoid Cells via TL1A/DR3. A Solution to Corticosteroid Resistance? American Journal of Respiratory and Critical Care Medicine 202: 1067-1069 (ARCN, CPC-M) https://doi.org/10.1164/rccm.202007-2658ED https://www.atsjournals.org/doi/abs/10.1164/rccm.202007-2658ED

Singh D, Watz H, Beeh KM, Kornmann O, Leaker B, Colgan B, Lucci G, Emirova A, Nandeuil MA, Santoro D, Balzano D, Govoni M (2020) COPD sputum eosinophils: relationship to blood eosinophils and the effect of inhaled PDE4 inhibition. Eur Respir J 56: 2000237 (ARCN) https://doi.org/10.1183/13993003.00237-2020 https://erj.ersjournals.com/content/early/2020/03/17/13993003.00237-2020

Singh D, Martinez FJ, Watz H, Bengtsson T, Maurer BT (2020) A dose-ranging study of the inhaled dual phosphodiesterase 3 and 4 inhibitor ensifentrine in COPD. Respir Res 21: 47-47 (ARCN) https://doi.org/10.1186/s12931-020-1307-4 https://www.ncbi.nlm.nih.gov/pubmed/32041601

Singh D, Bassi M, Balzano D, Lucci G, Emirova A, Anna Nandeuil M, Jellema G, Afolabi EK, Leaker B, Kornmann O, Michael Beeh K, Watz H, Govoni M (2020) COPD patients with chronic bronchitis and higher sputum eosinophil counts show increased type‐2 and PDE4 gene expression in sputum. Journal of Cellular and Molecular Medicine 25: 905-918 (ARCN) https://doi.org/10.1111/jcmm.16146 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jcmm.16146?download=true

Shu Y, Guo J, Ma X, Yan Y, Wang Y, Chen C, Sun X, Wang H, Yin J, Long Y, Yan X, Lu Z, Petersen F, Yu X, Qiu W (2020) Anti‐N‐methyl‐D‐aspartate receptor (NMDAR) encephalitis is associated with IRF7, BANK1 and TBX21 polymorphisms in two populations. Eur J Neurol 28: 595-601 (ARCN) https://doi.org/10.1111/ene.14596 https://onlinelibrary.wiley.com/doi/abs/10.1111/ene.14596

Shu Y, Guo J, Ma X, Yan Y, Wang Y, Chen C, Sun X, Wang H, Yin J, Long Y, Yan X, Lu Z, Petersen F, Yu X, Qiu W (2020) Anti‐N‐methyl‐D‐aspartate receptor (NMDAR) encephalitis is associated with IRF7, BANK1 and TBX21 polymorphisms in two populations. Eur J Neurol 28: 595-601 (ARCN) https://doi.org/10.1111/ene.14596 https://onlinelibrary.wiley.com/doi/10.1111/ene.14596

Schurr E, Godfroid M, Dagan T, Merker M, Kohl TA, Diel R, Maurer FP, Niemann S, Kupczok A (2020) Insertion and deletion evolution reflects antibiotics selection pressure in a Mycobacterium tuberculosis outbreak. PLOS Pathogens 16: e1008357 (ARCN, DZIF) https://doi.org/10.1371/journal.ppat.1008357 https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1008357&type=printable

Schneider H, Ahrens M, Strumpski M, Rüger C, Häfer M, Hüttmann G, Theisen-Kunde D, Schulz-Hildebrandt H, Haak R (2020) An Intraoral OCT Probe to Enhanced Detection of Approximal Carious Lesions and Assessment of Restorations. Journal of Clinical Medicine 9: 3257 (ARCN) https://doi.org/10.3390/jcm9103257 https://res.mdpi.com/d_attachment/jcm/jcm-09-03257/article_deploy/jcm-09-03257.pdf

Schlicht K, Rohmann N, Geisler C, Hollstein T, Knappe C, Hartmann K, Schwarz J, Tran F, Schunk D, Junker R, Bahmer T, Rosenstiel P, Schulte D, Türk K, Franke A, Schreiber S, Laudes M (2020) Circulating levels of soluble Dipeptidylpeptidase-4 are reduced in human subjects hospitalized for severe COVID-19 infections. International Journal of Obesity 44: 2335-2338 (ARCN) https://doi.org/10.1038/s41366-020-00689-y https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503441/pdf/41366_2020_Article_689.pdf

Roeder T (2020) The control of metabolic traits by octopamine and tyramine in invertebrates. The Journal of Experimental Biology 223: jeb194282 (ARCN) https://doi.org/10.1242/jeb.194282 https://jeb.biologists.org/content/223/7/jeb194282

Riemekasten G, Petersen F, Heidecke H (2020) What Makes Antibodies Against G Protein-Coupled Receptors so Special? A Novel Concept to Understand Chronic Diseases. Front Immunol 11: 564526 (ARCN) https://doi.org/10.3389/fimmu.2020.564526 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770155/pdf/fimmu-11-564526.pdf

Remon J, Passiglia F, Ahn M-J, Barlesi F, Forde PM, Garon EB, Gettinger S, Goldberg SB, Herbst RS, Horn L, Kubota K, Lu S, Mezquita L, Paz-Ares L, Popat S, Schalper KA, Skoulidis F, Reck M, Adjei AA, Scagliotti GV (2020) Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations. J Thorac Oncol 15: 914-947 (ARCN) https://doi.org/10.1016/j.jtho.2020.03.006 https://www.jto.org/article/S1556-0864(20)30198-2/pdf

Reinhold L, Möllering A, Wallis S, Palade E, Schäfer K, Drömann D, Rupp J, Graspeuntner S, Dalhoff K (2020) Dissimilarity of Airway and Lung Tissue Microbiota in Smokers Undergoing Surgery for Lung Cancer. Microorganisms 8: 794 (ARCN) https://doi.org/10.3390/microorganisms8060794 https://res.mdpi.com/d_attachment/microorganisms/microorganisms-08-00794/article_deploy/microorganisms-08-00794.pdf

Reck M, Wehler T, Orlandi F, Nogami N, Barone C, Moro-Sibilot D, Shtivelband M, González Larriba JL, Rothenstein J, Früh M, Yu W, Deng Y, Coleman S, Shankar G, Patel H, Kelsch C, Lee A, Piault E, Socinski MA (2020) Safety and Patient-Reported Outcomes of Atezolizumab Plus Chemotherapy With or Without Bevacizumab Versus Bevacizumab Plus Chemotherapy in Non–Small-Cell Lung Cancer. J Clin Oncol 38: 2530-2542 (ARCN) https://doi.org/10.1200/jco.19.03158

Reck M, Syrigos K, Miliauskas S, Zöchbauer-Müller S, Fischer JR, Buchner H, Kitzing T, Kaiser R, Radonjic D, Kerr K (2020) Non-interventional LUME-BioNIS study of nintedanib plus docetaxel after chemotherapy in adenocarcinoma non-small cell lung cancer: A subgroup analysis in patients with prior immunotherapy. Lung Cancer 148: 159-165 (ARCN) https://doi.org/10.1016/j.lungcan.2020.08.004 https://www.lungcancerjournal.info/article/S0169-5002(20)30576-6/pdf

Reck M, Luft A, Bondarenko I, Shevnia S, Trukhin D, Kovalenko NV, Vacharadze K, Andrea F, Hontsa A, Choi J, Shin D (2020) A phase III, randomized, double-blind, multicenter study to compare the efficacy, safety, pharmacokinetics, and immunogenicity between SB8 (proposed bevacizumab biosimilar) and reference bevacizumab in patients with metastatic or recurrent nonsquamous non-small cell lung cancer. Lung Cancer 146: 12-18 (ARCN) https://doi.org/10.1016/j.lungcan.2020.05.027

Randerath W, Dreher M, Gompelmann D, Held M, Koczulla R, Köhnlein T, Rohde G, Wälscher J, Watz H, Steinkamp G (2020) Expertentreffen COPD: Technologische Innovationen in der Pneumologie – Facetten aus Diagnostik und Therapie. Pneumologie 74: 585-600 (ACRN, UGMLC) https://doi.org/10.1055/a-1186-7333 https://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-1186-7333

Randerath W, Dreher M, Gompelmann D, Held M, Koczulla R, Köhnlein T, Rohde G, Wälscher J, Watz H, Steinkamp G (2020) Expertentreffen COPD: Technologische Innovationen in der Pneumologie – Facetten aus Diagnostik und Therapie. In Pneumologie.

Ramírez Caballero L, Kny C, Treudler R, Simon JC, Kern K, Jappe U, Szardenings M (2020) Identification of Seasonal Variations of Antibodies against PR-10-Specific Epitopes Can Be Improved Using Peptide-Phage Display. International Archives of Allergy and Immunology 181: 919-925 (ARCN) https://doi.org/10.1159/000509995 https://www.karger.com/Article/Abstract/509995

Rakhymzhan A, Reuter L, Raspe R, Bremer D, Günther R, Leben R, Heidelin J, Andresen V, Cheremukhin S, Schulz‐Hildebrandt H, Bixel MG, Adams RH, Radbruch H, Hüttmann G, Hauser AE, Niesner RA (2020) Coregistered Spectral Optical Coherence Tomography and Two‐Photon Microscopy for Multimodal Near‐Instantaneous Deep‐Tissue Imaging. Cytometry Part A 97: 515-527 (ARCN) https://doi.org/10.1002/cyto.a.24012 https://onlinelibrary.wiley.com/doi/full/10.1002/cyto.a.24012

Rabe KF, Martinez FJ, Singh D, McLaren J, Rose E, Ballal S, Darken P, Aurivillius M, Reisner C, Dorinsky P (2020) Improvements in Lung Function with Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Dual Therapies in Patients with COPD: A Sub-Study of the ETHOS Trial. American Journal of Respiratory and Critical Care Medicine 201 (ARCN) <Go to ISI>://WOS:000556622801033

Rabe KF, Martinez FJ, Ferguson GT, Wang C, Singh D, Wedzicha JA, Trivedi R, St. Rose E, Ballal S, McLaren J, Darken P, Aurivillius M, Reisner C, Dorinsky P (2020) Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD. New England Journal of Medicine 383: 35-48 (ARCN) https://doi.org/10.1056/NEJMoa1916046 https://www.nejm.org/doi/10.1056/NEJMoa1916046

Rabe KF, Martinez FJ, Ferguson GT, Wang C, Singh D, Wedzicha JA, Trivedi R, St Rose E, Ballal S, McLaren J, Darken P, Aurivillius M, Reisner C, Dorinsky P (2020) Single-Inhaler Triple Combination Therapy with Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) at Two Corticosteroid Dose Levels in COPD: ETHOS Trial. American Journal of Respiratory and Critical Care Medicine 201 (ARCN) <Go to ISI>://WOS:000556393502285

Rabe KF, Martinez FJ, Dorinsky P (2020) Triple Inhaled Therapy in COPD. New England Journal of Medicine 383: 1393-1395 (ARCN) https://doi.org/10.1056/NEJMc2026881 https://www.nejm.org/doi/full/10.1056/NEJMc2026881

Rabe KF, Halpin DMG, Han MK, Miravitlles M, Singh D, Grönke L, Voß F, Martinez FJ (2020) Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial. Respir Res 21: 177 (ARCN) https://doi.org/10.1186/s12931-020-01431-y <Go to ISI>://WOS:000551878900001

Rabe KF, Fabbri LM, Martinez FJ, Ferguson GT, Bourne E, Darken P, DeAngelis K, Aurivillius M, Reisner C, Dorinsky P (2020) Seasonal Variation in COPD Exacerbations: a Post-Hoc Analysis from the KRONOS Phase III Study of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI). Pneumologie 74: S44-S44 (ARCN) https://doi.org/10.1055/s-0039-3403160 <Go to ISI>://WOS:000588631500103

Rabe KF, Chalmers JD, Miravitlles M, Kocks JWH, Tsiligianni I, de la Hoz A, Xue W, Singh D, Ferguson GT, Wedzicha J (2020) Tiotropium/Olodaterol Delays Clinically Important Deterioration Compared with Tiotropium Monotherapy in Patients with Early COPD: a Post Hoc Analysis of the TONADO® Trials. Adv Ther (ARCN) https://doi.org/10.1007/s12325-020-01528-2 https://link.springer.com/content/pdf/10.1007/s12325-020-01528-2.pdf

Rabe KF, Chalmers JD, Miravitlles M, Kocks J, Tsiligianni I, de la Hoz A, Xue W, Wedzicha JA, Singh D, Ferguson GT (2020) Benefits of Tiotropium/Olodaterol Over Tiotropium Alone in Delaying Clinically Significant Deterioration in Patients with COPD. American Journal of Respiratory and Critical Care Medicine 201 (ARCN) <Go to ISI>://WOS:000556393505281

Rabe K, FitzGerald J, Bateman E, Castro M, Pavord I, Maspero J, Busse W, Rice M, Deniz Y, Rowe P, Patel N, Amin N, Ruddy M, Graham N, Teper A (2020) Dupilumab Efficacy in GINA-Defined Difficult-to-Treat Type 2 Asthma Patients. Journal of Allergy and Clinical Immunology 145: Ab19-Ab19 (ARCN) <Go to ISI>://WOS:000517092700057

Quell KM, Dutta K, Korkmaz ÜR, Nogueira de Almeida L, Vollbrandt T, König P, Lewkowich I, Deepe GS, Vershoor A, Köhl J, Laumonnier Y (2020) GM-CSF and IL-33 Orchestrate Polynucleation and Polyploidy of Resident Murine Alveolar Macrophages in a Murine Model of Allergic Asthma. Int J Mol Sci 21: 7487 (ARCN) https://doi.org/10.3390/ijms21207487 https://res.mdpi.com/d_attachment/ijms/ijms-21-07487/article_deploy/ijms-21-07487.pdf

Putora PM, Fischer GF, Früh M, Califano R, Faivre-Finn C, Van Houtte P, McDonald F, Nestle U, Dziadziuszko R, Le Pechoux C, Ramella S, Belderbos J, Slotman BJ, Troost EGC, Peeters S, Widder J, Pöttgen C, Reck M, Blackhall F, Cappuzzo F, Besse B, Novello S, Garrido P, Felip E, O’Brien M, Paz Ares L, de Marinis F, Westeel V, De Ruysscher D (2020) Treatment of brain metastases in small cell lung cancer: Decision-making amongst a multidisciplinary panel of European experts. Radiother Oncol 149: 84-88 (ARCN) https://doi.org/10.1016/j.radonc.2020.04.015 https://www.thegreenjournal.com/article/S0167-8140(20)30196-1/pdf

Popat S, Grohé C, Corral J, Reck M, Novello S, Gottfried M, Radonjic D, Kaiser R (2020) Anti-angiogenic agents in the age of resistance to immune checkpoint inhibitors: Do they have a role in non-oncogene-addicted non-small cell lung cancer? Lung Cancer 144: 76-84 (ARCN) https://doi.org/10.1016/j.lungcan.2020.04.009 https://doi.org/10.1016/j.lungcan.2020.04.009

Ponce Aix S, Talbot D, Govindan R, Dols MC, Postmus PE, Lewanski C, Bennouna J, Fischer JR, Juan-Vidal O, Stewart DJ, Ardizzoni A, Bhore R, Wolfsteiner M, Reck M, Ong TJ, Morgensztern D (2020) Quality of life with second or third line nab-paclitaxel-based regimens in advanced non-small-cell lung cancer. Future Oncology 16: 749-762 (ARCN) https://doi.org/10.2217/fon-2019-0796 https://www.futuremedicine.com/doi/pdfplus/10.2217/fon-2019-0796

Plavec D, Jünger C, Reimann M, Krabbe L, Gaede KI, Lange C, Herzmann C, Rüller S (2020) Non-invasive ventilation with pursed lips breathing mode for patients with COPD and hypercapnic respiratory failure: A retrospective analysis. PLoS One 15: e0238619 (ARCN) https://doi.org/10.1371/journal.pone.0238619 https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0238619&type=printable

Platts-Mills TAE, Commins SP, Biedermann T, van Hage M, Levin M, Beck LA, Diuk-Wasser M, Jappe U, Apostolovic D, Minnicozzi M, Plaut M, Wilson JM (2020) On the cause and consequences of IgE to galactose-α-1,3-galactose: A report from the National Institute of Allergy and Infectious Diseases Workshop on Understanding IgE-Mediated Mammalian Meat Allergy. Journal of Allergy and Clinical Immunology 145: 1061-1071 (ARCN) https://doi.org/10.1016/j.jaci.2020.01.047 https://pubmed.ncbi.nlm.nih.gov/32057766

Pieper M, Schulz-Hildebrandt H, Mall MA, Hüttmann G, König P (2020) Intravital microscopic optical coherence tomography imaging to assess mucus-mobilizing interventions for muco-obstructive lung disease in mice. American Journal of Physiology-Lung Cellular and Molecular Physiology 318: L518-L524 (ARCN, (TLRC, BIH)) https://doi.org/10.1152/ajplung.00287.2019 https://pubmed.ncbi.nlm.nih.gov/31994896

Pfaar O, Klimek L, Worm M, Bergmann KC, Bieber T, Buhl R, Buters J, Darsow U, Keil T, Kleine-Tebbe J, Lau S, Maurer M, Merk H, Mösges R, Saloga J, Staubach P, Stute P, Rabe K, Rabe U, Vogelmeier C, Biedermann T, Jung K, Schlenter W, Ring J, Chaker A, Wehrmann W, Becker S, Mülleneisen N, Nemat K, Czech W, Wrede H, Brehler R, Fuchs T, Tomazic PV, Aberer W, Fink-Wagner A, Horak F, Wöhrl S, Niederberger-Leppin V, Pali-Schöll I, Pohl W, Roller-Wirnsberger R, Spranger O, Valenta R, Akdis M, Akdis C, Hoffmann-Sommergruber K, Jutel M, Matricardi P, Spertini F, Khaltaev N, Michel JP, Nicod L, Schmid-Grendelmeier P, Hamelmann E, Jakob T, Werfel T, Wagenmann M, Taube C, Gerstlauer M, Vogelberg C, Bousquet J, Zuberbier T (2020) Allergen-Immuntherapie in der aktuellen COVID-19-Pandemie – ein Positionspapier von ARIA, EAACI, AeDA, GPA und DGAKI (Kurzversion) – Positionspapier der deutschen ARIA-GruppeA in Kooperation mit der österreichischen ARIA-GruppeB, der schweizerischen ARIA-GruppeC, dem Ärzteverband Deutscher Allergologen (AeDA)D, der Deutschen Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)E und der Gesellschaft für Pädiatrische Allergologie (GPA)F in Kooperation mit der AG Klinische Immunologie, Allergologie und Umweltmedizin der DGHNO-KHCG und der Europäischen Akademie für Allergologie und Klinische Immunologie (EAACI)H. Laryngo-Rhino-Otologie 99: 676-679 (ARCN, UGMLC) https://doi.org/10.1055/a-1170-8426 <Go to ISI>://WOS:000561325400001

Petry J, Rahmöller J, Dühring L, Lilienthal G-M, Lehrian S, Buhre JS, Bartsch YC, Epp A, Lunding HB, Moremen KW, Leliavski A, Ehlers M (2020) Enriched blood IgG sialylation attenuates IgG-mediated and IgG-controlled-IgE-mediated allergic reactions. Journal of Allergy and Clinical Immunology (ARCN) https://doi.org/10.1016/j.jaci.2020.05.056 https://www.jacionline.org/article/S0091-6749(20)30887-3/pdf

Peng B, Kopczynski D, Pratt BS, Ejsing CS, Burla B, Hermansson M, Benke PI, Tan SH, Chan MY, Torta F, Schwudke D, Meckelmann SW, Coman C, Schmitz OJ, MacLean B, Manke M-C, Borst O, Wenk MR, Hoffmann N, Ahrends R (2020) LipidCreator workbench to probe the lipidomic landscape. Nature Communications 11: 2057 (ARCN) https://doi.org/10.1038/s41467-020-15960-z https://www.nature.com/articles/s41467-020-15960-z.pdf

Passaro A, Addeo A, Von Garnier C, Blackhall F, Planchard D, Felip E, Dziadziuszko R, de Marinis F, Reck M, Bouchaab H, Peters S (2020) ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer. ESMO Open 5: e000820 (ARCN) https://doi.org/10.1136/esmoopen-2020-000820 https://esmoopen.bmj.com/content/esmoopen/5/Suppl_3/e000820.full.pdf

Otto-Knapp R, Häcker B, Breuer C, Diel R, Kaufmann SHE, Korr G, Pfeiffer M, Schaberg T, Schönfeld N, Witte P, Bauer T (2020) DZK-Stellungnahme zu Tuberkulose, BCG und COVID-19*. Pneumologie 74: 412-416 (ARCN) https://doi.org/10.1055/a-1199-6721 https://www.thieme-connect.de/products/ejournals/abstract/10.1055/a-1199-6721

Orinska Z, Hagemann PM, Halova I, Draber P (2020) Tetraspanins in the regulation of mast cell function. Medical Microbiology and Immunology 209: 531-543 ((ARCN)) https://doi.org/10.1007/s00430-020-00679-x https://link.springer.com/content/pdf/10.1007/s00430-020-00679-x.pdf

Nishio M, Seto T, Reck M, Garon EB, Chiu CH, Yoh K, Imamura F, Park K, Shih JY, Visseren‐Grul C, Frimodt‐Moller B, Zimmermann A, Homma G, Enatsu S, Nakagawa K (2020) Ramucirumab or placebo plus erlotinib in EGFR‐mutated, metastatic non‐small‐cell lung cancer: East Asian subset of RELAY. Cancer Sci 111: 4510-4525 (ARCN) https://doi.org/10.1111/cas.14655 https://onlinelibrary.wiley.com/doi/10.1111/cas.14655

Münter M, vom Endt M, Pieper M, Casper M, Ahrens M, Kohlfaerber T, Rahmanzadeh R, König P, Hüttmann G, Schulz-Hildebrandt H (2020) Dynamic contrast in scanning microscopic OCT. Optics Letters 45: 4766 (ARCN) https://doi.org/10.1364/ol.396134 https://www.osapublishing.org/ol/fulltext.cfm?uri=ol-45-17-4766&id=437452

Menis J, Reck M (2020) Checkpoint Inhibitors in SCLC: How Much Can We Trust in Randomized Cohorts of Phase I/II Trials? J Thorac Oncol 15: 308-310 (ARCN) https://doi.org/10.1016/j.jtho.2019.11.031 https://pubmed.ncbi.nlm.nih.gov/32093850

Matkivsky V, Moiseev A, Shilyagin P, Rodionov A, Spahr H, Pfäffle C, Hüttmann G, Hillmann D, Gelikonov G (2020) Determination and correction of aberrations in full field optical coherence tomography using phase gradient autofocus by maximizing the likelihood function. Journal of Biophotonics 13: e202000112 (ARCN) https://doi.org/10.1002/jbio.202000112 https://onlinelibrary.wiley.com/doi/abs/10.1002/jbio.202000112

Maspero JF, Katelaris CH, Busse WW, Castro M, Corren J, Chipps BE, Peters AT, Pavord ID, Ford LB, Sher L, Rabe KF, Rice MS, Rowe P, Lu Y, Harel S, Jagerschmidt A, Khan AH, Kamat S, Pirozzi G, Amin N, Ruddy M, Graham NMH, Mannent LP, Teper A (2020) Dupilumab Efficacy in Uncontrolled, Moderate-to-Severe Asthma with Self-Reported Chronic Rhinosinusitis. The Journal of Allergy and Clinical Immunology: In Practice 8: 527-539.e529 (ARCN) https://doi.org/10.1016/j.jaip.2019.07.016 <Go to ISI>://WOS:000512964500011

Marwitz S, Turkowski K, Nitschkowski D, Weigert A, Brandenburg J, Reiling N, Thomas M, Reck M, Drömann D, Seeger W, Rabe KF, Savai R, Goldmann T (2020) The Multi-Modal Effect of the Anti-fibrotic Drug Pirfenidone on NSCLC. Front Oncol 9: 1550-1550 (ARCN, TLRC, UGMLC) https://doi.org/10.3389/fonc.2019.01550 https://www.ncbi.nlm.nih.gov/pubmed/32039023

Martinez FJ, Rabe KF, Lipworth BJ, Arora S, Jenkins M, Martin UJ, Reisner C (2020) <p>Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Lung Function versus Monotherapies in GOLD Category A Patients with COPD: Pooled Data from the Phase III PINNACLE Studies</p>. Int J Chron Obstruct Pulmon Dis Volume 15: 99-106 (ARCN) https://doi.org/10.2147/copd.S229794 https://www.ncbi.nlm.nih.gov/pubmed/32021148

Martinez FJ, Rabe KF, Ferguson GT, Wedzicha JA, Trivedi R, St Rose E, Ballal S, Darken P, Aurivillius M, Dorinsky P, Reisner C (2020) Benefits of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) on Symptoms and Quality of Life in Patients with Chronic Obstructive Pulmonary Disease (COPD) in the ETHOS Trial. American Journal of Respiratory and Critical Care Medicine 201 (ARCN) <Go to ISI>://WOS:000556622801032

Martinez FJ, Rabe KF, Ferguson GT, Wedzicha JA, Singh D, Wang C, Rossman K, St. Rose E, Trivedi R, Ballal S, Darken P, Aurivillius M, Reisner C, Dorinsky P (2020) Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for COPD: A Randomized, Double-Blind, Multi-Center Parallel-Group Study. American Journal of Respiratory and Critical Care Medicine (ARCN) https://doi.org/10.1164/rccm.202006-2618OC

Martinez FJ, Lipworth BJ, Rabe KF, Collier DJ, Ferguson GT, Sethi S, Feldman GJ, O’Brien G, Jenkins M, Reisner C (2020) Benefits of glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI) in improving lung function and reducing exacerbations in patients with moderate-to-very severe COPD: a pooled analysis of the PINNACLE studies. Respir Res 21: 128 (ARCN) https://doi.org/10.1186/s12931-020-01388-y https://respiratory-research.biomedcentral.com/track/pdf/10.1186/s12931-020-01388-y

Marchetti R, Nieto Fabregat F, Pallach M, Gully D, Giraud E, Molinaro A, Duda KA, Silipo A (2020) The Peculiar Structure of Acetobacter pasteurianus CIP103108 LPS Core Oligosaccharide. ChemBioChem 22: 147-150 (ARCN) https://doi.org/10.1002/cbic.202000597 https://chemistry-europe.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cbic.202000597?download=true

Maqhuzu PN, Szentes BL, Kreuter M, Bahmer T, Kahn N, Claussen M, Holle R, Schwarzkopf L (2020) Determinants of health-related quality of life decline in interstitial lung disease. Health and Quality of Life Outcomes 18: 334 (ARCN, CPC-M, TLRC) https://doi.org/10.1186/s12955-020-01570-2 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542726/pdf/12955_2020_Article_1570.pdf

Mansfield AS, Każarnowicz A, Karaseva N, Sánchez A, De Boer R, Andric Z, Reck M, Atagi S, Lee JS, Garassino M, Liu SV, Horn L, Wen X, Quach C, Yu W, Kabbinavar F, Lam S, Morris S, Califano R (2020) Safety and patient-reported outcomes of atezolizumab, carboplatin, and etoposide in extensive-stage small-cell lung cancer (IMpower133): a randomized phase I/III trial. Ann Oncol 31: 310-317 (ARCN) https://doi.org/10.1016/j.annonc.2019.10.021 https://doi.org/10.1016/j.annonc.2019.10.021

Ma Y, Rivera-Ingraham G, Nommick A, Bickmeyer U, Roeder T (2020) Copper and cadmium administration induce toxicity and oxidative stress in the marine flatworm Macrostomum lignano. Aquat Toxicol 221: 105428 (ARCN) https://doi.org/10.1016/j.aquatox.2020.105428 https://www.ncbi.nlm.nih.gov/pubmed/32035411

Ma A, Wen L, Yin J, Hu Y, Yue X, Li J, Dong X, Gupta Y, Ludwig RJ, Krauss-Etschmann S, Riemekasten G, Petersen F, Yu X (2020) <p>Serum Levels of Autoantibodies Against Extracellular Antigens and Neutrophil Granule Proteins Increase in Patients with COPD Compared to Non-COPD Smokers</p>. Int J Chron Obstruct Pulmon Dis Volume 15: 189-200 (ARCN) https://doi.org/10.2147/copd.S235903 https://pubmed.ncbi.nlm.nih.gov/32099344

Lutter JI, Jörres RA, Welte T, Watz H, Waschki B, Alter P, Trudzinski FC, Ohlander J, Behr J, Bals R, Studnicka M, Holle R, Vogelmeier CF, Kahnert K (2020) <p>Impact of Education on COPD Severity and All-Cause Mortality in Lifetime Never-Smokers and Longtime Ex-Smokers: Results of the COSYCONET Cohort</p>. Int J Chron Obstruct Pulmon Dis Volume 15: 2787-2798 (ARCN, BREATH, CPC-M, TLRC) https://doi.org/10.2147/copd.S273839 https://www.dovepress.com/front_end/cr_data/cache/pdf/download_1605190339_5fad42c3bf16f/copd-273839-impact-of-education-on-copd-severity-and-all-cause-mortality.pdf

Lutter JI, Jörres RA, Kahnert K, Schwarzkopf L, Studnicka M, Karrasch S, Schulz H, Vogelmeier CF, Holle R (2020) Health-related quality of life associates with change in FEV1 in COPD: results from the COSYCONET cohort. BMC Pulm Med 20: 148 (ARCN, BREATH, CPC-M, TLRC, UGMLC) https://doi.org/10.1186/s12890-020-1147-5 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7257512/pdf/12890_2020_Article_1147.pdf

Lommatzsch M, Rabe KF, Taube C, Joest M, Kreuter M, Wirtz H, Blum TG, Kolditz M, Geerdes-Fenge H, Otto-Knapp R, Häcker B, Schaberg T, Ringshausen FC, Vogelmeier CF, Reinmuth N, Reck M, Gottlieb J, Konstantinides S, Meyer FJ, Worth H, Windisch W, Welte T, Bauer T (2020) Risikoabschätzung bei Patienten mit chronischen Atemwegs- und Lungenerkrankungen im Rahmen der SARS-CoV-2-Pandemie. Pneumologie 75: 19-30 (ARCN, BREATH, CPC-M, TLRC, UGMLC) https://doi.org/10.1055/a-1321-3400 https://www.thieme-connect.de/products/ejournals/abstract/10.1055/a-1321-3400

Lkhagvadorj K, Zeng Z, Song J, Reinders-Luinge M, Kooistra W, Song S, Krauss-Etschmann S, Melgert BN, Cao J, Hylkema MN (2020) Prenatal smoke exposure dysregulates lung epithelial cell differentiation in mouse offspring: role for AREG-induced EGFR signaling. American Journal of Physiology-Lung Cellular and Molecular Physiology 319: L742-L751 (ARCN) https://doi.org/10.1152/ajplung.00209.2020 https://journals.physiology.org/doi/pdf/10.1152/ajplung.00209.2020

Liu X, Tufman A, Behr J, Kiefl R, Goldmann T, Huber RM (2020) Role of the erythropoietin receptor in Lung Cancer cells: erythropoietin exhibits angiogenic potential. J Cancer 11: 6090-6100 (ARCN, CPC-M) https://doi.org/10.7150/jca.36924 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477424/pdf/jcav11p6090.pdf

Link CWM, Rau CN, Udoye CC, Ragab M, Korkmaz RÜ, Comdühr S, Clauder A-K, Lindemann T, Frehse B, Hofmann K, Almeida LN, Laumonnier Y, Beidaq AE, Finkelman FD, Manz RA (2020) IL-2-Agonist-Induced IFN-γ Exacerbates Systemic Anaphylaxis in Food Allergen-Sensitized Mice. Front Immunol 11 (ARCN) https://doi.org/10.3389/fimmu.2020.596772 https://www.frontiersin.org/article/10.3389/fimmu.2020.596772

Li Y, Romey-Glüsing R, Tahan Zadeh N, von Frieling J, Hoffmann J, Huebbe P, Bruchhaus I, Rimbach G, Fink C, Roeder T (2020) Furbellow (Brown Algae) Extract Increases Lifespan in Drosophila by Interfering with TOR-Signaling. Nutrients 12: 1172 (ARCN) https://doi.org/10.3390/nu12041172 https://res.mdpi.com/d_attachment/nutrients/nutrients-12-01172/article_deploy/nutrients-12-01172-v2.pdf

Li CH, Prokopec SD, Sun RX, Yousif F, Schmitz N, Boutros PC (2020) Sex differences in oncogenic mutational processes. Nature Communications 11: 4330 (ARCN) https://doi.org/10.1038/s41467-020-17359-2 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455744/pdf/41467_2020_Article_17359.pdf

Leuschner G, Klotsche J, Kreuter M, Prasse A, Wirtz H, Pittrow D, Frankenberger M, Behr J, Kneidinger N (2020) Idiopathic Pulmonary Fibrosis in Elderly Patients: Analysis of the INSIGHTS-IPF Observational Study. Frontiers in Medicine 7: 601279 (ARCN, BREATH, CPC-M, TLRC) https://doi.org/10.3389/fmed.2020.601279 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703706/pdf/fmed-07-601279.pdf

Lazaar AL, Miller BE, Donald AC, Keeley T, Ambery C, Russell J, Watz H, Tal-Singer R (2020) CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trial. Respir Res 21: 149 (ARCN) https://doi.org/10.1186/s12931-020-01401-4 https://respiratory-research.biomedcentral.com/track/pdf/10.1186/s12931-020-01401-4

Langer S, Horn J, Kluttig A, Mikolajczyk R, Karrasch S, Schulz H, Wichmann H-E, Linseisen J, Jaeschke L, Pischon T, Fricke J, Keil T, Ahrens W, Günther K, Kuß O, Schikowski T, Schmidt B, Jöckel K-H, Michels KB, Franzke C-W, Becher H, Jagodzinski A, Castell S, Kemmling Y, Lieb W, Waniek S, Wirkner K, Löffler M, Kaaks R, Greiser KH, Berger K, Legath N, Meinke-Franze C, Schipf S, Leitzmann M, Baurecht H, Weigl K, Amitay E, Gottschick C (2020) Häufigkeit von Asthma bronchiale und Alter bei der Erstdiagnose – erste Ergebnisse der NAKO Gesundheitsstudie. Bundesgesundheitsblatt – Gesundheitsforschung – Gesundheitsschutz 63: 397-403 (ARCN, CPC-M, TLRC) https://doi.org/10.1007/s00103-020-03105-y https://link.springer.com/content/pdf/10.1007/s00103-020-03105-y.pdf

Lange C, Aarnoutse R, Chesov D, van Crevel R, Gillespie SH, Grobbel H-P, Kalsdorf B, Kontsevaya I, van Laarhoven A, Nishiguchi T, Mandalakas A, Merker M, Niemann S, Köhler N, Heyckendorf J, Reimann M, Ruhwald M, Sanchez-Carballo P, Schwudke D, Waldow F, DiNardo AR (2020) Perspective for Precision Medicine for Tuberculosis. Front Immunol 11: 566608 (ARCN, DZIF) https://doi.org/10.3389/fimmu.2020.566608

Lahousse L, Bahmer T, Cuevas-Ocaña S, Flajolet P, Mathioudakis AG, McDonnell M, Uller L, Schleich F, Dortas Junior S, Idzko M, Singh D, Ricciardolo FLM, Adcock IM, Usmani O, Spanevello A, Bonvini SJ (2020) ERS International Congress, Madrid, 2019: highlights from the Airway Diseases, Asthma and COPD Assembly. ERJ Open Research 6: 00341-02019 (ARCN) https://doi.org/10.1183/23120541.00341-2019 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024762/pdf/00341-2019.pdf

Krause T, Röckendorf N, Meckelein B, Sinnecker H, Schwager C, Möckel S, Jappe U, Frey A (2020) IgE Epitope Profiling for Allergy Diagnosis and Therapy – Parallel Analysis of a Multitude of Potential Linear Epitopes Using a High Throughput Screening Platform. Front Immunol 11: 565243 (ARCN) https://doi.org/10.3389/fimmu.2020.565243

Kraft M, Scherer Hofmeier K, Ruëff F, Pföhler C, Renaudin J-M, Bilò MB, Treudler R, Lang R, Cichocka-Jarosz E, Fernandez-Rivas M, Christoff G, Papadopoulos NG, Ensina LF, Hourihane JOB, Maris I, Koehli A, García BE, Jappe U, Vogelberg C, Ott H, Lange L, Spindler T, Dölle-Bierke S, Worm M (2020) Risk Factors and Characteristics of Biphasic Anaphylaxis. The Journal of Allergy and Clinical Immunology: In Practice 8: 3388-3395.e3386 (ARCN) https://doi.org/10.1016/j.jaip.2020.07.036 https://www.sciencedirect.com/science/article/abs/pii/S2213219820307947?via%3Dihub

Kopp MV, Bovermann X, Klimek L (2020) Accelerated Dose Escalation with Three Injections of an Aluminum Hydroxide-Adsorbed Allergoid Preparation of Six Grasses Is Safe for Patients with Moderate to Severe Allergic Rhinitis. International Archives of Allergy and Immunology 181: 94-102 (ARCN) https://doi.org/10.1159/000503684 https://www.ncbi.nlm.nih.gov/pubmed/31865326

Komaniecka I, Susniak K, Choma A, Heine H, Holst O (2020) The Lipid A from the Lipopolysaccharide of the Phototrophic Bacterium Rhodomicrobium vannielii ATCC 17100 Revisited. Int J Mol Sci 22: 258 (ARCN) https://doi.org/10.3390/ijms22010258 https://res.mdpi.com/d_attachment/ijms/ijms-22-00258/article_deploy/ijms-22-00258.pdf

Klimek L, Pfaar O, Worm M, Eiwegger T, Hagemann J, Ollert M, Untersmayr E, Hoffmann-Sommergruber K, Vultaggio A, Agache I, Bavbek S, Bossios A, Casper I, Chan S, Chatzipetrou A, Vogelberg C, Firinu D, Kauppi P, Kolios A, Kothari A, Matucci A, Palomares O, Szépfalusi Z, Pohl W, Hötzenecker W, Rosenkranz AR, Bergmann K-C, Bieber T, Buhl R, Buters J, Darsow U, Keil T, Kleine-Tebbe J, Lau S, Maurer M, Merk H, Mösges R, Saloga J, Staubach P, Jappe U, Rabe KF, Rabe U, Vogelmeier C, Biedermann T, Jung K, Schlenter W, Ring J, Chaker A, Wehrmann W, Becker S, Freudelsperger L, Mülleneisen N, Nemat K, Czech W, Wrede H, Brehler R, Fuchs T, Tomazic P-V, Aberer W, Fink-Wagner A-H, Horak F, Wöhrl S, Niederberger-Leppin V, Pali-Schöll I, Pohl W, Roller-Wirnsberger R, Spranger O, Valenta R, Akdis M, Matricardi PM, Spertini F, Khaltaev N, Michel J-P, Nicod L, Schmid-Grendelmeier P, Idzko M, Hamelmann E, Jakob T, Werfel T, Wagenmann M, Taube C, Jensen-Jarolim E, Korn S, Hentges F, Schwarze J, O´Mahony L, Knol EF, Giacco Sd, Pérez TC, Bousquet J, Bedbrook A, Zuberbier T, Akdis C, Jutel M (2020) Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic. Allergologie select 4: 53-68 (ARCN, UGMLC) https://doi.org/10.5414/alx02166e

Klimek L, Pfaar O, Worm M, Eiwegger T, Hagemann J, Ollert M, Untersmayr E, Hoffmann-Sommergruber K, Vultaggio A, Agache I, Bavbek S, Bossios A, Casper I, Chan S, Chatzipetrou A, Vogelberg C, Firinu D, Kauppi P, Kolios A, Kothari A, Matucci A, Palomares O, Szépfalusi Z, Pohl W, Hötzenecker W, Rosenkranz A, Bergmann K-C, Bieber T, Buhl R, Buters J, Darsow U, Keil T, Kleine-Tebbe J, Lau S, Maurer M, Merk H, Mösges R, Saloga J, Staubach P, Jappe U, Rabe C, Rabe U, Vogelmeier C, Biedermann T, Jung K, Schlenter W, Ring J, Chaker A, Wehrmann W, Becker S, Freudelsperger L, Mülleneisen N, Nemat K, Czech W, Wrede H, Brehler R, Fuchs T, Tomazic P-V, Aberer W, Fink Wagner A, Horak F, Wöhrl S, Niederberger-Leppin V, Pali-Schöll I, Roller-Wirnsberger R, Spranger O, Valenta R, Akdis M, Matricardi PM, Spertini F, Khaltaev N, Michel J-P, Nicod L, Schmid-Grendelmeier P, Idzko M, Hamelmann E, Jakob T, Werfel T, Wagenmann M, Taube C, Jensen-Jarolim E, Korn S, Hentges F, Schwarze J, O´Mahony L, Knol E, del Giacco S, Chivato T, Bousquet J, Zuberbier T, Akdis C, Jutel M (2020) Anwendung von Biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen Covid-19-Pandemiea, b, c. Allergo J 29: 14-27 (ARCN, UGMLC) https://doi.org/10.1007/s15007-020-2553-y https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289636/pdf/15007_2020_Article_2553.pdf

Klimek L, Pfaar O, Worm M, Bergmann K-C, Bieber T, Buhl R, Buters J, Darsow U, Keil T, Kleine-Tebbe J, Lau S, Maurer M, Merk H, Mösges R, Saloga J, Staubach P, Poethig D, Rabe K, Rabe U, Vogelmeier C, Biedermann T, Jung K, Schlenter W, Ring J, Chaker A, Wehrmann W, Becker S, Mülleneisen N, Nemat K, Czech W, Wrede H, Brehler R, Fuchs T, Tomazic P-V, Aberer W, Fink-Wagner A, Horak F, Wöhrl S, Niederberger-Leppin V, Pali-Schöll I, Pohl W, Roller-Wirnsberger R, Spranger O, Valenta R, Akdis M, Akdis C, Hoffmann-Sommergruber K, Jutel M, Matricardi P, Spertini F, Khaltaev N, Michel J-P, Nicod L, Schmid-Grendelmeier P, Hamelmann E, Jakob T, Werfel T, Wagenmann M, Taube C, Bousquet J, Zuberbier T, Vogelberg C, Gerstlauer M (2020) Allergen-Immuntherapie in der aktuellen Covid-19-Pandemiea, b, c. Allergo J 29: 17-25 (ARCN, UGMLC) https://doi.org/10.1007/s15007-020-2539-9 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189005/pdf/15007_2020_Article_2539.pdf

Karrasch S, Peters A, Meisinger C, Ferland M, Jaeschke L, Pischon T, Fricke J, Keil T, Gastell S, Schulze M, Brandes M, Günther K, Kuß O, Schikowski T, Emmel C, Jöckel K-H, Michels KB, Franzke C-W, Langer S, Mikolajczyk R, Jagodzinski A, Becher H, Castell S, Kemmling Y, Waniek S, Lieb W, Wirkner K, Loeffler M, Greiser KH, Kaaks R, Legath N, Berger K, Schipf S, Hoffmann W, Sedlmeier A, Leitzmann M, Brenner H, Holleczek B, Schulz H (2020) Lungenfunktion in der NAKO Gesundheitsstudie: Methoden und erste Ergebnisse. Bundesgesundheitsblatt – Gesundheitsforschung – Gesundheitsschutz 63: 322-331 (ARCN, CPC-M, TLRC) https://doi.org/10.1007/s00103-020-03102-1 https://link.springer.com/content/pdf/10.1007/s00103-020-03102-1.pdf

Kamdem JP, Duarte AE, Ibrahim M, Lukong KE, Barros LM, Roeder T (2020) Bibliometric analysis of personalized humanized mouse and Drosophila models for effective combinational therapy in cancer patients. Biochimica et Biophysica Acta (BBA) – Molecular Basis of Disease 1866: 165880 (ARCN) https://doi.org/10.1016/j.bbadis.2020.165880 https://www.sciencedirect.com/science/article/abs/pii/S0925443920302283?via%3Dihub

Kahnert K, Jörres RA, Kauczor H-U, Biederer J, Jobst B, Alter P, Biertz F, Mertsch P, Lucke T, Lutter JI, Trudzinski FC, Behr J, Bals R, Watz H, Vogelmeier CF, Welte T, Stefan A, Robert B, Jürgen B, Kathrin K, Burkhard B, Bahmer T, Roland B, Ralf E, Beate S, Joachim H F, Manfred G, Christian G, Rainer H, Matthias H, Berthold J, Markus H, Felix H, Gerd H, Hugo A K, Anne-Marie K, Henrik W, Rembert K, Klaus K, Juliane K, Cornelia K-S, Christoph L, Peter Z, Michael P, Winfried J R, Werner S, Michael S, Christian T, Helmut T, Hartmut T, Christian VJ, Claus V, Ulrich W, Tobias W, Hubert W, Lehnert D, Struck B, Krabbe L, Arikan B, Tobias J, Spangel G, Teng J, Essen Rg, Pieper J, Gleiniger M, Markworth B, Hinz Z, Hundack-Winter P, Burmann E, Wons K, Rieber U, Schaufler B, Seibert M, Schwedler K, Michalewski S, Rohweder S, Kiel C, Berger P, Schottel D, Klöser M, Janke V, Untsch R, Graf J, Reichel A, Weiß G, Traugott E, Ziss B, Kietzmann I, Schrade-Illmann M, Polte B, Böckmann C, Hübner G, Sterk L, Wirz A (2020) Relationship between clinical and radiological signs of bronchiectasis in COPD patients: Results from COSYCONET. Respir Med 172: 106117 (ARCN, BREATH, CPC-M, TLRC, UGMLC) https://doi.org/10.1016/j.rmed.2020.106117 https://www.resmedjournal.com/article/S0954-6111(20)30257-2/fulltext

Kahnert K, Föhrenbach M, Lucke T, Alter P, Trudzinski FT, Bals R, Lutter JI, Timmermann H, Söhler S, Förderreuther S, Nowak D, Watz H, Waschki B, Behr J, Welte T, Vogelmeier CF, Jörres RA (2020) The impact of COPD on polyneuropathy: results from the German COPD cohort COSYCONET. Respir Res 21: 28-28 (ARCN, BREATH, CPC-M, UGMLC) https://doi.org/10.1186/s12931-020-1293-6 https://respiratory-research.biomedcentral.com/track/pdf/10.1186/s12931-020-1293-6

Jensen-Kondering U, Neumann A, Margraf NG, Gövert F, Brüggemann N, Schunk D, Bahmer T, Schramm P, Schreiber S, Jansen O (2020) Cerebral Imaging in Patients with COVID-19 and Neurological Symptoms: First Experience from two University Hospitals in Northern Germany. RöFo – Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren (ARCN) https://doi.org/10.1055/a-1265-7209 https://www.thieme-connect.de/products/ejournals/pdf/10.1055/a-1265-7209.pdf

Jäckle S, García-Vázquez V, Eixmann T, Matysiak F, von Haxthausen F, Sieren MM, Schulz-Hildebrandt H, Hüttmann G, Ernst F, Kleemann M, Pätz T (2020) Three-dimensional guidance including shape sensing of a stentgraft system for endovascular aneurysm repair. Int J Comput Assist Radiol Surg 15: 1033-1042 (ARCN) https://doi.org/10.1007/s11548-020-02167-2 https://link.springer.com/content/pdf/10.1007/s11548-020-02167-2.pdf

Illi S, Maison N, Omony J, Thiele D, Hansen G, Kopp MV, Bahmer T, Rabe K, Schaub B, Von Mutius E (2020) 17q21 and phenotypes of wheeze and asthma in children and adults. Allergy 75: 284-284 (ARCN, BREATH, CPC-M) <Go to ISI>://WOS:000566847300524

Hundt JE, Iwata H, Pieper M, Pfündl R, Bieber K, Zillikens D, König P, Ludwig RJ (2020) Visualization of autoantibodies and neutrophils in vivo identifies novel checkpoints in autoantibody-induced tissue injury. Sci Rep 10: 4509-4509 (ARCN) https://doi.org/10.1038/s41598-020-60233-w https://pubmed.ncbi.nlm.nih.gov/32161277

Humberg A, Fortmann I, Siller B, Kopp MV, Herting E, Göpel W, Härtel C (2020) Preterm birth and sustained inflammation: consequences for the neonate. Semin Immunopathol 42: 451-468 (ARCN) https://doi.org/10.1007/s00281-020-00803-2 https://link.springer.com/content/pdf/10.1007/s00281-020-00803-2.pdf

Herth F, Hohlfeld JM, Haas J, de la Hoz A, Jin X, Kreitner K-F, Vogelmeier C, Vogel-Claussen J, Watz H (2020) The effect of tiotropium/olodaterol versus fluticasone propionate/salmeterol on left ventricular filling and lung hyperinflation in patients with COPD. BMJ Open Respiratory Research 7: e000741 (ARCN, BREATH, UGMLC) https://doi.org/10.1136/bmjresp-2020-000741 https://bmjopenrespres.bmj.com/content/bmjresp/7/1/e000741.full.pdf

Herster F, Bittner Z, Archer NK, Dickhöfer S, Eisel D, Eigenbrod T, Knorpp T, Schneiderhan-Marra N, Löffler MW, Kalbacher H, Vierbuchen T, Heine H, Miller LS, Hartl D, Freund L, Schäkel K, Heister M, Ghoreschi K, Weber ANR (2020) Neutrophil extracellular trap-associated RNA and LL37 enable self-amplifying inflammation in psoriasis. Nature Communications 11: 105-105 (ARCN) https://doi.org/10.1038/s41467-019-13756-4 https://www.ncbi.nlm.nih.gov/pubmed/31913271

Hendriks LEL, Menis J, De Ruysscher DKM, Reck M (2020) Combination of Immunotherapy and Radiotherapy—The Next Magic Step in the Management of Lung Cancer? J Thorac Oncol 15: 166-169 (ARCN) https://doi.org/10.1016/j.jtho.2019.12.106 https://pubmed.ncbi.nlm.nih.gov/32127183

Gupta RK, Calderwood CJ, Yavlinsky A, Krutikov M, Quartagno M, Aichelburg MC, Altet N, Diel R, Dobler CC, Dominguez J, Doyle JS, Erkens C, Geis S, Haldar P, Hauri AM, Hermansen T, Johnston JC, Lange C, Lange B, van Leth F, Muñoz L, Roder C, Romanowski K, Roth D, Sester M, Sloot R, Sotgiu G, Woltmann G, Yoshiyama T, Zellweger J-P, Zenner D, Aldridge RW, Copas A, Rangaka MX, Lipman M, Noursadeghi M, Abubakar I (2020) Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings. Nat Med 26: 1941-1949 (ARCN) https://doi.org/10.1038/s41591-020-1076-0 https://www.nature.com/articles/s41591-020-1076-0

Gülsen A, Yigitbas BA, Uslu B, Drömann D, Kilinc O (2020) The Effect of Smoking on COVID-19 Symptom Severity: Systematic Review and Meta-Analysis. Pulm Med 2020: 1-11 (ARCN) https://doi.org/10.1155/2020/7590207 https://doi.org/10.1155/2020/7590207

Gülsen A, Wedi B, Jappe U (2020) Hypersensitivity reactions to biologics (part II): classifications and current diagnostic and treatment approaches. Allergo Journal International 29: 139-154 (ARCN) https://doi.org/10.1007/s40629-020-00127-5 https://doi.org/10.1007/s40629-020-00127-5

Gülsen A, Wedi B, Jappe U (2020) Hypersensitivity reactions to biologics (part I): allergy as an important differential diagnosis in complex immune-derived adverse events*. Allergo J 29: 32-61 (ARCN) https://doi.org/10.1007/s15007-020-2550-1 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289641/pdf/15007_2020_Article_2550.pdf

Gülsen A, Wedi B, Jappe U (2020) Hypersensitivity reactions to biologics (part I): allergy as an important differential diagnosis in complex immune-derived adverse events. Allergo Journal International 29: 97-125 (ARCN) https://doi.org/10.1007/s40629-020-00126-6 https://link.springer.com/content/pdf/10.1007/s40629-020-00126-6.pdf

Groth EE, Weber M, Bahmer T, Pedersen F, Kirsten A, Börnigen D, Rabe KF, Watz H, Ammerpohl O, Goldmann T (2020) Exploration of the sputum methylome and omics deconvolution by quadratic programming in molecular profiling of asthma and COPD: the road to sputum omics 2.0. Respir Res 21: 274 (ARCN) https://doi.org/10.1186/s12931-020-01544-4 https://respiratory-research.biomedcentral.com/track/pdf/10.1186/s12931-020-01544-4

Grote HJ, Feng Z, Schlichting M, Helwig C, Ruisi M, Jin H, Scheuenpflug J, Gann C-N, Su Z, Reck M, Vokes EE, Kerr KM (2020) Programmed Death-Ligand 1 Immunohistochemistry Assay Comparison Studies in NSCLC: Characterization of the 73-10 Assay. J Thorac Oncol 15: 1306-1316 (ARCN) https://doi.org/10.1016/j.jtho.2020.04.013 https://www.jto.org/article/S1556-0864(20)30327-0/pdf

Griesinger F, Eberhardt W, Nusch A, Reiser M, Zahn M-O, Maintz C, Bernhardt C, Losem C, Stenzinger A, Heukamp LC, Büttner R, Marschner N, Jänicke M, Fleitz A, Spring L, Sahlmann J, Karatas A, Hipper A, Weichert W, Heilmann M, Sadjadian P, Gleiber W, Grah C, Waller CF, Reck M, Rittmeyer A, Christopoulos P, Sebastian M, Thomas M (2020) Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315). Lung Cancer (ARCN, TLRC) https://doi.org/10.1016/j.lungcan.2020.10.012 https://www.lungcancerjournal.info/article/S0169-5002(20)30663-2/pdf

Govoni M, Bassi M, Vezzoli S, Lucci G, Emirova A, Nandeuil MA, Petruzzelli S, Jellema GL, Afolabi EK, Colgan B, Leaker B, Kornmann O, Beeh KM, Watz H, Singh D (2020) Sputum and blood transcriptomics characterisation of the inhaled PDE4 inhibitor CHF6001 on top of triple therapy in patients with chronic bronchitis. Respir Res 21: 72 (ARCN) https://doi.org/10.1186/s12931-020-1329-y https://respiratory-research.biomedcentral.com/track/pdf/10.1186/s12931-020-1329-y

Gosens R, Hiemstra PS, Adcock IM, Bracke KR, Dickson RP, Hansbro PM, Krauss-Etschmann S, Smits HH, Stassen FRM, Bartel S (2020) Host-microbe cross-talk in the lung microenvironment: implications for understanding and treating chronic lung disease. Eur Respir J 56: 1902320 (ARCN) https://doi.org/10.1183/13993003.02320-2019 https://erj.ersjournals.com/content/erj/56/2/1902320.full.pdf

Gosens R, Hiemstra PS, Adcock IM, Bracke KR, Dickson RP, Hansbro PM, Krauss-Etschmann S, Smits HH, Stassen FRM, Bartel S (2020) Host-microbe cross-talk in the lung microenvironment: implications for understanding and treating chronic lung disease. Eur Respir J: 1902320 (ARCN) https://doi.org/10.1183/13993003.02320-2019 https://erj.ersjournals.com/content/erj/early/2020/04/27/13993003.02320-2019.full.pdf

González Roldán N, Duda KA (2020) Editorial: Role of Lipids in the Dynamics of Allergic Airway Inflammation. Front Immunol 11 (ARCN) https://doi.org/10.3389/fimmu.2020.612297 https://www.frontiersin.org/article/10.3389/fimmu.2020.612297

Gloeckl R, Nell C, Schneeberger T, Jarosch I, Boensch M, Watz H, Wirtz H, Welte T, Kenn K, Koczulla AR (2020) Benefits of pulmonary rehabilitation in patients with advanced lymphangioleiomyomatosis (LAM) compared with COPD – a retrospective analysis. Orphanet J Rare Dis 15: 255 (ARCN, BREATH, UGMLC) https://doi.org/10.1186/s13023-020-01540-3 https://ojrd.biomedcentral.com/track/pdf/10.1186/s13023-020-01540-3

Gesierich W, Darwiche K, Döllinger F, Eberhardt R, Eisenmann S, Grah C, Heußel CP, Hübner RH, Ley-Zaporozhan J, Stanzel F, Welter S, Hoffmann H (2020) Positionspapier der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin und der Deutschen Gesellschaft für Thoraxchirurgie in Kooperation mit der Deutschen Röntgengesellschaft: Strukturvoraussetzungen von Zentren für die interventionelle Emphysemtherapie. Pneumologie 74: 17-23 (ARCN, TLRC) https://doi.org/10.1055/a-1069-2474 <Go to ISI>://WOS:000508210600012

Geng G, Yu X, Jiang J, Yu X (2020) Aetiology and pathogenesis of paraneoplastic autoimmune disorders. Autoimmun Rev 19: 102422 (ARCN) https://doi.org/10.1016/j.autrev.2019.102422 Garon EB, Scagliotti GV, Gautschi O, Reck M, Thomas M, Iglesias Docampo L, Kalofonos H, Kim J-H, Gans S, Te Brustugun O, Orlov SV, Cuyun Carter G, Zimmermann AH, Oton AB, Alexandris E, Lee P, Wolff K, Stefaniak VJ, Socinski MA, Pérol M (2020) Exploratory analysis of front-line therapies in REVEL: a randomised phase 3 study of ramucirumab plus docetaxel versus docetaxel for the treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy. ESMO Open 5: e000567 (ARCN, TLRC) https://doi.org/10.1136/esmoopen-2019-000567 https://www.ncbi.nlm.nih.gov/pubmed/31958290

Garassino MC, Gadgeel S, Esteban E, Felip E, Speranza G, Domine M, Hochmair MJ, Powell S, Cheng SY-S, Bischoff HG, Peled N, Reck M, Hui R, Garon EB, Boyer M, Wei Z, Burke T, Pietanza MC, Rodríguez-Abreu D (2020) Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. The Lancet Oncology 21: 387-397 (ARCN) https://doi.org/10.1016/s1470-2045(19)30801-0 https://www.ncbi.nlm.nih.gov/pubmed/32035514

Gao Y, Chen Y, Zhang Z, Yu X, Zheng J (2020) Recent Advances in Mouse Models of Sjögren’s Syndrome. Front Immunol 11: 1158 ((ARCN)) https://doi.org/10.3389/fimmu.2020.01158 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338666/pdf/fimmu-11-01158.pdf

Gadgeel S, Rodríguez-Abreu D, Speranza G, Esteban E, Felip E, Dómine M, Hui R, Hochmair MJ, Clingan P, Powell SF, Cheng SY-S, Bischoff HG, Peled N, Grossi F, Jennens RR, Reck M, Garon EB, Novello S, Rubio-Viqueira B, Boyer M, Kurata T, Gray JE, Yang J, Bas T, Pietanza MC, Garassino MC (2020) Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non–Small-Cell Lung Cancer. J Clin Oncol 38: 1505-1517 (ARCN) https://doi.org/10.1200/jco.19.03136 https://pubmed.ncbi.nlm.nih.gov/32150489

Früh M, Panje CM, Reck M, Blackhall F, Califano R, Cappuzzo F, Besse B, Novello S, Garrido P, Felip E, O’Brien M, Paz Ares L, de Marinis F, Westeel V, De Ruysscher D, Putora PM (2020) Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) – A decision-making analysis amongst European lung cancer experts. Lung Cancer 146: 6-11 (ARCN) https://doi.org/10.1016/j.lungcan.2020.03.024 https://www.lungcancerjournal.info/article/S0169-5002(20)30354-8/pdf

Frey A, Lunding LP, Ehlers JC, Weckmann M, Zissler UM, Wegmann M (2020) More Than Just a Barrier: The Immune Functions of the Airway Epithelium in Asthma Pathogenesis. Front Immunol 11: 761 (ARCN, CPC-M) https://doi.org/10.3389/fimmu.2020.00761 https://www.frontiersin.org/articles/10.3389/fimmu.2020.00761/full

Franzen KF, Belkin S, Goldmann T, Reppel M, Watz H, Mortensen K, Droemann D (2020) The impact of heated tobacco products on arterial stiffness. Vasc Med 25: 572-574 (ARCN) https://doi.org/10.1177/1358863×20943292 https://journals.sagepub.com/doi/abs/10.1177/1358863X20943292

Forstner C, Patchev V, Rohde G, Rupp J, Witzenrath M, Welte T, Burgmann H, Pletz MW, Dreher M, Cornelissen C, Knüppel W, Stolz D, Suttorp N, Witzenrath M, Creutz P, Mikolajewska A, Bauer T, Krieger D, Pankow W, Thiemig D, Hauptmeier B, Ewig S, Wehde D, Prediger M, Schmager S, Kolditz M, Schulte-Hubbert B, Langner S, Albrich W, Welte T, Freise J, Barten G, Arenas Toro O, Nawrocki M, Naim J, Witte M, Kröner W, Illig T, Klopp N, Kreuter M, Herth F, Hummler S, Ravn P, Vestergaard-Jensen A, Baunbaek-Knudsen G, Pletz M, Kroegel C, Frosinski J, Winning J, Schleenvoigt B, Dalhoff K, Rupp J, Hörster R, Drömann D, Rohde G, Drijkoningen J, Braeken D, Buschmann H, Schaberg T, Hering I, Panning M, Wallner M (2020) Rate and Predictors of Bacteremia in Afebrile Community-Acquired Pneumonia. Chest 157: 529-539 (ARCN, BREATH, TLRC) https://doi.org/10.1016/j.chest.2019.10.006 https://pubmed.ncbi.nlm.nih.gov/31669433

Ferguson GT, Shaikh A, Tetzlaff K, Mueller A, Magnussen H, Watz H (2020) <p>Effect of Inhaled Corticosteroid Withdrawal on Chronic Obstructive Pulmonary Disease Exacerbations in Patients Taking Triple Therapy at Baseline</p>. Int J Chron Obstruct Pulmon Dis Volume 15: 2879-2888 (ARCN) https://doi.org/10.2147/copd.S237408

Ferguson GT, Rabe KF, Martinez FJ, Wang C, Trivedi R, St Rose E, Ballal S, McLaren J, Darken P, Aurivillius M, Dorinsky P, Reisner C (2020) Rate of Severe COPD Exacerbations with Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Dual Therapies: A Post-Hoc Analysis of the ETHOS Trial Excluding Data from China. American Journal of Respiratory and Critical Care Medicine 201 (ARCN) <Go to ISI>://WOS:000556622801034

Ferguson GT, Rabe KF, Martinez FJ, Trivedi R, St Rose E, Ballal S, Darken P, Aurivillius M, Dorinsky P, Reisner C (2020) Cardiovascular Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Chronic Obstructive Pulmonary Disease (COPD): A 24-Hour Hotter Monitoring Sub-Study of the ETHOS Trial. American Journal of Respiratory and Critical Care Medicine 201 (ARCN) <Go to ISI>://WOS:000556622803050

Ferguson GT, Rabe KF, Bourne E, Ballal S, DeAngelis K, Aurivillius M, Reisner C, Dorinsky P (2020) 12-Hour Lung Function Assessment of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Delivered by Co-suspension Delivery Technology in Patients with COPD. Pneumologie 74: S43-S44 (ARCN) https://doi.org/10.1055/s-0039-3403158 <Go to ISI>://WOS:000588631500101

Ferastraoaru D, Bax HJ, Bergmann C, Capron M, Castells M, Dombrowicz D, Fiebiger E, Gould HJ, Hartmann K, Jappe U, Jordakieva G, Josephs DH, Levi-Schaffer F, Mahler V, Poli A, Rosenstreich D, Roth-Walter F, Shamji M, Steveling-Klein EH, Turner MC, Untersmayr E, Karagiannis SN, Jensen-Jarolim E (2020) AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer—a Position Paper of the European Academy of Allergy and Clinical Immunology (EAACI). Clinical and Translational Allergy 10: 32 (ARCN) https://doi.org/10.1186/s13601-020-00335-w https://ctajournal.biomedcentral.com/track/pdf/10.1186/s13601-020-00335-w

El-Faham MH, Gai F, Igetei JE, Richter S, Falcone FH, Schramm G, Doenhoff MJ (2020) Author Correction: Antigenic cross-reactivity between Schistosoma mansoni and allergenic invertebrates putatively due to shared glycanic epitopes. Sci Rep 10: 8623 ((ARCN)) https://doi.org/10.1038/s41598-020-65548-2 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239939/pdf/41598_2020_Article_65548.pdf

El-Faham MH, Gai F, Igetei JE, Richter S, Falcone FH, Schramm G, Doenhoff MJ (2020) Antigenic cross-reactivity between Schistosoma mansoni and allergenic invertebrates putatively due to shared glycanic epitopes. Sci Rep 10: 3350-3350 ((ARCN)) https://doi.org/10.1038/s41598-020-59892-6 https://pubmed.ncbi.nlm.nih.gov/32099050

Eguiluz‐Gracia I, Mathioudakis AG, Bartel S, Vijverberg SJH, Fuertes E, Comberiati P, Cai YS, Tomazic PV, Diamant Z, Vestbo J, Galan C, Hoffmann B (2020) The need for clean air: The way air pollution and climate change affect allergic rhinitis and asthma. Allergy 75: 2170-2184 (ARCN) https://doi.org/10.1111/all.14177 https://www.ncbi.nlm.nih.gov/pubmed/31916265

Dietz S, Christopoulos P, Yuan Z, Angeles AK, Gu L, Volckmar A-L, Ogrodnik SJ, Janke F, Fratte CD, Zemojtel T, Schneider MA, Kazdal D, Endris V, Meister M, Muley T, Cecchin E, Reck M, Schlesner M, Thomas M, Stenzinger A, Sültmann H (2020) Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA. EBioMedicine 62: 103103 (ARCN, TLRC) https://doi.org/10.1016/j.ebiom.2020.103103 https://www.thelancet.com/pdfs/journals/ebiom/PIIS2352-3964(20)30479-5.pdf

Diel R, Nienhaus A, Witte P, Ziegler R (2020) Protection of healthcare workers against transmission of Mycobacterium tuberculosis in hospitals: a review of the evidence. ERJ Open Research 6: 00317-02019 (ARCN) https://doi.org/10.1183/23120541.00317-2019 https://openres.ersjournals.com/content/erjor/6/1/00317-2019.full.pdf

Diel R, Nienhaus A (2020) Cost of illness of non-multidrug-resistant tuberculosis in Germany: an update. ERJ Open Research 6: 00329-02020 (ARCN) https://doi.org/10.1183/23120541.00329-2020 https://openres.ersjournals.com/content/erjor/6/4/00329-2020.full.pdf

Danov O, Wolff M, Bartel S, Böhlen S, Obernolte H, Wronski S, Jonigk D, Hammer B, Kovacevic D, Reuter S, Krauss-Etschmann S, Sewald K (2020) Cigarette Smoke Affects Dendritic Cell Populations, Epithelial Barrier Function, and the Immune Response to Viral Infection With H1N1. Frontiers in Medicine 7: 571003 (ARCN, BREATH) https://doi.org/10.3389/fmed.2020.571003

Consortium ITP-CAoWG (2020) Pan-cancer analysis of whole genomes. Nature 578: 82-93 (ARCN) https://doi.org/10.1038/s41586-020-1969-6 https://www.nature.com/articles/s41586-020-1969-6.pdf

Chen Y, Li S, Huang R, Zhang Z, Petersen F, Zheng J, Yu X (2020) Comprehensive meta-analysis reveals an association of the HLA-DRB1*1602 allele with autoimmune diseases mediated predominantly by autoantibodies. Autoimmun Rev 19: 102532 (ARCN) https://doi.org/10.1016/j.autrev.2020.102532 https://www.sciencedirect.com/science/article/abs/pii/S1568997220300872?via%3Dihub

Castro M, Rabe KF, Corren J, Pavord ID, Katelaris CH, Tohda Y, Zhang B, Rice MS, Maroni J, Rowe P, Pirozzi G, Amin N, Ruddy M, Akinlade B, Graham NMH, Teper A (2020) Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthma. ERJ Open Research 6: 00204-02019 (ARCN) https://doi.org/10.1183/23120541.00204-2019 <Go to ISI>://WOS:000532553200029

Castro M, Maspero J, Sher L, Rabe K, Casale T, Rice M, Ruddy M, Rowe P, Deniz Y (2020) Dupilumab Reduces Oral Corticosteroid Use and Severe Exacerbations and Improves Lung Function in Patients With Oral Corticosteroid-Dependent Severe Asthma With and Without Comorbid Allergic Rhinitis in the Phase 3 LIBERTY ASTHMA VENTURE Study. Journal of Allergy and Clinical Immunology 145: Ab173-Ab173 (ARCN) <Go to ISI>://WOS:000517092700555

Calabrò L, Peters S, Soria J-C, Di Giacomo AM, Barlesi F, Covre A, Altomonte M, Vegni V, Gridelli C, Reck M, Rizvi N, Maio M (2020) Challenges in lung cancer therapy during the COVID-19 pandemic. The Lancet Respiratory Medicine 8: 542-544 (ARCN) https://doi.org/10.1016/s2213-2600(20)30170-3

Brueckl WM, Reck M, Rittmeyer A, Kollmeier J, Wesseler C, Wiest GH, Christopoulos P, Tufman A, Hoffknecht P, Ulm B, Reich F, Ficker JH, Laack E (2020) Efficacy of Docetaxel Plus Ramucirumab as Palliative Third-Line Therapy Following Second-Line Immune-Checkpoint-Inhibitor Treatment in Patients With Non-Small-Cell Lung Cancer Stage IV. Clin Med Insights Oncol 14: 117955492095135 (ARCN) https://doi.org/10.1177/1179554920951358 https://doi.org/10.1177/1179554920951358

Bourdin A, Criner G, Devouassoux G, Dransfield M, Halpin DMG, Han MK, Jones CE, Kalhan R, Lange P, Lettis S, Lipson DA, Lomas DA, Echave-Sustaeta María-Tomé JM, Martin N, Martinez FJ, Quasny H, Sail L, Siler TM, Singh D, Thomashow B, Watz H, Wise R, Hanania NA (2020) InforMing the PAthway of COPD Treatment Single-Inhaler Triple Therapy (Fluticasone Furoate/ Umeclidinium/ Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium /Vilanterol in Patients With COPD: Analysis of the Western Europe and North America Regions. Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation (ARCN) https://doi.org/10.15326/jcopdf.2020.0158

Bossen J (2020) Driver mutations in major lung cancer oncogenes can be analyzed in Drosophila models. Altex (ARCN) https://doi.org/10.14573/altex.1912131 https://www.altex.org/index.php/altex/article/download/1499/2091

Boateng E, Krauss-Etschmann S (2020) miRNAs in Lung Development and Diseases. Int J Mol Sci 21: 2765 (ARCN) https://doi.org/10.3390/ijms21082765 https://res.mdpi.com/d_attachment/ijms/ijms-21-02765/article_deploy/ijms-21-02765-v2.pdf

Bernardes JP, Mishra N, Tran F, Bahmer T, Best L, Blase JI, Bordoni D, Franzenburg J, Geisen U, Josephs-Spaulding J, Köhler P, Künstner A, Rosati E, Aschenbrenner AC, Bacher P, Baran N, Boysen T, Brandt B, Bruse N, Dörr J, Dräger A, Elke G, Ellinghaus D, Fischer J, Forster M, Franke A, Franzenburg S, Frey N, Friedrichs A, Fuß J, Glück A, Hamm J, Hinrichsen F, Hoeppner MP, Imm S, Junker R, Kaiser S, Kan YH, Knoll R, Lange C, Laue G, Lier C, Lindner M, Marinos G, Markewitz R, Nattermann J, Noth R, Pickkers P, Rabe KF, Renz A, Röcken C, Rupp J, Schaffarzyk A, Scheffold A, Schulte-Schrepping J, Schunk D, Skowasch D, Ulas T, Wandinger K-P, Wittig M, Zimmermann J, Busch H, Hoyer BF, Kaleta C, Heyckendorf J, Kox M, Rybniker J, Schreiber S, Schultze JL, Rosenstiel P, Banovich NE, Desai T, Eickelberg O, Haniffa M, Horvath P, Kropski JA, Lafyatis R, Lundeberg J, Meyer K, Nawijn MC, Nikolic M, Ordovas Montanes J, Pe’er D, Tata PR, Rawlins E, Regev A, Reyfman P, Samakovlis C, Schultze J, Shalek A, Shepherd D, Spence J, Teichmann S, Theis F, Tsankov A, van den Berge M, von Papen M, Whitsett J, Zaragosi LE, Angelov A, Bals R, Bartholomäus A, Becker A, Bezdan D, Bonifacio E, Bork P, Clavel T, Colme-Tatche M, Diefenbach A, Dilthey A, Fischer N, Förstner K, Frick J-S, Gagneur J, Goesmann A, Hain T, Hummel M, Janssen S, Kalinowski J, Kallies R, Kehr B, Keller A, Kim-Hellmuth S, Klein C, Kohlbacher O, Korbel JO, Kurth I, Landthaler M, Li Y, Ludwig K, Makarewicz O, Marz M, McHardy A, Mertes C, Nöthen M, Nürnberg P, Ohler U, Ossowski S, Overmann J, Peter S, Pfeffer K, Poetsch AR, Pühler A, Rajewsky N, Ralser M, Rieß O, Ripke S, Nunes da Rocha U, Rosenstiel P, Saliba A-E, Sander LE, Sawitzki B, Schiffer P, Schulte E-C, Schultze JL, Sczyrba A, Stegle O, Stoye J, Theis F, Vehreschild J, Vogel J, von Kleist M, Walker A, Walter J, Wieczorek D, Ziebuhr J (2020) Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19. Immunity 53: 1296-1314.e1299 (ARCN, UGMLC) https://doi.org/10.1016/j.immuni.2020.11.017 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689306/pdf/main.pdf

Behr J, Prasse A, Wirtz H, Koschel D, Pittrow D, Held M, Klotsche J, Andreas S, Claussen M, Grohé C, Wilkens H, Hagmeyer L, Skowasch D, Meyer JF, Kirschner J, Gläser S, Kahn N, Welte T, Neurohr C, Schwaiblmair M, Bahmer T, Oqueka T, Frankenberger M, Kreuter M (2020) Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registry. Eur Respir J 56: 1902279 (ARCN, BREATH, CPC-M, TLRC) https://doi.org/10.1183/13993003.02279-2019 https://erj.ersjournals.com/content/56/2/1902279

Bédard A, Antó JM, Fonseca JA, Arnavielhe S, Bachert C, Bedbrook A, Bindslev‐Jensen C, Bosnic‐Anticevich S, Cardona V, Cruz AA, Fokkens WJ, Garcia‐Aymerich J, Hellings PW, Ivancevich JC, Klimek L, Kuna P, Kvedariene V, Larenas‐Linnemann D, Melén E, Monti R, Mösges R, Mullol J, Papadopoulos NG, Pham‐Thi N, Samolinski B, Tomazic PV, Toppila‐Salmi S, Ventura MT, Yorgancioglu A, Bousquet J, Pfaar O, Basagaña X, Aberer W, Agache I, Akdis CA, Akdis M, Aliberti MR, Almeida R, Amat F, Angles R, Annesi‐Maesano I, Ansotegui IJ, Anto JM, Arnavielle S, Asayag E, Asarnoj A, Arshad H, Avolio F, Bacci E, Baiardini I, Barbara C, Barbagallo M, Baroni I, Barreto BA, Bateman ED, Bedolla‐Barajas M, Bewick M, Beghé B, Bel EH, Bergmann KC, Bennoor KS, Benson M, Bertorello L, Białoszewski AZ, Bieber T, Bialek S, Bjermer L, Blain H, Blasi F, Blua A, Bochenska Marciniak M, Bogus‐Buczynska I, Boner AL, Bonini M, Bonini S, Bosse I, Bouchard J, Boulet LP, Bourret R, Bousquet PJ, Braido F, Briedis V, Brightling CE, Brozek J, Bucca C, Buhl R, Buonaiuto R, Panaitescu C, Burguete Cabañas MT, Burte E, Bush A, Caballero‐Fonseca F, Caillaud D, Caimmi D, Calderon MA, Camargos PAM, Camuzat T, Canfora G, Canonica GW, Carlsen KH, Carreiro‐Martins P, Carriazo AM, Carr W, Cartier C, Casale T, Castellano G, Cecchi L, Cepeda AM, Chavannes NH, Chen Y, Chiron R, Chivato T, Chkhartishvili E, Chuchalin AG, Chung KF, Ciaravolo MM, Ciceran A, Cingi C, Ciprandi G, Carvalho Coehlo AC, Colas L, Colgan E, Coll J, Conforti D, Constantinidis J, Correia de Sousa J, Cortés‐Grimaldo RM, Corti F, Costa E, Costa‐Dominguez MC, Courbis AL, Cox L, Crescenzo M, Custovic A, Czarlewski W, Dahlen SE, D’Amato G, Dario C, da Silva J, Dauvilliers Y, Darsow U, De Blay F, De Carlo G, Dedeu T, de Fátima Emerson M, De Feo G, De Vries G, De Martino B, Motta Rubini NP, Deleanu D, Denburg JA, Devillier P, Di Capua Ercolano S, Di Carluccio N, Didier A, Dokic D, Dominguez‐Silva MG, Douagui H, Dray G, Dubakiene R, Durham SR, Du Toit G, Dykewicz MS, El‐Gamal Y, Eklund P, Eller E, Emuzyte R, Farrell J, Farsi A, Ferreira de Mello J, Ferrero J, Fink‐Wagner A, Fiocchi A, Fontaine JF, Forti S, Fuentes‐Perez JM, Gálvez‐Romero JL, Gamkrelidze A, García‐Cobas CY, Garcia‐Cruz MH, Gemicioğlu B, Genova S, Christoff G, Gereda JE, Gerth van Wijk R, Gomez RM, Gómez‐Vera J, González Diaz S, Gotua M, Grisle I, Guidacci M, Guldemond NA, Gutter Z, Guzmán MA, Haahtela T, Hajjam J, Hernández L, Hourihane JB, Huerta‐Villalobos YR, Humbert M, Iaccarino G, Illario M, Ispayeva Z, Jares EJ, Jassem E, Johnston SL, Joos G, Jung KS, Just J, Jutel M, Kaidashev I, Kalayci O, Kalyoncu AF, Karjalainen J, Kardas P, Keil T, Keith PK, Khaitov M, Khaltaev N, Kleine‐Tebbe J, Kowalski ML, Kuitunen M, Kull I, Kupczyk M, Krzych‐Fałta E, Lacwik P, Laune D, Lauri D, Lavrut J, Le LTT, Lessa M, Levato G, Li J, Lieberman P, Lipiec A, Lipworth B, Lodrup Carlsen KC, Louis R, Lourenço O, Luna‐Pech JA, Magnan A, Mahboub B, Maier D, Mair A, Majer I, Malva J, Mandajieva E, Manning P, De Manuel Keenoy E, Marshall GD, Masjedi MR, Maspero JF, Mathieu‐Dupas E, Matta Campos JJ, Matos AL, Maurer M, Mavale‐Manuel S, Mayora O, Meco C, Medina‐Avalos MA, Melo‐Gomes E, Meltzer EO, Menditto E, Mercier J, Miculinic N, Mihaltan F, Milenkovic B, Moda G, Mogica‐Martinez MD, Mohammad Y, Momas I, Montefort S, Mora Bogado D, Morais‐Almeida M, Morato‐Castro FF, Mota‐Pinto A, Moura Santo P, Münter L, Muraro A, Murray R, Naclerio R, Nadif R, Nalin M, Napoli L, Namazova‐Baranova L, Neffen H, Niedeberger V, Nekam K, Neou A, Nieto A, Nogueira‐Silva L, Nogues M, Novellino E, Nyembue TD, O’Hehir RE, Odzhakova C, Ohta K, Okamoto Y, Okubo K, Onorato GL, Ortega Cisneros M, Ouedraogo S, Pali‐Schöll I, Palkonen S, Panzner P, Park HS, Papi A, Passalacqua G, Paulino E, Pawankar R, Pedersen S, Pépin JL, Pereira AM, Persico M, Phillips J, Picard R, Pigearias B, Pin I, Pitsios C, Plavec D, Pohl W, Popov TA, Portejoie F, Potter P, Pozzi AC, Price D, Prokopakis EP, Puy R, Pugin B, Pulido Ross RE, Przemecka M, Rabe KF, Raciborski F, Rajabian‐Soderlund R, Reitsma S, Ribeirinho I, Rimmer J, Rivero‐Yeverino D, Rizzo JA, Rizzo MC, Robalo‐Cordeiro C, Rodenas F, Rodo X, Rodriguez Gonzalez M, Rodriguez‐Mañas L, Rolland C, Rodrigues Valle S, Roman Rodriguez M, Romano A, Rodriguez‐Zagal E, Rolla G, Roller‐Wirnsberger RE, Romano M, Rosado‐Pinto J, Rosario N, Rottem M, Ryan D, Sagara H, Salimäki J, Sanchez‐Borges M, Sastre‐Dominguez J, Scadding GK, Schunemann HJ, Scichilone N, Schmid‐Grendelmeier P, Sarquis Serpa F, Shamai S, Sheikh A, Sierra M, Simons FER, Siroux V, Sisul JC, Skrindo I, Solé D, Somekh D, Sondermann M, Sooronbaev T, Sova M, Sorensen M, Sorlini M, Spranger O, Stellato C, Stelmach R, Stukas R, Sunyer J, Strozek J, Szylling A, Tebyriçá JN, Thibaudon M, To T, Todo‐Bom A, Trama U, Triggiani M, Suppli Ulrik C, Urrutia‐Pereira M, Valenta R, Valero A, Valiulis A, Valovirta E, van Eerd M, van Ganse E, van Hage M, Vandenplas O, Vezzani G, Vasankari T, Vatrella A, Verissimo MT, Viart F, Viegi G, Vicheva D, Vontetsianos T, Wagenmann M, Walker S, Wallace D, Wang DY, Waserman S, Werfel T, Westman M, Wickman M, Williams DM, Williams S, Wilson N, Wright J, Wroczynski P, Yakovliev P, Yawn BP, Yiallouros PK, Yusuf OM, Zar HJ, Zhang L, Zhong N, Zernotti ME, Zhanat I, Zidarn M, Zuberbier T, Zubrinich C, Zurkuhlen A (2020) Correlation between work impairment, scores of rhinitis severity and asthma using the MASK‐air®App. Allergy 75: 1672-1688 (ARCN) https://doi.org/10.1111/all.14204 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/all.14204?download=true

Bartsch YC, Eschweiler S, Leliavski A, Lunding HB, Wagt S, Petry J, Lilienthal G-M, Rahmöller J, de Haan N, Hölscher A, Erapaneedi R, Giannou AD, Aly L, Sato R, de Neef LA, Winkler A, Braumann D, Hobusch J, Kuhnigk K, Krémer V, Steinhaus M, Blanchard V, Gemoll T, Habermann JK, Collin M, Salinas G, Manz RA, Fukuyama H, Korn T, Waisman A, Yogev N, Huber S, Rabe B, Rose-John S, Busch H, Berberich-Siebelt F, Hölscher C, Wuhrer M, Ehlers M (2020) IgG Fc sialylation is regulated during the germinal center reaction following immunization with different adjuvants. Journal of Allergy and Clinical Immunology 146: 652-666.e611 (ARCN) https://doi.org/10.1016/j.jaci.2020.04.059 https://www.jacionline.org/article/S0091-6749(20)30728-4/pdf

Bang Y-J, Golan T, Dahan L, Fu S, Moreno V, Park K, Geva R, De Braud F, Wainberg ZA, Reck M, Goff L, Laing N, Mi G, Oliveira JM, Wasserstrom H, Lin C-C (2020) Ramucirumab and durvalumab for previously treated, advanced non–small-cell lung cancer, gastric/gastro-oesophageal junction adenocarcinoma, or hepatocellular carcinoma: An open-label, phase Ia/b study (JVDJ). Eur J Cancer 137: 272-284 (ARCN) https://doi.org/10.1016/j.ejca.2020.06.007 https://doi.org/10.1016/j.ejca.2020.06.007

Bailey MH, Meyerson WU, Dursi LJ, Wang L-B, Dong G, Liang W-W, Weerasinghe A, Li S, Li Y, Kelso S, Saksena G, Ellrott K, Wendl MC, Wheeler DA, Getz G, Simpson JT, Gerstein MB, Ding L (2020) Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples. Nature Communications 11: 6232 (ARCN) https://doi.org/10.1038/s41467-020-20128-w https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705717/pdf/41467_2020_Article_20128.pdf

Bailey MH, Meyerson WU, Dursi LJ, Wang L-B, Dong G, Liang W-W, Weerasinghe A, Li S, Li Y, Kelso S, Saksena G, Ellrott K, Wendl MC, Wheeler DA, Getz G, Simpson JT, Gerstein MB, Ding L (2020) Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples. Nature Communications 11: 4748 (ARCN) https://doi.org/10.1038/s41467-020-18151-y https://doi.org/10.1038/s41467-020-18151-y

Bahmer T, Weckmann M, Dittrich AM, Schaub B, Happle C, Fuchs O, Grychtol R, Ricklefs I, Maison N, Thiele D, Skevaki C, Nikolaizik W, Rietschel E, König I, Hansen G, Kopp M, Rabe KF, von Mutius E (2020) Asthmaphänotypen in der ALL Age Asthma Kohorte „ALLIANCE“ des DZL – Aktueller Stand, Ergebnisse, Ausblick. Pneumologie 74: S9-S9 (ARCN) https://doi.org/10.1055/s-0039-3403071 <Go to ISI>://WOS:000588631500014

Bahmer T, Sand JMB, Weckmann M (2020) Lost in transition. Curr Opin Pulm Med 26: 40-46 (ARCN) https://doi.org/10.1097/mcp.0000000000000641

Antoniou K, Ender F, Vollbrandt T, Laumonnier Y, Rathmann F, Pasare C, Singh H, Köhl J (2020) Allergen-Induced C5a/C5aR1 Axis Activation in Pulmonary CD11b+ cDCs Promotes Pulmonary Tolerance through Downregulation of CD40. Cells 9: 300 (ARCN) https://doi.org/10.3390/cells9020300 https://www.ncbi.nlm.nih.gov/pubmed/31991941

Alter P, Orszag J, Kellerer C, Kahnert K, Speicher T, Watz H, Bals R, Welte T, Vogelmeier CF, Jörres RA (2020) Prediction of air trapping or pulmonary hyperinflation by forced spirometry in COPD patients: results from COSYCONET. ERJ Open Research 6: 00092-02020 (ARCN, BREATH, (CPC-M), UGMLC) https://doi.org/10.1183/23120541.00092-2020 https://openres.ersjournals.com/content/erjor/6/3/00092-2020.full.pdf

Ackermann CJ, Adderley H, Ortega-Franco A, Khan A, Reck M, Califano R (2020) First-Line Immune Checkpoint Inhibition for Advanced Non-Small-Cell Lung Cancer: State of the Art and Future Directions. Drugs 80: 1783-1797 (ARCN) https://doi.org/10.1007/s40265-020-01409-6 https://link.springer.com/article/10.1007/s40265-020-01409-6

Abdo M, Watz H, Veith V, Kirsten A-M, Biller H, Pedersen F, von Mutius E, Kopp MV, Hansen G, Waschki B, Rabe KF, Trinkmann F, Bahmer T (2020) Small airway dysfunction as predictor and marker for clinical response to biological therapy in severe eosinophilic asthma: a longitudinal observational study. Respir Res 21: 278 (ARCN, BREATH, CPC-M, TLRC) https://doi.org/10.1186/s12931-020-01543-5 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579879/pdf/12931_2020_Article_1543.pdf

 

2019

Žukovskaja O, Ryabchykov O, Straßburger M, Heinekamp T, Brakhage AA, Hennings CJ, Hübner CA, Wegmann M, Cialla‐May D, Bocklitz TW, Weber K, Popp J (2019) Towards Raman spectroscopy of urine as screening tool. Journal of Biophotonics 13: e201900143 (ARCN) https://doi.org/10.1002/jbio.201900143 https://onlinelibrary.wiley.com/doi/abs/10.1002/jbio.201900143

Xu Y, Borcherding AF, Heier C, Tian G, Roeder T, Kühnlein RP (2019) Chronic dysfunction of Stromal interaction molecule by pulsed RNAi induction in fat tissue impairs organismal energy homeostasis in Drosophila. Sci Rep 9: 6989 (ARCN) https://doi.org/10.1038/s41598-019-43327-y https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502815/pdf/41598_2019_Article_43327.pdf

Wetzke M, Kopp MV, Seidenberg J, Vogelberg C, Ankermann T, Happle C, Voigt G, Köster H, Illig T, Lex C, Schuster A, Panning M, Barten G, Rohde G, Welte T, Hansen G (2019) PedCAPNETZ – prospective observational study on community acquired pneumonia in children and adolescents. BMC Pulm Med 19: 238-238 (ARCN, BREATH) https://doi.org/10.1186/s12890-019-1013-5 https://www.ncbi.nlm.nih.gov/pubmed/31818288

Webering S, Lunding LP, Vock C, Schröder A, Gaede KI, Herzmann C, Fehrenbach H, Wegmann M (2019) The alpha‐melanocyte‐stimulating hormone acts as a local immune homeostasis factor in experimental allergic asthma. Clin Exp Allergy 49: 1026-1039 (ARCN) https://doi.org/10.1111/cea.13400 https://www.ncbi.nlm.nih.gov/pubmed/30980429

Watz H, Nagelschmitz J, Kirsten A, Pedersen F, van der Mey D, Schwers S, Bandel T-J, Rabe KF (2019) Safety and efficacy of the human neutrophil elastase inhibitor BAY 85-8501 for the treatment of non-cystic fibrosis bronchiectasis: A randomized controlled trial. Pulm Pharmacol Ther 56: 86-93 (ARCN) https://doi.org/10.1016/j.pupt.2019.03.009 https://www.sciencedirect.com/science/article/pii/S1094553918302827?via%3Dihub

von Siemens SM, Perneczky R, Vogelmeier CF, Behr J, Kauffmann-Guerrero D, Alter P, Trudzinski FC, Bals R, Grohé C, Söhler S, Waschki B, Lutter JI, Welte T, Jörres RA, Kahnert K (2019) The association of cognitive functioning as measured by the DemTect with functional and clinical characteristics of COPD: results from the COSYCONET cohort. Respir Res 20: 257 (ARCN, BREATH, CPC-M, UGMLC) https://doi.org/10.1186/s12931-019-1217-5 https://respiratory-research.biomedcentral.com/track/pdf/10.1186/s12931-019-1217-5

Uddin M, Watz H, Malmgren A, Pedersen F (2019) NETopathic Inflammation in Chronic Obstructive Pulmonary Disease and Severe Asthma. Front Immunol 10: 47 (ARCN) https://doi.org/10.3389/fimmu.2019.00047 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370641/pdf/fimmu-10-00047.pdf

Twisselmann N, Bartsch YC, Pagel J, Wieg C, Hartz A, Ehlers M, Härtel C (2019) IgG Fc Glycosylation Patterns of Preterm Infants Differ With Gestational Age. Front Immunol 9: 3166 (ARCN) https://doi.org/10.3389/fimmu.2018.03166 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346593/pdf/fimmu-09-03166.pdf

Trudzinski FC, Kahnert K, Vogelmeier CF, Alter P, Seiler F, Fähndrich S, Watz H, Welte T, Speer T, Zewinger S, Biertz F, Kauczor HU, Jörres RA, Bals R, Stefan A, Robert B, Jürgen B, Kathrin K, Burkhard B, Roland B, Ralf E, Beate S, Joachim H F, Manfred G, Christian G, Rainer H, Matthias H, Berthold J, Markus H, Felix H, Gerd H, Hugo A K, Anne-Marie K, Henrik W, Rembert K, Klaus K, Juliane K, Cornelia K-S, Christoph L, Peter Z, Michael P, Winfried J R, eeger W, Michael S, Christian T, Helmut T, Hartmut T, Christian VJ, Claus V, Ulrich W, Tobias W, Hubert W (2019) Combined effects of lung function, blood gases and kidney function on the exacerbation risk in stable COPD: Results from the COSYCONET cohort. Respir Med 154: 18-26 (ARCN, BREATH, CPC-M, TLRC, UGMLC) https://doi.org/10.1016/j.rmed.2019.06.007 https://www.ncbi.nlm.nih.gov/pubmed/31203096

Trudzinski FC, Alqudrah M, Omlor A, Zewinger S, Fliser D, Speer T, Seiler F, Biertz F, Koch A, Vogelmeier C, Welte T, Watz H, Waschki B, Fähndrich S, Jörres R, Bals R (2019) Consequences of chronic kidney disease in chronic obstructive pulmonary disease. Respir Res 20: 151 (ARCN, BREATH, CPC-M, UGMLC) https://doi.org/10.1186/s12931-019-1107-x https://www.ncbi.nlm.nih.gov/pubmed/31299972

Tay RY, Heigener D, Reck M, Califano R (2019) Immune checkpoint blockade in small cell lung cancer. Lung Cancer 137: 31-37 (ARCN) https://doi.org/10.1016/j.lungcan.2019.08.024 https://www.lungcancerjournal.info/article/S0169-5002(19)30625-7/fulltext

Stahl M, Wielpütz MO, Ricklefs I, Dopfer C, Barth S, Schlegtendal A, Graeber SY, Sommerburg O, Diekmann G, Hüsing J, Koerner-Rettberg C, Nährlich L, Dittrich A-M, Kopp MV, Mall MA (2019) Preventive Inhalation of Hypertonic Saline in Infants with Cystic Fibrosis (PRESIS). A Randomized, Double-Blind, Controlled Study. American Journal of Respiratory and Critical Care Medicine 199: 1238-1248 (ARCN, BREATH, TLRC, UGMLC) https://doi.org/10.1164/rccm.201807-1203OC https://www.ncbi.nlm.nih.gov/pubmed/30409023

Spahr H, Pfäffle C, Hüttmann G, Hillmann D (2019) Artifacts in speckle tracking and multi-aperture Doppler OCT imaging of lateral motion. Optics Letters 44: 1315 (ARCN) https://doi.org/10.1364/ol.44.001315 https://www.ncbi.nlm.nih.gov/pubmed/30874639

Spahr H, Pfäffle C, Burhan S, Kutzner L, Hilge F, Hüttmann G, Hillmann D (2019) Phase-sensitive interferometry of decorrelated speckle patterns. Sci Rep 9: 11748 (ARCN) https://doi.org/10.1038/s41598-019-47979-8 https://www.nature.com/articles/s41598-019-47979-8.pdf

Soti AL, Usemann J, Schaub B, Frey U, Latzin P, Fuchs O (2019) Can biomarkers in umbilical cord blood predict atopic disease at school age? Pediatr Res (ARCN, CPC-M) https://doi.org/10.1038/s41390-019-0686-z https://www.nature.com/articles/s41390-019-0686-z

Shu Y, Qiu W, Zheng J, Sun X, Yin J, Yang X, Yue X, Chen C, Deng Z, Li S, Yang Y, Peng F, Lu Z, Hu X, Petersen F, Yu X (2019) HLA class II allele DRB1*16:02 is associated with anti-NMDAR encephalitis. J Neurol Neurosurg Psychiatry 90: 652-658 ((ARCN)) https://doi.org/10.1136/jnnp-2018-319714 https://jnnp.bmj.com/content/early/2019/01/12/jnnp-2018-319714

Sethi S, Kerwin E, Watz H, Ferguson GT, Mroz R, Segarra R, Molins E, Jarreta D, Garcia Gil E (2019) <p>AMPLIFY: a randomized, Phase III study evaluating the efficacy and safety of aclidinium/formoterol vs monocomponents and tiotropium in patients with moderate-to-very severe symptomatic COPD</p>. Int J Chron Obstruct Pulmon Dis Volume 14: 667-682 (ARCN) https://doi.org/10.2147/copd.S189138 https://www.dovepress.com/getfile.php?fileID=48690

Sebastian M, Schröder A, Scheel B, Hong HS, Muth A, von Boehmer L, Zippelius A, Mayer F, Reck M, Atanackovic D, Thomas M, Schneller F, Stöhlmacher J, Bernhard H, Gröschel A, Lander T, Probst J, Strack T, Wiegand V, Gnad-Vogt U, Kallen K-J, Hoerr I, von der Muelbe F, Fotin-Mleczek M, Knuth A, Koch SD (2019) A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer. Cancer Immunology, Immunotherapy 68: 799-812 (ARCN, TLRC) https://doi.org/10.1007/s00262-019-02315-x https://link.springer.com/article/10.1007%2Fs00262-019-02315-x

Sebastian M, Barlesi F, Califano R, Mansfield AS, Blackhall FH, Flahavan EM, Davies J, Arnold P, Morris S, Reck M (2019) Treatment (tx) characteristics and clinical outcomes in patients (pts) with extensive-stage small cell lung cancer (ES-SCLC) treated with carboplatin (carbo) or cisplatin (cis) in combination with etoposide (etop) in US clinical practice. Ann Oncol 30: ii24 (ARCN) https://doi.org/10.1093/annonc/mdz071.006 https://pubmed.ncbi.nlm.nih.gov/32131195

Schröder T, Wiese AV, Ender F, Quell KM, Vollbrandt T, Duhn J, Sünderhauf A, Künstner A, Moreno‐Fernandez ME, Derer S, Aherrahrou Z, Lewkowich I, Divanovic S, Sina C, Köhl J, Laumonnier Y (2019) Short‐term high‐fat diet feeding protects from the development of experimental allergic asthma in mice. Clin Exp Allergy 49: 1245-1257 (ARCN) https://doi.org/10.1111/cea.13454 https://onlinelibrary.wiley.com/doi/abs/10.1111/cea.13454

Schocker F, Kull S, Schwager C, Behrends J, Jappe U (2019) Individual Sensitization Pattern Recognition to Cow’s Milk and Human Milk Differs for Various Clinical Manifestations of Milk Allergy. Nutrients 11: 1331 (ARCN) https://doi.org/10.3390/nu11061331 https://res.mdpi.com/nutrients/nutrients-11-01331/article_deploy/nutrients-11-01331-v2.pdf?filename=&attachment=1

Scagliotti GV, Gaafar R, Nowak AK, Nakano T, van Meerbeeck J, Popat S, Vogelzang NJ, Grosso F, Aboelhassan R, Jakopovic M, Ceresoli GL, Taylor P, Orlandi F, Fennell DA, Novello S, Scherpereel A, Kuribayashi K, Cedres S, Sørensen JB, Pavlakis N, Reck M, Velema D, von Wangenheim U, Kim M, Barrueco J, Tsao AS (2019) Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial. The Lancet Respiratory Medicine 7: 569-580 (ARCN) https://doi.org/10.1016/s2213-2600(19)30139-0 https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(19)30139-0/fulltext

Sarker RSJ, Conlon TM, Morrone C, Srivastava B, Konyalilar N, Verleden SE, Bayram H, Fehrenbach H, Yildirim AÖ (2019) CARM1 regulates senescence during airway epithelial cell injury in COPD pathogenesis. American Journal of Physiology-Lung Cellular and Molecular Physiology 317: L602-L614 (ARCN, CPC-M) https://doi.org/10.1152/ajplung.00441.2018 https://www.physiology.org/doi/abs/10.1152/ajplung.00441.2018

Rossi A, Voigtlaender M, Klose H, Schlüter H, Schön G, Loges S, Paolini M, Bokemeyer C, Reck M, Tarro G, Binder M (2019) High Aldehyde Dehydrogenase Levels Are Detectable in the Serum of Patients with Lung Cancer and May Be Exploited as Screening Biomarkers. J Oncol 2019: 1-11 (ARCN) https://doi.org/10.1155/2019/8970645 http://downloads.hindawi.com/journals/jo/2019/8970645.pdf

Ringshausen FC, Rademacher J, Pink I, de Roux A, Hickstein L, Ploner T, Welte T, Diel R (2019) Increasing bronchiectasis prevalence in Germany, 2009–2017: a population-based cohort study. Eur Respir J 54: 1900499 (ARCN, BREATH) https://doi.org/10.1183/13993003.00499-2019 https://erj.ersjournals.com/content/early/2019/08/14/13993003.00499-2019

Recke A, Massalme EG, Jappe U, Steinmüller-Magin L, Schmidt J, Hellenbroich Y, Hüning I, Gillessen-Kaesbach G, Zillikens D, Hartmann K (2019) Identification of the recently described plasminogen gene mutation p.Lys330Glu in a family from Northern Germany with hereditary angioedema. Clinical and Translational Allergy 9: 9 (ARCN) https://doi.org/10.1186/s13601-019-0247-x https://ctajournal.biomedcentral.com/track/pdf/10.1186/s13601-019-0247-x

Reck M, Shankar G, Lee A, Coleman S, McCleland M, Papadimitrakopoulou VA, Socinski MA, Sandler A (2019) Atezolizumab in combination with bevacizumab, paclitaxel and carboplatin for the first-line treatment of patients with metastatic non-squamous non-small cell lung cancer, including patients with EGFR mutations. Expert Rev Respir Med 14: 125-136 (ARCN) https://doi.org/10.1080/17476348.2020.1701439 https://www.ncbi.nlm.nih.gov/pubmed/31829747

Reck M, Schenker M, Lee KH, Provencio M, Nishio M, Lesniewski-Kmak K, Sangha R, Ahmed S, Raimbourg J, Feeney K, Corre R, Franke FA, Richardet E, Penrod JR, Yuan Y, Nathan FE, Bhagavatheeswaran P, DeRosa M, Taylor F, Lawrance R, Brahmer J (2019) Nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced non–small-cell lung cancer with high tumour mutational burden: patient-reported outcomes results from the randomised, open-label, phase III CheckMate 227 trial. Eur J Cancer 116: 137-147 (ARCN) https://doi.org/10.1016/j.ejca.2019.05.008 https://doi.org/10.1016/j.ejca.2019.05.008

Reck M, Rodríguez–Abreu D, Robinson AG, Hui R, Csőszi T, Fülöp A, Gottfried M, Peled N, Tafreshi A, Cuffe S, O´Brien M, Rao S, Hotta K, Vandormael K, Riccio A, Yang J, Pietanza MC, Brahmer JR (2019) Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater. J Clin Oncol 37: 537-546 (ARCN) https://doi.org/10.1200/jco.18.00149 http://ascopubs.org/doi/abs/10.1200/JCO.18.00149

Reck M, Mok TSK, Nishio M, Jotte RM, Cappuzzo F, Orlandi F, Stroyakovskiy D, Nogami N, Rodríguez-Abreu D, Moro-Sibilot D, Thomas CA, Barlesi F, Finley G, Lee A, Coleman S, Deng Y, Kowanetz M, Shankar G, Lin W, Socinski MA, Reck M, Mok TSK, Nishio M, Jotte RM, Cappuzzo F, Orlandi F, Stroyakovskiy D, Nogami N, Rodríguez-Abreu D, Moro-Sibilot D, Thomas CA, Barlesi F, Finley G, Lee A, Coleman S, Deng Y, Kowanetz M, Shankar G, Lin W, Socinski MA (2019) Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial. The Lancet Respiratory Medicine 7: 387-401 (ARCN) https://doi.org/10.1016/s2213-2600(19)30084-0 https://doi.org/10.1016/S2213-2600(19)30084-0

Reck M, Kerr KM, Grohé C, Manegold C, Pavlakis N, Paz-Ares L, Huber RM, Popat S, Thatcher N, Park K, Hilberg F, Barrueco J, Kaiser R (2019) Defining aggressive or early progressing nononcogene-addicted non-small-cell lung cancer: a separate disease entity? Future Oncology 15: 1363-1383 (ARCN, CPC-M) https://doi.org/10.2217/fon-2018-0948 https://doi.org/10.2217/fon-2018-0948

Reck M, Horn L, Novello S, Barlesi F, Albert I, Juhász E, Kowalski D, Robinet G, Cadranel J, Bidoli P, Chung J, Fritsch A, Drews U, Wagner A, Govindan R (2019) Phase II Study of Roniciclib in Combination with Cisplatin/Etoposide or Carboplatin/Etoposide as First-Line Therapy in Patients with Extensive-Disease Small Cell Lung Cancer. J Thorac Oncol 14: 701-711 (ARCN) https://doi.org/10.1016/j.jtho.2019.01.010 https://www.jto.org/article/S1556-0864(19)30029-2/pdf

Reck M, Borghaei H, O’Byrne KJ (2019) Nivolumab plus ipilimumab in non-small-cell lung cancer. Future Oncology 15: 2287-2302 (ARCN) https://doi.org/10.2217/fon-2019-0031 https://www.futuremedicine.com/doi/pdfplus/10.2217/fon-2019-0031

Ready N, Hellmann MD, Awad MM, Otterson GA, Gutierrez M, Gainor JF, Borghaei H, Jolivet J, Horn L, Mates M, Brahmer J, Rabinowitz I, Reddy PS, Chesney J, Orcutt J, Spigel DR, Reck M, O’Byrne KJ, Paz-Ares L, Hu W, Zerba K, Li X, Lestini B, Geese WJ, Szustakowski JD, Green G, Chang H, Ramalingam SS (2019) First-Line Nivolumab Plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer (CheckMate 568): Outcomes by Programmed Death Ligand 1 and Tumor Mutational Burden as Biomarkers. J Clin Oncol 37: 992-1000 (ARCN) https://doi.org/10.1200/jco.18.01042 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494267/pdf/JCO.18.01042.pdf

Rausch P, Rühlemann M, Hermes BM, Doms S, Dagan T, Dierking K, Domin H, Fraune S, von Frieling J, Hentschel U, Heinsen F-A, Höppner M, Jahn MT, Jaspers C, Kissoyan KAB, Langfeldt D, Rehman A, Reusch TBH, Roeder T, Schmitz RA, Schulenburg H, Soluch R, Sommer F, Stukenbrock E, Weiland-Bräuer N, Rosenstiel P, Franke A, Bosch T, Baines JF (2019) Comparative analysis of amplicon and metagenomic sequencing methods reveals key features in the evolution of animal metaorganisms. Microbiome 7: 133-133 (ARCN) https://doi.org/10.1186/s40168-019-0743-1 https://pubmed.ncbi.nlm.nih.gov/31521200

Rabe KF, Martinez FJ, Ferguson GT, Wang C, Singh D, Wedzicha JA, Trivedi R, St Rose E, Ballal S, McLaren J, Darken P, Reisner C, Dorinsky P (2019) A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol. Respir Med 158: 59-66 (ARCN) https://doi.org/10.1016/j.rmed.2019.08.010 https://www.resmedjournal.com/article/S0954-6111(19)30267-7/pdf

Putora PM, Glatzer M, De Ruysscher D, Faivre-Finn C, Belderbos J, Besse B, Blackhall F, Califano R, Cappuzzo F, de Marinis F, Dziadiuszko R, Felip E, Früh M, Garrido P, Le Pechoux C, McDonald F, Nestle U, Novello S, O’ Brien M, Paz Ares L, Peeters S, Pöttgen C, Ramella S, Reck M, Troost EGC, Van Houtte P, Westeel V, Widder J, Mornex F, Slotman BJ (2019) Erratum to “Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts” [Radiother. Oncol. 135 (2019) 74–77]. Radiother Oncol 141: 332 (ARCN) https://doi.org/10.1016/j.radonc.2019.10.006 https://www.thegreenjournal.com/article/S0167-8140(19)33134-2/pdf

Putora PM, Glatzer M, De Ruysscher D, Faivre-Finn C, Belderbos J, Besse B, Blackhall F, Califano R, Cappuzzo F, de Marinis F, Dziadiuszko R, Felip E, Früh M, Garrido P, Le Pechoux C, McDonald F, Nestle U, Novello S, Brien MO, Paz Ares L, Peeters S, Pöttgen C, Ramella S, Reck M, Troost EGC, Van Houtte P, Westeel V, Widder J, Mornex F, Slotman BJ (2019) Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts. Radiother Oncol 135: 74-77 (ARCN) https://doi.org/10.1016/j.radonc.2019.02.010

Putora PM, Glatzer M, Belderbos J, Besse B, Blackhall F, Califano R, Cappuzzo F, de Marinis F, Dziadziuszko R, Felip E, Faivre-Finn C, Früh M, Garrido P, Le Pechoux C, McDonald F, Nestle U, Novello S, O‘Brien M, Paz Ares L, Peeters S, Pöttgen C, Ramella S, Reck M, Slotman B, Troost EGC, Van Houtte P, Westeel V, Widder J, Mornex F, De Ruysscher D (2019) Prophylactic cranial irradiation in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts. Radiother Oncol 133: 163-166 (ARCN) https://doi.org/10.1016/j.radonc.2018.12.014 https://www.thegreenjournal.com/article/S0167-8140(18)33653-3/fulltext

Planchard D, Popat S, Kerr K, Novello S, Smit EF, Faivre-Finn C, Mok TS, Reck M, Van Schil PE, Hellmann MD, Peters S (2019) Correction to: “Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”. Ann Oncol 30: 863-870 (ARCN) https://doi.org/10.1093/annonc/mdy474 https://www.ncbi.nlm.nih.gov/pubmed/30715168

Philipp R, Mehnert A, Müller V, Reck M, Vehling S (2019) Perceived relatedness, death acceptance, and demoralization in patients with cancer. Support Care Cancer (ARCN) https://doi.org/10.1007/s00520-019-05088-2 https://link.springer.com/article/10.1007%2Fs00520-019-05088-2

Philipp R, Mehnert A, Lo C, Müller V, Reck M, Vehling S (2019) Characterizing death acceptance among patients with cancer. Psychooncology 28: 854-862 (ARCN) https://doi.org/10.1002/pon.5030 https://onlinelibrary.wiley.com/doi/abs/10.1002/pon.5030

Pfäffle C, Spahr H, Kutzner L, Burhan S, Hilge F, Miura Y, Hüttmann G, Hillmann D (2019) Simultaneous functional imaging of neuronal and photoreceptor layers in living human retina. Optics Letters 44: 5671 (ARCN) https://doi.org/10.1364/ol.44.005671 http://ol.osa.org/abstract.cfm?URI=ol-44-23-5671

Pfaar O, Agache I, Blay F, Bonini S, Chaker AM, Durham SR, Gawlik R, Hellings PW, Jutel M, Kleine‐Tebbe J, Klimek L, Kopp MV, Nandy A, Rabin RL, Ree R, Renz H, Roberts G, Salapatek AM, Schmidt‐Weber CB, Shamji MH, Sturm GJ, Virchow JC, Wahn U, Willers C, Zieglmayer P, Akdis CA (2019) Perspectives in allergen immunotherapy: 2019 and beyond. Allergy 74: 3-25 (ARCN, CPC-M, UGMLC) https://doi.org/10.1111/all.14077 https://www.ncbi.nlm.nih.gov/pubmed/31872476

Peters S, Reck M, Smit EF, Mok T, Hellmann MD (2019) How to make the best use of immunotherapy as first-line treatment of advanced/metastatic non-small-cell lung cancer. Ann Oncol 30: 884-896 (ARCN) https://doi.org/10.1093/annonc/mdz109

Peters S, Dafni U, Boyer M, De Ruysscher D, Faivre-Finn C, Felip E, Garrido P, Girard N, Guckenberger M, Haanen J, Le Pechoux C, Mornex F, Ozsahin M, Paz-Ares L, Planchard D, Raben D, Ramalingam S, Reck M, Smit E, Stahel R, Stenzinger A, Swanton C, Vallone S, Garassino MC (2019) Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP). Ann Oncol 30: 161-165 (ARCN) https://doi.org/10.1093/annonc/mdy553 https://academic.oup.com/annonc/advance-article-abstract/doi/10.1093/annonc/mdy553/5280724?redirectedFrom=fulltext

Pedersen F, Zissler UM, Watz H, Rabe KF, Hohlfeld JM, Holz O (2019) Rating sputum cell quality in clinical trials for asthma and COPD treatment. Int J Chron Obstruct Pulmon Dis Volume 14: 195-198 (ARCN, BREATH, CPC-M) https://doi.org/10.2147/copd.S188033 https://www.dovepress.com/getfile.php?fileID=47391

Pavord I, Bahmer T, Braido F, Cosío BG, Humbert M, Idzko M, Adamek L (2019) Severe T2-high asthma in the biologics era: European experts’ opinion. European Respiratory Review 28: 190054 (ARCN) https://doi.org/10.1183/16000617.0054-2019 https://err.ersjournals.com/content/errev/28/152/190054.full.pdf

Pallach M, Di Lorenzo F, Duda KA, Le Pennec G, Molinaro A, Silipo A (2019) The Lipid A Structure from the Marine Sponge Symbiont Endozoicomonas sp. HEX 311. ChemBioChem 20: 230-236 (ARCN) https://doi.org/10.1002/cbic.201800441 https://onlinelibrary.wiley.com/doi/abs/10.1002/cbic.201800441

Omlor AJ, Trudzinski FC, Alqudrah M, Seiler F, Biertz F, Vogelmeier CF, Welte T, Watz H, Waschki B, Brinker TJ, Andreas S, Fähndrich S, Alter P, Jörres RA, Böhm M, Bals R (2019) Time-updated resting heart rate predicts mortality in patients with COPD. Clin Res Cardiol (ARCN, BREATH, CPC-M, UGMLC) https://doi.org/10.1007/s00392-019-01572-1 https://link.springer.com/article/10.1007%2Fs00392-019-01572-1

Nosaki K, Saka H, Hosomi Y, Baas P, de Castro G, Reck M, Wu Y-L, Brahmer JR, Felip E, Sawada T, Noguchi K, Han SR, Piperdi B, Kush DA, Lopes G (2019) Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1–positive advanced non–small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies. Lung Cancer 135: 188-195 (ARCN) https://doi.org/10.1016/j.lungcan.2019.07.004 https://doi.org/10.1016/j.lungcan.2019.07.004

Nitschkowski D, Marwitz S, Kotanidou SA, Reck M, Kugler C, Rabe KF, Ammerpohl O, Goldmann T (2019) Live and let die: epigenetic modifications of Survivin and Regucalcin in non-small cell lung cancer tissues contribute to malignancy. Clin Epigenetics 11: 157 (ARCN) https://doi.org/10.1186/s13148-019-0770-6 https://clinicalepigeneticsjournal.biomedcentral.com/track/pdf/10.1186/s13148-019-0770-6

Nikolić MZ, Garrido-Martin EM, Greiffo FR, Fabre A, Heijink IH, Boots A, Greene CM, Hiemstra Pieter S, Bartel S (2019) From the pathophysiology of the human lung alveolus to epigenetic editing: Congress 2018 highlights from ERS Assembly 3 “Basic and Translational Science.”. ERJ Open Research 5: 00194-02018 ((ARCN, CPC-M)) https://doi.org/10.1183/23120541.00194-2018 https://openres.ersjournals.com/content/erjor/5/2/00194-2018.full.pdf

Nakagawa K, Garon EB, Seto T, Nishio M, Ponce Aix S, Paz-Ares L, Chiu C-H, Park K, Novello S, Nadal E, Imamura F, Yoh K, Shih J-Y, Au KH, Moro-Sibilot D, Enatsu S, Zimmermann A, Frimodt-Moller B, Visseren-Grul C, Reck M, Chu Q, Cortot A, Pujol J-L, Moro-Sibilot D, Fabre E, Lamour C, Bischoff H, Kollmeier J, Reck M, Kimmich M, Engel-Riedel W, Hammerschmidt S, Schütte W, Syrigos K, Ho JCM, Au K-H, Novello S, Ardizzoni A, Pasello G, Gregorc V, Del Conte A, Galetta D, Takahashi T, Nakagawa K, Nishio M, Yoh K, Seto T, Imamura F, Kumagai T, Hotta K, Goto Y, Hosomi Y, Sakai H, Takiguchi Y, Kim YH, Kurata T, Yamaguchi H, Daga H, Okamoto I, Satouchi M, Ikeda S, Kasahara K, Atagi S, Azuma K, Kumagai T, Aoe K, Kumagai T, Aoe K, Horio Y, Yamamoto N, Tanaka H, Watanabe S, Nogami N, Ozaki T, Koyama R, Hirashima T, Kaneda H, Tomii K, Fujita Y, Seike M, Nishimura N, Kato T, Ichiki M, Saka H, Hirano K, Nakahara Y, Sugawara S, Park K, Kim S-W, Min YJ, Lee HW, Kang J-H, An HJ, Lee KH, Kim J-S, Lee G-W, Lee SY, Alexandru A, Udrea AA, Juan-Vidal Ó, Nadal-Alforja E, Gil-Bazo I, Ponce-Aix S, Paz-Ares L, Rubio-Viqueira B, Alonso Garcia M, Felip Font E, Fuentes Pradera J, Coves Sarto J, Lin M-C, Su W-C, Hsia T-C, Chang G-C, Wei Y-F, Chiu C-H, Shih J-Y, Su J, Cicin I, Goksel T, Harputluoglu H, Ozyilkan O, Henning I, Popat S, Hatcher O, Mileham K, Acoba J, Garon E, Jung G, Raj M, Martin W, Dakhil S (2019) Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet Oncology 20: 1655-1669 (ARCN) https://doi.org/10.1016/s1470-2045(19)30634-5 https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30634-5/fulltext

Mountzios G, Remon J, Novello S, Blais N, Califano R, Cufer T, Dingemans AM, Liu SV, Peled N, Pennell NA, Reck M, Rolfo C, Tan D, Vansteenkiste J, West H, Besse B (2019) Position of an international panel of lung cancer experts on the decision for expansion of approval for pembrolizumab in advanced non-small-cell lung cancer with a PD-L1 expression level of ≥1% by the USA Food and Drug Administration. Ann Oncol 30: 1686-1688 (ARCN) https://doi.org/10.1093/annonc/mdz295 https://www.ncbi.nlm.nih.gov/pubmed/31504132

Mørkve Knudsen GT, Rezwan FI, Johannessen A, Skulstad SM, Bertelsen RJ, Real FG, Krauss-Etschmann S, Patil V, Jarvis D, Arshad SH, Holloway JW, Svanes C, Szyf M (2019) Epigenome-wide association of father’s smoking with offspring DNA methylation: a hypothesis-generating study. Environmental Epigenetics 5 (ARCN) https://doi.org/10.1093/eep/dvz023 https://doi.org/10.1093/eep/dvz023

Michels S, Massutí B, Schildhaus H-U, Franklin J, Sebastian M, Felip E, Grohé C, Rodriguez-Abreu D, Abdulla DSY, Bischoff H, Brandts C, Carcereny E, Corral J, Dingemans A-MC, Pereira E, Fassunke J, Fischer RN, Gardizi M, Heukamp L, Insa A, Kron A, Menon R, Persigehl T, Reck M, Riedel R, Rothschild SI, Scheel AH, Scheffler M, Schmalz P, Smit EF, Limburg M, Provencio M, Karachaliou N, Merkelbach-Bruse S, Hellmich M, Nogova L, Büttner R, Rosell R, Wolf J (2019) Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical Trial. J Thorac Oncol 14: 1266-1276 (ARCN) https://doi.org/10.1016/j.jtho.2019.03.020 https://www.jto.org/article/S1556-0864(19)30276-X/pdf

Maurer F, Bauer T, Diel R, Häcker B, Lange C, Niemann S, Otto-Knapp R, Schönfeld N (2019) Gemeinsame Stellungnahme zur neuen Empfehlung der WHO zur Behandlung der multiresistenten und Rifampicin-resistenten Tuberkulose. Pneumologie 73: 270-273 (ARCN) https://doi.org/10.1055/a-0880-9987 https://www.thieme-connect.de/products/ejournals/abstract/10.1055/a-0880-9987

Marietta von Siemens S, Alter P, Lutter JI, Kauczor H-U, Jobst B, Bals R, Trudzinski FC, Söhler S, Behr J, Watz H, Waschki B, Bewig B, Jones PW, Welte T, Vogelmeier CF, Jörres RA, Kahnert K, Stefan A, Robert B, Jürgen B, Kathrin K, Burkhard B, Roland B, Ralf E, Beate S, Ficker JH, Manfred G, Christian G, Rainer H, Matthias H, Berthold J, Markus H, Felix H, Gerd H, Katus Hugo A, Anne-Marie K, Henrik W, Rembert K, Klaus K, Juliane K, Cornelia K-S, Christoph L, Peter Z, Michael P, Randerath Winfried J, Werner S, Michael S, Christian T, Helmut T, Hartmut T, Christian VJ, Claus V, Ulrich W, Tobias W, Hubert W, Lehnert D, Struck B, Krabbe L, Arikan B, Tobias J, Speth K, Pieper J, Gleiniger M, Markworth B, Hinz Z, Burmann E, Wons K, Rieber U, Schaufler B, Schwedler K, Michalewski S, Rohweder S, Berger P, Schottel D, Janke V, Untsch R, Graf J, Reichel A, Weiß G, Traugott E, Kietzmann I, Schrade-Illmann M, Polte B, Hübner G (2019) CAT score single item analysis in patients with COPD: Results from COSYCONET. Respir Med 159: 105810 (ARCN, BREATH, CPC-M, TLRC, UGMLC) https://doi.org/10.1016/j.rmed.2019.105810 https://www.resmedjournal.com/article/S0954-6111(19)30324-5/fulltext

Maltais F, Aumann J-L, Kirsten A-M, Nadreau É, Macesic H, Jin X, Hamilton A, O’Donnell DE (2019) Dual bronchodilation with tiotropium/olodaterol further reduces activity-related breathlessness versus tiotropium alone in COPD. Eur Respir J 53: 1802049 (ARCN) https://doi.org/10.1183/13993003.02049-2018 https://erj.ersjournals.com/content/erj/53/3/1802049.full.pdf

Lüersen K, Röder T, Rimbach G (2019) Drosophila melanogaster in nutrition research—the importance of standardizing experimental diets. Genes Nutr 14: 3 (ARCN) https://doi.org/10.1186/s12263-019-0627-9 https://doi.org/10.1186/s12263-019-0627-9

Lilis I, Ntaliarda G, Papaleonidopoulos V, Giotopoulou GA, Oplopoiou M, Marazioti A, Spella M, Marwitz S, Goldmann T, Bravou V, Giopanou I, Stathopoulos GT (2019) Interleukin-1β provided by KIT-competent mast cells is required for KRAS-mutant lung adenocarcinoma. Oncoimmunology 8: e1593802 (ARCN, CPC-M) https://doi.org/10.1080/2162402x.2019.1593802 https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2019.1593802?needAccess=true

Lieb W, Jacobs G, Wolf A, Richter G, Gaede KI, Schwarz J, Arnold N, Böhm R, Buyx A, Cascorbi I, Franke A, Glinicke C, Held-Feindt J, Junker R, Kalthoff H, Kramer H-H, Leypoldt F, Maass N, Maetzler W, May S, Mehdorn HM, Röcken C, Schafmayer C, Schrappe M, Schreiber S, Sebens S, Stephani U, Synowitz M, Weimer J, Zabel P, Nöthlings U, Röder C, Krawczak M (2019) Linking pre-existing biorepositories for medical research: the PopGen 2.0 Network. Journal of Community Genetics 10: 523-530 (ARCN) https://doi.org/10.1007/s12687-019-00417-8 https://pubmed.ncbi.nlm.nih.gov/30927239

Li C, Duda KA, Elverdal PL, Skovsted IC, Kjeldsen C, Duus JØ, Federle MJ (2019) Structural, Biosynthetic, and Serological Cross-Reactive Elucidation of Capsular Polysaccharides from Streptococcus pneumoniae Serogroup 16. J Bacteriol 201 (ARCN) https://doi.org/10.1128/jb.00453-19 https://jb.asm.org/content/early/2019/07/31/JB.00453-19

Levy A, Hendriks LEL, Le Péchoux C, Falk S, Besse B, Novello S, Dingemans A-MC, Hasan B, Reck M, Berghmans T, Faivre-Finn C (2019) Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group survey. Lung Cancer 136: 145-147 (ARCN) https://doi.org/10.1016/j.lungcan.2019.08.007 https://www.lungcancerjournal.info/article/S0169-5002(19)30582-3/fulltext

Levy A, Hendriks LEL, Berghmans T, Faivre-Finn C, GiajLevra M, GiajLevra N, Hasan B, Pochesci A, Girard N, Greillier L, Lantuéjoul S, Edwards J, O’Brien M, Reck M, Besse B, Novello S, Dingemans A-MC (2019) EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic disease. Eur J Cancer 122: 109-114 (ARCN) https://doi.org/10.1016/j.ejca.2019.09.012 https://www.ejcancer.com/article/S0959-8049(19)30734-8/fulltext

Kuempers C, van der Linde LIS, Reischl M, Vogel W, Stellmacher F, Reck M, Heigener D, Rabe KF, Kirfel J, Perner S, Welker L (2019) Comparison of PD-L1 expression between paired cytologic and histologic specimens from non-small cell lung cancer patients. Virchows Archiv 476: 261-271 (ARCN) https://doi.org/10.1007/s00428-019-02632-7 https://link.springer.com/article/10.1007%2Fs00428-019-02632-7

Kreuter M, Swigris J, Pittrow D, Geier S, Klotsche J, Prasse A, Wirtz H, Koschel D, Andreas S, Claussen M, Grohé C, Wilkens H, Hagmeyer L, Skowasch D, Meyer JF, Kirschner J, Gläser S, Kahn N, Welte T, Neurohr C, Schwaiblmair M, Held M, Bahmer T, Oqueka T, Frankenberger M, Behr J (2019) The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry. Respir Res 20: 59 (ARCN, BREATH, CPC-M, TLRC, UGMLC) https://doi.org/10.1186/s12931-019-1020-3 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420774/pdf/12931_2019_Article_1020.pdf

Kopp Matthias V, König Inke R, Friedrichs F, Umpfenbach Hans U, Niggemann B, Millner-Uhlemann M (2019) Comparison of Six Different Allergen Extracts for Subcutaneous Specific Immunotherapy in Children: An Open-Labelled, Prospective, Controlled Observational Trial. International Archives of Allergy and Immunology 180: 284-290 (ARCN) https://doi.org/10.1159/000503104 https://www.karger.com/Article/Abstract/503104

Königsdorfer N, Jörres RA, Söhler S, Welte T, Behr J, Ficker JH, Bals R, Watz H, Lutter JI, Lucke T, Biertz F, Alter P, Vogelmeier CF, Kahnert K (2019) <p>Adherence To Respiratory And Nonrespiratory Medication In Patients With COPD: Results Of The German COSYCONET Cohort</p>. Patient Preference and Adherence Volume 13: 1711-1721 (ARCN, BREATH, CPC-M, UGMLC) https://doi.org/10.2147/ppa.S223438 https://www.dovepress.com/getfile.php?fileID=53246

Klimek L, Bachert C, Pfaar O, Becker S, Bieber T, Brehler R, Buhl R, Casper I, Chaker A, Czech W, Fischer J, Fuchs T, Gerstlauer M, Hörmann K, Jakob T, Jung K, Kopp MV, Mahler V, Merk H, Mülleneisen N, Nemat K, Rabe U, Ring J, Saloga J, Schlenter W, Schmidt-Weber C, Seyfarth H, Sperl A, Spindler T, Staubach P, Strieth S, Treudler R, Vogelberg C, Wallrafen A, Wehrmann W, Wrede H, Zuberbier T, Bedbrook A, Canonica GW, Cardona V, Casale TB, Czarlewski W, Fokkens WJ, Hamelmann E, Hellings PW, Jutel M, Larenas-Linnemann D, Mullol J, Papadopoulos NG, Salmi ST, Werfel T, Bousquet J (2019) ARIA guideline 2019: treatment of allergic rhinitis in the German health system. Allergologie select 3: 22-50 (ARCN, CPC-M) https://doi.org/10.5414/alx02120e

Jappe U, Schwager C, Schromm AB, González Roldán N, Stein K, Heine H, Duda KA (2019) Lipophilic Allergens, Different Modes of Allergen-Lipid Interaction and Their Impact on Asthma and Allergy. Front Immunol 10: 122-122 (ARCN) https://doi.org/10.3389/fimmu.2019.00122 https://pubmed.ncbi.nlm.nih.gov/30837983

Jappe U, Breiteneder H (2019) Peanut allergy-Individual molecules as a key to precision medicine. Allergy 74: 216-219 (ARCN) https://doi.org/10.1111/all.13625 https://pubmed.ncbi.nlm.nih.gov/30281802

Jany B, Bals R, Dreher M, Held M, Jany L, Rembert Koczulla A, Pfeifer M, Randerath W, Watz H, Wilkens H, Steinkamp G (2019) Expertentreffen COPD: Lunge und Herz – ziemlich oft gemeinsam krank! Pneumologie 73: 651-669 (ÂRCN, UGMLC) https://doi.org/10.1055/a-0914-9566 https://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-0914-9566

Janning M, Kobus F, Babayan A, Wikman H, Velthaus J-L, Bergmann S, Schatz S, Falk M, Berger L-A, Böttcher L-M, Päsler S, Gorges TM, O’Flaherty L, Hille C, Joosse SA, Simon R, Tiemann M, Bokemeyer C, Reck M, Riethdorf S, Pantel K, Loges S (2019) Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors. Cancers (Basel) 11: 835 (ARCN) https://www.mdpi.com/2072-6694/11/6/835

Jagodzinski A, Johansen C, Koch-Gromus U, Aarabi G, Adam G, Anders S, Augustin M, der Kellen RB, Beikler T, Behrendt C-A, Betz CS, Bokemeyer C, Borof K, Briken P, Busch C-J, Büchel C, Brassen S, Debus ES, Eggers L, Fiehler J, Gallinat J, Gellißen S, Gerloff C, Girdauskas E, Gosau M, Graefen M, Härter M, Harth V, Heidemann C, Heydecke G, Huber TB, Hussein Y, Kampf MO, von dem Knesebeck O, Konnopka A, König H-H, Kromer R, Kubisch C, Kühn S, Loges S, Löwe B, Lund G, Meyer C, Nagel L, Nienhaus A, Pantel K, Petersen E, Püschel K, Reichenspurner H, Sauter G, Scherer M, Scherschel K, Schiffner U, Schnabel RB, Schulz H, Smeets R, Sokalskis V, Spitzer MS, Terschüren C, Thederan I, Thoma T, Thomalla G, Waschki B, Wegscheider K, Wenzel J-P, Wiese S, Zyriax B-C, Zeller T, Blankenberg S (2019) Rationale and Design of the Hamburg City Health Study. Eur J Epidemiol (ARCN) https://doi.org/10.1007/s10654-019-00577-4 https://link.springer.com/content/pdf/10.1007%2Fs10654-019-00577-4.pdf

Jäckle S, Eixmann T, Schulz-Hildebrandt H, Hüttmann G, Pätz T (2019) Fiber optical shape sensing of flexible instruments for endovascular navigation. Int J Comput Assist Radiol Surg 14: 2137-2145 (ARCN) https://doi.org/10.1007/s11548-019-02059-0 https://www.ncbi.nlm.nih.gov/pubmed/31493113

Ichinose M, Fukushima Y, Inoue Y, Hataji O, Ferguson GT, Rabe KF, Hayashi N, Okada H, Takikawa M, Bourne E, Ballal S, DeAngelis K, Aurivillius M, Reisner C, Dorinsky P (2019) <p>Long-Term Safety and Efficacy of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD</p>. Int J Chron Obstruct Pulmon Dis Volume 14: 2993-3002 (ARCN) https://doi.org/10.2147/copd.S220861 https://www.ncbi.nlm.nih.gov/pubmed/31920296

Ichinose M, Fukushima Y, Inoue Y, Hataji O, Ferguson GT, Rabe KF, Hayashi N, Okada H, Takikawa M, Bourne E, Ballal S, DeAngelis K, Aurivillius M, Dorinsky P, Reisner C (2019) <p>Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgroup Analysis of the KRONOS Study</p>. Int J Chron Obstruct Pulmon Dis Volume 14: 2979-2991 (ARCN) https://doi.org/10.2147/copd.S220850 https://www.ncbi.nlm.nih.gov/pubmed/31920295

Højen JF, Kristensen MLV, McKee AS, Wade MT, Azam T, Lunding LP, de Graaf DM, Swartzwelter BJ, Wegmann M, Tolstrup M, Beckman K, Fujita M, Fischer S, Dinarello CA (2019) IL-1R3 blockade broadly attenuates the functions of six members of the IL-1 family, revealing their contribution to models of disease. Nat Immunol 20: 1138-1149 (ARCN) https://doi.org/10.1038/s41590-019-0467-1 https://www.nature.com/articles/s41590-019-0467-1

Hillmann D, Pfäffle C, Spahr H, Burhan S, Kutzner L, Hilge F, Hüttmann G (2019) Computational adaptive optics for optical coherence tomography using multiple randomized subaperture correlations. Optics Letters 44: 3905 (ARCN) https://doi.org/10.1364/ol.44.003905 https://www.ncbi.nlm.nih.gov/pubmed/31368998

Herz A, Stichtenoth G, Tafazzoli-Lari K, Buchholz M, Ahrens P, Kopp MV (2019) Chronischer Husten mit rezidivierenden pulmonalen Infekten und Gedeihstörung: Seltene Ursache bei differenzialdiagnostischer Abklärung identifiziert. Klin Padiatr 232: 44-47 (ARCN) https://doi.org/10.1055/a-1038-4605 https://pubmed.ncbi.nlm.nih.gov/31860115

Hellmann MD, Paz-Ares L, Bernabe Caro R, Zurawski B, Kim S-W, Carcereny Costa E, Park K, Alexandru A, Lupinacci L, de la Mora Jimenez E, Sakai H, Albert I, Vergnenegre A, Peters S, Syrigos K, Barlesi F, Reck M, Borghaei H, Brahmer JR, O’Byrne KJ, Geese WJ, Bhagavatheeswaran P, Rabindran SK, Kasinathan RS, Nathan FE, Ramalingam SS (2019) Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer. New England Journal of Medicine 381: 2020-2031 (ARCN) https://doi.org/10.1056/NEJMoa1910231 https://www.nejm.org/doi/full/10.1056/NEJMoa1910231

Heigener DF, Reck M (2019) Immune Checkpoint Inhibition in Non-metastatic Non-small Cell Lung Cancer: Chance for Cure? Drugs 79: 1937-1945 (ARCN) https://doi.org/10.1007/s40265-019-01222-w https://link.springer.com/article/10.1007%2Fs40265-019-01222-w

Heigener DF, Kerr KM, Laing GM, Mok TSK, Moiseyenko FV, Reck M (2019) Redefining Treatment Paradigms in First-line Advanced Non–Small-Cell Lung Cancer. Clinical Cancer Research 25: 4881-4887 (ARCN) https://doi.org/10.1158/1078-0432.Ccr-18-1894 http://clincancerres.aacrjournals.org/content/clincanres/early/2019/04/16/1078-0432.CCR-18-1894.full.pdf

Gülsen A, Wallis S, Jappe U (2019) Combination of immunotherapies for severe allergic asthma. J Asthma 58: 75-78 (ARCN) https://doi.org/10.1080/02770903.2019.1658204 https://www.tandfonline.com/doi/full/10.1080/02770903.2019.1658204

Gülsen A (2019) Effects of Bronchoscopic Lung Volume Reduction Coil Treatment on Arterial Blood Gases. Journal of Bronchology & Interventional Pulmonology 26: 90-95 (ARCN) https://doi.org/10.1097/lbr.0000000000000529

Gschwendtner S, Kang H, Thiering E, Kublik S, Fösel B, Schulz H, Krauss-Etschmann S, Heinrich J, Schöler A, Schloter M, Standl M (2019) Early life determinants induce sustainable changes in the gut microbiome of six-year-old children. Sci Rep 9: 12675 (ARCN, CPC-M) https://doi.org/10.1038/s41598-019-49160-7 https://www.nature.com/articles/s41598-019-49160-7.pdf

Grivas P, Monk BJ, Petrylak D, Reck M, Foley G, Guenther S, Hennessy D, Makris C, Moehler M (2019) Immune Checkpoint Inhibitors as Switch or Continuation Maintenance Therapy in Solid Tumors: Rationale and Current State. Target Oncol 14: 505-525 (ARCN) https://doi.org/10.1007/s11523-019-00665-1 https://link.springer.com/article/10.1007%2Fs11523-019-00665-1

González Roldán N, Engel R, Düpow S, Jakob K, Koops F, Orinska Z, Vigor C, Oger C, Galano J-M, Durand T, Jappe U, Duda KA (2019) Lipid Mediators From Timothy Grass Pollen Contribute to the Effector Phase of Allergy and Prime Dendritic Cells for Glycolipid Presentation. Front Immunol 10 (ARCN) https://doi.org/10.3389/fimmu.2019.00974 https://www.frontiersin.org/article/10.3389/fimmu.2019.00974

Giesselmann P, Brändl B, Raimondeau E, Bowen R, Rohrandt C, Tandon R, Kretzmer H, Assum G, Galonska C, Siebert R, Ammerpohl O, Heron A, Schneider SA, Ladewig J, Koch P, Schuldt BM, Graham JE, Meissner A, Müller F-J (2019) Analysis of short tandem repeat expansions and their methylation state with nanopore sequencing. Nat Biotechnol 37: 1478-1481 (ARCN) https://doi.org/10.1038/s41587-019-0293-x https://pubmed.ncbi.nlm.nih.gov/31740840

Gessert N, Bengs M, Wittig L, Drömann D, Keck T, Schlaefer A, Ellebrecht DB (2019) Deep transfer learning methods for colon cancer classification in confocal laser microscopy images. Int J Comput Assist Radiol Surg 14: 1837-1845 (ARCN) https://doi.org/10.1007/s11548-019-02004-1 https://pubmed.ncbi.nlm.nih.gov/31129859

Gao X, Yin J, Wang X, Petersen F, Yu X (2019) A comprehensive comparison of hematological parameters among 39 common diseases. Scandinavian Journal of Clinical and Laboratory Investigation 79: 251-259 (ARCN) https://doi.org/10.1080/00365513.2019.1591636 https://www.tandfonline.com/doi/full/10.1080/00365513.2019.1591636

Frieling J, Roeder T (2019) Factors that affect the translation of dietary restriction into a longer life. IUBMB Life: 10.1002/iub.2224 (ARCN) https://doi.org/10.1002/iub.2224 https://www.ncbi.nlm.nih.gov/pubmed/31889425

Freund I, Buhl DK, Boutin S, Kotter A, Pichot F, Marchand V, Vierbuchen T, Heine H, Motorin Y, Helm M, Dalpke AH, Eigenbrod T (2019) 2′-O-methylation within prokaryotic and eukaryotic tRNA inhibits innate immune activation by endosomal Toll-like receptors but does not affect recognition of whole organisms. RNA 25: 869-880 (ARCN, TLRC) https://doi.org/10.1261/rna.070243.118 https://pubmed.ncbi.nlm.nih.gov/31019095

Fermont JM, Masconi KL, Jensen MT, Ferrari R, Di Lorenzo VAP, Marott JM, Schuetz P, Watz H, Waschki B, Müllerova H, Polkey MI, Wilkinson IB, Wood AM (2019) Biomarkers and clinical outcomes in COPD: a systematic review and meta-analysis. Thorax 74: 439-446 (ARCN) https://doi.org/10.1136/thoraxjnl-2018-211855 https://thorax.bmj.com/content/thoraxjnl/early/2019/01/04/thoraxjnl-2018-211855.full.pdf

Dudeck A, Köberle M, Goldmann O, Meyer N, Dudeck J, Lemmens S, Rohde M, Roldán NG, Dietze-Schwonberg K, Orinska Z, Medina E, Hendrix S, Metz M, Zenclussen AC, von Stebut E, Biedermann T (2019) Mast cells as protectors of health. Journal of Allergy and Clinical Immunology 144: S4-S18 (ARCN) https://doi.org/10.1016/j.jaci.2018.10.054 https://www.jacionline.org/article/S0091-6749(18)31605-1/pdf

Dingemans A-MC, Hendriks LEL, Berghmans T, Levy A, Hasan B, Faivre-Finn C, Giaj-Levra M, Giaj-Levra N, Girard N, Greillier L, Lantuéjoul S, Edwards J, O’Brien M, Reck M, Smit EF, Van Schil P, Postmus PE, Ramella S, Lievens Y, Gaga M, Peled N, Scagliotti GV, Senan S, Paz-Ares L, Guckenberger M, McDonald F, Ekman S, Cufer T, Gietema H, Infante M, Dziadziuszko R, Peters S, Porta RR, Vansteenkiste J, Dooms C, de Ruysscher D, Besse B, Novello S (2019) Definition of Synchronous Oligometastatic Non–Small Cell Lung Cancer—A Consensus Report. J Thorac Oncol 14: 2109-2119 (ARCN) https://doi.org/10.1016/j.jtho.2019.07.025 https://www.jto.org/article/S1556-0864(19)30655-0/pdf

Dietz S, Christopoulos P, Gu L, Volckmar A-L, Endris V, Yuan Z, Ogrodnik SJ, Zemojtel T, Heussel C-P, Schneider MA, Meister M, Muley T, Reck M, Schlesner M, Thomas M, Stenzinger A, Sültmann H (2019) Serial liquid biopsies for detection of treatment failure and profiling of resistance mechanisms in KLC1–ALK-rearranged lung cancer. Molecular Case Studies 5: a004630 (ARCN, TLRC) https://doi.org/10.1101/mcs.a004630 http://molecularcasestudies.cshlp.org/content/early/2019/11/21/mcs.a004630.full.pdf

Diel R, Schluger NW (2019) Is adding fluoroquinolones to regimens for treating isoniazid-resistant tuberculosis necessary? Eur Respir J 54: 1901494 (ARCN) https://doi.org/10.1183/13993003.01494-2019 https://erj.ersjournals.com/content/erj/54/4/1901494.full.pdf

Diel R, Nienhaus A (2019) Rapid Point-of-Care Influenza Testing for Patients in German Emergency Rooms – A Cost-Benefit Analysis. Journal of Health Economics and Outcomes Research 6: 203-212 (ARCN) https://doi.org/10.36469/001c.11206 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299473/pdf/jheor-6-3-001c.11206.pdf

Diel R, Nienhaus A (2019) Cost–Benefit Analysis of Real-Time Influenza Testing for Patients in German Emergency Rooms. International Journal of Environmental Research and Public Health 16: 2368 (ARCN) https://doi.org/10.3390/ijerph16132368 https://res.mdpi.com/ijerph/ijerph-16-02368/article_deploy/ijerph-16-02368-v2.pdf?filename=&attachment=1

Diel R, Mertsch P (2019) Intersectoral Cost of Treating Pulmonary Non-Tuberculosis Mycobacterial Disease (NTM-PD) in Germany—A Change of Perspective in Disease Management. International Journal of Environmental Research and Public Health 16: 3795 (ARCN, (CPC-M)) https://doi.org/10.3390/ijerph16203795 https://res.mdpi.com/d_attachment/ijerph/ijerph-16-03795/article_deploy/ijerph-16-03795.pdf

Diel R, Kohl TA, Maurer FP, Merker M, Meywald Walter K, Hannemann J, Nienhaus A, Supply P, Niemann S (2019) Accuracy of whole-genome sequencing to determine recent tuberculosis transmission: an 11-year population-based study in Hamburg, Germany. Eur Respir J 54: 1901154 (ARCN) https://doi.org/10.1183/13993003.01154-2019 https://erj.ersjournals.com/content/erj/54/5/1901154.full.pdf

Diel R, Ewig S, Blaas S, Jacob C, Juelich F, Korfmann G, Sohrab S, Sutharsan S, Rademacher J (2019) Incidence of patients with non-cystic fibrosis bronchiectasis in Germany – A healthcare insurance claims data analysis. Respir Med 151: 121-127 (ARCN, BREATH) https://doi.org/10.1016/j.rmed.2019.04.007 https://www.sciencedirect.com/science/article/abs/pii/S0954611119301283?via%3Dihub

Diel R, Chalmers JD, Rabe KF, Nienhaus A, Loddenkemper R, Ringshausen FC (2019) Economic burden of bronchiectasis in Germany. Eur Respir J 53: 1802033 (ARCN, BREATH) https://doi.org/10.1183/13993003.02033-2018 http://erj.ersjournals.com/content/early/2018/11/28/13993003.02033-2018

Denis MG, Lafourcade M-P, Le Garff G, Dayen C, Falchero L, Thomas P, Locher C, Oliviero G, Licour M, Reck M, Normanno N, Molinier O (2019) Circulating free tumor-derived DNA to detect EGFR mutations in patients with advanced NSCLC: French subset analysis of the ASSESS study. J Thorac Dis 11: 1370-1378 (ARCN) http://jtd.amegroups.com/article/view/28147

Chen X, Sieren MM, Berlin C, Oechtering TH, Hunold P, Drömann D, Barkhausen J, Frydrychowicz A (2019) Comparison of 4D Flow MRI to 2D Flow MRI in the pulmonary arteries in healthy volunteers and patients with pulmonary hypertension. PLoS One 14: e0224121 (ARCN) https://doi.org/10.1371/journal.pone.0224121 https://pubmed.ncbi.nlm.nih.gov/31648286

Casper MJ, Glahn J, Evers M, Schulz‐Hildebrandt H, Kositratna G, Birngruber R, Hüttmann G, Manstein D (2019) Capillary Refill—The Key to Assessing Dermal Capillary Capacity and Pathology in Optical Coherence Tomography Angiography. Lasers in Surgery and Medicine (ARCN) https://doi.org/10.1002/lsm.23188 https://onlinelibrary.wiley.com/doi/full/10.1002/lsm.23188

Casper M, Schulz-Hildebrandt H, Evers M, Birngruber R, Manstein D (2019) Optimization-based vessel segmentation pipeline for robust quantification of capillary networks in skin with optical coherence tomography angiography. J Biomed Opt 24: 1 (ARCN) https://doi.org/10.1117/1.Jbo.24.4.046005 https://www.spiedigitallibrary.org/journals/Journal-of-Biomedical-Optics/volume-24/issue-4/046005/Optimization-based-vessel-segmentation-pipeline-for-robust-quantification-of-capillary/10.1117/1.JBO.24.4.046005.pdf

Burgess JK, Weckmann M, Karsdal MA (2019) The message from the matrix—should we listen more closely? J Thorac Dis 11: S230-S233 (ARCN) https://doi.org/10.21037/jtd.2019.01.68 http://jtd.amegroups.com/article/view/27255/20198

Bossen J, Uliczka K, Steen L, Pfefferkorn R, Mai MM-Q, Burkhardt L, Spohn M, Bruchhaus I, Fink C, Heine H, Roeder T (2019) An EGFR-Induced Drosophila Lung Tumor Model Identifies Alternative Combination Treatments. Mol Cancer Ther 18: 1659-1668 (ARCN) https://doi.org/10.1158/1535-7163.Mct-19-0168 https://pubmed.ncbi.nlm.nih.gov/31217165

Bartel S, La Grutta S, Cilluffo G, Perconti G, Bongiovanni A, Giallongo A, Behrends J, Kruppa J, Hermann S, Chiang D, Pfaffl MW, Krauss‐Etschmann S (2019) Human airway epithelial extracellular vesicle miRNA signature is altered upon asthma development. Allergy 75: 346-356 (ARCN) https://doi.org/10.1111/all.14008 https://onlinelibrary.wiley.com/doi/abs/10.1111/all.14008

Bahmer T, Wälscher J, Fisser C, Kreuter M, Karg O, Böing S, Koczulla R, Raspe M (2019) Arbeitsbedingungen, Weiterbildungsqualität und -zufriedenheit in der Pneumologie – Status quo, Herausforderungen und Perspektiven. Pneumologie 73: 578-581 (ARCN, TLRC, UGMLC) https://doi.org/10.1055/a-1010-2863 https://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-1010-2863

Andreas S, Röver C, Heinz J, Straube S, Watz H, Friede T (2019) Decline of COPD exacerbations in clinical trials over two decades – a systematic review and meta-regression. Respir Res 20: 186 (ARCN) https://doi.org/10.1186/s12931-019-1163-2 https://respiratory-research.biomedcentral.com/track/pdf/10.1186/s12931-019-1163-2

Alving K, Diamant Z, Lucas S, Magnussen H, Pavord ID, Piacentini G, Price D, Roche N, Sastre J, Thomas M, Usmani O, Bjermer L (2019) Point‐of‐care biomarkers in asthma management: Time to move forward. Allergy ((ARCN)) https://doi.org/10.1111/all.14045 https://onlinelibrary.wiley.com/doi/abs/10.1111/all.14045

Alter P, Watz H, Kahnert K, Rabe KF, Biertz F, Fischer R, Jung P, Graf J, Bals R, Vogelmeier CF, Jörres RA (2019) Effects of airway obstruction and hyperinflation on electrocardiographic axes in COPD. Respir Res 20: 61 (ARCN, CPC-M, UGMLC) https://doi.org/10.1186/s12931-019-1025-y https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437876/pdf/12931_2019_Article_1025.pdf

Alter P, Mayerhofer BA, Kahnert K, Watz H, Waschki B, Andreas S, Biertz F, Bals R, Vogelmeier CF, Jörres RA (2019) <p>Prevalence of cardiac comorbidities, and their underdetection and contribution to exertional symptoms in COPD: results from the COSYCONET cohort</p>. Int J Chron Obstruct Pulmon Dis Volume 14: 2163-2172 (ARCN, CPC-M, UGMLC) https://doi.org/10.2147/copd.S209343 https://www.dovepress.com/getfile.php?fileID=52891

Almendros I, El-Merhie N, Jha A, Keir HR, Lykouras D, Mahmutovic Persson I, Ubags ND, Bartel S (2019) Early Career Members at the Lung Science Conference and the Sleep and Breathing Conference 2019. Breathe 15: 234-240 (ARCN) https://doi.org/10.1183/20734735.0203-2019 https://breathe.ersjournals.com/content/breathe/15/3/234.full.pdf

Ackermann CJ, Reck M, Paz-Ares L, Barlesi F, Califano R (2019) First-line immune checkpoint blockade for advanced non-small-cell lung cancer: Travelling at the speed of light. Lung Cancer 134: 245-253 (ARCN) https://doi.org/10.1016/j.lungcan.2019.06.007 https://doi.org/10.1016/j.lungcan.2019.06.007

Abegaz F, Chaichoompu K, Génin E, Fardo DW, König IR, Mahachie John JM, Van Steen K (2019) Principals about principal components in statistical genetics. Brief Bioinform 20: 2200-2216 (ARCN) https://doi.org/10.1093/bib/bby081 https://academic.oup.com/bib/advance-article-abstract/doi/10.1093/bib/bby081/5095727?redirectedFrom=fulltext

 

2018

Zissler UM, Ulrich M, Jakwerth CA, Rothkirch S, Guerth F, Weckmann M, Schiemann M, Haller B, Schmidt-Weber CB, Chaker AM (2018) Biomatrix for upper and lower airway biomarkers in patients with allergic asthma. Journal of Allergy and Clinical Immunology 142: 1980-1983 (ARCN, CPC-M) https://doi.org/10.1016/j.jaci.2018.07.027 https://www.jacionline.org/article/S0091-6749(18)31140-0/fulltext

Yue X, Yu X, Petersen F, Riemekasten G (2018) Recent advances in mouse models for systemic sclerosis. Autoimmun Rev 17: 1225-1234 (ARCN) https://doi.org/10.1016/j.autrev.2018.06.013 https://www.ncbi.nlm.nih.gov/pubmed/30316997

Yu X, Riemekasten G, Petersen F (2018) Autoantibodies against muscarinic acetylcholine receptor M3 in Sjogren’s syndrome and corresponding mouse models. Front Biosci (Landmark Ed) 23: 2053-2064 (ARCN) https://www.ncbi.nlm.nih.gov/pubmed/29772545

Yu X, Petersen F (2018) A methodological review of induced animal models of autoimmune diseases. Autoimmun Rev 17: 473-479 (ARCN) https://doi.org/10.1016/j.autrev.2018.03.001 https://www.ncbi.nlm.nih.gov/pubmed/29526631

Yu X, Kasprick A, Hartmann K, Petersen F (2018) The Role of Mast Cells in Autoimmune Bullous Dermatoses. Front Immunol 9: 386 (ARCN) https://doi.org/10.3389/fimmu.2018.00386 https://www.ncbi.nlm.nih.gov/pubmed/29541076

Yu X, Akbarzadeh R, Pieper M, Scholzen T, Gehrig S, Schultz C, Zillikens D, König P, Petersen F (2018) Neutrophil Adhesion Is a Prerequisite for Antibody-Mediated Proteolytic Tissue Damage in Experimental Models of Epidermolysis Bullosa Acquisita. J Invest Dermatol 138: 1990-1998 (ARCN, TLRC) https://doi.org/10.1016/j.jid.2018.03.1499 https://www.ncbi.nlm.nih.gov/pubmed/29559343

Yin J, Zheng J, Deng F, Zhao W, Chen Y, Huang Q, Huang R, Wen L, Yue X, Petersen F, Yu X (2018) Gene Expression Profiling of Lacrimal Glands Identifies the Ectopic Expression of MHC II on Glandular Cells as a Presymptomatic Feature in a Mouse Model of Primary Sjögren’s Syndrome. Front Immunol 9: 2362 (ARCN) https://doi.org/10.3389/fimmu.2018.02362 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220427/pdf/fimmu-09-02362.pdf

Wutkowski A, Krajewski M, Bagwan N, Schäfer M, Paudyal BR, Schaible UE, Schwudke D (2018) Software-aided quality control of parallel reaction monitoring based quantitation of lipid mediators. Anal Chim Acta 1037: 168-176 (ARCN) https://doi.org/10.1016/j.aca.2018.01.044 https://www.ncbi.nlm.nih.gov/pubmed/30292291

Wu D-D, Song J, Bartel S, Krauss-Etschmann S, Rots MG, Hylkema MN (2018) The potential for targeted rewriting of epigenetic marks in COPD as a new therapeutic approach. Pharmacol Ther 182: 1-14 (ARCN) https://doi.org/10.1016/j.pharmthera.2017.08.007 https://www.ncbi.nlm.nih.gov/pubmed/28830839

Wine JJ, Hansson GC, König P, Joo NS, Ermund A, Pieper M (2018) Progress in understanding mucus abnormalities in cystic fibrosis airways. Journal of Cystic Fibrosis 17: S35-S39 (ARCN) https://doi.org/10.1016/j.jcf.2017.09.003 https://www.ncbi.nlm.nih.gov/pubmed/28951068

Wielpütz MO, von Stackelberg O, Stahl M, Jobst BJ, Eichinger M, Puderbach MU, Nährlich L, Barth S, Schneider C, Kopp MV, Ricklefs I, Buchholz M, Tümmler B, Dopfer C, Vogel-Claussen J, Kauczor H-U, Mall MA (2018) Multicentre standardisation of chest MRI as radiation-free outcome measure of lung disease in young children with cystic fibrosis. Journal of Cystic Fibrosis 17: 518-527 (ARCN, BREATH, TLRC, UGMLC)

Wen L, Krauss-Etschmann S, Petersen F, Yu X (2018) Autoantibodies in Chronic Obstructive Pulmonary Disease. Front Immunol 9: 66 (ARCN) https://doi.org/10.3389/fimmu.2018.00066 https://www.ncbi.nlm.nih.gov/pubmed/29422903

Weigold F, Günther J, Pfeiffenberger M, Cabral-Marques O, Siegert E, Dragun D, Philippe A, Regensburger A-K, Recke A, Yu X, Petersen F, Catar R, Biesen R, Hiepe F, Burmester GR, Heidecke H, Riemekasten G (2018) Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis. Arthritis Research & Therapy 20: 52 (ARCN) https://doi.org/10.1186/s13075-018-1545-8 https://www.ncbi.nlm.nih.gov/pubmed/29566745

Watz H, Tetzlaff K, Magnussen H, Mueller A, Rodriguez-Roisin R, Wouters EFM, Vogelmeier C, Calverley PMA (2018) Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial. Respir Res 19: 251 (ARCN, UGMLC) https://doi.org/10.1186/s12931-018-0944-3 https://respiratory-research.biomedcentral.com/track/pdf/10.1186/s12931-018-0944-3

Watz H, Bagul N, Rabe KF, Rennard S, Alagappan VKT, Román J, Facius A, Calverley PMA (2018) Use of a 4-week up-titration regimen of roflumilast in patients with severe COPD. Int J Chron Obstruct Pulmon Dis Volume 13: 813-822 (ARCN) https://doi.org/10.2147/copd.S154012 https://www.ncbi.nlm.nih.gov/pubmed/29563781

Watermann I, Reck M (2018) CT-Screening beim Lungenkarzinom – wie ist die Evidenz? DMW – Deutsche Medizinische Wochenschrift 143: 494-497 (ARCN) https://doi.org/10.1055/s-0043-104919 https://www.ncbi.nlm.nih.gov/pubmed/29614540

Vreka M, Lilis I, Papageorgopoulou M, Giotopoulou GA, Lianou M, Giopanou I, Kanellakis NI, Spella M, Agalioti T, Armenis V, Goldmann T, Marwitz S, Yull FE, Blackwell TS, Pasparakis M, Marazioti A, Stathopoulos GT (2018) IκB Kinase α Is Required for Development and Progression ofKRAS-Mutant Lung Adenocarcinoma. Cancer Res 78: 2939-2951 (ARCN, CPC-M) https://doi.org/10.1158/0008-5472.Can-17-1944 https://www.ncbi.nlm.nih.gov/pubmed/29588349

von Pawel J, Spigel DR, Ervin T, Losonczy G, Barlesi F, Juhász E, Anderson M, McCall B, Wakshull E, Hegde P, Ye W, Chen D, Chang I, Rhee I, Reck M (2018) Randomized Phase II Trial of Parsatuzumab (Anti‐EGFL7) or Placebo in Combination with Carboplatin, Paclitaxel, and Bevacizumab for First‐Line Nonsquamous Non‐Small Cell Lung Cancer. The Oncologist 23: 654 (ARCN) https://doi.org/10.1634/theoncologist.2017-0690 https://www.ncbi.nlm.nih.gov/pubmed/29438092

von Frieling J, Fink C, Hamm J, Klischies K, Forster M, Bosch TCG, Roeder T, Rosenstiel P, Sommer F (2018) Grow With the Challenge – Microbial Effects on Epithelial Proliferation, Carcinogenesis, and Cancer Therapy. Front Microbiol 9: 2020 (ARCN) https://doi.org/10.3389/fmicb.2018.02020 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6159313/pdf/fmicb-09-02020.pdf

Vogelmeier C, Buhl R, Burghuber O, Criée CP, Ewig S, Godnic-Cvar J, Hartl S, Herth F, Kardos P, Kenn K, Nowak D, Rabe K, Studnicka M, Watz H, Welte T, Windisch W, Worth H (2018) Leitlinie zur Diagnostik und Therapie von Patienten mit chronisch obstruktiver Bronchitis und Lungenemphysem (COPD). Pneumologie 72: 253-308 (ARCN, BREATH, CPC-M, TLRC, UGMLC) https://doi.org/10.1055/s-0043-125031 https://www.ncbi.nlm.nih.gov/pubmed/29523017

Vierbuchen T, Stein K, Heine H (2018) RNA is taking its Toll: Impact of RNA‐specific Toll‐like receptors on health and disease. Allergy (ARCN) https://doi.org/10.1111/all.13680 https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.13680

Tykodi SS, Schadendorf D, Cella D, Reck M, Harrington K, Wagner S, Shaw JW (2018) Patient-reported outcomes with nivolumab in advanced solid cancers. Cancer Treat Rev 70: 75-87 (ARCN) https://doi.org/10.1016/j.ctrv.2018.08.001 https://www.ncbi.nlm.nih.gov/pubmed/30125799

Szentes BL, Kreuter M, Bahmer T, Birring SS, Claussen M, Waelscher J, Leidl R, Schwarzkopf L (2018) Quality of life assessment in interstitial lung diseases:a comparison of the disease-specific K-BILD with the generic EQ-5D-5L. Respir Res 19: 101 (ARCN, CPC-M, TLRC) https://doi.org/10.1186/s12931-018-0808-x https://www.ncbi.nlm.nih.gov/pubmed/29801506

Sudkamp H, Hillmann D, Koch P, Endt Mv, Spahr H, Münst M, Pfäffle C, Birngruber R, Hüttmann G (2018) Simple approach for aberration-corrected OCT imaging of the human retina. Optics Letters 43: 4224 (ARCN) https://doi.org/10.1364/ol.43.004224

Stephano F, Nolte S, Hoffmann J, El-Kholy S, von Frieling J, Bruchhaus I, Fink C, Roeder T (2018) Impaired Wnt signaling in dopamine containing neurons is associated with pathogenesis in a rotenone triggered Drosophila Parkinson’s disease model. Sci Rep 8: 2372 (ARCN) https://doi.org/10.1038/s41598-018-20836-w https://www.ncbi.nlm.nih.gov/pubmed/29403026

Stahl M, Graeber SY, Joachim C, Barth S, Ricklefs I, Diekmann G, Kopp MV, Naehrlich L, Mall MA (2018) Three-center feasibility of lung clearance index in infants and preschool children with cystic fibrosis and other lung diseases. Journal of Cystic Fibrosis 17: 249-255 (ARCN, TLRC, UGMLC) https://doi.org/10.1016/j.jcf.2017.08.001 https://www.ncbi.nlm.nih.gov/pubmed/28811149

Spengler D, Winoto-Morbach S, Kupsch S, Vock C, Blöchle K, Frank S, Rintz N, Diekötter M, Janga H, Weckmann M, Fuchs S, Schromm AB, Fehrenbach H, Schütze S, Krause MF (2018) Novel therapeutic roles for surfactant-inositols and -phosphatidylglycerols in a neonatal piglet ARDS model: a translational study. American Journal of Physiology-Lung Cellular and Molecular Physiology 314: L32-L53 (ARCN) https://doi.org/10.1152/ajplung.00128.2017 https://www.ncbi.nlm.nih.gov/pubmed/28860142

Spahr H, Hillmann D, Pfäffle C, Hüttmann G (2018) Comment on “Retinal pulse wave velocity measurement using spectral-domain optical coherence tomography”. Journal of Biophotonics 11: e201700347 (ARCN) https://doi.org/10.1002/jbio.201700347 https://www.ncbi.nlm.nih.gov/pubmed/29219240

Socinski MA, Obasaju C, Gandara D, Hirsch FR, Bonomi P, Bunn PA, Kim ES, Langer CJ, Natale RB, Novello S, Paz-Ares L, Pérol M, Reck M, Ramalingam SS, Reynolds CH, Spigel DR, Wakelee H, Thatcher N (2018) Current and Emergent Therapy Options for Advanced Squamous Cell Lung Cancer. J Thorac Oncol 13: 165-183 (ARCN) https://doi.org/10.1016/j.jtho.2017.11.111 https://www.ncbi.nlm.nih.gov/pubmed/29175116

Socinski MA, Jotte RM, Cappuzzo F, Orlandi F, Stroyakovskiy D, Nogami N, Rodríguez-Abreu D, Moro-Sibilot D, Thomas CA, Barlesi F, Finley G, Kelsch C, Lee A, Coleman S, Deng Y, Shen Y, Kowanetz M, Lopez-Chavez A, Sandler A, Reck M (2018) Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC. New England Journal of Medicine 378: 2288-2301 (ARCN) https://doi.org/10.1056/NEJMoa1716948 https://www.ncbi.nlm.nih.gov/pubmed/29863955

Smit EF, Garon EB, Reck M, Cappuzzo F, Bidoli P, Cohen RB, Gao L, O’Brien LM, Lee P, Zimmermann A, Ferry DR, Melemed AS, Pérol M (2018) Exposure–response relationship for ramucirumab from the randomized, double-blind, phase 3 REVEL trial (docetaxel versus docetaxel plus ramucirumab) in second-line treatment of metastatic non-small cell lung cancer. Cancer Chemother Pharmacol 82: 77-86 (ARCN) https://doi.org/10.1007/s00280-018-3560-5 https://www.ncbi.nlm.nih.gov/pubmed/29721850

Sinning C, Harbaum L, Schrage B, Rübsamen N, Magnussen C, Waschki B, Kleemann Wilko H, Baaske Kaaja M, Kögler M, Ojeda F, Fischer C, Benjamin N, Westermann D, Zengin E, Schäfer U, Egenlauf B, Klose Hans F, Blankenberg S, Grünig E (2018) Right Ventricular Index for Risk Stratification of Patients with Pulmonary Arterial Hypertension. Respiration 96: 249-258 (ARCN) https://doi.org/10.1159/000489231 https://www.karger.com/Article/Abstract/489231

Shu Y, Xu Y, Chen C, Li J, Li R, Wu H, Hu X, Lu Z, Yu X, Qiu W (2018) Serum Bilirubin and Albumin in Anti-<b><i>N</i></b>-Methyl-D-Aspartate Receptor Encephalitis. Neuroimmunomodulation 25: 206-214 ((ARCN)) https://doi.org/10.1159/000494801 https://www.karger.com/Article/Abstract/494801

Shu Y, Chang Y, Wu H, Li J, Cao B, Sun X, Wang J, Peng L, Hu X, Yu X, Qiu W (2018) Serum cystatin C and anti-N

-methyl-D-aspartate receptor encephalitis. Acta Neurol Scand 137: 515-522 ((ARCN)) https://doi.org/10.1111/ane.12894 https://onlinelibrary.wiley.com/doi/abs/10.1111/ane.12894

Schupp JC, Freitag-Wolf S, Bargagli E, Mihailović-Vučinić V, Rottoli P, Grubanovic A, Müller A, Jochens A, Tittmann L, Schnerch J, Olivieri C, Fischer A, Jovanovic D, Filipovic S, Videnovic-Ivanovic J, Bresser P, Jonkers R, O’Reilly K, Ho L-P, Gaede KI, Zabel P, Dubaniewicz A, Marshall B, Kieszko R, Milanowski J, Günther A, Weihrich A, Petrek M, Kolek V, Keane Michael P, O’Beirne S, Donnelly S, Haraldsdottir SO, Jorundsdottir KB, Costabel U, Bonella F, Wallaert B, Grah C, Peroš-Golubičić T, Luisetti M, Kadija Z, Pabst S, Grohé C, Strausz J, Vašáková M, Sterclova M, Millar A, Homolka J, Slováková A, Kendrick Y, Crawshaw A, Wuyts W, Spencer L, Pfeifer M, Valeyre D, Poletti V, Wirtz H, Prasse A, Schreiber S, Krawczak M, Müller-Quernheim J (2018) Phenotypes of organ involvement in sarcoidosis. Eur Respir J 51: 1700991 (ARCN, BREATH, UGMLC) https://doi.org/10.1183/13993003.00991-2017 https://erj.ersjournals.com/content/51/1/1700991

Schulz-Hildebrandt H, Pieper M, Stehmar C, Ahrens M, Idel C, Wollenberg B, König P, Hüttmann G (2018) Novel endoscope with increased depth of field for imaging human nasal tissue by microscopic optical coherence tomography. Biomedical Optics Express 9: 636 (ARCN) https://doi.org/10.1364/boe.9.000636 https://www.ncbi.nlm.nih.gov/pubmed/29552400

Schulz-Hildebrandt H, Pfeiffer T, Eixmann T, Lohmann S, Ahrens M, Rehra J, Draxinger W, König P, Huber R, Hüttmann G (2018) High-speed fiber scanning endoscope for volumetric multi-megahertz optical coherence tomography. Optics Letters 43: 4386 (ARCN) https://doi.org/10.1364/ol.43.004386 https://www.osapublishing.org/ol/abstract.cfm?uri=ol-43-18-4386

Schreiber S, Baumgart D, Drenth J, Filip R, Clayton L, Hylands K, Repici A, Hassan C (2018) Colon cleansing efficacy and safety with 1 L NER1006 versus sodium picosulfate with magnesium citrate: a randomized phase 3 trial. Endoscopy 51: 73-84 (ARCN) https://doi.org/10.1055/a-0639-5070 https://www.ncbi.nlm.nih.gov/pubmed/30025415

Schocker F, Recke A, Kull S, Worm M, Jappe U (2018) Persistent cow′s milk anaphylaxis from early childhood monitored by IgE and BAT to cow′s and human milk under therapy. Pediatr Allergy Immunol 29: 210-214 (ARCN) https://doi.org/10.1111/pai.12843 https://www.ncbi.nlm.nih.gov/pubmed/29197130

Schocker F, Recke A, Kull S, Worm M, Behrends J, Jappe U (2018) Reply to Chirumbolo et al. Pediatr Allergy Immunol 29: 461-462 (ARCN) https://doi.org/10.1111/pai.12892 https://onlinelibrary.wiley.com/doi/abs/10.1111/pai.12892

Schlaefer A, Zell A, Drömann D, Kugler C, Hüttmann G, Wittig L, Otte S, Otte C (2018) Investigating Recurrent Neural Networks for OCT A-scan Based Tissue Analysis. Methods of Information in Medicine 53: 245-249 (ARCN) https://doi.org/10.3414/me13-01-0135 http://www.ncbi.nlm.nih.gov/pubmed/24992968

Salzer HJF, Prattes J, Flick H, Reimann M, Heyckendorf J, Kalsdorf B, Obersteiner S, Gaede KI, Herzmann C, Johnson GL, Lange C, Hoenigl M (2018) Evaluation of Galactomannan Testing, the Aspergillus-Specific Lateral-Flow Device Test and Levels of Cytokines in Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis. Front Microbiol 9: 2223 (ARCN) https://doi.org/10.3389/fmicb.2018.02223 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176022/pdf/fmicb-09-02223.pdf

Ruhwald M, Diel R (2018) Escaping the Plato’s cave of latent tuberculosis testing: a path for developers of predictive tests for risk of tuberculosis. Eur Respir J 52: 1801616 (ARCN) https://doi.org/10.1183/13993003.01616-2018 http://erj.ersjournals.com/content/erj/52/4/1801616.full.pdf

Romey-Glüsing R, Li Y, Hoffmann J, von Frieling J, Knop M, Pfefferkorn R, Bruchhaus I, Fink C, Roeder T (2018) Nutritional regimens with periodically recurring phases of dietary restriction extend lifespan in Drosophila. The FASEB Journal 32: 1993-2003 (ARCN) https://doi.org/10.1096/fj.201700934R https://www.ncbi.nlm.nih.gov/pubmed/29196499

Rolfo C, Mack PC, Scagliotti GV, Baas P, Barlesi F, Bivona TG, Herbst RS, Mok TS, Peled N, Pirker R, Raez LE, Reck M, Riess JW, Sequist LV, Shepherd FA, Sholl LM, Tan DSW, Wakelee HA, Wistuba II, Wynes MW, Carbone DP, Hirsch FR, Gandara DR (2018) Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC. J Thorac Oncol 13: 1248-1268 (ARCN) https://doi.org/10.1016/j.jtho.2018.05.030 https://www.ncbi.nlm.nih.gov/pubmed/29885479

Rodriguez Abreu D, Garassino MC, Esteban E, Speranza G, Felip E, Domine M, Hochmair MJ, Powell SF, Cheng SYS, Bischoff H, Peled N, Hui R, Reck M, Garon EB, Boyer M, Grossi F, Jennens R, Yang J, Pietanza MC, Gadgeel SM (2018) KEYNOTE-189 study of pembrolizumab (pembro) plus pemetrexed (pem) and platinum vs placebo plus pem and platinum for untreated, metastatic, nonsquamous NSCLC: Does choice of platinum affect outcomes? Ann Oncol 29: viii529-viii530 (ARCN) https://doi.org/10.1093/annonc/mdy292.086 https://pubmed.ncbi.nlm.nih.gov/32137375

Ricklefs I, Hohmann-Ebbers M, Herz A, Kopp MV (2018) Use of complementary and alternative medicine in children with asthma. Pediatr Allergy Immunol 29: 326-328 (ARCN) https://doi.org/10.1111/pai.12863 https://www.ncbi.nlm.nih.gov/pubmed/29336063

Richter K, Sagawe S, Hecker A, Küllmar M, Askevold I, Damm J, Heldmann S, Pöhlmann M, Ruhrmann S, Sander M, Schlüter K-D, Wilker S, König IR, Kummer W, Padberg W, Hone AJ, McIntosh JM, Zakrzewicz AT, Koch C, Grau V (2018) C-Reactive Protein Stimulates Nicotinic Acetylcholine Receptors to Control ATP-Mediated Monocytic Inflammasome Activation. Front Immunol 9: 1604 (ARCN, UGMLC) https://doi.org/10.3389/fimmu.2018.01604 https://www.ncbi.nlm.nih.gov/pubmed/30105015

Richeldi L, Kreuter M, Selman M, Crestani B, Kirsten A-M, Wuyts WA, Xu Z, Bernois K, Stowasser S, Quaresma M, Costabel U (2018) Long-term treatment of patients with idiopathic pulmonary fibrosis with nintedanib: results from the TOMORROW trial and its open-label extension. Thorax 73: 581-583 (ARCN, TLRC) https://doi.org/10.1136/thoraxjnl-2016-209701 https://www.ncbi.nlm.nih.gov/pubmed/28993537

Reinmuth N, Reck M (2018) Breaking the Glass Ceiling of Overall Survival in Non–Small-Cell Lung Cancer. J Clin Oncol 36: 1647-1648 (ARCN, CPC-M) https://doi.org/10.1200/jco.2018.78.2102 https://www.ncbi.nlm.nih.gov/pubmed/29708807

Recke A, Regensburger A-K, Weigold F, Müller A, Heidecke H, Marschner G, Hammers CM, Ludwig RJ, Riemekasten G (2018) Autoantibodies in Serum of Systemic Scleroderma Patients: Peptide-Based Epitope Mapping Indicates Increased Binding to Cytoplasmic Domains of CXCR3. Front Immunol 9: 428 ((ARCN)) https://doi.org/10.3389/fimmu.2018.00428 https://www.ncbi.nlm.nih.gov/pubmed/29623076

Reck M, Wehler T, Orlandi F, Nogami N, Barone C, Moro-Sibilot D, Shtivelband M, González Larriba JL, Rothenstein J, Frueh M, Shankar G, Lee A, Deng Y, Patel H, Kelsch C, Lin W, Socinski MA (2018) IMpower150: Clinical safety, tolerability and immune-related adverse events in a phase III study of atezolizumab (atezo) + chemotherapy (chemo) ± bevacizumab (bev) vs chemo + bev in 1L nonsquamous NSCLC. Ann Oncol 29: viii498-viii499 (ARCN) https://doi.org/10.1093/annonc/mdy292.009 https://pubmed.ncbi.nlm.nih.gov/32137285

Reck M, Taylor F, Penrod JR, DeRosa M, Morrissey L, Dastani H, Orsini L, Gralla RJ (2018) Impact of Nivolumab versus Docetaxel on Health-Related Quality of Life and Symptoms in Patients with Advanced Squamous Non–Small Cell Lung Cancer: Results from the CheckMate 017 Study. J Thorac Oncol 13: 194-204 (ARCN) https://doi.org/10.1016/j.jtho.2017.10.029 https://www.ncbi.nlm.nih.gov/pubmed/29129758

Reck M, Mellemgaard A, Novello S, Postmus PE, Gaschler-Markefski B, Kaiser R, Buchner H (2018) Change in non-small-cell lung cancer tumor size in patients treated with nintedanib plus docetaxel: analyses from the Phase III LUME-Lung 1 study. Onco Targets Ther Volume 11: 4573-4582 (ARCN) https://doi.org/10.2147/ott.S170722 https://www.dovepress.com/getfile.php?fileID=43521

Reck M, Jotte RM, Socinski MA (2018) Atezolizumab Treatment of Nonsquamous NSCLC. New England Journal of Medicine 379: 1187-1188 (ARCN) https://doi.org/10.1056/NEJMc1809195 https://www.nejm.org/doi/pdf/10.1056/NEJMc1809195

Reck M, Garon EB, Paz-Ares L, Ponce S, Jaime JC, Juan O, Nadal E, Kiura K, Widau RC, He S, Dalal R, Lee P, Nakagawa K (2018) Randomized, Double-Blind Phase Ib/III Study of Erlotinib With Ramucirumab or Placebo in Previously Untreated EGFR -Mutant Metastatic Non–Small-Cell Lung Cancer (RELAY): Phase Ib Results. Clin Lung Cancer 19: 213-220.e214 (ARCN) https://doi.org/10.1016/j.cllc.2017.11.003 https://www.ncbi.nlm.nih.gov/pubmed/29317191

Reck M, Garassino MC, Imbimbo M, Shepherd FA, Socinski MA, Shih J-Y, Tsao A, Lee P, Winfree KB, Sashegyi A, Cheng R, Varea R, Levy B, Garon E (2018) Antiangiogenic therapy for patients with aggressive or refractory advanced non-small cell lung cancer in the second-line setting. Lung Cancer 120: 62-69 (ARCN) https://doi.org/10.1016/j.lungcan.2018.03.025 https://www.ncbi.nlm.nih.gov/pubmed/29748017

Reck M, Brahmer J, Bennett B, Taylor F, Penrod JR, DeRosa M, Dastani H, Spigel DR, Gralla RJ (2018) Evaluation of health-related quality of life and symptoms in patients with advanced non-squamous non-small cell lung cancer treated with nivolumab or docetaxel in CheckMate 057. Eur J Cancer 102: 23-30 (ARCN) https://doi.org/10.1016/j.ejca.2018.05.005 https://www.ejcancer.com/article/S0959-8049(18)30845-1/fulltext

Reck M (2018) Pembrolizumab as first-line therapy for metastatic non-small-cell lung cancer. Immunotherapy 10: 93-105 (ARCN) https://doi.org/10.2217/imt-2017-0121 https://www.ncbi.nlm.nih.gov/pubmed/29145737

Randerath W, Hetzel M, Pfeifer M, Voshaar T, Rabe K (2018) Stellungnahme der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DGP) und des Verbandes Pneumologischer Kliniken (VPK) zur Rolle der Pneumologie in der gestuften Notfallversorgung. Pneumologie 72: 817-819 (ARCN) https://doi.org/10.1055/a-0775-3517

Ramalingam SS, Pérol M, Reck M, Kowalyszyn RD, Gautschi O, Kimmich M, Cho EK, Czyzewicz G, Grigorescu A, Karaseva N, Dakhil S, Lee P, Zimmerman A, Sashegyi A, Alexandris E, Carter GC, Winfree KB, Garon EB (2018) Efficacy and Safety of Ramucirumab With Docetaxel Versus Placebo With Docetaxel as Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer: A Subgroup Analysis According to Patient Age in the REVEL Trial. Clin Lung Cancer 19: 270-279.e273 (ARCN) https://doi.org/10.1016/j.cllc.2017.12.011 https://www.ncbi.nlm.nih.gov/pubmed/29373274

Rabe KF, Watz H, Baraldo S, Pedersen F, Biondini D, Bagul N, Hanauer G, Göhring U-M, Purkayastha D, Román J, Alagappan VKT, Saetta M (2018) Anti-inflammatory effects of roflumilast in chronic obstructive pulmonary disease (ROBERT): a 16-week, randomised, placebo-controlled trial. The Lancet Respiratory Medicine 6: 827-836 (ARCN) https://doi.org/10.1016/s2213-2600(18)30331-x https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(18)30331-X/fulltext

Rabe KF, Nair P, Brusselle G, Maspero JF, Castro M, Sher L, Zhu H, Hamilton JD, Swanson BN, Khan A, Chao J, Staudinger H, Pirozzi G, Antoni C, Amin N, Ruddy M, Akinlade B, Graham NMH, Stahl N, Yancopoulos GD, Teper A (2018) Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma. New England Journal of Medicine 378: 2475-2485 (ARCN) https://doi.org/10.1056/NEJMoa1804093 https://www.ncbi.nlm.nih.gov/pubmed/29782224

Rabe KF, Hurst JR, Suissa S (2018) Cardiovascular disease and COPD: dangerous liaisons? European Respiratory Review 27: 180057 (ARCN) https://doi.org/10.1183/16000617.0057-2018 http://err.ersjournals.com/content/errev/27/149/180057.full.pdf

Prange R, Thiedmann M, Bhandari A, Mishra N, Sinha A, Häsler R, Rosenstiel P, Uliczka K, Wagner C, Yildirim AÖ, Fink C, Roeder T (2018) A <i>Drosophila</i> model of cigarette smoke induced COPD identifies Nrf2 signaling as an expedient target for intervention. Aging 10: 2122-2135 (ARCN, CPC-M) https://doi.org/10.18632/aging.101536

Pomés A, Davies JM, Gadermaier G, Hilger C, Holzhauser T, Lidholm J, Lopata AL, Mueller GA, Nandy A, Radauer C, Chan SK, Jappe U, Kleine-Tebbe J, Thomas WR, Chapman MD, van Hage M, van Ree R, Vieths S, Raulf M, Goodman RE (2018) WHO/IUIS Allergen Nomenclature: Providing a common language. Mol Immunol 100: 3-13 (ARCN) https://doi.org/10.1016/j.molimm.2018.03.003 https://www.ncbi.nlm.nih.gov/pubmed/29625844

Planchard D, Popat S, Kerr K, Novello S, Smit EF, Faivre-Finn C, Mok TS, Reck M, Van Schil PE, Hellmann MD, Peters S (2018) Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 29: iv192-iv237 (ARCN) https://doi.org/10.1093/annonc/mdy275

Pfaar O, Bonini S, Cardona V, Demoly P, Jakob T, Jutel M, Kleine-Tebbe J, Klimek L, Klysner S, Kopp MV, Kuna P, Larché M, Muraro A, Schmidt-Weber CB, Shamji MH, Simonsen K, Somoza C, Valovirta E, Zieglmayer P, Zuberbier T, Wahn U (2018) Perspectives in allergen immunotherapy: 2017 and beyond. Allergy 73: 5-23 (ARCN, CPC-M) https://doi.org/10.1111/all.13355 https://www.ncbi.nlm.nih.gov/pubmed/29171712

Pedersen F, Waschki B, Marwitz S, Goldmann T, Kirsten A, Malmgren A, Rabe KF, Uddin M, Watz H (2018) Neutrophil extracellular trap formation is regulated by CXCR2 in COPD neutrophils. Eur Respir J 51: 1700970 (ARCN) https://doi.org/10.1183/13993003.00970-2017 https://www.ncbi.nlm.nih.gov/pubmed/29449427

Pech M, Weckmann M, König IR, Franke A, Heinsen F-A, Oliver B, Ricklefs I, Fuchs O, Rabe K, Hansen G, v. Mutius E, Kopp MV (2018) Rhinovirus infections change DNA methylation and mRNA expression in children with asthma. PLoS One 13: e0205275 (ARCN, BREATH, CPC-M) https://doi.org/10.1371/journal.pone.0205275 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261460/pdf/pone.0205275.pdf

Pallach M, Di Lorenzo F, Facchini FA, Gully D, Giraud E, Peri F, Duda KA, Molinaro A, Silipo A (2018) Structure and inflammatory activity of the LPS isolated from Acetobacter pasteurianus CIP103108. Int J Biol Macromol 119: 1027-1035 (ARCN) https://doi.org/10.1016/j.ijbiomac.2018.08.035 https://www.ncbi.nlm.nih.gov/pubmed/30098357

Ourak M, Smits J, Esteveny L, Borghesan G, Gijbels A, Schoevaerdts L, Douven Y, Scholtes J, Lankenau E, Eixmann T, Schulz-Hildebrandt H, Hüttmann G, Kozlovszky M, Kronreif G, Willekens K, Stalmans P, Faridpooya K, Cereda M, Giani A, Staurenghi G, Reynaerts D, Vander Poorten EB (2018) Combined OCT distance and FBG force sensing cannulation needle for retinal vein cannulation: in vivo animal validation. Int J Comput Assist Radiol Surg 14: 301-309 (ARCN) https://doi.org/10.1007/s11548-018-1829-0 https://www.ncbi.nlm.nih.gov/pubmed/30056592

Olschewski H, Behr J, Bremer H, Claussen M, Douschan P, Halank M, Held M, Hoeper MM, Holt S, Klose H, Krüger S, Lange TJ, Reichenberger F, Skowasch D, Ulrich S, Wilkens H, Seeger W (2018) Pulmonary hypertension due to lung diseases: Updated recommendations from the Cologne Consensus Conference 2018. Int J Cardiol 272: 63-68 (ARCN, BREATH, CPC-M, UGMLC) https://doi.org/10.1016/j.ijcard.2018.08.043 https://www.ncbi.nlm.nih.gov/pubmed/30131231

Nissen G, Hollaender H, Tang FSM, Wegmann M, Lunding L, Vock C, Bachmann A, Lemmel S, Bartels R, Oliver BG, Burgess JK, Becker T, Kopp MV, Weckmann M (2018) Tumstatin fragment selectively inhibits neutrophil infiltration in experimental asthma exacerbation. Clin Exp Allergy 48: 1483-1493 (ARCN) https://doi.org/10.1111/cea.13236 https://www.ncbi.nlm.nih.gov/pubmed/30028047

Nikolić J, Nešić A, Kull S, Schocker F, Jappe U, Gavrović-Jankulović M (2018) Employment of proteomic and immunological based methods for the identification of catalase as novel allergen from banana. J Proteomics 175: 87-94 (ARCN) https://doi.org/10.1016/j.jprot.2018.01.007 https://www.ncbi.nlm.nih.gov/pubmed/29331514

Nenna R, Petrarca L, Parisi GF, Almendros I, Bartel S, De Brandt J (2018) Zooming in on the ERS fellowships and the International Congress. Breathe 14: 141-144 ((ARCN)) https://doi.org/10.1183/20734735.001818 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980470/pdf/EDU-0018-2018.pdf

Middleton G, Gridelli C, De Marinis F, Pujol J-L, Reck M, Ramlau R, Parente B, Pieters T, Visseren-Grul CM, San Antonio B, John WJ, Zimmermann AH, Chouaki N, Paz-Ares L (2018) Evaluation of changes in renal function in PARAMOUNT: a phase III study of maintenance pemetrexed plus best supportive care versus placebo plus best supportive care after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer. Curr Med Res Opin 34: 865-871 (ARCN) https://doi.org/10.1080/03007995.2018.1439462 https://www.ncbi.nlm.nih.gov/pubmed/29424248

Merker M, Barbier M, Cox H, Rasigade J-P, Feuerriegel S, Kohl TA, Diel R, Borrell S, Gagneux S, Nikolayevskyy V, Andres S, Nübel U, Supply P, Wirth T, Niemann S (2018) Compensatory evolution drives multidrug-resistant tuberculosis in Central Asia. eLife 7: e38200 (ARCN) https://doi.org/10.7554/eLife.38200 https://doi.org/10.7554/eLife.38200

Matthiesen J, Lender C, Haferkorn A, Fehling H, Meyer M, Matthies T, Tannich E, Roeder T, Lotter H, Bruchhaus I (2018) Trigger‐induced RNAi gene silencing to identify pathogenicity factors of

Entamoeba histolytica. The FASEB Journal 33: 1658-1668 (ARCN) https://doi.org/10.1096/fj.201801313R https://faseb.onlinelibrary.wiley.com/doi/full/10.1096/fj.201801313R

Marwitz S, Heinbockel L, Scheufele S, Kugler C, Reck M, Rabe KF, Perner S, Goldmann T, Ammerpohl O (2018) Fountain of youth for squamous cell carcinomas? On the epigenetic age of non-small cell lung cancer and corresponding tumor-free lung tissues. Int J Cancer 143: 3061-3070 (ARCN) https://doi.org/10.1002/ijc.31641 https://www.ncbi.nlm.nih.gov/pubmed/29974462

Martinez FJ, Rabe KF, Calverley PMA, Fabbri LM, Sethi S, Pizzichini E, McIvor A, Anzueto A, Alagappan VKT, Siddiqui S, Reisner C, Zetterstrand S, Román J, Purkayastha D, Bagul N, Rennard SI (2018) Determinants of Response to Roflumilast in Severe Chronic Obstructive Pulmonary Disease. Pooled Analysis of Two Randomized Trials. American Journal of Respiratory and Critical Care Medicine 198: 1268-1278 (ARCN) https://doi.org/10.1164/rccm.201712-2493OC https://www.ncbi.nlm.nih.gov/pubmed/29763572

Lindner K, Webering S, Stroebele M, Bockhorn H, Hansen T, König P, Fehrenbach H (2018) Low Dose Carbon Black Nanoparticle Exposure Does Not Aggravate Allergic Airway Inflammation in Mice Irrespective of the Presence of Surface Polycyclic Aromatic Hydrocarbons. Nanomaterials 8: 213 (ARCN) https://doi.org/10.3390/nano8040213 https://www.ncbi.nlm.nih.gov/pubmed/29614747

Lilienthal G-M, Rahmöller J, Petry J, Bartsch YC, Leliavski A, Ehlers M (2018) Potential of Murine IgG1 and Human IgG4 to Inhibit the Classical Complement and Fcγ Receptor Activation Pathways. Front Immunol 9: 958 (ARCN) https://doi.org/10.3389/fimmu.2018.00958 https://www.ncbi.nlm.nih.gov/pubmed/29867943

Levy A, Faivre-Finn C, Hasan B, De Maio E, Berghoff AS, Girard N, Greillier L, Lantuéjoul S, O’Brien M, Reck M, Dingemans A-MC, Novello S, Berghmans T, Besse B, Hendriks L (2018) Diversity of brain metastases screening and management in non-small cell lung cancer in Europe: Results of the European Organisation for Research and Treatment of Cancer Lung Cancer Group survey. Eur J Cancer 93: 37-46 (ARCN) https://doi.org/10.1016/j.ejca.2018.01.067 https://www.ncbi.nlm.nih.gov/pubmed/29477100

Lazaar AL, Miller BE, Tabberer M, Yonchuk J, Leidy N, Ambery C, Bloomer J, Watz H, Tal-Singer R (2018) Effect of the CXCR2 antagonist danirixin on symptoms and health status in COPD. Eur Respir J 52: 1801020 (ARCN) https://doi.org/10.1183/13993003.01020-2018 http://erj.ersjournals.com/content/early/2018/08/16/13993003.01020-2018

Lamprecht P, Kerstein A, Klapa S, Schinke S, Karsten CM, Yu X, Ehlers M, Epplen JT, Holl-Ulrich K, Wiech T, Kalies K, Lange T, Laudien M, Laskay T, Gemoll T, Schumacher U, Ullrich S, Busch H, Ibrahim S, Fischer N, Hasselbacher K, Pries R, Petersen F, Weppner G, Manz R, Humrich JY, Nieberding R, Riemekasten G, Müller A (2018) Pathogenetic and Clinical Aspects of Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitides. Front Immunol 9: 680 (ARCN) https://doi.org/10.3389/fimmu.2018.00680 https://www.ncbi.nlm.nih.gov/pubmed/29686675

Kordowski F, Kolarova J, Schafmayer C, Buch S, Goldmann T, Marwitz S, Kugler C, Scheufele S, Gassling V, Németh CG, Brosch M, Hampe J, Lucius R, Röder C, Kalthoff H, Siebert R, Ammerpohl O, Reiss K (2018) Aberrant DNA methylation of ADAMTS16 in colorectal and other epithelial cancers. BMC Cancer 18: 796 (ARCN) https://doi.org/10.1186/s12885-018-4701-2 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080380/pdf/12885_2018_Article_4701.pdf

Kordowski A, Reinicke AT, Wu D, Orinska Z, Hagemann P, Huber‐Lang M, Lee JB, Wang YH, Hogan SP, Köhl J (2018) C5a receptor 1−/−mice are protected from the development of IgE‐mediated experimental food allergy. Allergy 74: 767-779 (ARCN) https://doi.org/10.1111/all.13637 https://onlinelibrary.wiley.com/doi/abs/10.1111/all.13637

Kohl TA, Harmsen D, Rothgänger J, Walker T, Diel R, Niemann S (2018) Harmonized Genome Wide Typing of Tubercle Bacilli Using a Web-Based Gene-By-Gene Nomenclature System. EBioMedicine 34: 131-138 (ARCN) https://doi.org/10.1016/j.ebiom.2018.07.030 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116475/pdf/main.pdf

Knuhr K, Langhans K, Nyenhuis S, Viertmann K, Kildemoes AMO, Doenhoff MJ, Haas H, Schramm G (2018) Schistosoma mansoni Egg-Released IPSE/alpha-1 Dampens Inflammatory Cytokine Responses via Basophil Interleukin (IL)-4 and IL-13. Front Immunol 9: 2293 (ARCN) https://doi.org/10.3389/fimmu.2018.02293 https://www.ncbi.nlm.nih.gov/pubmed/30364177

Kasprick A, Holtsche MM, Rose EL, Hussain S, Schmidt E, Petersen F, Panicker S, Ludwig RJ (2018) The Anti-C1s Antibody TNT003 Prevents Complement Activation in the Skin Induced by Bullous Pemphigoid Autoantibodies. J Invest Dermatol 138: 458-461 (ARCN) https://doi.org/10.1016/j.jid.2017.08.030 https://www.ncbi.nlm.nih.gov/pubmed/28899686

Kalemkerian GP, Narula N, Kennedy EB, Biermann WA, Donington J, Leighl NB, Lew M, Pantelas J, Ramalingam SS, Reck M, Saqi A, Simoff M, Singh N, Sundaram B (2018) Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update. J Clin Oncol 36: 911-919 (ARCN) https://doi.org/10.1200/jco.2017.76.7293 https://www.ncbi.nlm.nih.gov/pubmed/29401004

Kahnert K, Jobst B, Biertz F, Biederer J, Watz H, Huber RM, Behr J, Grenier PA, Alter P, Vogelmeier CF, Kauczor H-U, Jörres RA (2018) Relationship of spirometric, body plethysmographic, and diffusing capacity parameters to emphysema scores derived from CT scans. Chron Respir Dis 16: 147997231877542 (ARCN, CPC-M, TLRC, UGMLC) https://doi.org/10.1177/1479972318775423 https://www.ncbi.nlm.nih.gov/pubmed/29742906

Kahnert K, Alter P, Young D, Lucke T, Heinrich J, Huber RM, Behr J, Wacker M, Biertz F, Watz H, Bals R, Welte T, Wirtz H, Herth F, Vestbo J, Wouters EF, Vogelmeier CF, Jörres RA (2018) The revised GOLD 2017 COPD categorization in relation to comorbidities. Respir Med 134: 79-85 (ARCN, BREATH, CPC-M, TLRC, UGMLC) https://doi.org/10.1016/j.rmed.2017.12.003 https://www.resmedjournal.com/article/S0954-6111(17)30411-0/pdf

Kahnert K, Alter P, Welte T, Huber RM, Behr J, Biertz F, Watz H, Bals R, Vogelmeier CF, Jörres RA (2018) Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach. Respir Res 19: 110 (ARCN, BREATH, CPC-M, UGMLC) https://doi.org/10.1186/s12931-018-0815-y https://www.ncbi.nlm.nih.gov/pubmed/29866121

Kahn NC, Bartel S, Amaral AFS, Bos LD, De Brandt J (2018) New kids on the block in the ECMC and opportunities for early career members in 2018. Breathe 14: 55-57 ((ARCN)) https://doi.org/10.1183/20734735.019517 http://spiral.imperial.ac.uk/bitstream/10044/1/54808/9/55.full.pdf

Jappe U, Minge S, Kreft B, Ludwig A, Przybilla B, Walker A, Varga R, Seidel P, Biedermann T, Anemüller W, Kromminga A, Ruëff F, Merk H, Wagner N, Treudler R, Worm M, Waldmann I, Saloga J, Becker WM, Goldmann T, Platts-Mills TA, Homann A (2018) Meat allergy associated with galactosyl-α-(1,3)-galactose (α-Gal)-Closing diagnostic gaps by anti-α-Gal IgE immune profiling. Allergy 73: 93-105 (ARCN) https://doi.org/10.1111/all.13238 https://www.ncbi.nlm.nih.gov/pubmed/28670695

Jappe U, Kull S, Opitz A, Zabel P (2018) Anaphylaxis to vanilla ice cream: a near fatal cross-reactivity phenomenon. J Eur Acad Dermatol Venereol 32: e22-e23 (ARCN) https://doi.org/10.1111/jdv.14445 https://www.ncbi.nlm.nih.gov/pubmed/28662315

Jappe U (2018) Nahrungsmittelallergien – Theorie und Praxis. DMW – Deutsche Medizinische Wochenschrift 143: 713-721 (ARCN) https://doi.org/10.1055/s-0043-121014 https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0043-121014

Jacobs G, Wolf A, Krawczak M, Lieb W (2018) Biobanks in the Era of Digital Medicine. Clin Pharmacol Ther 103: 761-762 (ARCN) https://doi.org/10.1002/cpt.968 https://www.ncbi.nlm.nih.gov/pubmed/29285753

Horn L, Mansfield AS, Szczęsna A, Havel L, Krzakowski M, Hochmair MJ, Huemer F, Losonczy G, Johnson ML, Nishio M, Reck M, Mok T, Lam S, Shames DS, Liu J, Ding B, Lopez-Chavez A, Kabbinavar F, Lin W, Sandler A, Liu SV (2018) First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer. New England Journal of Medicine 379: 2220-2229 (ARCN) https://doi.org/10.1056/NEJMoa1809064 https://www.ncbi.nlm.nih.gov/pubmed/30280641

Hoffmann FM, Berger JL, Lingel I, Laumonnier Y, Lewkowich IP, Schmudde I, König P (2018) Distribution and Interaction of Murine Pulmonary Phagocytes in the Naive and Allergic Lung. Front Immunol 9: 1046 (ARCN) https://doi.org/10.3389/fimmu.2018.01046 https://www.ncbi.nlm.nih.gov/pubmed/29868009

Hirsch FR, Kerr KM, Bunn PA, Kim ES, Obasaju C, Pérol M, Bonomi P, Bradley JD, Gandara D, Jett JR, Langer CJ, Natale RB, Novello S, Paz-Ares L, Ramalingam SS, Reck M, Reynolds CH, Smit EF, Socinski MA, Spigel DR, Stinchcombe TE, Vansteenkiste JF, Wakelee H, Thatcher N (2018) Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies. Clin Lung Cancer 19: 331-339 (ARCN) https://doi.org/10.1016/j.cllc.2018.03.014 https://www.ncbi.nlm.nih.gov/pubmed/29773328

Hendriks LEL, Menis J, Reck M (2018) Prospects of targeted and immune therapies in SCLC. Expert Rev Anticancer Ther 19: 151-167 (ARCN) https://doi.org/10.1080/14737140.2019.1559057

Hellmann MD, Ciuleanu T-E, Pluzanski A, Lee JS, Otterson GA, Audigier-Valette C, Minenza E, Linardou H, Burgers S, Salman P, Borghaei H, Ramalingam SS, Brahmer J, Reck M, O’Byrne KJ, Geese WJ, Green G, Chang H, Szustakowski J, Bhagavatheeswaran P, Healey D, Fu Y, Nathan F, Paz-Ares L (2018) Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden. New England Journal of Medicine 378: 2093-2104 (ARCN) https://doi.org/10.1056/NEJMoa1801946 https://www.ncbi.nlm.nih.gov/pubmed/29658845

Heinbockel L, Weindl G, Martinez-de-Tejada G, Correa W, Sanchez-Gomez S, Bárcena-Varela S, Goldmann T, Garidel P, Gutsmann T, Brandenburg K (2018) Inhibition of Lipopolysaccharide- and Lipoprotein-Induced Inflammation by Antitoxin Peptide Pep19-2.5. Front Immunol 9: 1704 (ARCN) https://doi.org/10.3389/fimmu.2018.01704 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070603/pdf/fimmu-09-01704.pdf

Heinbockel L, Marwitz S, Schromm A, Watz H, Kugler C, Ammerpohl O, Schnepf K, Rabe KF, Droemann D, Goldmann T (2018) Identification of novel target genes in human lung tissue involved in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis Volume 13: 2255-2259 (ARCN) https://doi.org/10.2147/copd.S161958 https://www.ncbi.nlm.nih.gov/pubmed/30100715

Heigener DF, Reck M (2018) Crizotinib. Recent Results Cancer Res 211: 57-65 (ARCN) https://doi.org/10.1007/978-3-319-91442-8_4 https://link.springer.com/chapter/10.1007%2F978-3-319-91442-8_4

Heigener DF, Reck M (2018) Impact of PD-L1 Expression in EGFR-Positive NSCLC? The Answer Remains the Same…. J Thorac Oncol 13: 1060-1061 (ARCN) https://doi.org/10.1016/j.jtho.2018.06.001 https://www.ncbi.nlm.nih.gov/pubmed/30056859

Heigener DF, Reck M (2018) Advanced non-small cell lung cancer: the role of PD-L1 inhibitors. J Thorac Dis 10: S1468-S1473 (ARCN) https://doi.org/10.21037/jtd.2018.01.112 http://jtd.amegroups.com/article/view/19002/16421

Hammer B, Wagner C, Divac Rankov A, Reuter S, Bartel S, Hylkema MN, Krüger A, Svanes C, Krauss-Etschmann S (2018) In utero exposure to cigarette smoke and effects across generations: A conference of animals on asthma. Clin Exp Allergy 48: 1378-1390 (ARCN) https://doi.org/10.1111/cea.13283 https://www.ncbi.nlm.nih.gov/pubmed/30244507

Gülsen A, Jappe U (2018) Lipid transfer protein sensitization in an apple-allergic patient: a case report from northern Europe. Eur Ann Allergy Clin Immunol 51: 80 (ARCN) https://doi.org/10.23822/EurAnnACI.1764-1489.63 https://www.ncbi.nlm.nih.gov/pubmed/29542892

Gulsen A (2018) Importance of bronchoscopic lung volume reduction coil therapy in potential candidates for lung transplantation. Biosci Trends 12: 395-402 ((ARCN)) https://doi.org/10.5582/bst.2018.01134 https://www.jstage.jst.go.jp/article/bst/advpub/0/advpub_2018.01134/_pdf

Greulich T, Mager S, Lucke T, Koczulla AR, Bals R, Fähndrich S, Jörres RA, Alter P, Kirsten A-M, Vogelmeier CF, Watz H (2018) Longitudinal stability of blood eosinophil count strata in the COPD COSYCONET cohort. Int J Chron Obstruct Pulmon Dis Volume 13: 2999-3002 (ARCN, CPC-M, UGMLC) https://doi.org/10.2147/copd.S165909 https://www.dovepress.com/getfile.php?fileID=44843

Greulich T, Hohlfeld JM, Neuser P, Lueer K, Klemmer A, Schade-Brittinger C, Harnisch S, Garn H, Renz H, Homburg U, Renz J, Kirsten A, Pedersen F, Müller M, Vogelmeier CF, Watz H (2018) A GATA3-specific DNAzyme attenuates sputum eosinophilia in eosinophilic COPD patients: a feasibility randomized clinical trial. Respir Res 19: 55 (ARCN, BREATH, UGMLC) https://doi.org/10.1186/s12931-018-0751-x https://www.ncbi.nlm.nih.gov/pubmed/29615049

Graf J, Lucke T, Herrera R, Watz H, Holle R, Vogelmeier C, Ficker JH, Jörres RA (2018) Compatibility of medication with PRISCUS criteria and identification of drug interactions in a large cohort of patients with COPD. Pulm Pharmacol Ther 49: 123-129 (ARCN, CPC-M, UGMLC) https://doi.org/10.1016/j.pupt.2018.01.011 https://www.ncbi.nlm.nih.gov/pubmed/29421666

Goring SM, Wilson JB, Risebrough NR, Gallagher J, Carroll S, Heap KJ, Obradovic M, Loebinger MR, Diel R (2018) The cost of Mycobacterium avium complex lung disease in Canada, France, Germany, and the United Kingdom: a nationally representative observational study. BMC Health Serv Res 18: 700 (ARCN) https://doi.org/10.1186/s12913-018-3489-8 https://www.ncbi.nlm.nih.gov/pubmed/30200944

Goldmann T, Zissel G, Watz H, Drömann D, Reck M, Kugler C, Rabe KF, Marwitz S (2018) Human alveolar epithelial cells type II are capable of TGFβ-dependent epithelial-mesenchymal-transition and collagen-synthesis. Respir Res 19: 138 (ARCN) https://doi.org/10.1186/s12931-018-0841-9 https://www.ncbi.nlm.nih.gov/pubmed/30041633

Gerber DE, Horn L, Boyer M, Sanborn R, Natale R, Palmero R, Bidoli P, Bondarenko I, Germonpre P, Ghizdavescu D, Kotsakis A, Lena H, Losonczy G, Park K, Su WC, Tang M, Lai J, Kallinteris NL, Shan JS, Reck M, Spigel DR (2018) Randomized phase III study of docetaxel plus bavituximab in previously treated advanced non-squamous non-small-cell lung cancer. Ann Oncol 29: 1548-1553 (ARCN) https://doi.org/10.1093/annonc/mdy177 https://www.ncbi.nlm.nih.gov/pubmed/29767677

García-Basteiro AL, Schaaf HS, Diel R, Migliori Giovanni B (2018) Adolescents and young adults: a neglected population group for tuberculosis surveillance. Eur Respir J 51: 1800176 (ARCN) https://doi.org/10.1183/13993003.00176-2018 https://www.ncbi.nlm.nih.gov/pubmed/29467211

Gao Y, Li S, Zhang Z, Yu X, Zheng J (2018) The Role of Long Non-coding RNAs in the Pathogenesis of RA, SLE, and SS. Frontiers in Medicine 5: 193 ((ARCN)) https://doi.org/10.3389/fmed.2018.00193 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038710/pdf/fmed-05-00193.pdf

Gandhi L, Rodríguez-Abreu D, Gadgeel S, Esteban E, Felip E, De Angelis F, Domine M, Clingan P, Hochmair MJ, Powell SF, Cheng SYS, Bischoff HG, Peled N, Grossi F, Jennens RR, Reck M, Hui R, Garon EB, Boyer M, Rubio-Viqueira B, Novello S, Kurata T, Gray JE, Vida J, Wei Z, Yang J, Raftopoulos H, Pietanza MC, Garassino MC (2018) Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer. New England Journal of Medicine 378: 2078-2092 (ARCN) https://doi.org/10.1056/NEJMoa1801005 https://www.ncbi.nlm.nih.gov/pubmed/29658856

Fuchs O, Bahmer T, Weckmann M, Dittrich A-M, Schaub B, Rösler B, Happle C, Brinkmann F, Ricklefs I, König IR, Watz H, Rabe KF, Kopp MV, Hansen G, von Mutius E (2018) Correction to: The all age asthma cohort (ALLIANCE) – from early beginnings to chronic disease: a longitudinal cohort study. BMC Pulm Med 18: 165 (ARCN, BREATH, CPC-M) https://doi.org/10.1186/s12890-018-0717-2 https://bmcpulmmed.biomedcentral.com/track/pdf/10.1186/s12890-018-0717-2

Fuchs O, Bahmer T, Weckmann M, Dittrich A-M, Schaub B, Rösler B, Happle C, Brinkmann F, Ricklefs I, König IR, Watz H, Rabe KF, Kopp MV, Hansen G, von Mutius E (2018) The all age asthma cohort (ALLIANCE) – from early beginnings to chronic disease: a longitudinal cohort study. BMC Pulm Med 18: 140 (ARCN, BREATH, CPC-M) https://doi.org/10.1186/s12890-018-0705-6 https://bmcpulmmed.biomedcentral.com/track/pdf/10.1186/s12890-018-0705-6

Franzen KF, Willig J, Cayo Talavera S, Meusel M, Sayk F, Reppel M, Dalhoff K, Mortensen K, Droemann D (2018) E-cigarettes and cigarettes worsen peripheral and central hemodynamics as well as arterial stiffness: A randomized, double-blinded pilot study. Vasc Med 23: 419-425 (ARCN) https://doi.org/10.1177/1358863×18779694 https://www.ncbi.nlm.nih.gov/pubmed/29985113

Ferreira DS, Carvalho-Pinto RM, Gregório MG, Annoni R, Teles AM, Buttignol M, Araújo-Paulino BB, Katayama EH, Oliveira BL, Del Frari HS, Cukier A, Dolhnikoff M, Stelmach R, Rabe KF, Mauad T (2018) Airway pathology in severe asthma is related to airflow obstruction but not symptom control. Allergy 73: 635-643 (ARCN) https://doi.org/10.1111/all.13323 https://www.ncbi.nlm.nih.gov/pubmed/28960335

Ferguson GT, Rabe KF, Martinez FJ, Fabbri LM, Wang C, Ichinose M, Bourne E, Ballal S, Darken P, DeAngelis K, Aurivillius M, Dorinsky P, Reisner C (2018) Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial. The Lancet Respiratory Medicine 6: 747-758 (ARCN) https://doi.org/10.1016/s2213-2600(18)30327-8 https://www.ncbi.nlm.nih.gov/pubmed/30232048

Faiz A, Weckmann M, Tasena H, Vermeulen Corneel J, Van den Berge M, ten Hacken NHT, Halayko AJ, Ward JPT, Lee TH, Tjin G, Black Judith L, Haghi M, Xu C-J, King GG, Farah CS, Oliver BG, Heijink IH, Burgess Janette K (2018) Profiling of healthy and asthmatic airway smooth muscle cells following interleukin-1β treatment: a novel role for CCL20 in chronic mucus hypersecretion. Eur Respir J 52: 1800310 (ARCN) https://doi.org/10.1183/13993003.00310-2018 https://www.ncbi.nlm.nih.gov/pubmed/29946002

Facius A, Marostica E, Gardiner P, Watz H, Lahu G (2018) Pharmacokinetic and Pharmacodynamic Modelling to Characterize the Tolerability of Alternative Up-Titration Regimens of Roflumilast in Patients with Chronic Obstructive Pulmonary Disease. Clin Pharmacokinet 57: 1029-1038 (ARCN) https://doi.org/10.1007/s40262-018-0671-4 https://www.ncbi.nlm.nih.gov/pubmed/29797235

Epp A, Hobusch J, Bartsch YC, Petry J, Lilienthal G-M, Koeleman CAM, Eschweiler S, Möbs C, Hall A, Morris SC, Braumann D, Engellenner C, Bitterling J, Rahmöller J, Leliavski A, Thurmann R, Collin M, Moremen KW, Strait RT, Blanchard V, Petersen A, Gemoll T, Habermann JK, Petersen F, Nandy A, Kahlert H, Hertl M, Wuhrer M, Pfützner W, Jappe U, Finkelman FD, Ehlers M (2018) Sialylation of IgG antibodies inhibits IgG-mediated allergic reactions. Journal of Allergy and Clinical Immunology 141: 399-402.e398 (ARCN) https://doi.org/10.1016/j.jaci.2017.06.021 https://www.ncbi.nlm.nih.gov/pubmed/28728998

El Husseiny I, Elbrense H, Roeder T, El Kholy S (2018) Hormonal modulation of cannibalistic behaviors in mosquito (Culex pipiens) larvae. J Insect Physiol 109: 144-148 (ARCN) https://doi.org/10.1016/j.jinsphys.2018.08.001 https://www.ncbi.nlm.nih.gov/pubmed/30077702

Diel R, Nienhaus A, Ringshausen FC, Richter E, Welte T, Rabe KF, Loddenkemper R (2018) Microbiologic Outcome of Interventions Against Mycobacterium avium Complex Pulmonary Disease. Chest 153: 888-921 (ARCN, BREATH) https://doi.org/10.1016/j.chest.2018.01.024 https://www.ncbi.nlm.nih.gov/pubmed/29410162

Diel R, Niemann S, Nienhaus A (2018) Risk of tuberculosis transmission among healthcare workers. ERJ Open Research 4: 00161-02017 (ARCN) https://doi.org/10.1183/23120541.00161-2017 https://www.ncbi.nlm.nih.gov/pubmed/29637080

Diel R, Lipman M, Hoefsloot W (2018) High mortality in patients with Mycobacterium avium complex lung disease: a systematic review. BMC Infect Dis 18: 206 (ARCN) https://doi.org/10.1186/s12879-018-3113-x https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934808/pdf/12879_2018_Article_3113.pdf

Delgado-Eckert E, Fuchs O, Kumar N, Pekkanen J, Dalphin J-C, Riedler J, Lauener R, Kabesch M, Kupczyk M, Dahlen S-E, Mutius Ev, Frey U (2018) Functional phenotypes determined by fluctuation-based clustering of lung function measurements in healthy and asthmatic cohort participants. Thorax 73: 107-115 (ARCN, CPC-M, UGMLC) https://doi.org/10.1136/thoraxjnl-2016-209919 https://www.ncbi.nlm.nih.gov/pubmed/28866644

Dehmel S, Nathan P, Bartel S, El-Merhie N, Scherb H, Milger K, John-Schuster G, Yildirim AO, Hylkema M, Irmler M, Beckers J, Schaub B, Eickelberg O, Krauss-Etschmann S (2018) Intrauterine smoke exposure deregulates lung function, pulmonary transcriptomes, and in particular insulin-like growth factor (IGF)-1 in a sex-specific manner. Sci Rep 8: 7547 (ARCN, CPC-M) https://doi.org/10.1038/s41598-018-25762-5 https://www.ncbi.nlm.nih.gov/pubmed/29765129

Dalhoff K, Abele-Horn M, Andreas S, Deja M, Ewig S, Gastmeier P, Gatermann S, Gerlach H, Grabein B, Heußel C, Höffken G, Kolditz M, Kramme E, Kühl H, Lange C, Mayer K, Nachtigall I, Panning M, Pletz M, Rath PM, Rohde G, Rosseau S, Schaaf B, Schreiter D, Schütte H, Seifert H, Spies C, Welte T (2018) Epidemiologie, Diagnostik und Therapie erwachsener Patienten mit nosokomialer Pneumonie – Update 2017. Pneumologie 72: 15-63 (ARCN, BREATH, TLRC, UGMLC) https://doi.org/10.1055/s-0043-121734 https://www.ncbi.nlm.nih.gov/pubmed/29341032

Consortium CR, the GP, Allix-Beguec C, Arandjelovic I, Bi L, Beckert P, Bonnet M, Bradley P, Cabibbe AM, Cancino-Munoz I, Caulfield MJ, Chaiprasert A, Cirillo DM, Clifton DA, Comas I, Crook DW, De Filippo MR, de Neeling H, Diel R, Drobniewski FA, Faksri K, Farhat MR, Fleming J, Fowler P, Fowler TA, Gao Q, Gardy J, Gascoyne-Binzi D, Gibertoni-Cruz AL, Gil-Brusola A, Golubchik T, Gonzalo X, Grandjean L, He G, Guthrie JL, Hoosdally S, Hunt M, Iqbal Z, Ismail N, Johnston J, Khanzada FM, Khor CC, Kohl TA, Kong C, Lipworth S, Liu Q, Maphalala G, Martinez E, Mathys V, Merker M, Miotto P, Mistry N, Moore DAJ, Murray M, Niemann S, Omar SV, Ong RT, Peto TEA, Posey JE, Prammananan T, Pym A, Rodrigues C, Rodrigues M, Rodwell T, Rossolini GM, Sanchez Padilla E, Schito M, Shen X, Shendure J, Sintchenko V, Sloutsky A, Smith EG, Snyder M, Soetaert K, Starks AM, Supply P, Suriyapol P, Tahseen S, Tang P, Teo YY, Thuong TNT, Thwaites G, Tortoli E, van Soolingen D, Walker AS, Walker TM, Wilcox M, Wilson DJ, Wyllie D, Yang Y, Zhang H, Zhao Y, Zhu B (2018) Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing. New England Journal of Medicine 379: 1403-1415 (ARCN) https://doi.org/10.1056/NEJMoa1800474 https://www.ncbi.nlm.nih.gov/pubmed/30280646

Chu HW, Danov O, Jiménez Delgado SM, Obernolte H, Seehase S, Dehmel S, Braubach P, Fieguth H-G, Matschiner G, Fitzgerald M, Jonigk D, Knauf S, Pfennig O, Warnecke G, Wichmann J, Braun A, Sewald K (2018) Human lung tissue provides highly relevant data about efficacy of new anti-asthmatic drugs. PLoS One 13: e0207767 (ARCN, BREATH) https://doi.org/10.1371/journal.pone.0207767 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267969/pdf/pone.0207767.pdf

Castro M, Corren J, Pavord ID, Maspero J, Wenzel S, Rabe KF, Busse WW, Ford L, Sher L, FitzGerald JM, Katelaris C, Tohda Y, Zhang B, Staudinger H, Pirozzi G, Amin N, Ruddy M, Akinlade B, Khan A, Chao J, Martincova R, Graham NMH, Hamilton JD, Swanson BN, Stahl N, Yancopoulos GD, Teper A (2018) Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma. New England Journal of Medicine 378: 2486-2496 (ARCN) https://doi.org/10.1056/NEJMoa1804092 https://www.ncbi.nlm.nih.gov/pubmed/29782217

Cabanillas B, Jappe U, Novak N (2018) Allergy to Peanut, Soybean, and Other Legumes: Recent Advances in Allergen Characterization, Stability to Processing and IgE Cross-Reactivity. Mol Nutr Food Res 62: 1700446 (ARCN) https://doi.org/10.1002/mnfr.201700446 https://www.ncbi.nlm.nih.gov/pubmed/28944625

Busse WW, Bateman ED, Caplan AL, Kelly HW, O’Byrne PM, Rabe KF, Chinchilli VM (2018) Combined Analysis of Asthma Safety Trials of Long-Acting β2-Agonists. New England Journal of Medicine 378: 2497-2505 (ARCN) https://doi.org/10.1056/NEJMoa1716868 https://www.ncbi.nlm.nih.gov/pubmed/29949492

Burgy O, Fernandez Fernandez E, Rolandsson Enes S, Königshoff M, Greene CM, Bartel S (2018) New players in chronic lung disease identified at the European Respiratory Society International Congress in Paris 2018: from microRNAs to extracellular vesicles. J Thorac Dis 10: S2983-S2987 ((ARCN), CPC-M) https://doi.org/10.21037/jtd.2018.08.20 http://jtd.amegroups.com/article/view/23548/18039

Brueckl WM, Laack E, Reck M, Griesinger F, Schäfer H, Kortsik C, Gaska T, Rawluk J, Krüger S, Kokowski K, Budweiser S, Schueler A, Kiessling S (2018) Efficacy of afatinib in the clinical practice: First results of the GIDEON trial: A prospective non-interventional study (NIS) in EGFR mutated NSCLC in Germany. Ann Oncol 29: viii524 (ARCN) https://doi.org/10.1093/annonc/mdy292.071 https://pubmed.ncbi.nlm.nih.gov/32137360

Brückl W, Ficker J, Tiemann M, Schumann C, Reinmuth N, Heigener D, Schütte W, Eberhardt R, Darwiche K, Wagner M (2018) Empfehlung der Sektionen 2 und 11 der DGP zur Rebiopsie bei Lungenkarzinomen. Pneumologie 72: 617-623 (ARCN, CPC-M, TLRC) https://doi.org/10.1055/a-0632-9174 https://www.ncbi.nlm.nih.gov/pubmed/30071539

Bozorgmehr F, Hommertgen A, Lasitschka F, Krisam J, Debus J, Fischer JR, Bischof M, Atmaca A, Wetzel S, Faehling M, Bottke D, Grohe C, Engel-Riedel W, Ingenhoff E, Heigener DF, Reinmuth N, Schumann C, Wermke M, Thomas M, Rieken S (2018) Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer: The FORCE trial. Ann Oncol 29: viii544 (ARCN, CPC-M, TLRC) https://doi.org/10.1093/annonc/mdy292.123 https://pubmed.ncbi.nlm.nih.gov/32137418

Bonomi PD, Gandara D, Hirsch FR, Kerr KM, Obasaju C, Paz-Ares L, Bellomo C, Bradley JD, Bunn Jr PA, Culligan M, Jett JR, Kim ES, Langer CJ, Natale RB, Novello S, Pérol M, Ramalingam SS, Reck M, Reynolds CH, Smit EF, Socinski MA, Spigel DR, Vansteenkiste JF, Wakelee H, Thatcher N (2018) Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer. Ann Oncol 29: 1701-1709 (ARCN) https://doi.org/10.1093/annonc/mdy196 https://www.ncbi.nlm.nih.gov/pubmed/29905778

Bonniaud P, Fabre A, Frossard N, Guignabert C, Inman M, Kuebler WM, Maes T, Shi W, Stampfli M, Uhlig S, White E, Witzenrath M, Bellaye P-S, Crestani B, Eickelberg O, Fehrenbach H, Guenther A, Jenkins G, Joos G, Magnan A, Maitre B, Maus Ulrich A, Reinhold P, Vernooy JHJ, Richeldi L, Kolb M (2018) Optimising experimental research in respiratory diseases: an ERS statement. Eur Respir J 51: 1702133 (ARCN, BREATH, UGMLC) https://doi.org/10.1183/13993003.02133-2017 https://www.ncbi.nlm.nih.gov/pubmed/29773606

Bönisch E, Oh YJ, Anzengruber J, Hager FF, López-Guzmán A, Zayni S, Hinterdorfer P, Kosma P, Messner P, Duda KA, Schäffer C (2018) Lipoteichoic acid mediates binding of a Lactobacillus S-layer protein. Glycobiology 28: 148-158 (ARCN) https://doi.org/10.1093/glycob/cwx102 https://www.ncbi.nlm.nih.gov/pubmed/29309573

Berger L-A, Janning M, Velthaus J-L, Ben-Batalla I, Schatz S, Falk M, Iglauer P, Simon R, Cao R, Forcato C, Manaresi N, Bramlett K, Buson G, Hanssen A, Tiemann M, Sauter G, Bokemeyer C, Riethdorf S, Reck M, Pantel K, Wikman H, Loges S (2018) Identification of a High-Level MET Amplification in CTCs and cfTNA of an ALK-Positive NSCLC Patient Developing Evasive Resistance to Crizotinib. J Thorac Oncol 13: e243-e246 (ARCN) https://doi.org/10.1016/j.jtho.2018.08.2025 https://www.jto.org/article/S1556-0864(18)33041-7/pdf

Bartsch YC, Rahmöller J, Mertes MMM, Eiglmeier S, Lorenz FKM, Stoehr AD, Braumann D, Lorenz AK, Winkler A, Lilienthal G-M, Petry J, Hobusch J, Steinhaus M, Hess C, Holecska V, Schoen CT, Oefner CM, Leliavski A, Blanchard V, Ehlers M (2018) Sialylated Autoantigen-Reactive IgG Antibodies Attenuate Disease Development in Autoimmune Mouse Models of Lupus Nephritis and Rheumatoid Arthritis. Front Immunol 9: 1183 (ARCN) https://doi.org/10.3389/fimmu.2018.01183 https://www.ncbi.nlm.nih.gov/pubmed/29928274

Bartel S, Carraro G, Alessandrini F, Krauss-Etschmann S, Ricciardolo FLM, Bellusci S (2018) miR-142-3p is associated with aberrant WNT signaling during airway remodeling in asthma. American Journal of Physiology-Lung Cellular and Molecular Physiology 315: L328-L333 (ARCN, UGMLC) https://doi.org/10.1152/ajplung.00113.2018 https://www.ncbi.nlm.nih.gov/pubmed/29722559

Ballmann M, Hubert D, Assael BM, Staab D, Hebestreit A, Naehrlich L, Nickolay T, Prinz N, Holl RW, Staden U, Claßen M, Schuster A, Mellies U, Posselt H-G, Wiebel M, Rietschel E, Stern M, Teschler H, Smaczny C, Köhnlein T, Wienhausen-Wilke V, Claaß A, Biedermann T, Dockter G, Köster H, Hebestreit H, Ballke E-H, Heuer H-E, Kamin W, Küster P, Szczepanski R, Keller K-M, Generlich H, Bresser H-G, Kopp M, Herting E, Feickert H-J, Hautz J, Schilling B, Meyer E, Mall MA, Wiebicke W, Tegtmeyer F-K, Honer M, Mosnier-Pudar H, Lenoir G, Robert J-J, Kessler L, Weiss L, Nove-Josserand R, Vantyghem M-C, Munck A, Wizla N, Leroy S, Loeuille G-A, Serreau R, Aissat F, Thalhammer GH, Huttegger I, Eichler I, Götz M (2018) Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: a multicentre, open-label, randomised trial. The Lancet Diabetes & Endocrinology 6: 114-121 (ARCN, TLRC, UGMLC) https://doi.org/10.1016/s2213-8587(17)30400-x https://www.ncbi.nlm.nih.gov/pubmed/29199116

Bahmer T, Watz H, Develaska M, Waschki B, Rabe Klaus F, Magnussen H, Kirsten D, Kirsten A-M (2018) Physical Activity and Fatigue in Patients with Sarcoidosis. Respiration 95: 18-26 (ARCN) https://doi.org/10.1159/000481827 https://www.ncbi.nlm.nih.gov/pubmed/29131111

Arriola E, Paredes-Lario A, García-Gomez R, Diz-Tain P, Constenla M, García-Girón C, Márquez G, Reck M, López-Vivanco G (2018) Comparison of plasma ctDNA and tissue/cytology-based techniques for the detection of EGFR mutation status in advanced NSCLC: Spanish data subset from ASSESS. Clinical and Translational Oncology 20: 1261-1267 (ARCN) https://doi.org/10.1007/s12094-018-1855-y https://www.ncbi.nlm.nih.gov/pubmed/29623586

Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, Kurata T, Chiappori A, Lee KH, de Wit M, Cho BC, Bourhaba M, Quantin X, Tokito T, Mekhail T, Planchard D, Kim Y-C, Karapetis CS, Hiret S, Ostoros G, Kubota K, Gray JE, Paz-Ares L, de Castro Carpeño J, Faivre-Finn C, Reck M, Vansteenkiste J, Spigel DR, Wadsworth C, Melillo G, Taboada M, Dennis PA, Özgüroğlu M (2018) Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC. New England Journal of Medicine 379: 2342-2350 (ARCN) https://doi.org/10.1056/NEJMoa1809697

Anemüller W, Mohr M, Brans R, Homann A, Jappe U (2018) Alpha-Gal-assoziierte verzögerte Anaphylaxie gegen rotes Fleisch als Berufskrankheit. Der Hautarzt 69: 848-852 (ARCN) https://doi.org/10.1007/s00105-018-4224-4 https://www.ncbi.nlm.nih.gov/pubmed/29951852

Amatngalim GD, Vieira RP, Meiners S, Bartel S (2018) Novel insights into the effects of cigarette smoke on the airway epithelial surface—lessons learned at the European Respiratory Society International Congress 2018 in Paris. J Thorac Dis 10: S2977-S2982 ((ARCN), CPC-M) https://doi.org/10.21037/jtd.2018.08.17 http://jtd.amegroups.com/article/view/23493/18037

Alter P, Watz H, Kahnert K, Pfeifer M, Randerath WJ, Andreas S, Waschki B, Kleibrink BE, Welte T, Bals R, Schulz H, Biertz F, Young D, Vogelmeier CF, Jörres RA (2018) Airway obstruction and lung hyperinflation in COPD are linked to an impaired left ventricular diastolic filling. Respir Med 137: 14-22 (ARCN, BREATH, CPC-M, UGMLC) https://doi.org/10.1016/j.rmed.2018.02.011 https://www.ncbi.nlm.nih.gov/pubmed/29605197

Alter P, Rabe KF, Schulz H, Vogelmeier C, Jörres R (2018) Influence of body mass on predicted values of static hyperinflation in COPD. Int J Chron Obstruct Pulmon Dis Volume 13: 2551-2555 (ARCN, CPC-M, UGMLC) https://doi.org/10.2147/copd.S164096 https://www.ncbi.nlm.nih.gov/pubmed/30197511

Alter P, Jörres RA, Watz H, Welte T, Gläser S, Schulz H, Bals R, Karch A, Wouters EFM, Vestbo J, Young D, Vogelmeier CF (2018) Left ventricular volume and wall stress are linked to lung function impairment in COPD. Int J Cardiol 261: 172-178 (ARCN, BREATH, CPC-M, UGMLC) https://doi.org/10.1016/j.ijcard.2018.02.074 https://www.ncbi.nlm.nih.gov/pubmed/29657040

Almendros I, Alsafadi HN, Bölükbas D, Collins JJP, Duch P, Garrido-Martin EM, Kahn N, Karampitsakos T, Mahmutovic Persson I, Tzouvelekis A, Uhl FE, Bartel S (2018) Early Career Members at the ERS Lung Science Conference: cell-matrix interactions in lung disease and regeneration. Breathe 14: e78-e83 ((ARCN)) https://doi.org/10.1183/20734735.016818 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095238/pdf/EDU-0168-2018.pdf

Adanitsch F, Shi J, Shao F, Beyaert R, Heine H, Zamyatina A (2018) Synthetic glycan-based TLR4 agonists targeting caspase-4/11 for the development of adjuvants and immunotherapeutics. Chemical Science 9: 3957-3963 (ARCN) https://doi.org/10.1039/c7sc05323a https://www.ncbi.nlm.nih.gov/pubmed/29780528

 

2017

Zimmermann A, Knecht H, Häsler R, Zissel G, Gaede KI, Hofmann S, Nebel A, Müller-Quernheim J, Schreiber S, Fischer A (2017) Atopobium and Fusobacterium as novel candidates for sarcoidosis-associated microbiota. Eur Respir J 50: 1600746 (ARCN) https://doi.org/10.1183/13993003.00746-2016 https://www.ncbi.nlm.nih.gov/pubmed/29242257

Zheng J, Huang Q, Huang R, Deng F, Yue X, Yin J, Zhao W, Chen Y, Wen L, Zhou J, Huang R, Riemekasten G, Liu Z, Petersen F, Yu X (2017) B Cells Are Indispensable for a Novel Mouse Model of Primary Sjögren’s Syndrome. Front Immunol 8: 1384 (ARCN) https://doi.org/10.3389/fimmu.2017.01384 https://www.ncbi.nlm.nih.gov/pubmed/29118759

Zhao W, Yue X, Liu K, Zheng J, Huang R, Zou J, Riemekasten G, Petersen F, Yu X (2017) The status of pulmonary fibrosis in systemic sclerosis is associated with IRF5, STAT4, IRAK1, and CTGF polymorphisms. Rheumatol Int 37: 1303-1310 (ARCN) https://doi.org/10.1007/s00296-017-3722-5 https://www.ncbi.nlm.nih.gov/pubmed/28434122

Yao C, Rudnitzki F, Hüttmann G, Zhang Z, Rahmanzadeh R (2017) Important factors for cell-membrane permeabilization by gold nanoparticles activated by nanosecond-laser irradiation. International Journal of Nanomedicine Volume 12: 5659-5672 (ARCN) https://doi.org/10.2147/ijn.S140620 https://www.ncbi.nlm.nih.gov/pubmed/28848345

Yang F, Zhao J, Dinkel J, Warth A, Penzel R, Reinmuth N, Schnabel P, Muley T, Meister M, Zabeck H, Steins M, Yang J-y, Zhou Q, Schlemmer H-P, Herth FJF, Kauczor H-U, Heussel CP (2017) CT characteristics in pulmonary adenocarcinoma with epidermal growth factor receptor mutation. PLoS One 12: e0182741 (ARCN, CPC-M, TLRC) https://doi.org/10.1371/journal.pone.0182741 https://www.ncbi.nlm.nih.gov/pubmed/28949965

Westphal A, Cheng W, Yu J, Grassl G, Krautkrämer M, Holst O, Föger N, Lee K-H (2017) Lysosomal trafficking regulator Lyst links membrane trafficking to toll-like receptor–mediated inflammatory responses. The Journal of Experimental Medicine 214: 227-244 (ARCN) https://doi.org/10.1084/jem.20141461 https://www.ncbi.nlm.nih.gov/pubmed/27881733

Weinrich JM, Diel R, Sauer M, Henes FO, Meywald-Walter K, Adam G, Schön G, Bannas P (2017) Yield of chest X-ray tuberculosis screening of immigrants during the European refugee crisis of 2015: a single-centre experience. Eur Radiol 27: 3244-3248 (ARCN) https://doi.org/10.1007/s00330-016-4684-9 https://www.ncbi.nlm.nih.gov/pubmed/28050691

Wehler T, Thomas M, Schumann C, Bosch-Barrera J, Viñolas Segarra N, Dickgreber NJ, Dalhoff K, Sebastian M, Corral Jaime J, Alonso M, Hynes SM, Lin J, Hurt K, Bence Lin A, Calvo E, Paz-Ares L (2017) A randomized, phase 2 evaluation of the CHK1 inhibitor, LY2603618, administered in combination with pemetrexed and cisplatin in patients with advanced nonsquamous non‐small cell lung cancer. Lung Cancer 108: 212-216 (ARCN, TLRC) https://doi.org/10.1016/j.lungcan.2017.03.001 https://www.ncbi.nlm.nih.gov/pubmed/28625637

Wegmann M (2017) Targeting cytokines in asthma therapy: could IL-37 be a solution? Expert Rev Respir Med 11: 675-677 (ARCN) https://doi.org/10.1080/17476348.2017.1354701 https://www.ncbi.nlm.nih.gov/pubmed/28699819

Wedzicha JA, Miravitlles M, Hurst JR, Calverley PMA, Albert RK, Anzueto A, Criner GJ, Papi A, Rabe KF, Rigau D, Sliwinski P, Tonia T, Vestbo J, Wilson KC, Krishnan JA (2017) Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J 49: 1600791 (ARCN) https://doi.org/10.1183/13993003.00791-2016 https://www.ncbi.nlm.nih.gov/pubmed/28298398

Wedzicha JA, Calverley PMA, Albert RK, Anzueto A, Criner GJ, Hurst JR, Miravitlles M, Papi A, Rabe KF, Rigau D, Sliwinski P, Tonia T, Vestbo J, Wilson KC, Krishnan JA (2017) Prevention of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J 50: 1602265 (ARCN) https://doi.org/10.1183/13993003.02265-2016 https://www.ncbi.nlm.nih.gov/pubmed/28889106

Weckmann M, Becker T, Nissen G, Pech M, Kopp MV (2017) SiMA: A simplified migration assay for analyzing neutrophil migration. Cytometry Part A 91: 675-685 (ARCN) https://doi.org/10.1002/cyto.a.23114 https://www.ncbi.nlm.nih.gov/pubmed/28544679

Watz H, Uddin M, Pedersen F, Kirsten A, Goldmann T, Stellmacher F, Groth E, Larsson B, Böttcher G, Malmgren A, Kraan M, Rabe KF (2017) Effects of the CXCR2 antagonist AZD5069 on lung neutrophil recruitment in asthma. Pulm Pharmacol Ther 45: 121-123 (ARCN) https://doi.org/10.1016/j.pupt.2017.05.012 https://www.ncbi.nlm.nih.gov/pubmed/28549850

Watz H, Troosters T, Beeh KM, Garcia Aymerich J, Paggiaro P, Molins E, Notari M, Zapata A, Jarreta D, Garcia Gil E (2017) ACTIVATE: the effect of aclidinium/formoterol on hyperinflation, exercise capacity, and physical activity in patients with COPD. Int J Chron Obstruct Pulmon Dis Volume 12: 2545-2558 (ARCN) https://doi.org/10.2147/copd.S143488 https://www.ncbi.nlm.nih.gov/pubmed/28883722

Watz H, Mailänder C, May C, Baier M, Kirsten A-M (2017) Fast onset of action of glycopyrronium compared with tiotropium in patients with moderate to severe COPD — A randomised, multicentre, crossover trial. Pulm Pharmacol Ther 42: 13-20 (ARCN) https://doi.org/10.1016/j.pupt.2016.12.001 https://www.ncbi.nlm.nih.gov/pubmed/27940287

Watz H (2017) Next generation of anti-inflammatory therapy for COPD? Eur Respir J 50: 1702084 (ARCN) https://doi.org/10.1183/13993003.02084-2017 https://www.ncbi.nlm.nih.gov/pubmed/29074550

Watz H (2017) Chronic obstructive pulmonary disease: inhale deeply and start to exercise. Eur Respir J 49: 1700424 (ARCN) https://doi.org/10.1183/13993003.00424-2017 https://www.ncbi.nlm.nih.gov/pubmed/28424367

Waschki B, Watz H, Holz O, Magnussen H, Olejnicka B, Welte T, Rabe KF, Janciauskiene S (2017) Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function. Int J Chron Obstruct Pulmon Dis Volume 12: 981-987 (ARCN, BREATH) https://doi.org/10.2147/copd.S128689 https://www.ncbi.nlm.nih.gov/pubmed/28356730

Walsh SLF, Maher TM, Kolb M, Poletti V, Nusser R, Richeldi L, Vancheri C, Wilsher ML, Antoniou KM, Behr J, Bendstrup E, Brown K, Calandriello L, Corte TJ, Cottin V, Crestani B, Flaherty K, Glaspole I, Grutters J, Inoue Y, Kokosi M, Kondoh Y, Kouranos V, Kreuter M, Johannson K, Judge E, Ley B, Margaritopoulos G, Martinez FJ, Molina-Molina M, Morais A, Nunes H, Raghu G, Ryerson CJ, Selman M, Spagnolo P, Taniguchi H, Tomassetti S, Valeyre D, Wijsenbeek M, Wuyts W, Hansell D, Wells A (2017) Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case–cohort study. Eur Respir J 50: 1700936 (ARCN, CPC-M, TLRC) https://doi.org/10.1183/13993003.00936-2017 https://www.ncbi.nlm.nih.gov/pubmed/28860269

Vierbuchen T, Bang C, Rosigkeit H, Schmitz RA, Heine H (2017) The Human-Associated Archaeon Methanosphaera stadtmanae Is Recognized through Its RNA and Induces TLR8-Dependent NLRP3 Inflammasome Activation. Front Immunol 8: 1535 (ARCN) https://doi.org/10.3389/fimmu.2017.01535 https://www.ncbi.nlm.nih.gov/pubmed/29181003

van den Bruck R, Weil PP, Ziegenhals T, Schreiner P, Juranek S, Gödde D, Vogel S, Schuster F, Orth V, Dörner J, Pembaur D, Röper M, Störkel S, Zirngibl H, Wirth S, Jenke ACW, Postberg J, Boy N, Heringer J, Haege G, Glahn EM, Hoffmann GF, Garbade SF, Burgard P, Kölker S, Chao C-M, Yahya F, Moiseenko A, Shrestha A, Ahmadvand N, Quantius J, Wilhelm J, El-Agha E, Zimmer K-P, Bellusci S, Staufner C, Kölker S, Prokisch H, Hoffmann GF, Seeliger S, Müller M, Hippe A, Steinkraus H, Wauer R, Lachmann B, Hofmann SR, Hedrich CM, Zierk J, Arzideh F, Haeckel R, Rascher W, Rauh M, Metzler M, Thieme S, Bandoła J, Richter C, Ryser M, Jamal A, Ashton MP, von Bonin M, Kuhn M, Hedrich CM, Bonifacio E, Berner R, Brenner S, Hammersen J, Has C, Naumann-Bartsch N, Stachel D, Kiritsi D, Söder S, Tardieu M, Metzler M, Bruckner-Tuderman L, Schneider H, Bohne F, Langer D, Cencic R, Eggermann T, Zechner U, Pelletier J, Zepp F, Enklaar T, Prawitt D, Pech M, Weckmann M, Heinsen F-A, Franke A, Happle C, Dittrich A-M, Hansen G, Fuchs O, von Mutius E, Oliver BG, Kopp MV, Paret C, Russo A, Theruvath J, Keller B, El Malki K, Lehmann N, Wingerter A, Neu MA, Aslihan G-A, Wagner W, Sommer C, Pietsch T, Seidmann L, Faber J, Schreiner F, Ackermann M, Michalik M, Rother E, Bilkei-Gorzo A, Racz I, Bindila L, Lutz B, Dötsch J, Zimmer A, Woelfle J, Fischer HS, Ullrich TL, Bührer C, Czernik C, Schmalisch G, Stein R, Hofmann SR, Hagenbuchner J, Kiechl-Kohlendorfer U, Obexer P, Ausserlechner MJ, Loges NT, Frommer AT, Wallmeier J, Omran H, Öner-Sieben S, Gimpfl M, Rozman J, Irmler M, Beckers J, De Angelis MH, Roscher A, Wolf E, Ensenauer R, Nemes K, Frühwald M, Hasselblatt M, Siebert R, Kordes U, Kool M, Wang H, Hardy H, Refai O, Barwick KES, Zimmerman HH, Weis J, Baple EL, Crosby AH, Cirak S, Hellmuth C, Uhl O, Standl M, Heinrich J, Thiering E, Koletzko B, Blümel L, Kerl K, Picard D, Frühwald MC, Liebau MC, Reifenberger G, Borkhardt A, Hasselblatt M, Remke M, Tews D, Wabitsch M, Fischer-Posovszky P, Westhoff M-A, Nonnenmacher L, Langhans J, Schneele L, Trenkler N, Debatin K-M (2017) Abstracts of the 52nd Workshop for Pediatric Research. Molecular and Cellular Pediatrics 4: 5 (ARCN, BREATH, CPC-M, UGMLC) https://doi.org/10.1186/s40348-017-0071-0 https://www.ncbi.nlm.nih.gov/pubmed/28516419

Treudler R, Franke A, Schmiedeknecht A, Ballmer-Weber B, Worm M, Werfel T, Jappe U, Biedermann T, Schmitt J, Brehler R, Kleinheinz A, Kleine-Tebbe J, Brüning H, Ruëff F, Ring J, Saloga J, Schäkel K, Holzhauser T, Vieths S, Simon JC (2017) BASALIT trial: double-blind placebo-controlled allergen immunotherapy with rBet v 1-FV in birch-related soya allergy. Allergy 72: 1243-1253 (ARCN) https://doi.org/10.1111/all.13112 https://www.ncbi.nlm.nih.gov/pubmed/27998002

Torrens C, Altmäe S, Segura MT, Esteban FJ, Bartel S, Brandi P, Irmler M, Beckers J, Demmelmair H, López-Sabater C, Koletzko B, Krauss-Etschmann S, Campoy C (2017) Maternal Pre-Pregnancy Obesity Is Associated with Altered Placental Transcriptome. PLoS One 12: e0169223 (ARCN) https://doi.org/10.1371/journal.pone.0169223 https://www.ncbi.nlm.nih.gov/pubmed/28125591

Tamò L, Simillion C, Hibaoui Y, Feki A, Gugger M, Prasse A, Jäger B, Goldmann T, Geiser T, Gazdhar A (2017) Gene Network Analysis of Interstitial Macrophages After Treatment with Induced Pluripotent Stem Cells Secretome (iPSC-cm) in the Bleomycin Injured Rat Lung. Stem Cell Reviews and Reports 14: 412-424 (ARCN) https://doi.org/10.1007/s12015-017-9790-9 https://www.ncbi.nlm.nih.gov/pubmed/29256173

Stölzel F, Brosch M, Horvath S, Kramer M, Thiede C, von Bonin M, Ammerpohl O, Middeke M, Schetelig J, Ehninger G, Hampe J, Bornhäuser M (2017) Dynamics of epigenetic age following hematopoietic stem cell transplantation. Haematologica 102: e321-e323 (ARCN) https://doi.org/10.3324/haematol.2016.160481 https://www.ncbi.nlm.nih.gov/pubmed/28550187

Stein K, Brand S, Jenckel A, Sigmund A, Chen ZJ, Kirschning CJ, Kauth M, Heine H (2017) Endosomal recognition of Lactococcus lactis G121 and its RNA by dendritic cells is key to its allergy-protective effects. Journal of Allergy and Clinical Immunology 139: 667-678.e665 (ARCN) https://doi.org/10.1016/j.jaci.2016.06.018 https://www.ncbi.nlm.nih.gov/pubmed/27544739

Spina G, Spruit MA, Alison J, Benzo RP, Calverley PMA, Clarenbach CF, Costello RW, Donaire-Gonzalez D, Dürr S, Garcia-Aymerich J, van Gestel AJR, Gramm M, Hernandes NA, Hill K, Hopkinson NS, Jarreta D, Kohler M, Kirsten AM, Leuppi JD, Magnussen H, Maltais F, Man WDC, McKeough ZJ, Mesquita R, Miedinger D, Pitta F, Singh SJ, Smeenk FWJM, Tal-Singer R, Vagaggini B, Waschki B, Watz H, Wouters EFM, Zogg S, den Brinker AC (2017) Analysis of nocturnal actigraphic sleep measures in patients with COPD and their association with daytime physical activity. Thorax 72: 694-701 (ARCN) https://doi.org/10.1136/thoraxjnl-2016-208900 https://www.ncbi.nlm.nih.gov/pubmed/28082529

Sommer F, Rühlemann MC, Bang C, Höppner M, Rehman A, Kaleta C, Schmitt-Kopplin P, Dempfle A, Weidinger S, Ellinghaus E, Krauss-Etschmann S, Schmidt-Arras D, Aden K, Schulte D, Ellinghaus D, Schreiber S, Tholey A, Rupp J, Laudes M, Baines JF, Rosenstiel P, Franke A (2017) Microbiomarkers in inflammatory bowel diseases: caveats come with caviar. Gut 66: 1734-1738 (ARCN) https://doi.org/10.1136/gutjnl-2016-313678 https://www.ncbi.nlm.nih.gov/pubmed/28733278

Smid DE, Franssen FME, Gonik M, Miravitlles M, Casanova C, Cosio BG, de Lucas-Ramos P, Marin JM, Martinez C, Mir I, Soriano JB, de Torres JP, Agusti A, Atalay NB, Billington J, Boutou AK, Brighenti-Zogg S, Chaplin E, Coster S, Dodd JW, Dürr S, Fernandez-Villar A, Groenen MTJ, Guimarães M, Hejduk K, Higgins V, Hopkinson NS, Horita N, Houben-Wilke S, Janssen DJA, Jehn M, Joerres R, Karch A, Kelly JL, Kim Y-I, Kimura H, Koblizek V, Kocks JH, Kon SSC, Kwon N, Ladeira I, Lee S-D, Leuppi JD, Locantore N, Lopez-Campos JL, D-C Man W, Maricic L, Mendoza L, Miedinger D, Mihaltan F, Minami S, van der Molen T, Murrells TJ, Nakken N, Nishijima Y, Norman IJ, Novotna B, O’Donnell DE, Ogata Y, Pereira ED, Piercy J, Price D, Pothirat C, Raghavan N, Ringbaek T, Sajkov D, Sigari N, Singh S, Small M, da Silva GF, Tanner RJ, Tsiligianni IG, Tulek B, Tzanakis N, Vanfleteren LEGW, Watz H, Webb KA, Wouters EFM, Xie GG, Yoshikawa M, Spruit MA (2017) Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease. J Am Med Dir Assoc 18: 1097.e1011-1097.e1024 (ARCN, CPC-M) https://doi.org/10.1016/j.jamda.2017.09.003 https://www.ncbi.nlm.nih.gov/pubmed/29169740

Sezin T, Krajewski M, Wutkowski A, Mousavi S, Chakievska L, Bieber K, Ludwig RJ, Dahlke M, Rades D, Schulze FS, Schmidt E, Kalies K, Gupta Y, Schilf P, Ibrahim SM, König P, Schwudke D, Zillikens D, Sadik CD (2017) The Leukotriene B4 and its Receptor BLT1 Act as Critical Drivers of Neutrophil Recruitment in Murine Bullous Pemphigoid-Like Epidermolysis Bullosa Acquisita. J Invest Dermatol 137: 1104-1113 (ARCN) https://doi.org/10.1016/j.jid.2016.12.021 https://www.ncbi.nlm.nih.gov/pubmed/28108297

Segura MT, Demmelmair H, Krauss-Etschmann S, Nathan P, Dehmel S, Padilla MC, Rueda R, Koletzko B, Campoy C (2017) Maternal BMI and gestational diabetes alter placental lipid transporters and fatty acid composition. Placenta 57: 144-151 (ARCN) https://doi.org/10.1016/j.placenta.2017.07.001 https://www.ncbi.nlm.nih.gov/pubmed/28864004

Schwager C, Kull S, Behrends J, Röckendorf N, Schocker F, Frey A, Homann A, Becker W-M, Jappe U (2017) Peanut oleosins associated with severe peanut allergy—importance of lipophilic allergens for comprehensive allergy diagnostics. Journal of Allergy and Clinical Immunology 140: 1331-1338.e1338 (ARCN) https://doi.org/10.1016/j.jaci.2017.02.020 https://www.ncbi.nlm.nih.gov/pubmed/28342912

Schuette W, Schneider C-P, Engel-Riedel W, Schumann C, Kohlhaeufl M, Serke M, Hoeffken G, Kortsik C, Reck M (2017) 65Plus: open-label study of bevacizumab in combination with pemetrexed or pemetrexed/carboplatin as first-line treatment of patients with advanced or recurrent nonsquamous non-small-cell lung cancer. Lung Cancer: Targets and Therapy Volume 8: 217-229 (ARCN) https://doi.org/10.2147/lctt.S142972 https://www.ncbi.nlm.nih.gov/pubmed/29158696

Schocker F, Scharf A, Kull S, Jappe U (2017) Detection of the Peanut Allergens Ara h 2 and Ara h 6 in Human Breast Milk: Development of 2 Sensitive and Specific Sandwich ELISA Assays. International Archives of Allergy and Immunology 174: 17-25 (ARCN) https://doi.org/10.1159/000479388 https://www.ncbi.nlm.nih.gov/pubmed/28950267

Schnuch A, Müller BP, Geier J (2017) Differences in contents of organochlorine impurities do not influence responses to patch testing with Majantol®. Contact Dermatitis 76: 11-18 (ARCN) https://doi.org/10.1111/cod.12650 https://www.ncbi.nlm.nih.gov/pubmed/27555089

Schaberg T, Bauer T, Brinkmann F, Diel R, Feiterna-Sperling C, Haas W, Hartmann P, Hauer B, Heyckendorf J, Lange C, Nienhaus A, Otto-Knapp R, Priwitzer M, Richter E, Rumetshofer R, Schenkel K, Schoch O, Schönfeld N, Stahlmann R (2017) S2k-Leitlinie: Tuberkulose im Erwachsenenalter. Pneumologie 71: 325-397 (ARCN) https://doi.org/10.1055/s-0043-105954 https://www.ncbi.nlm.nih.gov/pubmed/28651293

Scagliotti GV, Gaafar R, Nowak AK, Reck M, Tsao AS, van Meerbeeck J, Vogelzang NJ, Nakano T, von Wangenheim U, Velema D, Morsli N, Popat S (2017) LUME-Meso: Design and Rationale of the Phase III Part of a Placebo-Controlled Study of Nintedanib and Pemetrexed/Cisplatin Followed by Maintenance Nintedanib in Patients With Unresectable Malignant Pleural Mesothelioma. Clin Lung Cancer 18: 589-593 (ARCN) https://doi.org/10.1016/j.cllc.2017.03.010 https://www.ncbi.nlm.nih.gov/pubmed/28690011

Rodriguez-Roisin R, Rabe KF, Vestbo J, Vogelmeier C, Agustí A (2017) Global Initiative for Chronic Obstructive Lung Disease (GOLD) 20th Anniversary: a brief history of time. Eur Respir J 50: 1700671 (ARCN, UGMLC) https://doi.org/10.1183/13993003.00671-2017 https://www.ncbi.nlm.nih.gov/pubmed/28679615

Richter G, Krawczak M, Lieb W, Wolff L, Schreiber S, Buyx A (2017) Broad consent for health care–embedded biobanking: understanding and reasons to donate in a large patient sample. Genet Med 20: 76-82 (ARCN) https://doi.org/10.1038/gim.2017.82 https://www.ncbi.nlm.nih.gov/pubmed/28640237

Remon J, Menis J, Hasan B, Peric A, De Maio E, Novello S, Reck M, Berghmans T, Wasag B, Besse B, Dziadziuszko R (2017) The APPLE Trial: Feasibility and Activity of AZD9291 (Osimertinib) Treatment on Positive PLasma T790M in EGFR -mutant NSCLC Patients. EORTC 1613. Clin Lung Cancer 18: 583-588 (ARCN) https://doi.org/10.1016/j.cllc.2017.02.005 https://www.ncbi.nlm.nih.gov/pubmed/28341106

Reisner C, Fabbri LM, Kerwin EM, Fogarty C, Spangenthal S, Rabe KF, Ferguson GT, Martinez FJ, Donohue JF, Darken P, St. Rose E, Orevillo C, Strom S, Fischer T, Golden M, Dwivedi S (2017) A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease. Respir Res 18: 8 (ARCN) https://doi.org/10.1186/s12931-016-0491-8 https://www.ncbi.nlm.nih.gov/pubmed/28061907

Reisner C, Fabbri LM, Kerwin EM, Fogarty C, Spangenthal S, Rabe KF, Ferguson GT, Martinez FJ, Donohue JF, Darken P, St. Rose E, Orevillo C, Strom S, Fischer T, Golden M, Dwivedi S (2017) Erratum to: A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease. Respir Res 18: 158 (ARCN) https://doi.org/10.1186/s12931-017-0638-2 https://www.ncbi.nlm.nih.gov/pubmed/28826397

Reinmuth N, Gröschel A, Schumann C, Sebastian M, Wiewrodt R, Reck M (2017) Aktualisierte Therapieempfehlung metastasiertes nicht kleinzelliges Lungenkarzinom. Pneumologie 72: 138-154 (ARCN, CPC-M) https://doi.org/10.1055/s-0043-118904 https://www.ncbi.nlm.nih.gov/pubmed/29270953

Reck M, Rabe KF (2017) Advanced Non–Small-Cell Lung Cancer. New England Journal of Medicine 377: 1997-1999 (ARCN) https://doi.org/10.1056/NEJMc1712794 https://www.ncbi.nlm.nih.gov/pubmed/29141160

Reck M, Paz-Ares L, Bidoli P, Cappuzzo F, Dakhil S, Moro-Sibilot D, Borghaei H, Johnson M, Jotte R, Pennell NA, Shepherd FA, Tsao A, Thomas M, Carter GC, Chan-Diehl F, Alexandris E, Lee P, Zimmermann A, Sashegyi A, Pérol M (2017) Outcomes in patients with aggressive or refractory disease from REVEL: A randomized phase III study of docetaxel with ramucirumab or placebo for second-line treatment of stage IV non-small-cell lung cancer. Lung Cancer 112: 181-187 (ARCN, TLRC) https://doi.org/10.1016/j.lungcan.2017.07.038 https://www.ncbi.nlm.nih.gov/pubmed/29191593

Reck M, Longo DL, Rabe KF (2017) Precision Diagnosis and Treatment for Advanced Non–Small-Cell Lung Cancer. New England Journal of Medicine 377: 849-861 (ARCN) https://doi.org/10.1056/NEJMra1703413 https://www.ncbi.nlm.nih.gov/pubmed/28854088

Reck M, Brahmer JR (2017) Pembrolizumab in Non–Small-Cell Lung Cancer. New England Journal of Medicine 376: 996-997 (ARCN) https://doi.org/10.1056/NEJMc1615559 https://www.ncbi.nlm.nih.gov/pubmed/28273022

Reck M, Blais N, Juhasz E, Gorbunova V, Jones CM, Urban L, Orlov S, Barlesi F, Kio E, Keilholz U, Qin Q, Qian J, Nickner C, Dziubinski J, Xiong H, Mittapalli RK, Dunbar M, Ansell P, He L, McKee M, Giranda V, Ramalingam SS (2017) Smoking History Predicts Sensitivity to PARP Inhibitor Veliparib in Patients with Advanced Non–Small Cell Lung Cancer. J Thorac Oncol 12: 1098-1108 (ARCN) https://doi.org/10.1016/j.jtho.2017.04.010 https://www.ncbi.nlm.nih.gov/pubmed/28461256

Ramalingam SS, Blais N, Mazieres J, Reck M, Jones CM, Juhasz E, Urban L, Orlov S, Barlesi F, Kio E, Keiholz U, Qin Q, Qian J, Nickner C, Dziubinski J, Xiong H, Ansell P, McKee M, Giranda V, Gorbunova V (2017) Randomized, Placebo-Controlled, Phase II Study of Veliparib in Combination with Carboplatin and Paclitaxel for Advanced/Metastatic Non–Small Cell Lung Cancer. Clinical Cancer Research 23: 1937-1944 (ARCN) https://doi.org/10.1158/1078-0432.Ccr-15-3069 https://www.ncbi.nlm.nih.gov/pubmed/27803064

Raby A-C, Colmont CS, Kift-Morgan A, Köhl J, Eberl M, Fraser D, Topley N, Labéta MO (2017) Toll-Like Receptors 2 and 4 Are Potential Therapeutic Targets in Peritoneal Dialysis–Associated Fibrosis. J Am Soc Nephrol 28: 461-478 (ARCN) https://doi.org/10.1681/asn.2015080923 https://www.ncbi.nlm.nih.gov/pubmed/27432741

Rabe KF, Watz H (2017) Chronic obstructive pulmonary disease. The Lancet 389: 1931-1940 (ARCN) https://doi.org/10.1016/s0140-6736(17)31222-9 https://www.ncbi.nlm.nih.gov/pubmed/28513453

Rabe KF, Calverley PMA, Martinez FJ, Fabbri LM (2017) Effect of roflumilast in patients with severe COPD and a history of hospitalisation. Eur Respir J 50: 1700158 (ARCN) https://doi.org/10.1183/13993003.00158-2017 https://www.ncbi.nlm.nih.gov/pubmed/28679611

Rabe KF, Beghé B, Fabbri LM (2017) Peripheral eosinophil count as a biomarker for the management of COPD: not there yet. Eur Respir J 50: 1702165 (ARCN) https://doi.org/10.1183/13993003.02165-2017 https://www.ncbi.nlm.nih.gov/pubmed/29167308

Rabe KF (2017) GFF MDI for the improvement of lung function in COPD – A look at the PINNACLE-1 and PINNACLE-2 data and beyond. Expert Rev Clin Pharmacol 10: 685-698 (ARCN) https://doi.org/10.1080/17512433.2017.1320218 https://www.ncbi.nlm.nih.gov/pubmed/28443352

Quell KM, Karsten CM, Kordowski A, Almeida LN, Briukhovetska D, Wiese AV, Sun J, Ender F, Antoniou K, Schröder T, Schmudde I, Berger JL, König P, Vollbrandt T, Laumonnier Y, Köhl J (2017) Monitoring C3aR Expression Using a Floxed tdTomato-C3aR Reporter Knock-in Mouse. The Journal of Immunology 199: 688-706 (ARCN) https://doi.org/10.4049/jimmunol.1700318 https://www.ncbi.nlm.nih.gov/pubmed/28626064

Proost P, Bang C, Vierbuchen T, Gutsmann T, Heine H, Schmitz RA (2017) Immunogenic properties of the human gut-associated archaeon Methanomassiliicoccus luminyensis and its susceptibility to antimicrobial peptides. PLoS One 12: e0185919 (ARCN) https://doi.org/10.1371/journal.pone.0185919 https://www.ncbi.nlm.nih.gov/pubmed/28982164

Popat S, Mellemgaard A, Reck M, Hastedt C, Griebsch I (2017) Nintedanib plus docetaxel as second-line therapy in patients with non-small-cell lung cancer of adenocarcinoma histology: a network meta-analysis vs new therapeutic options. Future Oncology 13: 1159-1171 (ARCN) https://doi.org/10.2217/fon-2016-0493 https://www.ncbi.nlm.nih.gov/pubmed/28326832

Pooe OJ, Köllisch G, Heine H, Shonhai A (2017) Plasmodium falciparum Heat Shock Protein 70 Lacks Immune Modulatory Activity. Protein Peptide Lett 24: 503-510 (ARCN) https://doi.org/10.2174/0929866524666170214141909 https://www.ncbi.nlm.nih.gov/pubmed/28201964

Pfäffle C, Spahr H, Hillmann D, Sudkamp H, Franke G, Koch P, Hüttmann G (2017) Reduction of frame rate in full-field swept-source optical coherence tomography by numerical motion correction [Invited]. Biomedical Optics Express 8: 1499 (ARCN) https://doi.org/10.1364/boe.8.001499 https://www.ncbi.nlm.nih.gov/pubmed/28663845

Petersen F, Yue X, Riemekasten G, Yu X (2017) Dysregulated homeostasis of target tissues or autoantigens – A novel principle in autoimmunity. Autoimmun Rev 16: 602-611 (ARCN) https://doi.org/10.1016/j.autrev.2017.04.006 https://www.ncbi.nlm.nih.gov/pubmed/28411168

Peters S, Gettinger S, Johnson ML, Jänne PA, Garassino MC, Christoph D, Toh CK, Rizvi NA, Chaft JE, Carcereny Costa E, Patel JD, Chow LQM, Koczywas M, Ho C, Früh M, van den Heuvel M, Rothenstein J, Reck M, Paz-Ares L, Shepherd FA, Kurata T, Li Z, Qiu J, Kowanetz M, Mocci S, Shankar G, Sandler A, Felip E (2017) Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1–Selected Advanced Non–Small-Cell Lung Cancer (BIRCH). J Clin Oncol 35: 2781-2789 (ARCN) https://doi.org/10.1200/jco.2016.71.9476 https://www.ncbi.nlm.nih.gov/pubmed/28609226

Peters S, Camidge DR, Shaw AT, Gadgeel S, Ahn JS, Kim D-W, Ou S-HI, Pérol M, Dziadziuszko R, Rosell R, Zeaiter A, Mitry E, Golding S, Balas B, Noe J, Morcos PN, Mok T (2017) Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer. New England Journal of Medicine 377: 829-838 (ARCN) https://doi.org/10.1056/NEJMoa1704795 https://www.ncbi.nlm.nih.gov/pubmed/28586279

Paz-Ares LG, Pérol M, Ciuleanu T-E, Kowalyszyn RD, Reck M, Lewanski CR, Syrigos K, Arrieta O, Prabhash K, Park K, Pikiel J, Göksel T, Lee P, Zimmermann A, Carter GC, Alexandris E, Garon EB (2017) Treatment outcomes by histology in REVEL: A randomized phase III trial of Ramucirumab plus docetaxel for advanced non-small cell lung cancer. Lung Cancer 112: 126-133 (ARCN) https://doi.org/10.1016/j.lungcan.2017.05.021 https://www.ncbi.nlm.nih.gov/pubmed/29191585

Pagel R, Bär F, Schröder T, Sünderhauf A, Künstner A, Ibrahim SM, Autenrieth SE, Kalies K, König P, Tsang AH, Bettenworth D, Divanovic S, Lehnert H, Fellermann K, Oster H, Derer S, Sina C (2017) Circadian rhythm disruption impairs tissue homeostasis and exacerbates chronic inflammation in the intestine. The FASEB Journal 31: 4707-4719 (ARCN) https://doi.org/10.1096/fj.201700141RR https://www.ncbi.nlm.nih.gov/pubmed/28710114

Novello S, Scagliotti G, de Castro G, Kiyik M, Kowalyszyn R, Deppermann K-M, Arriola E, Bosquee L, Novosiadly RD, Nguyen TS, Forest A, Tang S, Kambhampati SRP, Cosaert J, Reck M (2017) An Open-Label, Multicenter, Randomized, Phase II Study of Cisplatin and Pemetrexed With or Without Cixutumumab (IMC-A12) as a First-Line Therapy in Patients With Advanced Nonsquamous Non–Small Cell Lung Cancer. J Thorac Oncol 12: 383-389 (ARCN) https://doi.org/10.1016/j.jtho.2016.07.013 https://www.ncbi.nlm.nih.gov/pubmed/27464970

Nakatani Y, Opel-Reading HK, Merker M, Machado D, Andres S, Kumar SS, Moradigaravand D, Coll F, Perdigão J, Portugal I, Schön T, Nair D, Devi KRU, Kohl TA, Beckert P, Clark TG, Maphalala G, Khumalo D, Diel R, Klaos K, Aung HL, Cook GM, Parkhill J, Peacock SJ, Swaminathan S, Viveiros M, Niemann S, Krause KL, Köser CU (2017) Role of Alanine Racemase Mutations in Mycobacterium tuberculosis d-Cycloserine Resistance. Antimicrob Agents Chemother 61 (ARCN) https://doi.org/10.1128/aac.01575-17 https://www.ncbi.nlm.nih.gov/pubmed/28971867

Nair P, Wenzel S, Rabe KF, Bourdin A, Lugogo NL, Kuna P, Barker P, Sproule S, Ponnarambil S, Goldman M (2017) Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe Asthma. New England Journal of Medicine 376: 2448-2458 (ARCN) https://doi.org/10.1056/NEJMoa1703501 https://www.ncbi.nlm.nih.gov/pubmed/28530840

Müller T, Fay S, Vieira RP, Karmouty-Quintana H, Cicko S, Ayata K, Zissel G, Goldmann T, Lungarella G, Ferrari D, Di Virgilio F, Robaye B, Boeynaems J-M, Blackburn MR, Idzko M (2017) The purinergic receptor subtype P2Y<sub>2</sub> mediates chemotaxis of neutrophils and fibroblasts in fibrotic lung disease. Oncotarget 8: 35962-35972 (ARCN) https://doi.org/10.18632/oncotarget.16414 https://www.ncbi.nlm.nih.gov/pubmed/28415591

Müller T, Fay S, Vieira RP, Karmouty-Quintana H, Cicko S, Ayata CK, Zissel G, Goldmann T, Lungarella G, Ferrari D, Di Virgilio F, Robaye B, Boeynaems J-M, Lazarowski ER, Blackburn MR, Idzko M (2017) P2Y6 Receptor Activation Promotes Inflammation and Tissue Remodeling in Pulmonary Fibrosis. Front Immunol 8: 1028 (ARCN) https://doi.org/10.3389/fimmu.2017.01028 https://www.ncbi.nlm.nih.gov/pubmed/28878780

Milger K, Yu Y, Brudy E, Irmler M, Skapenko A, Mayinger M, Lehmann M, Beckers J, Reichenberger F, Behr J, Eickelberg O, Königshoff M, Krauss-Etschmann S (2017) Pulmonary CCR2+CD4+T cells are immune regulatory and attenuate lung fibrosis development. Thorax 72: 1007-1020 (ARCN, CPC-M) https://doi.org/10.1136/thoraxjnl-2016-208423 https://www.ncbi.nlm.nih.gov/pubmed/28780502

Milger K, Götschke J, Krause L, Nathan P, Alessandrini F, Tufman A, Fischer R, Bartel S, Theis FJ, Behr J, Dehmel S, Mueller NS, Kneidinger N, Krauss-Etschmann S (2017) Identification of a plasma miRNA biomarker signature for allergic asthma: A translational approach. Allergy 72: 1962-1971 (ARCN, CPC-M) https://doi.org/10.1111/all.13205 https://www.ncbi.nlm.nih.gov/pubmed/28513859

Meyer KF, Krauss-Etschmann S, Kooistra W, Reinders-Luinge M, Timens W, Kobzik L, Plösch T, Hylkema MN (2017) Prenatal exposure to tobacco smoke sex dependently influences methylation and mRNA levels of the Igf axis in lungs of mouse offspring. American Journal of Physiology-Lung Cellular and Molecular Physiology 312: L542-L555 (ARCN) https://doi.org/10.1152/ajplung.00271.2016 https://www.ncbi.nlm.nih.gov/pubmed/28130259

Metwally NG, Tilly A-K, Lubiana P, Roth LK, Dörpinghaus M, Lorenzen S, Schuldt K, Witt S, Bachmann A, Tidow H, Gutsmann T, Burmester T, Roeder T, Tannich E, Bruchhaus I (2017) Characterisation of Plasmodium falciparum populations selected on the human endothelial receptors P-selectin, E-selectin, CD9 and CD151. Sci Rep 7: 4069 (ARCN) https://doi.org/10.1038/s41598-017-04241-3 https://www.ncbi.nlm.nih.gov/pubmed/28642573

Mesquita R, Spina G, Pitta F, Donaire-Gonzalez D, Deering BM, Patel MS, Mitchell KE, Alison J, van Gestel AJR, Zogg S, Gagnon P, Abascal-Bolado B, Vagaggini B, Garcia-Aymerich J, Jenkins SC, Romme EAPM, Kon SSC, Albert PS, Waschki B, Shrikrishna D, Singh SJ, Hopkinson NS, Miedinger D, Benzo RP, Maltais F, Paggiaro P, McKeough ZJ, Polkey MI, Hill K, Man WDC, Clarenbach CF, Hernandes NA, Savi D, Wootton S, Furlanetto KC, Cindy Ng LW, Vaes AW, Jenkins C, Eastwood PR, Jarreta D, Kirsten A, Brooks D, Hillman DR, Sant’Anna T, Meijer K, Dürr S, Rutten EPA, Kohler M, Probst VS, Tal-Singer R, Gil EG, den Brinker AC, Leuppi JD, Calverley PMA, Smeenk FWJM, Costello RW, Gramm M, Goldstein R, Groenen MTJ, Magnussen H, Wouters EFM, ZuWallack RL, Amft O, Watz H, Spruit MA (2017) Physical activity patterns and clusters in 1001 patients with COPD. Chron Respir Dis 14: 256-269 (ARCN) https://doi.org/10.1177/1479972316687207 https://www.ncbi.nlm.nih.gov/pubmed/28774199

Mathioudakis AG, Eguiluz Gracia I, Bartel S, Tsilochristou O (2017) ERS Early Career Members meet EAACI Junior Members: the launch of a strong, fruitful collaboration. Breathe 13: 231-233 ((ARCN)) https://doi.org/10.1183/20734735.009017 https://www.ncbi.nlm.nih.gov/pubmed/28894484

Mateescu B, Kowal EJK, van Balkom BWM, Bartel S, Bhattacharyya SN, Buzás EI, Buck AH, de Candia P, Chow FWN, Das S, Driedonks TAP, Fernández-Messina L, Haderk F, Hill AF, Jones JC, Van Keuren-Jensen KR, Lai CP, Lässer C, di Liegro I, Lunavat TR, Lorenowicz MJ, Maas SLN, Mäger I, Mittelbrunn M, Momma S, Mukherjee K, Nawaz M, Pegtel DM, Pfaffl MW, Schiffelers RM, Tahara H, Théry C, Tosar JP, Wauben MHM, Witwer KW, Nolte-‘t Hoen ENM (2017) Obstacles and opportunities in the functional analysis of extracellular vesicle RNA – an ISEV position paper. Journal of Extracellular Vesicles 6: 1286095 (ARCN) https://doi.org/10.1080/20013078.2017.1286095 https://www.ncbi.nlm.nih.gov/pubmed/28326170

Marwitz S, Scheufele S, Perner S, Reck M, Ammerpohl O, Goldmann T (2017) Epigenetic modifications of the immune-checkpoint genes CTLA4 and PDCD1 in non-small cell lung cancer results in increased expression. Clin Epigenetics 9: 51 (ARCN) https://doi.org/10.1186/s13148-017-0354-2 https://www.ncbi.nlm.nih.gov/pubmed/28503213

Marwitz S, Heinbockel L, Scheufele S, Nitschkowski D, Kugler C, Perner S, Reck M, Ammerpohl O, Goldmann T (2017) Epigenetic modifications of the VGF gene in human non-small cell lung cancer tissues pave the way towards enhanced expression. Clin Epigenetics 9: 123 (ARCN) https://doi.org/10.1186/s13148-017-0423-6 https://www.ncbi.nlm.nih.gov/pubmed/29209432

Martinez FJ, Rabe KF, Ferguson GT, Fabbri LM, Rennard S, Feldman GJ, Sethi S, Spangenthal S, Gottschlich GM, Rodriguez-Roisin R, Arora S, Siler TM, Siddiqui S, Darken P, Fischer T, Maes A, Golden M, Orevillo C, Reisner C (2017) Efficacy and Safety of Glycopyrrolate/Formoterol Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Patients With COPD. Chest 151: 340-357 (ARCN) https://doi.org/10.1016/j.chest.2016.11.028 https://www.ncbi.nlm.nih.gov/pubmed/27916620

Mari B, Ikari J, Nelson AJ, Obaid J, Giron-Martinez A, Ikari K, Makino F, Iwasawa S, Gunji Y, Farid M, Wang X, Basma H, Demeo D, Feghali-Bostwick C, Holz O, Rabe K, Liu X, Rennard SI (2017) Reduced microRNA-503 expression augments lung fibroblast VEGF production in chronic obstructive pulmonary disease. PLoS One 12: e0184039 (ARCN, BREATH) https://doi.org/10.1371/journal.pone.0184039

Mari B, Ikari J, Nelson AJ, Obaid J, Giron-Martinez A, Ikari K, Makino F, Iwasawa S, Gunji Y, Farid M, Wang X, Basma H, Demeo D, Feghali-Bostwick C, Holz O, Rabe K, Liu X, Rennard SI (2017) Reduced microRNA-503 expression augments lung fibroblast VEGF production in chronic obstructive pulmonary disease. PLoS One 12: e0184039 (ARCN, BREATH) https://doi.org/10.1371/journal.pone.0184039 https://www.ncbi.nlm.nih.gov/pubmed/28880936

Mantis NJ, Röckendorf N, Meckelein B, Scherf KA, Schalk K, Koehler P, Frey A (2017) Identification of novel antibody-reactive detection sites for comprehensive gluten monitoring. PLoS One 12: e0181566 (ARCN) https://doi.org/10.1371/journal.pone.0181566 https://www.ncbi.nlm.nih.gov/pubmed/28759621

Manegold C, Dingemans A-MC, Gray JE, Nakagawa K, Nicolson M, Peters S, Reck M, Wu Y-L, Brustugun OT, Crinò L, Felip E, Fennell D, Garrido P, Huber RM, Marabelle A, Moniuszko M, Mornex F, Novello S, Papotti M, Pérol M, Smit EF, Syrigos K, van Meerbeeck JP, van Zandwijk N, Chih-Hsin Yang J, Zhou C, Vokes E (2017) The Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLC. J Thorac Oncol 12: 194-207 (ARCN, CPC-M) https://doi.org/10.1016/j.jtho.2016.10.003 https://www.ncbi.nlm.nih.gov/pubmed/27729297

Manegold C, Adjei A, Bussolino F, Cappuzzo F, Crino L, Dziadziuszko R, Ettinger D, Fennell D, Kerr K, Le Chevalier T, Leighl N, Papotti M, Paz-Ares L, Pérol M, Peters S, Pirker R, Quoix E, Reck M, Smit E, Vokes E, van Zandwijk N, Zhou C (2017) Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapy. ESMO Open 1: e000118 (ARCN) https://doi.org/10.1136/esmoopen-2016-000118 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729303/pdf/esmoopen-2016-000118.pdf

Magnussen H, Arzt M, Andreas S, Plate T, Ribera A, Seoane B, Watz H, Kirsten A-M (2017) Aclidinium bromide improves symptoms and sleep quality in COPD: a pilot study. Eur Respir J 49: 1700485 (ARCN) https://doi.org/10.1183/13993003.00485-2017 https://www.ncbi.nlm.nih.gov/pubmed/28642315

Magnussen C, Ojeda FM, Rzayeva N, Zeller T, Sinning CR, Pfeiffer N, Beutel M, Blettner M, Lackner KJ, Blankenberg S, Münzel T, Rabe KF, Wild PS, Schnabel RB (2017) FEV1 and FVC predict all-cause mortality independent of cardiac function — Results from the population-based Gutenberg Health Study. Int J Cardiol 234: 64-68 (ARCN) https://doi.org/10.1016/j.ijcard.2017.02.012 https://www.ncbi.nlm.nih.gov/pubmed/28214081

Loukides S, Kahnert K, Lucke T, Huber RM, Behr J, Biertz F, Vogt A, Watz H, Alter P, Fähndrich S, Bals R, Holle R, Karrasch S, Söhler S, Wacker M, Ficker JH, Parhofer KG, Vogelmeier C, Jörres RA (2017) Relationship of hyperlipidemia to comorbidities and lung function in COPD: Results of the COSYCONET cohort. PLoS One 12: e0177501 (ARCN, CPC-M, UGMLC) https://doi.org/10.1371/journal.pone.0177501 https://www.ncbi.nlm.nih.gov/pubmed/28505167

Lorenz J, Bals R, Dreher M, Jany B, Koczulla R, Pfeifer M, Randerath W, Steinkamp G, Taube C, Watz H, Windisch W (2017) Expertentreffen COPD: Exazerbation der COPD. Pneumologie 71: 269-289 (ARCN) https://doi.org/10.1055/s-0043-106559 https://www.ncbi.nlm.nih.gov/pubmed/28505687

Lindner K, Ströbele M, Schlick S, Webering S, Jenckel A, Kopf J, Danov O, Sewald K, Buj C, Creutzenberg O, Tillmann T, Pohlmann G, Ernst H, Ziemann C, Hüttmann G, Heine H, Bockhorn H, Hansen T, König P, Fehrenbach H (2017) Biological effects of carbon black nanoparticles are changed by surface coating with polycyclic aromatic hydrocarbons. Part Fibre Toxicol 14: 8 (ARCN, BREATH) https://doi.org/10.1186/s12989-017-0189-1 https://www.ncbi.nlm.nih.gov/pubmed/28327162

Li Y, Tiedemann L, von Frieling J, Nolte S, El-Kholy S, Stephano F, Gelhaus C, Bruchhaus I, Fink C, Roeder T (2017) The Role of Monoaminergic Neurotransmission for Metabolic Control in the Fruit Fly Drosophila Melanogaster. Front Syst Neurosci 11: 60 (ARCN) https://doi.org/10.3389/fnsys.2017.00060 https://www.ncbi.nlm.nih.gov/pubmed/28878633

Lautenschläger I, Wong YL, Sarau J, Goldmann T, Zitta K, Albrecht M, Frerichs I, Weiler N, Uhlig S (2017) Signalling mechanisms in PAF-induced intestinal failure. Sci Rep 7: 13382 (ARCN) https://doi.org/10.1038/s41598-017-13850-x https://www.ncbi.nlm.nih.gov/pubmed/29042668

Larsson L-O, Polverino E, Hoefsloot W, Codecasa LR, Diel R, Jenkins SG, Loebinger MR (2017) Pulmonary disease by non-tuberculous mycobacteria – clinical management, unmet needs and future perspectives. Expert Rev Respir Med 11: 1-13 (ARCN) https://doi.org/10.1080/17476348.2017.1386563 https://www.ncbi.nlm.nih.gov/pubmed/28967797

Kuijvenhoven JC, Crombag L, Breen DP, van den Berk I, Versteegh MIM, Braun J, Winkelman TA, van Boven W, Bonta PI, Rabe KF, Annema JT (2017) Esophageal ultrasound (EUS) assessment of T4 status in NSCLC patients. Lung Cancer 114: 50-55 (ARCN) https://doi.org/10.1016/j.lungcan.2017.10.017 https://www.ncbi.nlm.nih.gov/pubmed/29173765

Kreuter M, Swigris J, Pittrow D, Geier S, Klotsche J, Prasse A, Wirtz H, Koschel D, Andreas S, Claussen M, Grohé C, Wilkens H, Hagmeyer L, Skowasch D, Meyer JF, Kirschner J, Gläser S, Herth FJF, Welte T, Neurohr C, Schwaiblmair M, Held M, Bahmer T, Frankenberger M, Behr J (2017) Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry. Respir Res 18: 139 ((ARCN), BREATH, CPC-M, TLRC) https://doi.org/10.1186/s12931-017-0621-y https://www.ncbi.nlm.nih.gov/pubmed/28709421

Kretschmer S, Pieper M, Klinger A, Hüttmann G, König P (2017) Imaging of Wound Closure of Small Epithelial Lesions in the Mouse Trachea. The American Journal of Pathology 187: 2451-2460 (ARCN) https://doi.org/10.1016/j.ajpath.2017.07.006 https://www.ncbi.nlm.nih.gov/pubmed/28823872

Kostric M, Milger K, Krauss-Etschmann S, Engel M, Vestergaard G, Schloter M, Schöler A (2017) Development of a Stable Lung Microbiome in Healthy Neonatal Mice. Microb Ecol 75: 529-542 (ARCN) https://doi.org/10.1007/s00248-017-1068-x https://www.ncbi.nlm.nih.gov/pubmed/28905200

König IR, Fuchs O, Hansen G, von Mutius E, Kopp MV (2017) What is precision medicine? Eur Respir J 50: 1700391 (ARCN, BREATH, CPC-M) https://doi.org/10.1183/13993003.00391-2017 https://www.ncbi.nlm.nih.gov/pubmed/29051268

Kolbe K, Möckl L, Sohst V, Brandenburg J, Engel R, Malm S, Bräuchle C, Holst O, Lindhorst TK, Reiling N (2017) Azido Pentoses: A New Tool To Efficiently Label Mycobacterium tuberculosis

Clinical Isolates. ChemBioChem 18: 1172-1176 (ARCN) https://doi.org/10.1002/cbic.201600706 https://www.ncbi.nlm.nih.gov/pubmed/28249101

Koch A, Watz H, Maleki-Yazdi MR, Bothner U, Tetzlaff K, Voß F, McGarvey L (2017) Comprehensive assessment of the safety of olodaterol 5 µg in the Respimat® device for maintenance treatment of COPD: comparison with the long-acting β2-agonist formoterol. npj Primary Care Respiratory Medicine 27: 60 (ARCN, CPC-M) https://doi.org/10.1038/s41533-017-0059-1 https://www.ncbi.nlm.nih.gov/pubmed/29061968

Kepert I, Fonseca J, Müller C, Milger K, Hochwind K, Kostric M, Fedoseeva M, Ohnmacht C, Dehmel S, Nathan P, Bartel S, Eickelberg O, Schloter M, Hartmann A, Schmitt-Kopplin P, Krauss-Etschmann S (2017) D-tryptophan from probiotic bacteria influences the gut microbiome and allergic airway disease. Journal of Allergy and Clinical Immunology 139: 1525-1535 (ARCN, CPC-M) https://doi.org/10.1016/j.jaci.2016.09.003 https://www.ncbi.nlm.nih.gov/pubmed/27670239

Kaufhold I, Osbahr S, Shima K, Marwitz S, Rohmann K, Drömann D, Goldmann T, Dalhoff K, Rupp J (2017) Nontypeable Haemophilus influenzae (NTHi) directly interfere with the regulation of E-cadherin in lung epithelial cells. Microb Infect 19: 560-566 (ARCN) https://doi.org/10.1016/j.micinf.2017.07.002 https://www.ncbi.nlm.nih.gov/pubmed/28802586

Kästle M, Bartel S, Geillinger-Kästle K, Irmler M, Beckers J, Ryffel B, Eickelberg O, Krauss-Etschmann S (2017) microRNA cluster 106a~363 is involved in T helper 17 cell differentiation. Immunology 152: 402-413 (ARCN, CPC-M) https://doi.org/10.1111/imm.12775 https://www.ncbi.nlm.nih.gov/pubmed/28617945

Kahnert K, Lucke T, Biertz F, Lechner A, Watz H, Alter P, Bals R, Behr J, Holle R, Huber RM, Karrasch S, Stubbe B, Wacker M, Söhler S, Wouters EFM, Vogelmeier C, Jörres RA (2017) Transfer factor for carbon monoxide in patients with COPD and diabetes: results from the German COSYCONET cohort. Respir Res 18: 14 (ARCN, CPC-M, UGMLC) https://doi.org/10.1186/s12931-016-0499-0 https://www.ncbi.nlm.nih.gov/pubmed/28086884

Kaehler M, Ruemenapp J, Gonnermann D, Nagel I, Bruhn O, Haenisch S, Ammerpohl O, Wesch D, Cascorbi I, Bruckmueller H (2017) MicroRNA-212/ABCG2-axis contributes to development of imatinib-resistance in leukemic cells. Oncotarget 8: 92018-92031 (ARCN) https://doi.org/10.18632/oncotarget.21272 https://www.ncbi.nlm.nih.gov/pubmed/29190894

Jensen AV, Faurholt-Jepsen D, Egelund GB, Andersen SB, Petersen PT, Benfield T, Witzenrath M, Rohde G, Ravn P, Dreher M, Cornelissen C, Knüppel W, Stolz D, Suttorp N, Creutz P, Bauer T, Sabha T, Pankow W, Lies A, Thiemig D, Hauptmeier B, Ewig S, Wehde D, Prediger M, Schmager S, Höffken G, Kolditz M, Schulte-Hubbert B, Langner S, Welte T, Barten G, Abrahamczik M, Naim J, Kröner W, Illig T, Klopp N, Kroegel C, Pletz M, Happe J, Frosinski J, Winning J, Moeser A, Dalhoff K, Dageförde K, Franzen K, Hyzy F, Schmieg H, Parschke P, Thiemann P, Ahrens J, Hardel T, Drijkoningen J, Buschmann H, Kröning R, Schütte H, Schaberg T, Hering I, Kropf-Sanchen C, Illmann T, Wallner M, Burghuber O, Rainer G (2017) Undiagnosed Diabetes Mellitus in Community-Acquired Pneumonia: A Prospective Cohort Study. Clin Infect Dis 65: 2091-2098 (ARCN, BREATH) https://doi.org/10.1093/cid/cix703 https://www.ncbi.nlm.nih.gov/pubmed/29095981

Jatzlauk G, Bartel S, Heine H, Schloter M, Krauss-Etschmann S (2017) Influences of environmental bacteria and their metabolites on allergies, asthma, and host microbiota. Allergy 72: 1859-1867 (ARCN) https://doi.org/10.1111/all.13220 https://www.ncbi.nlm.nih.gov/pubmed/28600901

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.13220

Jappe U, Schwager C (2017) Relevance of Lipophilic Allergens in Food Allergy Diagnosis. Curr Allergy Asthma Rep 17: 61 (ARCN) https://doi.org/10.1007/s11882-017-0731-0 https://www.ncbi.nlm.nih.gov/pubmed/28795292

Jappe U (2017) Nomenklatur der Allergene. Der Hautarzt 69: 90-91 (ARCN) https://doi.org/10.1007/s00105-017-4103-4 https://www.ncbi.nlm.nih.gov/pubmed/29260247

Jappe U (2017) Molekular-allergologische Aspekte der allergenspezifischen Immuntherapie. Der Hautarzt 68: 271-281 (ARCN) https://doi.org/10.1007/s00105-017-3958-8 https://www.ncbi.nlm.nih.gov/pubmed/28293695

Huebbe P, Nikolai S, Schloesser A, Herebian D, Campbell G, Glüer C-C, Zeyner A, Demetrowitsch T, Schwarz K, Metges CC, Roeder T, Schultheiss G, Ipharraguerre IR, Rimbach G (2017) An extract from the Atlantic brown algae <i>Saccorhiza polyschides</i> counteracts diet-induced obesity in mice via a gut related multi-factorial mechanisms. Oncotarget 8: 73501-73515 (ARCN) https://doi.org/10.18632/oncotarget.18113 https://www.ncbi.nlm.nih.gov/pubmed/29088722

Huang X, Reck M (2017) Response to Letter to the Editor. J Thorac Oncol 12: e192 (ARCN) https://doi.org/10.1016/j.jtho.2017.08.018 https://www.ncbi.nlm.nih.gov/pubmed/29074216

Houben-Wilke S, Jörres RA, Bals R, Franssen FME, Gläser S, Holle R, Karch A, Koch A, Magnussen H, Obst A, Schulz H, Spruit MA, Wacker ME, Welte T, Wouters EFM, Vogelmeier C, Watz H (2017) Peripheral Artery Disease and Its Clinical Relevance in Patients with Chronic Obstructive Pulmonary Disease in the COPD and Systemic Consequences–Comorbidities Network Study. American Journal of Respiratory and Critical Care Medicine 195: 189-197 (ARCN, BREATH, CPC-M, UGMLC) https://doi.org/10.1164/rccm.201602-0354OC https://www.ncbi.nlm.nih.gov/pubmed/27532739

Horstmann J, Schulz-Hildebrandt H, Bock F, Siebelmann S, Lankenau E, Hüttmann G, Steven P, Cursiefen C (2017) Label-Free In Vivo Imaging of Corneal Lymphatic Vessels Using Microscopic Optical Coherence Tomography. Investigative Opthalmology & Visual Science 58: 5880 (ARCN) https://doi.org/10.1167/iovs.17-22286 https://www.ncbi.nlm.nih.gov/pubmed/29149239

Horn L, Spigel DR, Vokes EE, Holgado E, Ready N, Steins M, Poddubskaya E, Borghaei H, Felip E, Paz-Ares L, Pluzanski A, Reckamp KL, Burgio MA, Kohlhäeufl M, Waterhouse D, Barlesi F, Antonia S, Arrieta O, Fayette J, Crinò L, Rizvi N, Reck M, Hellmann MD, Geese WJ, Li A, Blackwood-Chirchir A, Healey D, Brahmer J, Eberhardt WEE (2017) Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057). J Clin Oncol 35: 3924-3933 (ARCN) https://doi.org/10.1200/jco.2017.74.3062 https://www.ncbi.nlm.nih.gov/pubmed/29023213

Hoppe J, Ünal CM, Thiem S, Grimpe L, Goldmann T, Gaßler N, Richter M, Shevchuk O, Steinert M (2017) PilY1 Promotes Legionella pneumophila Infection of Human Lung Tissue Explants and Contributes to Bacterial Adhesion, Host Cell Invasion, and Twitching Motility. Frontiers in Cellular and Infection Microbiology 7: 63 (ARCN) https://doi.org/10.3389/fcimb.2017.00063 https://www.ncbi.nlm.nih.gov/pubmed/28326293

Homann A, Schramm G, Jappe U (2017) Glycans and glycan-specific IgE in clinical and molecular allergology: Sensitization, diagnostics, and clinical symptoms. Journal of Allergy and Clinical Immunology 140: 356-368 (ARCN) https://doi.org/10.1016/j.jaci.2017.04.019 https://www.ncbi.nlm.nih.gov/pubmed/28479330

Homann A, Röckendorf N, Kromminga A, Frey A, Platts-Mills TA, Jappe U (2017) Glycan and Peptide IgE Epitopes of the TNF-alpha Blockers Infliximab and Adalimumab – Precision Diagnostics by Cross-Reactivity Immune Profiling of Patient Sera. Theranostics 7: 4699-4709 (ARCN) https://doi.org/10.7150/thno.20654 https://www.ncbi.nlm.nih.gov/pubmed/29187897

Hillmann D, Spahr H, Sudkamp H, Hain C, Hinkel L, Franke G, Hüttmann G (2017) Off-axis reference beam for full-field swept-source OCT and holoscopy. Opt Express 25: 27770 (ARCN) https://doi.org/10.1364/oe.25.027770 https://www.ncbi.nlm.nih.gov/pubmed/29092247

Heß N, Waldow F, Kohler TP, Rohde M, Kreikemeyer B, Gómez-Mejia A, Hain T, Schwudke D, Vollmer W, Hammerschmidt S, Gisch N (2017) Lipoteichoic acid deficiency permits normal growth but impairs virulence of Streptococcus pneumoniae. Nature Communications 8: 2093 (ARCN) https://doi.org/10.1038/s41467-017-01720-z https://www.ncbi.nlm.nih.gov/pubmed/29233962

Hellings PW, Fokkens WJ, Bachert C, Akdis CA, Bieber T, Agache I, Bernal-Sprekelsen M, Canonica GW, Gevaert P, Joos G, Lund V, Muraro A, Onerci M, Zuberbier T, Pugin B, Seys SF, Bousquet J (2017) Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement. Allergy 72: 1297-1305 (ARCN, CPC-M) https://doi.org/10.1111/all.13162 https://www.ncbi.nlm.nih.gov/pubmed/28306159

Heigener DF, Reck M (2017) Giant steps and stumbling blocks. Nature Reviews Clinical Oncology 15: 71-72 (ARCN) https://doi.org/10.1038/nrclinonc.2017.178 https://www.ncbi.nlm.nih.gov/pubmed/29158589

Heigener DF, Reck M (2017) Lungenkarzinom. Internist (Berl) 58: 1258-1263 (ARCN) https://doi.org/10.1007/s00108-017-0339-4 https://www.ncbi.nlm.nih.gov/pubmed/29043377

Heigener DF, Reck M (2017) PD-1 Axis Inhibition in EGFR Positives: A Blunt Sword? J Thorac Oncol 12: 171-172 (ARCN) https://doi.org/10.1016/j.jtho.2016.12.013 https://www.ncbi.nlm.nih.gov/pubmed/28115107

Harkness LM, Weckmann M, Kopp M, Becker T, Ashton AW, Burgess JK (2017) Tumstatin regulates the angiogenic and inflammatory potential of airway smooth muscle extracellular matrix. Journal of Cellular and Molecular Medicine 21: 3288-3297 (ARCN) https://doi.org/10.1111/jcmm.13232 https://www.ncbi.nlm.nih.gov/pubmed/28608951

Han B, Tjulandin S, Hagiwara K, Normanno N, Wulandari L, Laktionov K, Hudoyo A, He Y, Zhang Y-P, Wang M-Z, Liu CY, Ratcliffe M, McCormack R, Reck M (2017) EGFR mutation prevalence in Asia-Pacific and Russian patients with advanced NSCLC of adenocarcinoma and non-adenocarcinoma histology: The IGNITE study. Lung Cancer 113: 37-44 (ARCN) https://doi.org/10.1016/j.lungcan.2017.08.021 https://www.ncbi.nlm.nih.gov/pubmed/29110846

Grosso F, Steele N, Novello S, Nowak AK, Popat S, Greillier L, John T, Leighl NB, Reck M, Taylor P, Planchard D, Sørensen JB, Socinski MA, von Wangenheim U, Loembé AB, Barrueco J, Morsli N, Scagliotti G (2017) Nintedanib Plus Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Phase II Results From the Randomized, Placebo-Controlled LUME-Meso Trial. J Clin Oncol 35: 3591-3600 (ARCN) https://doi.org/10.1200/jco.2017.72.9012 https://www.ncbi.nlm.nih.gov/pubmed/28892431

Govindan R, Szczesna A, Ahn M-J, Schneider C-P, Gonzalez Mella PF, Barlesi F, Han B, Ganea DE, Von Pawel J, Vladimirov V, Fadeeva N, Lee KH, Kurata T, Zhang L, Tamura T, Postmus PE, Jassem J, O’Byrne K, Kopit J, Li M, Tschaika M, Reck M (2017) Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non–Small-Cell Lung Cancer. J Clin Oncol 35: 3449-3457 (ARCN) https://doi.org/10.1200/jco.2016.71.7629 https://www.ncbi.nlm.nih.gov/pubmed/28854067

Gottfried M, Bennouna J, Bondarenko I, Douillard J-Y, Heigener DF, Krzakowski M, Mellemgaard A, Novello S, Orlov S, Summers Y, von Pawel J, Stöhr J, Kaiser R, Reck M (2017) Efficacy and Safety of Nintedanib Plus Docetaxel in Patients with Advanced Lung Adenocarcinoma: Complementary and Exploratory Analyses of the Phase III LUME-Lung 1 Study. Target Oncol 12: 475-485 (ARCN) https://doi.org/10.1007/s11523-017-0517-2 https://www.ncbi.nlm.nih.gov/pubmed/28702806

Goedicke-Fritz S, Härtel C, Krasteva-Christ G, Kopp MV, Meyer S, Zemlin M (2017) Preterm Birth Affects the Risk of Developing Immune-Mediated Diseases. Front Immunol 8: 1266 (ARCN, UGMLC) https://doi.org/10.3389/fimmu.2017.01266 https://www.ncbi.nlm.nih.gov/pubmed/29062316

Gharaibeh M, Hagedorn M, Lilla S, Hauptmann M, Heine H, Fleischer B, Keller C, Roy CR (2017) Reply to Tantibhedhyangkul et al., ‘Suspected Mycoplasma Contamination in the Study “Toll-Like Receptor 2 Recognizes Orientia tsutsugamushi and Increases Susceptibility to Murine Experimental Scrub Typhus”’. Infection and Immunity 85 (ARCN) https://doi.org/10.1128/iai.00326-17 https://www.ncbi.nlm.nih.gov/pubmed/28821641

George L, Mitra A, Thimraj TA, Irmler M, Vishweswaraiah S, Lunding L, Hühn D, Madurga A, Beckers J, Fehrenbach H, Upadhyay S, Schulz H, Leikauf GD, Ganguly K (2017) Transcriptomic analysis comparing mouse strains with extreme total lung capacities identifies novel candidate genes for pulmonary function. Respir Res 18: 152 (ARCN, CPC-M) https://doi.org/10.1186/s12931-017-0629-3 https://www.ncbi.nlm.nih.gov/pubmed/28793908

Gaschler-Markefski B, Sikken P, Heymach JV, Gottfried M, Mellemgaard A, Novello S, Gann C-N, Barrueco J, Reck M, Hanna NH, Kaiser R (2017) Time since start of first-line therapy as a predictive clinical marker for nintedanib in patients with previously treated non-small cell lung cancer. ESMO Open 2: e000102 (ARCN) https://doi.org/10.1136/esmoopen-2016-000102 https://www.ncbi.nlm.nih.gov/pubmed/28761724

Garon EB, Reck M, Paz-Ares L, Ponce S, Jaime JC, Juan O, Nadal E, Lee P, Dalal R, Liu J, He S, Treat J, Nakagawa K (2017) Treatment Rationale and Study Design for the RELAY Study: A Multicenter, Randomized, Double-Blind Study of Erlotinib With Ramucirumab or Placebo in Patients With Epidermal Growth Factor Receptor Mutation-Positive Metastatic Non–Small-Cell Lung Cancer. Clin Lung Cancer 18: 96-99 (ARCN) https://doi.org/10.1016/j.cllc.2016.05.023 https://www.ncbi.nlm.nih.gov/pubmed/27894601

Gaber R, Watermann I, Kugler C, Vollmer E, Perner S, Reck M, Goldmann T (2017) Preselection of EGFR mutations in non-small-cell lung cancer patients by immunohistochemistry: comparison with DNA-sequencing, EGFR wild-type expression, gene copy number gain and clinicopathological data. Rom J Morphol Embryol 58: 1175-1184 (ARCN)

Fuchs O, Bahmer T, Rabe KF, von Mutius E (2017) Asthma transition from childhood into adulthood. The Lancet Respiratory Medicine 5: 224-234 (ARCN, CPC-M) https://doi.org/10.1016/s2213-2600(16)30187-4 https://www.ncbi.nlm.nih.gov/pubmed/27666650

Ficker JH, Rabe KF, Welte T (2017) Role of dual bronchodilators in COPD: A review of the current evidence for indacaterol/glycopyrronium. Pulm Pharmacol Ther 45: 19-33 (ARCN, BREATH) https://doi.org/10.1016/j.pupt.2017.04.002 https://www.ncbi.nlm.nih.gov/pubmed/28389258

Fehrenbach H, Wagner C, Wegmann M (2017) Airway remodeling in asthma: what really matters. Cell and Tissue Research 367: 551-569 (ARCN) https://doi.org/10.1007/s00441-016-2566-8 https://www.ncbi.nlm.nih.gov/pubmed/28190087

Esser RW, Stoeckel MC, Kirsten A, Watz H, Taube K, Lehmann K, Magnussen H, Büchel C, von Leupoldt A (2017) Brain Activation during Perception and Anticipation of Dyspnea in Chronic Obstructive Pulmonary Disease. Front Physiol 8: 617 (ARCN) https://doi.org/10.3389/fphys.2017.00617 https://www.ncbi.nlm.nih.gov/pubmed/28878693

Eggers LF, Müller J, Marella C, Scholz V, Watz H, Kugler C, Rabe KF, Goldmann T, Schwudke D (2017) Lipidomes of lung cancer and tumour-free lung tissues reveal distinct molecular signatures for cancer differentiation, age, inflammation, and pulmonary emphysema. Sci Rep 7: 11087 (ARCN) https://doi.org/10.1038/s41598-017-11339-1 https://www.ncbi.nlm.nih.gov/pubmed/28894173

Diel R, Ringshausen F, Richter E, Welker L, Schmitz J, Nienhaus A (2017) Microbiological and Clinical Outcomes of Treating Non- Mycobacterium Avium Complex Nontuberculous Mycobacterial Pulmonary Disease. Chest 152: 120-142 (ARCN, BREATH) https://doi.org/10.1016/j.chest.2017.04.166 https://www.ncbi.nlm.nih.gov/pubmed/28461147

Diel R, Jacob J, Lampenius N, Loebinger M, Nienhaus A, Rabe KF, Ringshausen FC (2017) Burden of non-tuberculous mycobacterial pulmonary disease in Germany. Eur Respir J 49: 1602109 (ARCN, BREATH) https://doi.org/10.1183/13993003.02109-2016 https://www.ncbi.nlm.nih.gov/pubmed/28446559

Diel R (2017) Long-term Effect of Bacille Calmette-Guérin Vaccination in Tuberculin Skin Testing. Chest 152: 235-236 (ARCN) https://doi.org/10.1016/j.chest.2017.03.011 https://www.ncbi.nlm.nih.gov/pubmed/28797384

Di Lorenzo F, Palmigiano A, Duda KA, Pallach M, Busset N, Sturiale L, Giraud E, Garozzo D, Molinaro A, Silipo A (2017) Structure of the Lipopolysaccharide from the Bradyrhizobium sp. ORS285 rfaLMutant Strain. ChemistryOpen 6: 541-553 (ARCN) https://doi.org/10.1002/open.201700074 https://www.ncbi.nlm.nih.gov/pubmed/28794950

Di Lorenzo F, Palmigiano A, Al Bitar-Nehme S, Sturiale L, Duda KA, Gully D, Lanzetta R, Giraud E, Garozzo D, Bernardini ML, Molinaro A, Silipo A (2017) The Lipid A fromRhodopseudomonas palustrisStrain BisA53 LPS Possesses a Unique Structure and Low Immunostimulant Properties. Chemistry – A European Journal 23: 3637-3647 (ARCN) https://doi.org/10.1002/chem.201604379 https://www.ncbi.nlm.nih.gov/pubmed/28004420

Deng F, Chen Y, Zheng J, Huang Q, Cao X, Zillikens D, Petersen F, Yu X (2017) CD11b-deficient mice exhibit an increased severity in the late phase of antibody transfer-induced experimental epidermolysis bullosa acquisita. Exp Dermatol 26: 1175-1178 (ARCN) https://doi.org/10.1111/exd.13434 https://www.ncbi.nlm.nih.gov/pubmed/28857285

De Castro C, Holst O, Lam J (2017) Microbial glycans: papers from the 7th biennial Baltic Meeting on Microbial Carbohydrates (BMMC). Antonie Van Leeuwenhoek 110: 1373-1375 (ARCN) https://doi.org/10.1007/s10482-017-0945-0 https://www.ncbi.nlm.nih.gov/pubmed/28956177

Cottin V, Bel E, Bottero P, Dalhoff K, Humbert M, Lazor R, Sinico RA, Sivasothy P, Wechsler ME, Groh M, Marchand-Adam S, Khouatra C, Wallaert B, Taillé C, Delaval P, Cadranel J, Bonniaud P, Prévot G, Hirschi S, Gondouin A, Dunogué B, Chatté G, Briault C, Pagnoux C, Jayne D, Guillevin L, Cordier J-F (2017) Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Autoimmun Rev 16: 1-9 (ARCN) https://doi.org/10.1016/j.autrev.2016.09.018 https://www.ncbi.nlm.nih.gov/pubmed/27671089

Choy SL, Bernin H, Aiba T, Bifeld E, Lender SC, Mühlenpfordt M, Noll J, Eick J, Marggraff C, Niss H, Roldán NG, Tanaka S, Kitamura M, Fukase K, Clos J, Tannich E, Fujimoto Y, Lotter H (2017) Synthetic analogs of an Entamoeba histolytica glycolipid designed to combat intracellular Leishmania infection. Sci Rep 7: 9472 (ARCN) https://doi.org/10.1038/s41598-017-09894-8 https://www.ncbi.nlm.nih.gov/pubmed/28842620

Chavakis T, Ender F, Wiese AV, Schmudde I, Sun J, Vollbrandt T, König P, Laumonnier Y, Köhl J (2017) Differential regulation of C5a receptor 1 in innate immune cells during the allergic asthma effector phase. PLoS One 12: e0172446 (ARCN) https://doi.org/10.1371/journal.pone.0172446 https://www.ncbi.nlm.nih.gov/pubmed/28231307

Carbone DP, Reck M, Paz-Ares L, Creelan B, Horn L, Steins M, Felip E, van den Heuvel MM, Ciuleanu T-E, Badin F, Ready N, Hiltermann TJN, Nair S, Juergens R, Peters S, Minenza E, Wrangle JM, Rodriguez-Abreu D, Borghaei H, Blumenschein GR, Villaruz LC, Havel L, Krejci J, Corral Jaime J, Chang H, Geese WJ, Bhagavatheeswaran P, Chen AC, Socinski MA (2017) First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer. New England Journal of Medicine 376: 2415-2426 (ARCN) https://doi.org/10.1056/NEJMoa1613493 https://www.ncbi.nlm.nih.gov/pubmed/28636851

Calverley PMA, Tetzlaff K, Vogelmeier C, Fabbri LM, Magnussen H, Wouters EFM, Mezzanotte W, Disse B, Finnigan H, Asijee G, Hallmann C, Watz H (2017) Eosinophilia, Frequent Exacerbations, and Steroid Response in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine 196: 1219-1221 (ARCN, UGMLC) https://doi.org/10.1164/rccm.201612-2525LE https://www.ncbi.nlm.nih.gov/pubmed/28306321

Cahn A, Hamblin JN, Begg M, Wilson R, Dunsire L, Sriskantharajah S, Montembault M, Leemereise CN, Galinanes-Garcia L, Watz H, Kirsten AM, Fuhr R, Hessel EM (2017) Safety, pharmacokinetics and dose-response characteristics of GSK2269557, an inhaled PI3Kδ inhibitor under development for the treatment of COPD. Pulm Pharmacol Ther 46: 69-77 (ARCN) https://doi.org/10.1016/j.pupt.2017.08.008 https://www.ncbi.nlm.nih.gov/pubmed/28823947

Buhl R, Bals R, Baur X, Berdel D, Criée CP, Gappa M, Gillissen A, Greulich T, Haidl P, Hamelmann E, Kardos P, Kenn K, Klimek L, Korn S, Lommatzsch M, Magnussen H, Nicolai T, Nowak D, Pfaar O, Rabe K, Riedler J, Ritz T, Schultz K, Schuster A, Spindler T, Taube R, Taube K, Vogelmeier C, von Leupold A, Wantke F, Weise S, Wildhaber J, Worth H, Zacharasiewicz A (2017) S2k-Leitlinie zur Diagnostik und Therapie von Patienten mit Asthma. Pneumologie 71: 849-919 (ARCN, CPC-M, UGMLC) https://doi.org/10.1055/s-0043-119504 https://www.ncbi.nlm.nih.gov/pubmed/29216678

Brinkmann R, Hüttmann G, Horstmann J, Schmarbeck B, Münter M, Buj C (2017) Noncontact holographic detection for photoacoustic tomography. J Biomed Opt 22: 1 (ARCN) https://doi.org/10.1117/1.Jbo.22.10.106007 https://www.ncbi.nlm.nih.gov/pubmed/29030943

Brahmer JR, Rodríguez-Abreu D, Robinson AG, Hui R, Csőszi T, Fülöp A, Gottfried M, Peled N, Tafreshi A, Cuffe S, O’Brien M, Rao S, Hotta K, Zhang J, Lubiniecki GM, Deitz AC, Rangwala R, Reck M (2017) Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial. The Lancet Oncology 18: 1600-1609 (ARCN) https://doi.org/10.1016/s1470-2045(17)30690-3 https://www.ncbi.nlm.nih.gov/pubmed/29129441

Bousquet J, Farrell J, Crooks G, Hellings P, Bel EH, Bewick M, Chavannes NH, de Sousa JC, Cruz AA, Haahtela T, Joos G, Khaltaev N, Malva J, Muraro A, Nogues M, Palkonen S, Pedersen S, Robalo-Cordeiro C, Samolinski B, Strandberg T, Valiulis A, Yorgancioglu A, Zuberbier T, Bedbrook A, Aberer W, Adachi M, Agusti A, Akdis CA, Akdis M, Ankri J, Alonso A, Annesi-Maesano I, Ansotegui IJ, Anto JM, Arnavielhe S, Arshad H, Bai C, Baiardini I, Bachert C, Baigenzhin AK, Barbara C, Bateman ED, Beghé B, Kheder AB, Bennoor KS, Benson M, Bergmann KC, Bieber T, Bindslev-Jensen C, Bjermer L, Blain H, Blasi F, Boner AL, Bonini M, Bonini S, Bosnic-Anticevitch S, Boulet LP, Bourret R, Bousquet PJ, Braido F, Briggs AH, Brightling CE, Brozek J, Buhl R, Burney PG, Bush A, Caballero-Fonseca F, Caimmi D, Calderon MA, Calverley PM, Camargos PAM, Canonica GW, Camuzat T, Carlsen KH, Carr W, Carriazo A, Casale T, Cepeda Sarabia AM, Chatzi L, Chen YZ, Chiron R, Chkhartishvili E, Chuchalin AG, Chung KF, Ciprandi G, Cirule I, Cox L, Costa DJ, Custovic A, Dahl R, Dahlen SE, Darsow U, De Carlo G, De Blay F, Dedeu T, Deleanu D, De Manuel Keenoy E, Demoly P, Denburg JA, Devillier P, Didier A, Dinh-Xuan AT, Djukanovic R, Dokic D, Douagui H, Dray G, Dubakiene R, Durham SR, Dykewicz MS, El-Gamal Y, Emuzyte R, Fabbri LM, Fletcher M, Fiocchi A, Fink Wagner A, Fonseca J, Fokkens WJ, Forastiere F, Frith P, Gaga M, Gamkrelidze A, Garces J, Garcia-Aymerich J, Gemicioğlu B, Gereda JE, González Diaz S, Gotua M, Grisle I, Grouse L, Gutter Z, Guzmán MA, Heaney LG, Hellquist-Dahl B, Henderson D, Hendry A, Heinrich J, Heve D, Horak F, Hourihane JOB, Howarth P, Humbert M, Hyland ME, Illario M, Ivancevich JC, Jardim JR, Jares EJ, Jeandel C, Jenkins C, Johnston SL, Jonquet O, Julge K, Jung KS, Just J, Kaidashev I, Khaitov MR, Kalayci O, Kalyoncu AF, Keil T, Keith PK, Klimek L, Koffi N’Goran B, Kolek V, Koppelman GH, Kowalski ML, Kull I, Kuna P, Kvedariene V, Lambrecht B, Lau S, Larenas-Linnemann D, Laune D, Le LTT, Lieberman P, Lipworth B, Li J, Lodrup Carlsen K, Louis R, MacNee W, Magard Y, Magnan A, Mahboub B, Mair A, Majer I, Makela MJ, Manning P, Mara S, Marshall GD, Masjedi MR, Matignon P, Maurer M, Mavale-Manuel S, Melén E, Melo-Gomes E, Meltzer EO, Menzies-Gow A, Merk H, Michel JP, Miculinic N, Mihaltan F, Milenkovic B, Mohammad GMY, Molimard M, Momas I, Montilla-Santana A, Morais-Almeida M, Morgan M, Mösges R, Mullol J, Nafti S, Namazova-Baranova L, Naclerio R, Neou A, Neffen H, Nekam K, Niggemann B, Ninot G, Nyembue TD, O’Hehir RE, Ohta K, Okamoto Y, Okubo K, Ouedraogo S, Paggiaro P, Pali-Schöll I, Panzner P, Papadopoulos N, Papi A, Park HS, Passalacqua G, Pavord I, Pawankar R, Pengelly R, Pfaar O, Picard R, Pigearias B, Pin I, Plavec D, Poethig D, Pohl W, Popov TA, Portejoie F, Potter P, Postma D, Price D, Rabe KF, Raciborski F, Radier Pontal F, Repka-Ramirez S, Reitamo S, Rennard S, Rodenas F, Roberts J, Roca J, Rodriguez Mañas L, Rolland C, Roman Rodriguez M, Romano A, Rosado-Pinto J, Rosario N, Rosenwasser L, Rottem M, Ryan D, Sanchez-Borges M, Scadding GK, Schunemann HJ, Serrano E, Schmid-Grendelmeier P, Schulz H, Sheikh A, Shields M, Siafakas N, Sibille Y, Similowski T, Simons FER, Sisul JC, Skrindo I, Smit HA, Solé D, Sooronbaev T, Spranger O, Stelmach R, Sterk PJ, Sunyer J, Thijs C, To T, Todo-Bom A, Triggiani M, Valenta R, Valero AL, Valia E, Valovirta E, Van Ganse E, van Hage M, Vandenplas O, Vasankari T, Vellas B, Vestbo J, Vezzani G, Vichyanond P, Viegi G, Vogelmeier C, Vontetsianos T, Wagenmann M, Wallaert B, Walker S, Wang DY, Wahn U, Wickman M, Williams DM, Williams S, Wright J, Yawn BP, Yiallouros PK, Yusuf OM, Zaidi A, Zar HJ, Zernotti ME, Zhang L, Zhong N, Zidarn M, Mercier J (2017) Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5). Clinical and Translational Allergy 7: 5 (ARCN, CPC-M, UGMLC) https://doi.org/10.1186/s13601-016-0135-6 https://www.ncbi.nlm.nih.gov/pubmed/28239450

Bos LD, Bartel S, Mathioudakis AG, Flood E (2017) Opportunities for early career members. Breathe 13: 127-128 ((ARCN)) https://doi.org/10.1183/20734735.004617 https://www.ncbi.nlm.nih.gov/pubmed/28620433

Bhat J, Helmuth J, Chitadze G, Kouakanou L, Peters C, Vingron M, Ammerpohl O, Kabelitz D (2017) Stochastics of Cellular Differentiation Explained by Epigenetics: The Case of T-Cell Differentiation and Functional Plasticity. Scand J Immunol 86: 184-195 (ARCN) https://doi.org/10.1111/sji.12589 https://www.ncbi.nlm.nih.gov/pubmed/28799233

Bergroth E, Roponen M, Karvonen AM, Keski-Nisula L, Remes S, Riedler J, Roduit C, Dalphin J-C, Kaulek V, Loss GJ, Lauener R, Hirvonen M-R, Genuneit J, Schmaußer-Hechfellner E, Renz H, Pfefferle PI, Krauss-Etschmann S, Schaub B, von Mutius E, Pekkanen J (2017) Enhanced T helper 1 and 2 cytokine responses at birth associate with lower risk of middle ear infections in infancy. Pediatr Allergy Immunol 28: 53-59 (ARCN, CPC-M, UGMLC) https://doi.org/10.1111/pai.12658 https://www.ncbi.nlm.nih.gov/pubmed/27633913

Bergmann AK, Castellano G, Alten J, Ammerpohl O, Kolarova J, Nordlund J, Martin-Subero JI, Schrappe M, Siebert R (2017) DNA methylation profiling of pediatric B-cell lymphoblastic leukemia withKMT2Arearrangement identifies hypomethylation at enhancer sites. Pediatr Blood Cancer 64: e26251 (ARCN) https://doi.org/10.1002/pbc.26251 https://www.ncbi.nlm.nih.gov/pubmed/27786413

Behr J, Neuser P, Prasse A, Kreuter M, Rabe K, Schade-Brittinger C, Wagner J, Günther A (2017) Exploring efficacy and safety of oral Pirfenidone for progressive, non-IPF lung fibrosis (RELIEF) – a randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial. BMC Pulm Med 17: 122 (ARCN, BREATH, CPC-M, TLRC, UGMLC) https://doi.org/10.1186/s12890-017-0462-y https://www.ncbi.nlm.nih.gov/pubmed/28877715

Becker J, Diel R (2017) Screening for Methicillin-resistant Staphylococcus aureus in a residence home for elderly in Germany. J Occup Med Toxicol 12: 3 (ARCN) https://doi.org/10.1186/s12995-017-0149-6 https://www.ncbi.nlm.nih.gov/pubmed/28174596

Bartel S, Schulz N, Alessandrini F, Schamberger AC, Pagel P, Theis FJ, Milger K, Noessner E, Stick SM, Kicic A, Eickelberg O, Freishtat RJ, Krauss-Etschmann S (2017) Pulmonary microRNA profiles identify involvement of Creb1 and Sec14l3 in bronchial epithelial changes in allergic asthma. Sci Rep 7: 46026 (ARCN, CPC-M) https://doi.org/10.1038/srep46026 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382551/pdf/srep46026.pdf

Bartel S, Greene CM (2017) Best of Milan 2017—ERS Lung Science Conference session “Lung tissue repair and remodeling in chronic lung diseases: mechanisms and therapeutic approaches”. J Thorac Dis 9: S1541-S1543 ((ARCN)) https://doi.org/10.21037/jtd.2017.11.40 https://www.ncbi.nlm.nih.gov/pubmed/29255636

Bartel S, Bhakta N, Christenson S (2017) More Than Meets the Eye: Cigarette Smoke Induces Genomic Changes in the Small Airway Epithelium Independent of Histologic Changes. American Journal of Respiratory and Critical Care Medicine 196: 260-262 ((ARCN)) https://doi.org/10.1164/rccm.201704-0665ED https://www.ncbi.nlm.nih.gov/pubmed/28762786

Bárcena-Varela S, Martínez-de-Tejada G, Martin L, Schuerholz T, Gil-Royo AG, Fukuoka S, Goldmann T, Droemann D, Correa W, Gutsmann T, Brandenburg K, Heinbockel L (2017) Coupling killing to neutralization: combined therapy with ceftriaxone/Pep19-2.5 counteracts sepsis in rabbits. Exp Mol Med 49: e345-e345 (ARCN) https://doi.org/10.1038/emm.2017.75 https://www.ncbi.nlm.nih.gov/pubmed/28620220

Bandeira de Melo C, Wiese AV, Ender F, Quell KM, Antoniou K, Vollbrandt T, König P, Köhl J, Laumonnier Y (2017) The C5a/C5aR1 axis controls the development of experimental allergic asthma independent of LysM-expressing pulmonary immune cells. PLoS One 12: e0184956 (ARCN) https://doi.org/10.1371/journal.pone.0184956 https://www.ncbi.nlm.nih.gov/pubmed/28931049

Bahmer T, Waschki B, Schatz F, Herzmann C, Zabel P, Kirsten A-M, Rabe KF, Watz H (2017) Physical activity, airway resistance and small airway dysfunction in severe asthma. Eur Respir J 49: 1601827 (ARCN) https://doi.org/10.1183/13993003.01827-2016 https://www.ncbi.nlm.nih.gov/pubmed/28052957

Bahmer T, Kirsten A-M, Waschki B, Rabe KF, Magnussen H, Kirsten D, Gramm M, Hummler S, Brunnemer E, Kreuter M, Watz H (2017) Prognosis and longitudinal changes of physical activity in idiopathic pulmonary fibrosis. BMC Pulm Med 17: 104 (ARCN, TLRC) https://doi.org/10.1186/s12890-017-0444-0 https://www.ncbi.nlm.nih.gov/pubmed/28743305

Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, Yokoi T, Chiappori A, Lee KH, de Wit M, Cho BC, Bourhaba M, Quantin X, Tokito T, Mekhail T, Planchard D, Kim Y-C, Karapetis CS, Hiret S, Ostoros G, Kubota K, Gray JE, Paz-Ares L, de Castro Carpeño J, Wadsworth C, Melillo G, Jiang H, Huang Y, Dennis PA, Özgüroğlu M (2017) Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer. New England Journal of Medicine 377: 1919-1929 (ARCN) https://doi.org/10.1056/NEJMoa1709937 https://www.ncbi.nlm.nih.gov/pubmed/28885881

Almendros I, Bartel S, Bostantzoglou C, Jubrail J, Lehmann M, Wagner D (2017) Early Career Members at the ERS LSC 2017: mechanistic overlap between chronic lung injury and cancer. Breathe 13: 323-326 ((ARCN), CPC-M) https://doi.org/10.1183/20734735.010217 https://www.ncbi.nlm.nih.gov/pubmed/29209426

Ajileye A, Alvarez N, Merker M, Walker TM, Akter S, Brown K, Moradigaravand D, Schön T, Andres S, Schleusener V, Omar SV, Coll F, Huang H, Diel R, Ismail N, Parkhill J, de Jong BC, Peto TEA, Crook DW, Niemann S, Robledo J, Smith EG, Peacock SJ, Köser CU (2017) Some Synonymous and Nonsynonymous gyrA Mutations in Mycobacterium tuberculosis Lead to Systematic False-Positive Fluoroquinolone Resistance Results with the Hain GenoType MTBDR sl Assays. Antimicrob Agents Chemother 61 (ARCN) https://doi.org/10.1128/aac.02169-16 https://www.ncbi.nlm.nih.gov/pubmed/28137812

 

2016

Zimmer J, Weitnauer M, Boutin S, Küblbeck G, Thiele S, Walker P, Lasitschka F, Lunding L, Orinska Z, Vock C, Arnold B, Wegmann M, Dalpke A (2016) Nuclear Localization of Suppressor of Cytokine Signaling-1 Regulates Local Immunity in the Lung. Front Immunol 7: 514 (ARCN, TLRC) https://doi.org/10.3389/fimmu.2016.00514 https://www.ncbi.nlm.nih.gov/pubmed/27917175

Yokoi T, Reck M, Hagiwara K, Han B, Tjulandin S, McCormack R, Ratcliffe M, Normanno N (2016) Plasma ctDNA for the detection of EGFR mutation status in advanced nsclc (aNSCLC) as per local diagnostic practices: Japanese subset data from assess. Pathology 48: S162 (ARCN) https://doi.org/10.1016/j.pathol.2015.12.444 https://www.ncbi.nlm.nih.gov/pubmed/27772972

Wright MN, Ziegler A, König IR (2016) Do little interactions get lost in dark random forests? BMC Bioinformatics 17: 145 (ARCN) https://doi.org/10.1186/s12859-016-0995-8 https://www.ncbi.nlm.nih.gov/pubmed/27029549

Wittmann T, Frixel S, Höppner S, Schindlbeck U, Schams A, Kappler M, Hegermann J, Wrede C, Liebisch G, Vierzig A, Zacharasiewicz A, Kopp MV, Poets CF, Baden W, Hartl D, van Kaam AH, Lohse P, Aslanidis C, Zarbock R, Griese M (2016) Increased Risk of Interstitial Lung Disease in Children with a Single R288K Variant of ABCA3. Mol Med 22: 183-191 (ARCN, CPC-M) https://doi.org/10.2119/molmed.2015.00244 https://www.ncbi.nlm.nih.gov/pubmed/26928390

Weiss S, Rosendahl A, Czesla D, Meyer-Schwesinger C, Stahl RAK, Ehmke H, Kurts C, Zipfel PF, Köhl J, Wenzel UO (2016) The complement receptor C5aR1 contributes to renal damage but protects the heart in angiotensin II-induced hypertension. American Journal of Physiology-Renal Physiology 310: F1356-F1365 (ARCN) https://doi.org/10.1152/ajprenal.00040.2016 https://www.ncbi.nlm.nih.gov/pubmed/27053686

Wedzicha J, Calverley P, Rabe K (2016) Roflumilast: a review of its use in the treatment of COPD. Int J Chron Obstruct Pulmon Dis 11: 81 (ARCN) https://doi.org/10.2147/copd.S89849 https://www.ncbi.nlm.nih.gov/pubmed/26792988

Weckmann M, Schultheiss C, Hollaender A, Bobis I, Rupp J, Kopp MV (2016) Treatment with rhDNase in patients with cystic fibrosis altersin-vitroCHIT-1 activity of isolated leucocytes. Clin Exp Immunol 185: 382-391 (ARCN) https://doi.org/10.1111/cei.12827 https://www.ncbi.nlm.nih.gov/pubmed/27324468

Watz H, Tetzlaff K, Wouters EFM, Kirsten A, Magnussen H, Rodriguez-Roisin R, Vogelmeier C, Fabbri LM, Chanez P, Dahl R, Disse B, Finnigan H, Calverley PMA (2016) Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial. The Lancet Respiratory Medicine 4: 390-398 (ARCN, UGMLC) https://doi.org/10.1016/s2213-2600(16)00100-4 https://www.ncbi.nlm.nih.gov/pubmed/27066739

Watz H, Mailänder C, Baier M, Kirsten A (2016) Effects of indacaterol/glycopyrronium (QVA149) on lung hyperinflation and physical activity in patients with moderate to severe COPD: a randomised, placebo-controlled, crossover study (The MOVE Study). BMC Pulm Med 16: 95 (ARCN) https://doi.org/10.1186/s12890-016-0256-7 https://www.ncbi.nlm.nih.gov/pubmed/27301417

Watz H (2016) Chronic Obstructive Pulmonary Disease: When Pulmonologists Do Something Good for the Heart. American Journal of Respiratory and Critical Care Medicine 193: 703-704 (ARCN) https://doi.org/10.1164/rccm.201512-2340ED https://www.ncbi.nlm.nih.gov/pubmed/27035775

Watz H (2016) Asthma-COPD-Overlap-Syndrom. DMW – Deutsche Medizinische Wochenschrift 141: 700-703 (ARCN) https://doi.org/10.1055/s-0042-105173 https://www.ncbi.nlm.nih.gov/pubmed/27176063

Watz H (2016) Chronische Atemwegserkrankungen: Jeder zweite Raucher hat trotz guter Lungenfunktion Symptome. DMW – Deutsche Medizinische Wochenschrift 141: 1002-1002 (ARCN) https://doi.org/10.1055/s-0042-108516 https://www.ncbi.nlm.nih.gov/pubmed/27404926

Waschki B, Kirsten AM, Holz O, Meyer T, Lichtinghagen R, Rabe KF, Magnussen H, Welte T, Watz H, Janciauskiene S (2016) Angiopoietin-like protein 4 and cardiovascular function in COPD. BMJ Open Respiratory Research 3: e000161 (ARCN, BREATH) https://doi.org/10.1136/bmjresp-2016-000161 https://www.ncbi.nlm.nih.gov/pubmed/27933182

Wang S, Hüttmann G, Scholzen T, Zhang Z, Vogel A, Hasan T, Rahmanzadeh R (2016) A light-controlled switch after dual targeting of proliferating tumor cells via the membrane receptor EGFR and the nuclear protein Ki-67. Sci Rep 6: 27032 (ARCN) https://doi.org/10.1038/srep27032 https://www.ncbi.nlm.nih.gov/pubmed/27246531

Wang S, Hüttmann G, Rudnitzki F, Diddens-Tschoeke H, Zhang Z, Rahmanzadeh R (2016) Indocyanine green as effective antibody conjugate for intracellular molecular targeted photodynamic therapy. J Biomed Opt 21: 078001 (ARCN) https://doi.org/10.1117/1.Jbo.21.7.078001 https://www.ncbi.nlm.nih.gov/pubmed/27424607

Wahl S, Drong A, Lehne B, Loh M, Scott WR, Kunze S, Tsai P-C, Ried JS, Zhang W, Yang Y, Tan S, Fiorito G, Franke L, Guarrera S, Kasela S, Kriebel J, Richmond RC, Adamo M, Afzal U, Ala-Korpela M, Albetti B, Ammerpohl O, Apperley JF, Beekman M, Bertazzi PA, Black SL, Blancher C, Bonder M-J, Brosch M, Carstensen-Kirberg M, de Craen AJM, de Lusignan S, Dehghan A, Elkalaawy M, Fischer K, Franco OH, Gaunt TR, Hampe J, Hashemi M, Isaacs A, Jenkinson A, Jha S, Kato N, Krogh V, Laffan M, Meisinger C, Meitinger T, Mok ZY, Motta V, Ng HK, Nikolakopoulou Z, Nteliopoulos G, Panico S, Pervjakova N, Prokisch H, Rathmann W, Roden M, Rota F, Rozario MA, Sandling JK, Schafmayer C, Schramm K, Siebert R, Slagboom PE, Soininen P, Stolk L, Strauch K, Tai ES, Tarantini L, Thorand B, Tigchelaar EF, Tumino R, Uitterlinden AG, van Duijn C, van Meurs JBJ, Vineis P, Wickremasinghe AR, Wijmenga C, Yang T-P, Yuan W, Zhernakova A, Batterham RL, Smith GD, Deloukas P, Heijmans BT, Herder C, Hofman A, Lindgren CM, Milani L, van der Harst P, Peters A, Illig T, Relton CL, Waldenberger M, Järvelin M-R, Bollati V, Soong R, Spector TD, Scott J, McCarthy MI, Elliott P, Bell JT, Matullo G, Gieger C, Kooner JS, Grallert H, Chambers JC (2016) Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity. Nature 541: 81-86 (ARCN) https://doi.org/10.1038/nature20784 https://www.ncbi.nlm.nih.gov/pubmed/28002404

Wacker ME, Jörres RA, Karch A, Wilke S, Heinrich J, Karrasch S, Koch A, Schulz H, Watz H, Leidl R, Vogelmeier C, Holle R (2016) Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities. BMC Pulm Med 16: 70 (ARCN, CPC-M, UGMLC ) https://doi.org/10.1186/s12890-016-0238-9 https://www.ncbi.nlm.nih.gov/pubmed/27160582

Vogt B, Zhao Z, Zabel P, Weiler N, Frerichs I (2016) Regional lung response to bronchodilator reversibility testing determined by electrical impedance tomography in chronic obstructive pulmonary disease. American Journal of Physiology-Lung Cellular and Molecular Physiology 311: L8-L19 (ARCN) https://doi.org/10.1152/ajplung.00463.2015 https://www.ncbi.nlm.nih.gov/pubmed/27190067

Verschoor A, Karsten CM, Broadley SP, Laumonnier Y, Köhl J (2016) Old dogs-new tricks: immunoregulatory properties of C3 and C5 cleavage fragments. Immunol Rev 274: 112-126 (ARCN) https://doi.org/10.1111/imr.12473 https://www.ncbi.nlm.nih.gov/pubmed/27782330

Tschurtschenthaler M, Kachroo P, Heinsen F-A, Adolph TE, Rühlemann MC, Klughammer J, Offner FA, Ammerpohl O, Krueger F, Smallwood S, Szymczak S, Kaser A, Franke A (2016) Paternal chronic colitis causes epigenetic inheritance of susceptibility to colitis. Sci Rep 6: 31640 (ARCN) https://doi.org/10.1038/srep31640 https://www.ncbi.nlm.nih.gov/pubmed/27538787

Treudler R, Franke A, Schmiedeknecht A, Ballmer-Weber BK, Worm M, Werfel T, Jappe U, Biedermann T, Schmitt J, Brehler R, Kleinheinz A, Kleine-Tebbe J, Brüning H, Ruëff F, Ring J, Saloga J, Schäkel K, Holzhauser T, Vieths S, Simon JC (2016) Standardization of double blind placebo controlled food challenge with soy within a multicentre trial. Clinical and Translational Allergy 6: 39 (ARCN) https://doi.org/10.1186/s13601-016-0129-4 https://www.ncbi.nlm.nih.gov/pubmed/27826414

Tiwari S, Ammerpohl O, Kalthoff H (2016) Target Gene Discovery for Novel Therapeutic Agents in Cancer Treatment. Methods Mol Biol 1381: 181-200 (ARCN) https://doi.org/10.1007/978-1-4939-3204-7_10 https://www.ncbi.nlm.nih.gov/pubmed/26667461

Svanes C, Koplin J, Skulstad SM, Johannessen A, Bertelsen RJ, Benediktsdottir B, Bråbäck L, Elie Carsin A, Dharmage S, Dratva J, Forsberg B, Gislason T, Heinrich J, Holm M, Janson C, Jarvis D, Jögi R, Krauss-Etschmann S, Lindberg E, Macsali F, Malinovschi A, Modig L, Norbäck D, Omenaas E, Waatevik Saure E, Sigsgaard T, Skorge TD, Svanes Ø, Torén K, Torres C, Schlünssen V, Gomez Real F (2016) Father’s environment before conception and asthma risk in his children: a multi-generation analysis of the Respiratory Health In Northern Europe study. Int J Epidemiol 46: dyw151 (ARCN, CPC-M) https://doi.org/10.1093/ije/dyw151 https://www.ncbi.nlm.nih.gov/pubmed/27565179

Sudkamp H, Koch P, Spahr H, Hillmann D, Franke G, Münst M, Reinholz F, Birngruber R, Hüttmann G (2016) In-vivo retinal imaging with off-axis full-field time-domain optical coherence tomography. Optics Letters 41: 4987 (ARCN) https://doi.org/10.1364/ol.41.004987 https://www.ncbi.nlm.nih.gov/pubmed/27805666

Stucki D, Brites D, Jeljeli L, Coscolla M, Liu Q, Trauner A, Fenner L, Rutaihwa L, Borrell S, Luo T, Gao Q, Kato-Maeda M, Ballif M, Egger M, Macedo R, Mardassi H, Moreno M, Vilanova GT, Fyfe J, Globan M, Thomas J, Jamieson F, Guthrie JL, Asante-Poku A, Yeboah-Manu D, Wampande E, Ssengooba W, Joloba M, Boom WH, Basu I, Bower J, Saraiva M, Vasconcellos SEG, Suffys P, Koch A, Wilkinson R, Gail-Bekker L, Malla B, Ley SD, Beck H-P, de Jong BC, Toit K, Sanchez-Padilla E, Bonnet M, Gil-Brusola A, Frank M, Penlap Beng VN, Eisenach K, Alani I, Ndung’u PW, Revathi G, Gehre F, Akter S, Ntoumi F, Stewart-Isherwood L, Ntinginya NE, Rachow A, Hoelscher M, Cirillo DM, Skenders G, Hoffner S, Bakonyte D, Stakenas P, Diel R, Crudu V, Moldovan O, Al-Hajoj S, Otero L, Barletta F, Carter EJ, Diero L, Supply P, Comas I, Niemann S, Gagneux S (2016) Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages. Nat Genet 48: 1535-1543 (ARCN) https://doi.org/10.1038/ng.3704 https://www.ncbi.nlm.nih.gov/pubmed/27798628

Steffens T, Duda K, Lindner B, Vorhölter F-J, Bednarz H, Niehaus K, Holst O (2016) The lipopolysaccharide of the crop pathogenXanthomonas translucenspv. translucens: chemical characterization and determination of signaling events in plant cells. Glycobiology 27: 264-274 (ARCN) https://doi.org/10.1093/glycob/cww093 https://www.ncbi.nlm.nih.gov/pubmed/28177490

Spangenberg L, Zenger M, Garcia-Torres F, Mueller V, Reck M, Mehnert A, Vehling S (2016) Dimensionality, Stability, and Validity of the Beck Hopelessness Scale in Cancer Patients Receiving Curative and Palliative Treatment. J Pain Symptom Manage 51: 615-622 (ARCN) https://doi.org/10.1016/j.jpainsymman.2015.11.008 https://www.ncbi.nlm.nih.gov/pubmed/26654946

Spahr H, Hillmann D, Hain C, Pfäffle C, Sudkamp H, Franke G, Koch P, Hüttmann G (2016) Darstellung von Blutfluss und Pulsation in retinalen Gefäßen mit Full-Field-Swept-Source-OCT. Klin Monbl Augenheilkd 233: 1324-1330 (ARCN) https://doi.org/10.1055/s-0042-120279 https://www.ncbi.nlm.nih.gov/pubmed/27984838

Socinski MA, Obasaju C, Gandara D, Hirsch FR, Bonomi P, Bunn P, Kim ES, Langer CJ, Natale RB, Novello S, Paz-Ares L, Pérol M, Reck M, Ramalingam SS, Reynolds CH, Spigel DR, Stinchcombe TE, Wakelee H, Mayo C, Thatcher N (2016) Clinicopathologic Features of Advanced Squamous NSCLC. J Thorac Oncol 11: 1411-1422 (ARCN) https://doi.org/10.1016/j.jtho.2016.05.024 https://www.ncbi.nlm.nih.gov/pubmed/27296106

Smit EF, Wu Y-L, Gervais R, Zhou C, Felip E, Feng J, Guclu SZ, Hoiczyk M, Dorokhova E, Freudensprung U, Grange S, Perez-Moreno PD, Mitchell L, Reck M (2016) A randomized, double-blind, phase III study comparing two doses of erlotinib for second-line treatment of current smokers with advanced non-small-cell lung cancer (CurrentS). Lung Cancer 99: 94-101 (ARCN) https://doi.org/10.1016/j.lungcan.2016.06.019 https://www.ncbi.nlm.nih.gov/pubmed/27565921

Siebelmann S, Steven P, Hos D, Hüttmann G, Lankenau E, Bachmann B, Cursiefena C (2016) Errata: Advantages of microscope-integrated intraoperative online optical coherence tomography: usage in Boston keratoprosthesis type I surgery. J Biomed Opt 21: 029801 (ARCN) https://doi.org/10.1117/1.Jbo.21.2.029801 https://www.ncbi.nlm.nih.gov/pubmed/26836211

Siebelmann S, Steven P, Hos D, Hüttmann G, Lankenau E, Bachmann B, Cursiefen C (2016) Advantages of microscope-integrated intraoperative online optical coherence tomography: usage in Boston keratoprosthesis type I surgery. J Biomed Opt 21: 016005 (ARCN) https://doi.org/10.1117/1.Jbo.21.1.016005 https://www.ncbi.nlm.nih.gov/pubmed/26780223

Shima K, Coopmeiners J, Graspeuntner S, Dalhoff K, Rupp J (2016) Impact of micro-environmental changes on respiratory tract infections with intracellular bacteria. FEBS Lett 590: 3887-3904 (ARCN) https://doi.org/10.1002/1873-3468.12353 https://www.ncbi.nlm.nih.gov/pubmed/27509029

Schoenfeld N, Haas W, Richter E, Bauer T, Boes L, Castell S, Hauer B, Magdorf K, Matthiessen W, Mauch H, Reuss A, Schenkel K, Ruesch-Gerdes S, Zabel P, Dalhoff K, Schaberg T, Loddenkemper R (2016) Recommendations of the German Central Committee against Tuberculosis (DZK) and the German Respiratory Society (DGP) for the Diagnosis and Treatment of Non-tuberculous Mycobacterioses. Pneumologie 70: 250-276 (ARCN) https://doi.org/10.1055/s-0041-111494 https://www.ncbi.nlm.nih.gov/pubmed/27064418

Schocker F, Baumert J, Kull S, Petersen A, Becker W-M, Jappe U (2016) Prospective investigation on the transfer of Ara h 2, the most potent peanut allergen, in human breast milk. Pediatr Allergy Immunol 27: 348-355 (ARCN) https://doi.org/10.1111/pai.12533 https://www.ncbi.nlm.nih.gov/pubmed/26842773

Schnerch J, Prasse A, Vlachakis D, Schuchardt KL, Pechkovsky DV, Goldmann T, Gaede KI, Müller-Quernheim J, Zissel G (2016) Functional Toll-Like Receptor 9 Expression and CXCR3 Ligand Release in Pulmonary Sarcoidosis. Am J Respir Cell Mol Biol 55: 749-757 (ARCN) https://doi.org/10.1165/rcmb.2015-0278OC https://www.ncbi.nlm.nih.gov/pubmed/27390897

Schneider SA, Scharffetter C, Wagner AE, Boesch C, Bruchhaus I, Rimbach G, Roeder T (2016) Social stress increases the susceptibility to infection in the ant Harpegnathos saltator. Sci Rep 6: 25800 (ARCN) https://doi.org/10.1038/srep25800 https://www.ncbi.nlm.nih.gov/pubmed/27161621

Schmitt J, Schwarz K, Baurecht H, Hotze M, Fölster-Holst R, Rodríguez E, Lee YAE, Franke A, Degenhardt F, Lieb W, Gieger C, Kabesch M, Nöthen MM, Irvine AD, McLean WHI, Deckert S, Stephan V, Schwarz P, Aringer M, Novak N, Weidinger S (2016) Atopic dermatitis is associated with an increased risk for rheumatoid arthritis and inflammatory bowel disease, and a decreased risk for type 1 diabetes. Journal of Allergy and Clinical Immunology 137: 130-136 (ARCN) https://doi.org/10.1016/j.jaci.2015.06.029 https://www.ncbi.nlm.nih.gov/pubmed/26253344

Schmauck-Gómez J, Menrath I, Kaiser M, Herz A, Kopp M (2016) Kinder und Jugendliche mit Asthma unterscheiden sich in ihrer Lungenfunktion und im exhalierten NO von Kindern und Jugendlichen mit Adipositas. Klin Padiatr 228: 189-194 (ARCN) https://doi.org/10.1055/s-0042-102254 https://www.ncbi.nlm.nih.gov/pubmed/27362410

Rodríguez-Roisin R, Tetzlaff K, Watz H, Wouters E, Disse B, Finnigan H, Magnussen H, Calverley PMA (2016) Daily home-based spirometry during withdrawal of inhaled corticosteroid in severe to very severe chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis Volume 11: 1973-1981 (ARCN) https://doi.org/10.2147/copd.S106142 https://www.ncbi.nlm.nih.gov/pubmed/27578972

Rivera NV, Ronninger M, Shchetynsky K, Franke A, Nöthen MM, Müller-Quernheim J, Schreiber S, Adrianto I, Karakaya B, van Moorsel CHM, Navratilova Z, Kolek V, Rybicki BA, Iannuzzi MC, Petrek M, Grutters JC, Montgomery C, Fischer A, Eklund A, Padyukov L, Grunewald J (2016) High-Density Genetic Mapping Identifies New Susceptibility Variants in Sarcoidosis Phenotypes and Shows Genomic-driven Phenotypic Differences. American Journal of Respiratory and Critical Care Medicine 193: 1008-1022 (ARCN) https://doi.org/10.1164/rccm.201507-1372OC https://www.ncbi.nlm.nih.gov/pubmed/26651848

Ringshausen FC, Wagner D, de Roux A, Diel R, Hohmann D, Hickstein L, Welte T, Rademacher J (2016) Prevalence of Nontuberculous Mycobacterial Pulmonary Disease, Germany, 2009–2014. Emerging Infectious Diseases 22: 1102-1105 (ARCN, BREATH) https://doi.org/10.3201/eid2206.151642 https://www.ncbi.nlm.nih.gov/pubmed/27191473

Rennard S, Martinez F, Rabe K, Sethi S, Pizzichini E, McIvor A, Siddiqui S, Anzueto A, Zhu H (2016) Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting &beta;<sub>2</sub>-agonist fixed-dose combination: RE<sup>2</sup>SPOND rationale and study design. Int J Chron Obstruct Pulmon Dis Volume 11: 1921-1928 (ARCN) https://doi.org/10.2147/copd.S109661 https://www.ncbi.nlm.nih.gov/pubmed/27574416

Reinmuth N, Reck M (2016) Immunotherapy for Lung Cancer. Oncology Research and Treatment 39: 360-368 (ARCN, CPC-M) https://doi.org/10.1159/000446726 https://www.ncbi.nlm.nih.gov/pubmed/27259861

Reinmuth N, Gröschel A, Schumann C, Sebastian M, Wiewrodt R, Reck M (2016) Therapieempfehlung für das metastasierte nicht-kleinzellige Lungenkarzinom. Pneumologie 70: 567-578 (ARCN, CPC-M) https://doi.org/10.1055/s-0042-113087 https://www.ncbi.nlm.nih.gov/pubmed/27603945

Reck M, Thomas M, Kropf-Sanchen C, Mezger J, Socinski MA, Depenbrock H, Soldatenkova V, Brown J, Krause T, Thatcher N (2016) Necitumumab plus Gemcitabine and Cisplatin as First-Line Therapy in Patients with Stage IV EGFR- Expressing Squamous Non-Small-Cell Lung Cancer: German Subgroup Data from an Open-Label, Randomized Controlled Phase 3 Study (SQUIRE). Oncology Research and Treatment 39: 539-547 (ARCN, TLRC) https://doi.org/10.1159/000448085 https://www.ncbi.nlm.nih.gov/pubmed/27614872

Reck M, Socinski MA, Luft A, Szczęsna A, Dediu M, Ramlau R, Losonczy G, Molinier O, Schumann C, Gralla RJ, Bonomi P, Brown J, Soldatenkova V, Chouaki N, Obasaju C, Peterson P, Thatcher N (2016) The Effect of Necitumumab in Combination with Gemcitabine plus Cisplatin on Tolerability and on Quality of Life: Results from the Phase 3 SQUIRE Trial. J Thorac Oncol 11: 808-818 (ARCN) https://doi.org/10.1016/j.jtho.2016.03.002 https://www.ncbi.nlm.nih.gov/pubmed/26980471

Reck M, Rodríguez-Abreu D, Robinson AG, Hui R, Csőszi T, Fülöp A, Gottfried M, Peled N, Tafreshi A, Cuffe S, O’Brien M, Rao S, Hotta K, Leiby MA, Lubiniecki GM, Shentu Y, Rangwala R, Brahmer JR (2016) Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer. New England Journal of Medicine 375: 1823-1833 (ARCN) https://doi.org/10.1056/NEJMoa1606774 https://www.ncbi.nlm.nih.gov/pubmed/27718847

Reck M, Luft A, Szczesna A, Havel L, Kim S-W, Akerley W, Pietanza MC, Wu Y-l, Zielinski C, Thomas M, Felip E, Gold K, Horn L, Aerts J, Nakagawa K, Lorigan P, Pieters A, Kong Sanchez T, Fairchild J, Spigel D (2016) Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer. J Clin Oncol 34: 3740-3748 (ARCN, TLRC) https://doi.org/10.1200/jco.2016.67.6601 https://www.ncbi.nlm.nih.gov/pubmed/27458307

Reck M, Heigener D, Reinmuth N (2016) Immunotherapy for small-cell lung cancer: emerging evidence. Future Oncology 12: 931-943 (ARCN) https://doi.org/10.2217/fon-2015-0012 https://www.ncbi.nlm.nih.gov/pubmed/26882955

Reck M, Hagiwara K, Han B, Tjulandin S, Grohé C, Yokoi T, Morabito A, Novello S, Arriola E, Molinier O, McCormack R, Ratcliffe M, Normanno N (2016) ctDNA Determination of EGFR Mutation Status in European and Japanese Patients with Advanced NSCLC: The ASSESS Study. J Thorac Oncol 11: 1682-1689 (ARCN) https://doi.org/10.1016/j.jtho.2016.05.036 https://www.ncbi.nlm.nih.gov/pubmed/27468938

Reck M (2016) Antwort. Pneumologie 70: 835-835 (ARCN) https://doi.org/10.1055/s-0042-119183 https://www.ncbi.nlm.nih.gov/pubmed/27931059

Rabe KF (2016) Update in Asthma 2015. American Journal of Respiratory and Critical Care Medicine 194: 259-264 (ARCN) https://doi.org/10.1164/rccm.201602-0222UP https://www.ncbi.nlm.nih.gov/pubmed/27479060

Quentmeier H, Pommerenke C, Ammerpohl O, Geffers R, Hauer V, MacLeod RAF, Nagel S, Romani J, Rosati E, Rosén A, Uphoff CC, Zaborski M, Drexler HG (2016) Subclones in B-lymphoma cell lines: isogenic models for the study of gene regulation. Oncotarget 7: 63456-63465 (ARCN) https://doi.org/10.18632/oncotarget.11524 https://www.ncbi.nlm.nih.gov/pubmed/27566572

Pérol M, Ciuleanu T-E, Arrieta O, Prabhash K, Syrigos KN, Goksel T, Park K, Kowalyszyn RD, Pikiel J, Lewanski CR, Thomas M, Dakhil S, Kim J-H, Karaseva N, Yurasov S, Zimmermann A, Lee P, Carter GC, Reck M, Cappuzzo F, Garon EB (2016) Quality of life results from the phase 3 REVEL randomized clinical trial of ramucirumab-plus-docetaxel versus placebo-plus-docetaxel in advanced/metastatic non-small cell lung cancer patients with progression after platinum-based chemotherapy. Lung Cancer 93: 95-103 (ARCN, TLRC) https://doi.org/10.1016/j.lungcan.2016.01.007 https://www.ncbi.nlm.nih.gov/pubmed/26898621

Owonikoko T, Ready N, Postmus P, Reck M, Peters S, Pieters A, Selvaggi G, Fairchild J, Govindan R (2016) PS01.58: A Phase 3 Trial of Nivolumab, Nivolumab Plus Ipilimumab, or Placebo Maintenance for Extensive-Stage SCLC After First-Line Chemotherapy. J Thorac Oncol 11: S306-S307 (ARCN) https://doi.org/10.1016/j.jtho.2016.09.093 https://www.ncbi.nlm.nih.gov/pubmed/27969525

Novello S, Barlesi F, Califano R, Cufer T, Ekman S, Levra MG, Kerr K, Popat S, Reck M, Senan S, Simo GV, Vansteenkiste J, Peters S (2016) Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 27: v1-v27 (ARCN) https://doi.org/10.1093/annonc/mdw326 https://www.ncbi.nlm.nih.gov/pubmed/27664245

Normanno N, Denis MG, Thress KS, Ratcliffe M, Reck M (2016) Guide to detecting epidermal growth factor receptor ( EGFR ) mutations in ctDNA of patients with advanced non-small-cell lung cancer. Oncotarget 8: 12501-12516 (ARCN) https://doi.org/10.18632/oncotarget.13915 https://www.ncbi.nlm.nih.gov/pubmed/27980215

Normanno N, Brown H, Haddad V, Ratcliffe M, McCormack R, Tjulandin S, Hagiwara K, Han B, Reck M (2016) 580_PR: Clinical and demographic features that influence EGFR mutation detection in plasma from patients (pts) with aNSCLC: The ASSESS experience. J Thorac Oncol 11: S151 (ARCN) https://doi.org/10.1016/s1556-0864(16)30323-9 https://www.ncbi.nlm.nih.gov/pubmed/27198351

Moreno-Fernandez ME, Aliberti J, Groeneweg S, Köhl J, Chougnet CA (2016) A Novel Role for the Receptor of the Complement Cleavage Fragment C5a, C5aR1, in CCR5-Mediated Entry of HIV into Macrophages. AIDS Research and Human Retroviruses 32: 399-408 (ARCN) https://doi.org/10.1089/aid.2015.0099 https://www.ncbi.nlm.nih.gov/pubmed/26537334

Michelfelder M, Becker M, Riedlinger A, Siegert E, Drömann D, Yu X, Petersen F, Riemekasten G (2016) Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity. Clin Rheumatol 36: 381-390 (ARCN) https://doi.org/10.1007/s10067-016-3504-6 https://www.ncbi.nlm.nih.gov/pubmed/28028682

Metze K, Ramaker K, Bade S, Röckendorf N, Meckelein B, Vollmer E, Schultz H, Fröschle G-W, Frey A (2016) Absence of the Epithelial Glycocalyx As Potential Tumor Marker for the Early Detection of Colorectal Cancer. PLoS One 11: e0168801 (ARCN) https://doi.org/10.1371/journal.pone.0168801 https://www.ncbi.nlm.nih.gov/pubmed/28033349

Matricardi PM, Kleine-Tebbe J, Hoffmann HJ, Valenta R, Hilger C, Hofmaier S, Aalberse RC, Agache I, Asero R, Ballmer-Weber B, Barber D, Beyer K, Biedermann T, Bilò MB, Blank S, Bohle B, Bosshard PP, Breiteneder H, Brough HA, Caraballo L, Caubet JC, Crameri R, Davies JM, Douladiris N, Ebisawa M, Eigenmann PA, Fernandez-Rivas M, Ferreira F, Gadermaier G, Glatz M, Hamilton RG, Hawranek T, Hellings P, Hoffmann-Sommergruber K, Jakob T, Jappe U, Jutel M, Kamath SD, Knol EF, Korosec P, Kuehn A, Lack G, Lopata AL, Mäkelä M, Morisset M, Niederberger V, Nowak-Węgrzyn AH, Papadopoulos NG, Pastorello EA, Pauli G, Platts-Mills T, Posa D, Poulsen LK, Raulf M, Sastre J, Scala E, Schmid JM, Schmid-Grendelmeier P, van Hage M, van Ree R, Vieths S, Weber R, Wickman M, Muraro A, Ollert M (2016) EAACI Molecular Allergology User’s Guide. Pediatr Allergy Immunol 27: 1-250 (ARCN) https://doi.org/10.1111/pai.12563 https://www.ncbi.nlm.nih.gov/pubmed/27288833

Marwitz S, Depner S, Dvornikov D, Merkle R, Szczygieł M, Müller-Decker K, Lucarelli P, Wäsch M, Mairbäurl H, Rabe KF, Kugler C, Vollmer E, Reck M, Scheufele S, Kröger M, Ammerpohl O, Siebert R, Goldmann T, Klingmüller U (2016) Downregulation of the TGFβ Pseudoreceptor BAMBI in Non–Small Cell Lung Cancer Enhances TGFβ Signaling and Invasion. Cancer Res 76: 3785-3801 (ARCN, TLRC) https://doi.org/10.1158/0008-5472.Can-15-1326 https://www.ncbi.nlm.nih.gov/pubmed/27197161

Martinez FJ, Rabe KF, Sethi S, Pizzichini E, McIvor A, Anzueto A, Alagappan VKT, Siddiqui S, Rekeda L, Miller CJ, Zetterstrand S, Reisner C, Rennard SI (2016) Effect of Roflumilast and Inhaled Corticosteroid/Long-Acting β2-Agonist on Chronic Obstructive Pulmonary Disease Exacerbations (RE2SPOND). A Randomized Clinical Trial. American Journal of Respiratory and Critical Care Medicine 194: 559-567 (ARCN) https://doi.org/10.1164/rccm.201607-1349OC https://www.ncbi.nlm.nih.gov/pubmed/27585384

Magnussen H, Tetzlaff K, Bateman ED, Watz H, Kirsten AM, Wouters EFM, Disse B, Finnigan H, Rodriguez-Roisin R, Calverley PMA (2016) Lung function changes over time following withdrawal of inhaled corticosteroids in patients with severe COPD. Eur Respir J 47: 651-654 (ARCN) https://doi.org/10.1183/13993003.01644-2015 https://www.ncbi.nlm.nih.gov/pubmed/26585433

Lunding L, Webering S, Vock C, Schroder A, Raedler D, Schaub B, Fehrenbach H, Wegmann M (2016) Effect of IL-37 on Allergic Airway Inflammation. Ann Am Thorac Soc 13 Suppl 1: S95-96 (ARCN, CPC-M) https://doi.org/10.1513/AnnalsATS.201506-380MG https://www.ncbi.nlm.nih.gov/pubmed/27027963

Lorenz J, Bals R, Ewert R, Jany B, Koczulla A, Köhnlein T, Randerath W, Steinkamp G, Watz H, Welte T (2016) Expertentreffen COPD: Personalisierte Therapie der COPD – Wunsch oder Wirklichkeit? Pneumologie 70: 638-650 (ARCN, BREATH, UGMLC) https://doi.org/10.1055/s-0042-112044 https://www.ncbi.nlm.nih.gov/pubmed/27723914

Loddenkemper R, Brönnecke M, Castell S, Diel R (2016) Tuberkulose und Rauchen. Pneumologie 70: 17-22 (ARCN) https://doi.org/10.1055/s-0041-109601 https://www.ncbi.nlm.nih.gov/pubmed/26789428

Li Y, Hoffmann J, Li Y, Stephano F, Bruchhaus I, Fink C, Roeder T (2016) Octopamine controls starvation resistance, life span and metabolic traits in Drosophila. Sci Rep 6: 35359 (ARCN) https://doi.org/10.1038/srep35359 https://www.ncbi.nlm.nih.gov/pubmed/27759117

Langer CJ, Obasaju C, Bunn P, Bonomi P, Gandara D, Hirsch FR, Kim ES, Natale RB, Novello S, Paz-Ares L, Pérol M, Reck M, Ramalingam SS, Reynolds CH, Socinski MA, Spigel DR, Wakelee H, Mayo C, Thatcher N (2016) Incremental Innovation and Progress in Advanced Squamous Cell Lung Cancer: Current Status and Future Impact of Treatment. J Thorac Oncol 11: 2066-2081 (ARCN) https://doi.org/10.1016/j.jtho.2016.08.138 https://www.ncbi.nlm.nih.gov/pubmed/27575423

Kulkarni U, Karsten CM, Kohler T, Hammerschmidt S, Bommert K, Tiburzy B, Meng L, Thieme L, Recke A, Ludwig RJ, Pollok K, Kalies K, Bogen B, Boettcher M, Kamradt T, Hauser AE, Langer C, Huber-Lang M, Finkelman FD, Köhl J, Wong DM, Manz RA (2016) IL-10 mediates plasmacytosis-associated immunodeficiency by inhibiting complement-mediated neutrophil migration. Journal of Allergy and Clinical Immunology 137: 1487-1497.e1486 (ARCN) https://doi.org/10.1016/j.jaci.2015.10.018 https://www.ncbi.nlm.nih.gov/pubmed/26653800

Kreuter M, Vansteenkiste J, Fischer JR, Eberhardt WE, Zabeck H, Kollmeier J, Serke M, Frickhofen N, Reck M, Engel-Riedel W, Neumann S, Thomeer M, Schumann C, De Leyn P, Graeter T, Stamatis G, Griesinger F, Thomas M (2016) Three-Year Follow-Up of a Randomized Phase II Trial on Refinement of Early-Stage NSCLC Adjuvant Chemotherapy with Cisplatin and Pemetrexed versus Cisplatin and Vinorelbine (the TREAT Study). J Thorac Oncol 11: 85-93 (ARCN, TLRC) https://doi.org/10.1016/j.jtho.2015.09.014 https://www.ncbi.nlm.nih.gov/pubmed/26762743

Kreuter M, Kirsten D, Bahmer T, Penzel R, Claussen M, Ehlers-Tenenbaum S, Muley T, Palmowski K, Eichinger M, Leider M, Herth FJF, Rabe KF, Bittmann I, Warth A (2016) Screening for <b><i>Helicobacter pylori</i></b> in Idiopathic Pulmonary Fibrosis Lung Biopsies. Respiration 91: 3-8 (ARCN, TLRC) https://doi.org/10.1159/000442449 http://www.ncbi.nlm.nih.gov/pubmed/26645213

Kretschmer S, Pieper M, Hüttmann G, Bölke T, Wollenberg B, Marsh LM, Garn H, König P (2016) Autofluorescence multiphoton microscopy for visualization of tissue morphology and cellular dynamics in murine and human airways. Lab Invest 96: 918-931 (ARCN, UGMLC) https://doi.org/10.1038/labinvest.2016.69 https://www.ncbi.nlm.nih.gov/pubmed/27400364

Krause T, Röckendorf N, Gaede KI, Ramaker K, Sinnecker H, Frey A (2016) Validation of antibody reagents for mucin analysis in chronic inflammatory airway diseases. MAbs 9: 333-341 (ARCN) https://doi.org/10.1080/19420862.2016.1264551 https://www.ncbi.nlm.nih.gov/pubmed/27911216

König IR, Auerbach J, Gola D, Held E, Holzinger ER, Legault M-A, Sun R, Tintle N, Yang H-C (2016) Machine learning and data mining in complex genomic data—a review on the lessons learned in Genetic Analysis Workshop 19. BMC Genet 17: 1 (ARCN) https://doi.org/10.1186/s12863-015-0315-8 https://www.ncbi.nlm.nih.gov/pubmed/26866367

Kolarova J, Bens S, Ammerpohl O, Hilger AC, Zhang R, Reutter H, Siebert R (2016) PLAGL1epimutation and bladder exstrophy: Coincidence or concurrent etiology? Birth Defects Res Part A: Clin Mol Teratol 106: 724-728 (ARCN) https://doi.org/10.1002/bdra.23521 https://www.ncbi.nlm.nih.gov/pubmed/27223093

Klughammer B, Brugger W, Cappuzzo F, Ciuleanu T, Mok T, Reck M, Tan EH, Delmar P, Klingelschmitt G, Yin A-Y, Spleiss O, Wu L, Shames DS (2016) Examining Treatment Outcomes with Erlotinib in Patients with Advanced Non–Small Cell Lung Cancer Whose Tumors Harbor Uncommon EGFR Mutations. J Thorac Oncol 11: 545-555 (ARCN) https://doi.org/10.1016/j.jtho.2015.12.107 https://www.ncbi.nlm.nih.gov/pubmed/26773740

Kenyon JJ, Duda KA, De Felice A, Cunneen MM, Molinaro A, Laitinen J, Skurnik M, Holst O, Reeves PR, De Castro C (2016) Serotype O:8 isolates in theYersinia pseudotuberculosiscomplex have different O-antigen gene clusters and produce various forms of rough LPS. Innate Immun 22: 205-217 (ARCN) https://doi.org/10.1177/1753425916631403 https://www.ncbi.nlm.nih.gov/pubmed/26873504

Kauth M, Heine H (2016) Allergy protection by cowshed bacteria – recent findings and future prospects. Pediatr Allergy Immunol 27: 340-347 (ARCN) https://doi.org/10.1111/pai.12559 https://www.ncbi.nlm.nih.gov/pubmed/26919229

Karpf S, Eibl M, Sauer B, Reinholz F, Hüttmann G, Huber R (2016) Two-photon microscopy using fiber-based nanosecond excitation. Biomedical Optics Express 7: 2432 (ARCN) https://doi.org/10.1364/boe.7.002432 https://www.ncbi.nlm.nih.gov/pubmed/27446680

Karch A, Vogelmeier C, Welte T, Bals R, Kauczor H-U, Biederer J, Heinrich J, Schulz H, Gläser S, Holle R, Watz H, Korn S, Adaskina N, Biertz F, Vogel C, Vestbo J, Wouters EFM, Rabe KF, Söhler S, Koch A, Jörres RA (2016) The German COPD cohort COSYCONET: Aims, methods and descriptive analysis of the study population at baseline. Respir Med 114: 27-37 (ARCN, BREATH, CPC-M, TLRC, UGMLC) https://doi.org/10.1016/j.rmed.2016.03.008 https://www.ncbi.nlm.nih.gov/pubmed/27109808

Kammerl IE, Dann A, Mossina A, Brech D, Lukas C, Vosyka O, Nathan P, Conlon TM, Wagner DE, Overkleeft HS, Prasse A, Rosas IO, Straub T, Krauss-Etschmann S, Königshoff M, Preissler G, Winter H, Lindner M, Hatz R, Behr J, Heinzelmann K, Yildirim AÖ, Noessner E, Eickelberg O, Meiners S (2016) Impairment of Immunoproteasome Function by Cigarette Smoke and in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine 193: 1230-1241 (ARCN, BREATH, CPC-M) https://doi.org/10.1164/rccm.201506-1122OC https://www.ncbi.nlm.nih.gov/pubmed/26756824

Jotte RM, Socinski MA, Reck M, Papadimitrakopoulou V, West HJ, Mok T, Sandler A, Mocci S, Coleman S, Asakawa T, Cappuzzo F (2016) PS01.53: First-Line Atezolizumab Plus Chemotherapy in Chemotherapy-Naive Patients with Advanced NSCLC: A Phase III Clinical Program. J Thorac Oncol 11: S302-S303 (ARCN) https://doi.org/10.1016/j.jtho.2016.09.088 https://www.ncbi.nlm.nih.gov/pubmed/27969520

Joerger M, von Pawel J, Kraff S, Fischer JR, Eberhardt W, Gauler TC, Mueller L, Reinmuth N, Reck M, Kimmich M, Mayer F, Kopp HG, Behringer DM, Ko YD, Hilger RA, Roessler M, Kloft C, Henrich A, Moritz B, Miller MC, Salamone SJ, Jaehde U (2016) Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC). Ann Oncol 27: 1895-1902 (ARCN) https://doi.org/10.1093/annonc/mdw290 https://www.ncbi.nlm.nih.gov/pubmed/27502710

Jappe U, Nikolic J, Opitz A, Homann A, Zabel P, Gavrovic-Jankulovic M (2016) Apparent IgE negative anaphylactic reaction to banana combined with kiwi allergy – complementary diagnostic value of purified single banana allergens. J Eur Acad Dermatol Venereol 30: 1220-1222 (ARCN) https://doi.org/10.1111/jdv.13146 https://www.ncbi.nlm.nih.gov/pubmed/25827794

Ilhan-Mutlu A, Osswald M, Liao Y, Go mmel M, Reck M, Miles D, Mariani P, Gianni L, Lutiger B, Nendel V, Srock S, Perez-Moreno P, Thorsen F, von Baumgarten L, Preusser M, Wick W, Winkler F (2016) Bevacizumab Prevents Brain Metastases Formation in Lung Adenocarcinoma. Mol Cancer Ther 15: 702-710 (ARCN) https://doi.org/10.1158/1535-7163.Mct-15-0582 https://www.ncbi.nlm.nih.gov/pubmed/26809491

Horstmann J, Siebelmann S, Schulz-Hildebrandt H, Glasunow I, Schadschneider A, Hüttmann G (2016) OCT verstehen – Teil 2: Praktische Aspekte und Anwendung. Klin Monbl Augenheilkd 234: 233-247 (ARCN) https://doi.org/10.1055/s-0033-1358249 https://www.ncbi.nlm.nih.gov/pubmed/27871110

Horstmann J, Siebelmann S, Schulz-Hildebrandt H, Glasunow I, Schadschneider A, Hüttmann G (2016) OCT verstehen – Teil 1: Physikalische Grundlagen. Klin Monbl Augenheilkd 234: 131-143 (ARCN) https://doi.org/10.1055/s-0042-119126 https://www.ncbi.nlm.nih.gov/pubmed/27871111

Hornig NC, Ukat M, Schweikert HU, Hiort O, Werner R, Drop SLS, Cools M, Hughes IA, Audi L, Ahmed SF, Demiri J, Rodens P, Worch L, Wehner G, Kulle AE, Dunstheimer D, Müller-Roßberg E, Reinehr T, Hadidi AT, Eckstein AK, van der Horst C, Seif C, Siebert R, Ammerpohl O, Holterhus PM (2016) Identification of an AR Mutation-Negative Class of Androgen Insensitivity by Determining Endogenous AR Activity. The Journal of Clinical Endocrinology & Metabolism 101: 4468-4477 (ARCN) https://doi.org/10.1210/jc.2016-1990 https://www.ncbi.nlm.nih.gov/pubmed/27583472

Horn L, Reck M, Spigel DR (2016) The Future of Immunotherapy in the Treatment of Small Cell Lung Cancer. The Oncologist 21: 910-921 (ARCN) https://doi.org/10.1634/theoncologist.2015-0523 https://www.ncbi.nlm.nih.gov/pubmed/27354668

Horn L, Reck M, Mok T, Johnson ML, Tang X, Lam S, Waterkamp D, Lopez-Chavez A, Sandler A, Giacconne G, Liu SV (2016) PS01.57: IMpower133: a Phase I/III Study of 1L Atezolizumab with Carboplatin and Etoposide in Patients with Extensive-Stage SCLC. J Thorac Oncol 11: S305-S306 (ARCN) https://doi.org/10.1016/j.jtho.2016.09.092 https://www.ncbi.nlm.nih.gov/pubmed/27969524

Hoffmann F, Ender F, Schmudde I, Lewkowich IP, Köhl J, König P, Laumonnier Y (2016) Origin, Localization, and Immunoregulatory Properties of Pulmonary Phagocytes in Allergic Asthma. Front Immunol 7: 107 (ARCN) https://doi.org/10.3389/fimmu.2016.00107 https://www.ncbi.nlm.nih.gov/pubmed/27047494

Hillmann D, Spahr H, Pfäffle C, Sudkamp H, Franke G, Hüttmann G (2016) In vivo optical imaging of physiological responses to photostimulation in human photoreceptors. Proceedings of the National Academy of Sciences 113: 13138-13143 (ARCN) https://doi.org/10.1073/pnas.1606428113 https://www.ncbi.nlm.nih.gov/pubmed/27729536

Hillmann D, Spahr H, Hain C, Sudkamp H, Franke G, Pfäffle C, Winter C, Hüttmann G (2016) Aberration-free volumetric high-speed imaging of in vivo retina. Sci Rep 6: 35209 (ARCN) https://doi.org/10.1038/srep35209 https://www.ncbi.nlm.nih.gov/pubmed/27762314

Herzmann C, Sotgiu G, Bellinger O, Diel R, Gerdes S, Goetsch U, Heykes-Uden H, Schaberg T, Lange C (2016) Risk for latent and active tuberculosis in Germany. Infection 45: 283-290 (ARCN) https://doi.org/10.1007/s15010-016-0963-2 https://www.ncbi.nlm.nih.gov/pubmed/27866367

Herth FJF, Slebos D-J, Rabe KF, Shah PL (2016) Endoscopic Lung Volume Reduction: An Expert Panel Recommendation. Respiration 91: 241-250 (ARCN, TLRC) https://doi.org/10.1159/000444090 https://www.ncbi.nlm.nih.gov/pubmed/26910845

Henkel M, Röckendorf N, Frey A (2016) Selective and Efficient Cysteine Conjugation by Maleimides in the Presence of Phosphine Reductants. Bioconjugate Chemistry 27: 2260-2265 (ARCN) https://doi.org/10.1021/acs.bioconjchem.6b00371 https://www.ncbi.nlm.nih.gov/pubmed/27631603

Heigener DF, Horn M, Reck M (2016) Targeted Therapy und Precision Medicine. Internist (Berl) 57: 1243-1249 (ARCN) https://doi.org/10.1007/s00108-016-0121-z https://www.ncbi.nlm.nih.gov/pubmed/27587193

Härtel C, Humberg A, Viemann D, Stein A, Orlikowsky T, Rupp J, Kopp MV, Herting E, Göpel W (2016) Preterm Birth during Influenza Season Is Associated with Adverse Outcome in Very Low Birth Weight Infants. Frontiers in Pediatrics 4: 130 (ARCN) https://doi.org/10.3389/fped.2016.00130 https://www.ncbi.nlm.nih.gov/pubmed/27965950

Han B, Ratcliffe M, Haddad V, Brown H, Tjulandin S, Hagiwara K, Reck M, Normanno N (2016) 59PD Association of EGFR mutation subtypes with clinical and demographic characteristics of patients (pts) with aNSCLC: IGNITE and ASSESS pooled analysis. J Thorac Oncol 11: S79-S80 (ARCN) https://doi.org/10.1016/s1556-0864(16)30172-1 https://www.ncbi.nlm.nih.gov/pubmed/27198415

Gralla RJ, Spigel D, Bennett B, Taylor F, Penrod JR, Derosa M, Dastani H, Orsini L, Mathias C, Reck M (2016) PD1.01 (also presented as P2.46): LCSS as a Marker of Treatment Benefit With Nivolumab vs Docetaxel in Pts With Advanced Non-Squamous NSCLC From Checkmate 057. J Thorac Oncol 11: S171 (ARCN) https://doi.org/10.1016/j.jtho.2016.08.009 https://www.ncbi.nlm.nih.gov/pubmed/27676476

Gralla RJ, Spigel D, Bennett B, Taylor F, Penrod JR, Derosa M, Dastani H, Orsini L, Mathias C, Reck M (2016) P2.46 (also presented as PD1.01): LCSS as a Marker of Treatment Benefit With Nivolumab vs Docetaxel in Pts With Advanced Non-Squamous NSCLC From Checkmate 057. J Thorac Oncol 11: S247 (ARCN) https://doi.org/10.1016/j.jtho.2016.08.117 https://www.ncbi.nlm.nih.gov/pubmed/27676580

Gonzalez Roldan N, Orinska Z, Ewers H, Bulfone-Paus S (2016) CD252 regulates mast cell mediated, CD1d-restricted NKT-cell activation in mice. Eur J Immunol 46: 432-439 (ARCN) https://doi.org/10.1002/eji.201545879 https://www.ncbi.nlm.nih.gov/pubmed/26564814

Goldmann T, Kugler C, Reinmuth N, Vollmer E, Reck M (2016) PD-L1 copy number gain in nonsmall-cell lung cancer defines a new subset of patients for anti PD-L1 therapy. Ann Oncol 27: 206-207 (ARCN) https://doi.org/10.1093/annonc/mdv510 https://www.ncbi.nlm.nih.gov/pubmed/26487587

Goldman JW, Shi P, Reck M, Paz-Ares L, Koustenis A, Hurt KC (2016) Treatment Rationale and Study Design for the JUNIPER Study: A Randomized Phase III Study of Abemaciclib With Best Supportive Care Versus Erlotinib With Best Supportive Care in Patients With Stage IV Non–Small-Cell Lung Cancer With a Detectable KRAS Mutation Whose Disease Has Progressed After Platinum-Based Chemotherapy. Clin Lung Cancer 17: 80-84 (ARCN) https://doi.org/10.1016/j.cllc.2015.08.003 https://www.ncbi.nlm.nih.gov/pubmed/26432508

Gola D, Mahachie John JM, van Steen K, König IR (2016) A roadmap to multifactor dimensionality reduction methods. Brief Bioinform 17: 293-308 (ARCN) https://doi.org/10.1093/bib/bbv038 https://www.ncbi.nlm.nih.gov/pubmed/26108231

Gola D, König IR (2016) Identification of interactions using model-based multifactor dimensionality reduction. BMC Proc 10: 135-139 (ARCN) https://doi.org/10.1186/s12919-016-0019-8 https://www.ncbi.nlm.nih.gov/pubmed/27980625

Gilles-Stein S, Beck I, Chaker A, Bas M, McIntyre M, Cifuentes L, Petersen A, Gutermuth J, Schmidt-Weber C, Behrendt H, Traidl-Hoffmann C (2016) Pollen derived low molecular compounds enhance the human allergen specific immune responsein vivo. Clin Exp Allergy 46: 1355-1365 (ARCN, CPC-M) https://doi.org/10.1111/cea.12739 https://www.ncbi.nlm.nih.gov/pubmed/27061126

Gharaibeh M, Hagedorn M, Lilla S, Hauptmann M, Heine H, Fleischer B, Keller C, Roy CR (2016) Toll-Like Receptor 2 Recognizes Orientia tsutsugamushi and Increases Susceptibility to Murine Experimental Scrub Typhus. Infection and Immunity 84: 3379-3387 (ARCN) https://doi.org/10.1128/iai.00185-16 https://www.ncbi.nlm.nih.gov/pubmed/27620720

Geier J, Lessmann H, Hillen U, Skudlik C, Jappe U (2016) Sensitization to reactive diluents and hardeners in epoxy resin systems. IVDK data 2002-2011. Part II: concomitant reactions. Contact Dermatitis 74: 94-101 (ARCN) https://doi.org/10.1111/cod.12490 https://www.ncbi.nlm.nih.gov/pubmed/26537833

Geier J, Lessmann H, Hillen U, Skudlik C, Jappe U (2016) Sensitization to reactive diluents and hardeners in epoxy resin systems. IVDK data 2002-2011. Part I: reaction frequencies. Contact Dermatitis 74: 83-93 (ARCN) https://doi.org/10.1111/cod.12491 https://www.ncbi.nlm.nih.gov/pubmed/26538018

Ganbat D, Seehase S, Richter E, Vollmer E, Reiling N, Fellenberg K, Gaede KI, Kugler C, Goldmann T (2016) Mycobacteria infect different cell types in the human lung and cause species dependent cellular changes in infected cells. BMC Pulm Med 16: 19 (ARCN) https://doi.org/10.1186/s12890-016-0185-5 https://www.ncbi.nlm.nih.gov/pubmed/26803467

Frerichs I, Zhao Z, Becher T, Zabel P, Weiler N, Vogt B (2016) Regional lung function determined by electrical impedance tomography during bronchodilator reversibility testing in patients with asthma. Physiol Meas 37: 698-712 (ARCN) https://doi.org/10.1088/0967-3334/37/6/698 https://www.ncbi.nlm.nih.gov/pubmed/27203725

Franssen FME, Soriano JB, Roche N, Bloomfield PH, Brusselle G, Fabbri LM, García-Rio F, Kearney MT, Kwon N, Lundbäck B, Rabe KF, Raillard A, Muellerova H, Cockcroft JR (2016) Lung Function Abnormalities in Smokers with Ischemic Heart Disease. American Journal of Respiratory and Critical Care Medicine 194: 568-576 (ARCN) https://doi.org/10.1164/rccm.201512-2480OC https://www.ncbi.nlm.nih.gov/pubmed/27442601

Fischer U, Torrealba D, Seras-Franzoso J, Mamat U, Wilke K, Villaverde A, Roher N, Garcia-Fruitós E (2016) Complex Particulate Biomaterials as Immunostimulant-Delivery Platforms. PLoS One 11: e0164073 (ARCN) https://doi.org/10.1371/journal.pone.0164073 https://www.ncbi.nlm.nih.gov/pubmed/27716780

Finch D, Pavord I, Jones P, Burgel PR, Rabe KF (2016) Exacerbations of COPD. Int J Chron Obstruct Pulmon Dis 11 Spec Iss: 21 (ARCN) https://doi.org/10.2147/copd.S85978 https://www.ncbi.nlm.nih.gov/pubmed/26937187

Finch D, Jones P, Watz H, Wouters E, Cazzola M (2016) COPD: the patient perspective. Int J Chron Obstruct Pulmon Dis 11 Spec Iss: 13 (ARCN) https://doi.org/10.2147/copd.S85977 https://www.ncbi.nlm.nih.gov/pubmed/26937186

Ferrario PG, König IR (2016) Transferring entropy to the realm of GxG interactions. Brief Bioinform: bbw086 (ARCN) https://doi.org/10.1093/bib/bbw086 https://www.ncbi.nlm.nih.gov/pubmed/27769993

Ewig S, Höffken G, Kern W, Rohde G, Flick H, Krause R, Ott S, Bauer T, Dalhoff K, Gatermann S, Kolditz M, Krüger S, Lorenz J, Pletz M, de Roux A, Schaaf B, Schaberg T, Schütte H, Welte T (2016) Behandlung von erwachsenen Patienten mit ambulant erworbener Pneumonie und Prävention – Update 2016. Pneumologie 70: 151-200 (ARCN, BREATH) https://doi.org/10.1055/s-0042-101873 https://www.ncbi.nlm.nih.gov/pubmed/26926396

Esser RW, Stoeckel MC, Kirsten A, Watz H, Taube K, Lehmann K, Petersen S, Magnussen H, von Leupoldt A (2016) Structural Brain Changes in Patients With COPD. Chest 149: 426-434 (ARCN) https://doi.org/10.1378/chest.15-0027 https://www.ncbi.nlm.nih.gov/pubmed/26203911

Engelman CD, Greenwood CMT, Bailey JN, Cantor RM, Kent JW, König IR, Bermejo JL, Melton PE, Santorico SA, Schillert A, Wijsman EM, MacCluer JW, Almasy L (2016) Genetic Analysis Workshop 19: methods and strategies for analyzing human sequence and gene expression data in extended families and unrelated individuals. BMC Proc 10: 67-70 (ARCN) https://doi.org/10.1186/s12919-016-0007-z https://www.ncbi.nlm.nih.gov/pubmed/27980613

Duda KA, Petersen S, Holst O (2016) Structural characterization of the lipoteichoic acid isolated from Staphylococcus sciuri W620. Carbohydr Res 430: 44-47 (ARCN) https://doi.org/10.1016/j.carres.2016.04.026 https://www.ncbi.nlm.nih.gov/pubmed/27196311

Diesner SC, Bergmayr C, Pfitzner B, Assmann V, Krishnamurthy D, Starkl P, Endesfelder D, Rothballer M, Welzl G, Rattei T, Eiwegger T, Szépfalusi Z, Fehrenbach H, Jensen-Jarolim E, Hartmann A, Pali-Schöll I, Untersmayr E (2016) A distinct microbiota composition is associated with protection from food allergy in an oral mouse immunization model. Clin Immunol 173: 10-18 (ARCN) https://doi.org/10.1016/j.clim.2016.10.009 https://www.ncbi.nlm.nih.gov/pubmed/27789346

Diel R, Nienhaus A, Hillemann D, Richter E (2016) Cost–benefit analysis of Xpert MTB/RIF for tuberculosis suspects in German hospitals. Eur Respir J 47: 575-587 (ARCN) https://doi.org/10.1183/13993003.01333-2015 https://www.ncbi.nlm.nih.gov/pubmed/26647440

Diel R, Loddenkemper R, Nienhaus A (2016) Consequences of tuberculosis among asylum seekers for health care workers in Germany. J Occup Med Toxicol 11: 4 (ARCN) https://doi.org/10.1186/s12995-016-0093-x https://www.ncbi.nlm.nih.gov/pubmed/26884805

Diederich A-K, Duda KA, Romero-Saavedra F, Engel R, Holst O, Huebner J (2016) Deletion of fabN in Enterococcus faecalis results in unsaturated fatty acid auxotrophy and decreased release of inflammatory cytokines. Innate Immun 22: 284-293 (ARCN) https://doi.org/10.1177/1753425916639669 https://www.ncbi.nlm.nih.gov/pubmed/27009913

Dankowski T, Schröder T, Möller S, Yu X, Ellinghaus D, Bär F, Fellermann K, Lehnert H, Schreiber S, Franke A, Sina C, Ibrahim SM, König IR (2016) Male-specific association between MT-ND4 11719 A/G polymorphism and ulcerative colitis: a mitochondria-wide genetic association study. BMC Gastroenterol 16: 118 (ARCN) https://doi.org/10.1186/s12876-016-0509-1 https://www.ncbi.nlm.nih.gov/pubmed/27716073

Cottin V, Bel E, Bottero P, Dalhoff K, Humbert M, Lazor R, Sinico RA, Sivasothy P, Wechsler ME, Groh M, Marchand-Adam S, Khouatra C, Wallaert B, Taillé C, Delaval P, Cadranel J, Bonniaud P, Prévot G, Hirschi S, Gondouin A, Dunogué B, Chatté G, Briault A, Jayne D, Guillevin L, Cordier J-F (2016) Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg–Strauss). Eur Respir J 48: 1429-1441 (ARCN) https://doi.org/10.1183/13993003.00097-2016 https://www.ncbi.nlm.nih.gov/pubmed/27587545

Contoli M, Bellini F, Morandi L, Forini G, Bianchi S, Gnesini G, Marku B, Rabe KF, Papi A (2016) Assessing small airway impairment in mild-to-moderate smoking asthmatic patients. Eur Respir J 47: 1264-1267 (ARCN) https://doi.org/10.1183/13993003.01708-2015 https://www.ncbi.nlm.nih.gov/pubmed/26869674

Chiorini JA, Chen Y, Zheng J, Huang Q, Deng F, Huang R, Zhao W, Yin J, Song L, Chen J, Gao X, Liu Z, Petersen F, Yu X (2016) Autoantibodies against the Second Extracellular Loop of M3R Do neither Induce nor Indicate Primary Sjögren’s Syndrome. PLoS One 11: e0149485 (ARCN)

Burtin C, ter Riet G, Puhan MA, Waschki B, Garcia-Aymerich J, Pinto-Plata V, Celli B, Watz H, Spruit MA (2016) Handgrip weakness and mortality risk in COPD: a multicentre analysis. Thorax 71: 86-87 (ARCN) https://doi.org/10.1136/thoraxjnl-2015-207451 https://www.ncbi.nlm.nih.gov/pubmed/26514408

Bradley P, Gordon NC, Walker TM, Dunn L, Heys S, Huang B, Earle S, Pankhurst LJ, Anson L, de Cesare M, Piazza P, Votintseva AA, Golubchik T, Wilson DJ, Wyllie DH, Diel R, Niemann S, Feuerriegel S, Kohl TA, Ismail N, Omar SV, Smith EG, Buck D, McVean G, Walker AS, Peto TEA, Crook DW, Iqbal Z (2016) Erratum: Corrigendum: Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis. Nature Communications 7: 11465 (ARCN) https://doi.org/10.1038/ncomms11465 https://www.ncbi.nlm.nih.gov/pubmed/27095245

Bousquet J, Schünemann HJ, Hellings PW, Arnavielhe S, Bachert C, Bedbrook A, Bergmann K-C, Bosnic-Anticevich S, Brozek J, Calderon M, Canonica GW, Casale TB, Chavannes NH, Cox L, Chrystyn H, Cruz AA, Dahl R, De Carlo G, Demoly P, Devillier P, Dray G, Fletcher M, Fokkens WJ, Fonseca J, Gonzalez-Diaz SN, Grouse L, Keil T, Kuna P, Larenas-Linnemann D, Lodrup Carlsen KC, Meltzer EO, Mullol J, Muraro A, Naclerio RN, Palkonen S, Papadopoulos NG, Passalacqua G, Price D, Ryan D, Samolinski B, Scadding GK, Sheikh A, Spertini F, Valiulis A, Valovirta E, Walker S, Wickman M, Yorgancioglu A, Haahtela T, Zuberbier T, Aberer W, Adachi M, Agache I, Akdis C, Akdis M, Annesi-Maesano I, Ansotegui IJ, Anto JM, Arshad SH, Baiardini I, Baigenzhin AK, Barbara C, Bateman ED, Beghé B, Bel EH, Ben Kheder A, Bennoor KS, Benson M, Bernstein D, Michael B, Thomas B, Bindslev-Jensen C, Bjermer L, Blain H, Boner A, Bonini M, Bonini S, Bosse I, Bouchard J, Boulet L-P, Bourret RA, Bousquet PJ, Braido F, Briggs AH, Brightling CE, Buhl R, Burney P, Bush A, Caballero-Fonseca F, Caimmi DP, Camargos P, Camuzat T, Carlsen K-H, Carr W, Casale TB, Sarabia AC, Chatzi L, Chen Y, Chiron R, Chkhartishvili E, Chuchalin A, Ciprandi G, Cirule I, Correia de Sousa J, Costa D, Crooks G, Custovic A, Dahlen S-E, Darsow U, De Blay F, De Manuel Keenoy E, Dedeu T, Deleanu D, Denburg J, Didier A, Dinh-Xuan A-T, Dokic D, Douagui HB, Dubakiene R, Durham S, Dykewicz M, El-Gamal Y, Emuzyte R, Fink-Wagner A, Fiocchi A, Forastiere F, Gamkrelidze A, Gemicioğlu B, Gereda JE, Gerth van Wijk R, Gotua M, Grisle I, Guzmán MA, Haahtela T, Heinrich J, Hellquist-Dahl B, Horak F, Howarth PH, Humbert M, Hyland M, Ivancevich J-C, Jares EJ, Johnston SL, Jonquet O, Joos G, Jung K-S, Just J, Jutel M, Kaidashev IP, Khaitov M, Kalayci O, Kalyoncu F, Keith P, Khaltaev N, Kleine-Tebbe J, Klimek L, N’Goran BK, Kolek V, Koppelman GH, Kowalski M, Kull I, Kvedariene V, Lambrecht B, Lau S, Laune D, Le Thi Tuyet L, Li J, Lieberman P, Lipworth BJ, Renaud L, Magard Y, Magnan A, Mahboub B, Majer I, Makela M, Manning PJ, Masjedi MR, Maurer M, Mavale-Manuel S, Melén E, Melo-Gomes E, Mercier J, Merk H, Miculinic N, Mihaltan F, Milenkovic B, Mohammad Y, Molimard M, Momas I, Montilla-Santana A, Morais-Almeida M, Mösges R, Nadif R, Namazova-Baranova L, Neffen H, Nekam K, Neou A, Niggemann B, Nyembue D, O’Hehir R, Ohta K, Okamoto Y, Okubo K, Ouedraogo S, Paggiaro P-L, Pali-Schöll I, Palmer S, Panzner P, Papi A, Park H-S, Pavord I, Pawankar R, Pfaar O, Picard R, Pigearias B, Pin I, Plavec D, Pohl W, Popov T, Postma DS, Potter P, Poulsen LK, Rabe KF, Raciborski F, Pontal FR, Reitamo S, Repka-Ramirez M-S, Robalo-Cordeiro C, Roberts G, Rodenas F, Rolland C, Rodriguez MR, Romano A, Rosado-Pinto J, Rosario NA, Rosenwasser L, Rottem M, Sanchez-Borges M, Sastre-Dominguez J, Schmid-Grendelmeier P, Serrano E, Simons FER, Sisul J-C, Skrindo I, Smit HA, Solé D, Sooronbaev T, Spranger O, Stelmach R, Strandberg T, Sunyer J, Thijs C, Todo-Bom A-M, Triggiani M, Valenta R, Valero AL, van Hage M, Vandenplas O, Vezzani G, Vichyanond P, Viegi G, Wagenmann M, Wahn U, De Yun W, Williams D, Wright J, Yawn BP, Yiallouros P, Yusuf OM, Zar HJ, Zernotti M, Zhang L, Zhong N, Zidarn M (2016) MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis. Journal of Allergy and Clinical Immunology 138: 367-374.e362 (ARCN) https://doi.org/10.1016/j.jaci.2016.03.025 https://www.ncbi.nlm.nih.gov/pubmed/27260321

Bousquet J, Hellings PW, Agache I, Bedbrook A, Bachert C, Bergmann KC, Bewick M, Bindslev-Jensen C, Bosnic-Anticevitch S, Bucca C, Caimmi DP, Camargos PAM, Canonica GW, Casale T, Chavannes NH, Cruz AA, De Carlo G, Dahl R, Demoly P, Devillier P, Fonseca J, Fokkens WJ, Guldemond NA, Haahtela T, Illario M, Just J, Keil T, Klimek L, Kuna P, Larenas-Linnemann D, Morais-Almeida M, Mullol J, Murray R, Naclerio R, O’Hehir RE, Papadopoulos NG, Pawankar R, Potter P, Ryan D, Samolinski B, Schunemann HJ, Sheikh A, Simons FER, Stellato C, Todo-Bom A, Tomazic PV, Valiulis A, Valovirta E, Ventura MT, Wickman M, Young I, Yorgancioglu A, Zuberbier T, Aberer W, Akdis CA, Akdis M, Annesi-Maesano I, Ankri J, Ansotegui IJ, Anto JM, Arnavielhe S, Asarnoj A, Arshad H, Avolio F, Baiardini I, Barbara C, Barbagallo M, Bateman ED, Beghé B, Bel EH, Bennoor KS, Benson M, Białoszewski AZ, Bieber T, Bjermer L, Blain H, Blasi F, Boner AL, Bonini M, Bonini S, Bosse I, Bouchard J, Boulet LP, Bourret R, Bousquet PJ, Braido F, Briggs AH, Brightling CE, Brozek J, Buhl R, Bunu C, Burte E, Bush A, Caballero-Fonseca F, Calderon MA, Camuzat T, Cardona V, Carreiro-Martins P, Carriazo AM, Carlsen KH, Carr W, Cepeda Sarabia AM, Cesari M, Chatzi L, Chiron R, Chivato T, Chkhartishvili E, Chuchalin AG, Chung KF, Ciprandi G, de Sousa JC, Cox L, Crooks G, Custovic A, Dahlen SE, Darsow U, Dedeu T, Deleanu D, Denburg JA, De Vries G, Didier A, Dinh-Xuan AT, Dokic D, Douagui H, Dray G, Dubakiene R, Durham SR, Du Toit G, Dykewicz MS, Eklund P, El-Gamal Y, Ellers E, Emuzyte R, Farrell J, Fink Wagner A, Fiocchi A, Fletcher M, Forastiere F, Gaga M, Gamkrelidze A, Gemicioğlu B, Gereda JE, van Wick RG, González Diaz S, Grisle I, Grouse L, Gutter Z, Guzmán MA, Hellquist-Dahl B, Heinrich J, Horak F, Hourihane JOB, Humbert M, Hyland M, Iaccarino G, Jares EJ, Jeandel C, Johnston SL, Joos G, Jonquet O, Jung KS, Jutel M, Kaidashev I, Khaitov M, Kalayci O, Kalyoncu AF, Kardas P, Keith PK, Kerkhof M, Kerstjens HAM, Khaltaev N, Kogevinas M, Kolek V, Koppelman GH, Kowalski ML, Kuitunen M, Kull I, Kvedariene V, Lambrecht B, Lau S, Laune D, Le LTT, Lieberman P, Lipworth B, Li J, Lodrup Carlsen KC, Louis R, Lupinek C, MacNee W, Magar Y, Magnan A, Mahboub B, Maier D, Majer I, Malva J, Manning P, De Manuel Keenoy E, Marshall GD, Masjedi MR, Mathieu-Dupas E, Maurer M, Mavale-Manuel S, Melén E, Melo-Gomes E, Meltzer EO, Mercier J, Merk H, Miculinic N, Mihaltan F, Milenkovic B, Millot-Keurinck J, Mohammad Y, Momas I, Mösges R, Muraro A, Namazova-Baranova L, Nadif R, Neffen H, Nekam K, Nieto A, Niggemann B, Nogueira-Silva L, Nogues M, Nyembue TD, Ohta K, Okamoto Y, Okubo K, Olive-Elias M, Ouedraogo S, Paggiaro P, Pali-Schöll I, Palkonen S, Panzner P, Papi A, Park HS, Passalacqua G, Pedersen S, Pereira AM, Pfaar O, Picard R, Pigearias B, Pin I, Plavec D, Pohl W, Popov TA, Portejoie F, Postma D, Poulsen LK, Price D, Rabe KF, Raciborski F, Roberts G, Robalo-Cordeiro C, Rodenas F, Rodriguez-Mañas L, Rolland C, Roman Rodriguez M, Romano A, Rosado-Pinto J, Rosario N, Rottem M, Sanchez-Borges M, Sastre-Dominguez J, Scadding GK, Scichilone N, Schmid-Grendelmeier P, Serrano E, Shields M, Siroux V, Sisul JC, Skrindo I, Smit HA, Solé D, Sooronbaev T, Spranger O, Stelmach R, Sterk PJ, Strandberg T, Sunyer J, Thijs C, Triggiani M, Valenta R, Valero A, van Eerd M, van Ganse E, van Hague M, Vandenplas O, Varona LL, Vellas B, Vezzani G, Vazankari T, Viegi G, Vontetsianos T, Wagenmann M, Walker S, Wang DY, Wahn U, Werfel T, Whalley B, Williams DM, Williams S, Wilson N, Wright J, Yawn BP, Yiallouros PK, Yusuf OM, Zaidi A, Zar HJ, Zernotti ME, Zhang L, Zhong N, Zidarn M (2016) ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. Clinical and Translational Allergy 6: 47 (ARCN, CPC-M) https://doi.org/10.1186/s13601-016-0137-4 https://www.ncbi.nlm.nih.gov/pubmed/28050247

Bousquet J, Farrell J, Crooks G, Hellings P, Bel EH, Bewick M, Chavannes NH, de Sousa JC, Cruz AA, Haahtela T, Joos G, Khaltaev N, Malva J, Muraro A, Nogues M, Palkonen S, Pedersen S, Robalo-Cordeiro C, Samolinski B, Strandberg T, Valiulis A, Yorgancioglu A, Zuberbier T, Bedbrook A, Aberer W, Adachi M, Agusti A, Akdis CA, Akdis M, Ankri J, Alonso A, Annesi-Maesano I, Ansotegui IJ, Anto JM, Arnavielhe S, Arshad H, Bai C, Baiardini I, Bachert C, Baigenzhin AK, Barbara C, Bateman ED, Beghé B, Kheder AB, Bennoor KS, Benson M, Bergmann KC, Bieber T, Bindslev-Jensen C, Bjermer L, Blain H, Blasi F, Boner AL, Bonini M, Bonini S, Bosnic-Anticevitch S, Boulet LP, Bourret R, Bousquet PJ, Braido F, Briggs AH, Brightling CE, Brozek J, Buhl R, Burney PG, Bush A, Caballero-Fonseca F, Caimmi D, Calderon MA, Calverley PM, Camargos PAM, Canonica GW, Camuzat T, Carlsen KH, Carr W, Carriazo A, Casale T, Cepeda Sarabia AM, Chatzi L, Chen YZ, Chiron R, Chkhartishvili E, Chuchalin AG, Chung KF, Ciprandi G, Cirule I, Cox L, Costa DJ, Custovic A, Dahl R, Dahlen SE, Darsow U, De Carlo G, De Blay F, Dedeu T, Deleanu D, De Manuel Keenoy E, Demoly P, Denburg JA, Devillier P, Didier A, Dinh-Xuan AT, Djukanovic R, Dokic D, Douagui H, Dray G, Dubakiene R, Durham SR, Dykewicz MS, El-Gamal Y, Emuzyte R, Fabbri LM, Fletcher M, Fiocchi A, Fink Wagner A, Fonseca J, Fokkens WJ, Forastiere F, Frith P, Gaga M, Gamkrelidze A, Garces J, Garcia-Aymerich J, Gemicioğlu B, Gereda JE, González Diaz S, Gotua M, Grisle I, Grouse L, Gutter Z, Guzmán MA, Heaney LG, Hellquist-Dahl B, Henderson D, Hendry A, Heinrich J, Heve D, Horak F, Hourihane JOB, Howarth P, Humbert M, Hyland ME, Illario M, Ivancevich JC, Jardim JR, Jares EJ, Jeandel C, Jenkins C, Johnston SL, Jonquet O, Julge K, Jung KS, Just J, Kaidashev I, Kaitov MR, Kalayci O, Kalyoncu AF, Keil T, Keith PK, Klimek L, Koffi N’Goran B, Kolek V, Koppelman GH, Kowalski ML, Kull I, Kuna P, Kvedariene V, Lambrecht B, Lau S, Larenas-Linnemann D, Laune D, Le LTT, Lieberman P, Lipworth B, Li J, Lodrup Carlsen K, Louis R, MacNee W, Magard Y, Magnan A, Mahboub B, Mair A, Majer I, Makela MJ, Manning P, Mara S, Marshall GD, Masjedi MR, Matignon P, Maurer M, Mavale-Manuel S, Melén E, Melo-Gomes E, Meltzer EO, Menzies-Gow A, Merk H, Michel JP, Miculinic N, Mihaltan F, Milenkovic B, Mohammad GMY, Molimard M, Momas I, Montilla-Santana A, Morais-Almeida M, Morgan M, Mösges R, Mullol J, Nafti S, Namazova-Baranova L, Naclerio R, Neou A, Neffen H, Nekam K, Niggemann B, Ninot G, Nyembue TD, O’Hehir RE, Ohta K, Okamoto Y, Okubo K, Ouedraogo S, Paggiaro P, Pali-Schöll I, Panzner P, Papadopoulos N, Papi A, Park HS, Passalacqua G, Pavord I, Pawankar R, Pengelly R, Pfaar O, Picard R, Pigearias B, Pin I, Plavec D, Poethig D, Pohl W, Popov TA, Portejoie F, Potter P, Postma D, Price D, Rabe KF, Raciborski F, Radier Pontal F, Repka-Ramirez S, Reitamo S, Rennard S, Rodenas F, Roberts J, Roca J, Rodriguez Mañas L, Rolland C, Roman Rodriguez M, Romano A, Rosado-Pinto J, Rosario N, Rosenwasser L, Rottem M, Ryan D, Sanchez-Borges M, Scadding GK, Schunemann HJ, Serrano E, Schmid-Grendelmeier P, Schulz H, Sheikh A, Shields M, Siafakas N, Sibille Y, Similowski T, Simons FER, Sisul JC, Skrindo I, Smit HA, Solé D, Sooronbaev T, Spranger O, Stelmach R, Sterk PJ, Sunyer J, Thijs C, To T, Todo-Bom A, Triggiani M, Valenta R, Valero AL, Valia E, Valovirta E, Van Ganse E, van Hage M, Vandenplas O, Vasankari T, Vellas B, Vestbo J, Vezzani G, Vichyanond P, Viegi G, Vogelmeier C, Vontetsianos T, Wagenmann M, Wallaert B, Walker S, Wang DY, Wahn U, Wickman M, Williams DM, Williams S, Wright J, Yawn BP, Yiallouros PK, Yusuf OM, Zaidi A, Zar HJ, Zernotti ME, Zhang L, Zhong N, Zidarn M, Mercier J (2016) Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5). Clinical and Translational Allergy 6: 29 (ARCN, CPC-M, UGMLC) https://doi.org/10.1186/s13601-016-0116-9 https://www.ncbi.nlm.nih.gov/pubmed/27478588

Bos LD, Bartel S, Ojanguren Arranz I, Kahn NC, Mathioudakis AG, Flood E, Petrarca L, Singanayagam A, Hardavella G (2016) Early Career Members at the ERS International Congress London 2016. Breathe 12: 364-368 ((ARCN)) https://doi.org/10.1183/20734735.017216 https://www.ncbi.nlm.nih.gov/pubmed/28210322

Borghaei H, Brahmer J, Horn L, Ready N, Steins M, Felip E, Paz-Ares L, Xx X, Barlesi F, Antonia S, Fayette J, Rizvi N, Crino L, Reck M, Erich Eberhardt WE, Hellmann M, Desai K, Li A, Healey D, Spigel D, Mathias C (2016) P2.35: Nivolumab vs Docetaxel in Advanced NSCLC: CheckMate 017/057 2-Y Update and Exploratory Cytokine Profile Analysis. J Thorac Oncol 11: S237-S238 (ARCN) https://doi.org/10.1016/j.jtho.2016.08.106 https://www.ncbi.nlm.nih.gov/pubmed/27676569

Bieber K, Witte M, Sun S, Hundt JE, Kalies K, Dräger S, Kasprick A, Twelkmeyer T, Manz RA, König P, Köhl J, Zillikens D, Ludwig RJ (2016) T cells mediate autoantibody-induced cutaneous inflammation and blistering in epidermolysis bullosa acquisita. Sci Rep 6: 38357 (ARCN) https://doi.org/10.1038/srep38357 https://www.ncbi.nlm.nih.gov/pubmed/27917914

Biancosino C, Welker L, Krüger M, Bölükbas S, Bittmann I, Kirsten D (2016) Diagnostic Gain from Surgical Biopsy for Interstitial Lung Disease – When is it Worth the Risk? Pneumologie 70: 205-210 (ARCN) https://doi.org/10.1055/s-0042-100551 https://www.ncbi.nlm.nih.gov/pubmed/26977754

Biancosino C, Krüger M, Vollmer E, Welker L (2016) Intraoperative fine needle aspirations – diagnosis and typing of lung cancer in small biopsies: challenges and limitations. Diagn Pathol 11: 59 (ARCN) https://doi.org/10.1186/s13000-016-0510-6 https://www.ncbi.nlm.nih.gov/pubmed/27388913

Bhat J, Sosna J, Fritsch J, Quabius ES, Schütze S, Zeissig S, Ammerpohl O, Adam D, Kabelitz D (2016) Expression of non-secreted IL-4 is associated with HDAC inhibitor-induced cell death, histone acetylation and c-Jun regulation in human gamma/delta T-cells. Oncotarget 7: 64743-64756 (ARCN) https://doi.org/10.18632/oncotarget.11462 https://www.ncbi.nlm.nih.gov/pubmed/27556516

Bernhart SH, Kretzmer H, Holdt LM, Jühling F, Ammerpohl O, Bergmann AK, Northoff BH, Doose G, Siebert R, Stadler PF, Hoffmann S (2016) Changes of bivalent chromatin coincide with increased expression of developmental genes in cancer. Sci Rep 6: 37393 (ARCN) https://doi.org/10.1038/srep37393 https://www.ncbi.nlm.nih.gov/pubmed/27876760

Bens S, Kolarova J, Beygo J, Buiting K, Caliebe A, Eggermann T, Gillessen-Kaesbach G, Prawitt D, Thiele-Schmitz S, Begemann M, Enklaar T, Gutwein J, Haake A, Paul U, Richter J, Soellner L, Vater I, Monk D, Horsthemke B, Ammerpohl O, Siebert R (2016) Phenotypic spectrum and extent of DNA methylation defects associated with multilocus imprinting disturbances. Epigenomics 8: 801-816 (ARCN) https://doi.org/10.2217/epi-2016-0007 https://www.ncbi.nlm.nih.gov/pubmed/27323310

Baum C, Ojeda FM, Wild PS, Rzayeva N, Zeller T, Sinning CR, Pfeiffer N, Beutel M, Blettner M, Lackner KJ, Blankenberg S, Münzel T, Rabe KF, Schnabel RB (2016) Subclinical impairment of lung function is related to mild cardiac dysfunction and manifest heart failure in the general population. Int J Cardiol 218: 298-304 (ARCN) https://doi.org/10.1016/j.ijcard.2016.05.034 https://www.ncbi.nlm.nih.gov/pubmed/27240155

Bateman ED, Goehring U-M, Richard F, Watz H (2016) Roflumilast combined with montelukast versus montelukast alone as add-on treatment in patients with moderate-to-severe asthma. Journal of Allergy and Clinical Immunology 138: 142-149.e148 (ARCN) https://doi.org/10.1016/j.jaci.2015.11.035 https://www.ncbi.nlm.nih.gov/pubmed/26915674

Bardoni B, Hornig NC, de Beaufort C, Denzer F, Cools M, Wabitsch M, Ukat M, Kulle AE, Schweikert H-U, Werner R, Hiort O, Audi L, Siebert R, Ammerpohl O, Holterhus P-M (2016) A Recurrent Germline Mutation in the 5’UTR of the Androgen Receptor Causes Complete Androgen Insensitivity by Activating Aberrant uORF Translation. PLoS One 11: e0154158 (ARCN) https://doi.org/10.1371/journal.pone.0154158 https://www.ncbi.nlm.nih.gov/pubmed/27110943

Bahmer T, Watz H, Waschki B, Gramm M, Magnussen H, Rabe KF, Wirtz H, Kirsten D, Kirsten A (2016) Reduced physical activity in lymphangioleiomyomatosis compared with COPD and healthy controls: disease-specific impact and clinical correlates. Thorax 71: 662-663 (ARCN) https://doi.org/10.1136/thoraxjnl-2015-207852 https://www.ncbi.nlm.nih.gov/pubmed/26968971

Bahmer T, Romagnoli M, Girelli F, Claussen M, Rabe KF (2016) The use of auto-antibody testing in the evaluation of interstitial lung disease (ILD) – A practical approach for the pulmonologist. Respir Med 113: 80-92 (ARCN) https://doi.org/10.1016/j.rmed.2016.01.019 https://www.ncbi.nlm.nih.gov/pubmed/26921132

Bahmer T, Kirsten A-M, Waschki B, Rabe KF, Magnussen H, Kirsten D, Gramm M, Hummler S, Brunnemer E, Kreuter M, Watz H (2016) Clinical Correlates of Reduced Physical Activity in Idiopathic Pulmonary Fibrosis. Respiration 91: 497-502 (ARCN, TLRC) https://doi.org/10.1159/000446607 https://www.ncbi.nlm.nih.gov/pubmed/27240427

Athanazio R, Carvalho-Pinto R, Fernandes FLA, Rached S, Rabe K, Cukier A, Stelmach R (2016) Can severe asthmatic patients achieve asthma control? A systematic approach in patients with difficult to control asthma followed in a specialized clinic. BMC Pulm Med 16: 153 (ARCN) https://doi.org/10.1186/s12890-016-0314-1 https://www.ncbi.nlm.nih.gov/pubmed/27852260

Arriola E, Paredes A, Gomez RG, Diz P, Constenla M, Girón CG, Amador M, Reck M, Vivanco GL (2016) 147P: Level of concordance between EGFR mutation status obtained from tissue/cytology and blood (plasma) for advanced non-small-cell lung cancer in Spain: ASSESS study. J Thorac Oncol 11: S122 (ARCN) https://doi.org/10.1016/s1556-0864(16)30257-x https://www.ncbi.nlm.nih.gov/pubmed/27198285

Arbore G, West EE, Spolski R, Robertson AAB, Klos A, Rheinheimer C, Dutow P, Woodruff TM, Yu ZX, Oneill LA, Coll RC, Sher A, Leonard WJ, Kohl J, Monk P, Cooper MA, Arno M, Afzali B, Lachmann HJ, Cope AP, Mayer-Barber KD, Kemper C (2016) T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells. Science 352: aad1210-aad1210 (ARCN) https://doi.org/10.1126/science.aad1210 https://www.ncbi.nlm.nih.gov/pubmed/27313051

Ammerpohl O, Haake A, Kolarova J, Siebert R (2016) Quantitative DNA Methylation Profiling in Cancer. Methods Mol Biol 1381: 75-92 (ARCN) https://doi.org/10.1007/978-1-4939-3204-7_5 https://www.ncbi.nlm.nih.gov/pubmed/26667456

Akbarzadeh R, Yu X, Vogl T, Ludwig RJ, Schmidt E, Zillikens D, Petersen F (2016) Myeloid-related proteins-8 and -14 are expressed but dispensable in the pathogenesis of experimental epidermolysis bullosa acquisita and bullous pemphigoid. J Dermatol Sci 81: 165-172 (ARCN) https://doi.org/10.1016/j.jdermsci.2015.12.001 https://www.ncbi.nlm.nih.gov/pubmed/26692467

 

2015

Zissler UM, Chaker AM, Effner R, Ulrich M, Guerth F, Piontek G, Dietz K, Regn M, Knapp B, Theis FJ, Heine H, Suttner K, Schmidt-Weber CB (2015) Interleukin-4 and interferon-γ orchestrate an epithelial polarization in the airways. Mucosal Immunol 9: 917-926 (ARCN, CPC-M) https://doi.org/10.1038/mi.2015.110 https://www.ncbi.nlm.nih.gov/pubmed/26577568

Ziegler A, Rabe K (2015) Sind deutsche Disease-Management-Programme wirksam? DMW – Deutsche Medizinische Wochenschrift 140: 417 (ARCN) https://doi.org/10.1055/s-0041-101074 http://www.ncbi.nlm.nih.gov/pubmed/25774731

Zheng J, Huang R, Huang Q, Deng F, Chen Y, Yin J, Chen J, Wang Y, Shi G, Gao X, Liu Z, Petersen F, Yu X (2015) The GTF2I rs117026326 polymorphism is associated with anti-SSA-positive primary Sjögren’s syndrome. Rheumatology 54: 562-564 (ARCN) https://doi.org/10.1093/rheumatology/keu466 http://www.ncbi.nlm.nih.gov/pubmed/25480810

Yu X, Kasprick A, Petersen F (2015) Revisiting the role of mast cells in autoimmunity. Autoimmun Rev 14: 751-759 (ARCN) https://doi.org/10.1016/j.autrev.2015.04.008 http://www.ncbi.nlm.nih.gov/pubmed/25913139

Yu X, Huang Q, Petersen F (2015) History and milestones of mouse models of autoimmune diseases. Curr Pharm Des 21: 2308-2319 (ARCN) https://www.ncbi.nlm.nih.gov/pubmed/25777764

Worm M, Reese I, Ballmer-Weber B, Beyer K, Bischoff SC, Classen M, Fischer PJ, Fuchs T, Huttegger I, Jappe U, Klimek L, Koletzko B, Lange L, Lepp U, Mahler V, Niggemann B, Rabe U, Raithel M, Saloga J, Schäfer C, Schnadt S, Schreiber J, Szépfalusi Z, Treudler R, Wagenmann M, Watzl B, Werfel T, Zuberbier T, Kleine-Tebbe J (2015) Guidelines on the management of IgE-mediated food allergies. Allergo Journal International 24: 256-293 (ARCN) https://doi.org/10.1007/s40629-015-0074-0 https://www.ncbi.nlm.nih.gov/pubmed/27069841

Wong YL, Lautenschlager I, Dombrowsky H, Zitta K, Bein B, Krause T, Goldmann T, Frerichs I, Steinfath M, Weiler N, Albrecht M (2015) Correction: Hydroxyethyl Starch (HES 130/0.4) Impairs Intestinal Barrier Integrity and Metabolic Function: Findings from a Mouse Model of the Isolated Perfused Small Intestine. PLoS One 10: e0127136 (ARCN) https://doi.org/10.1371/journal.pone.0127136 http://www.ncbi.nlm.nih.gov/pubmed/25905466

Wolfson LJ, Gibbert J, Wirth D, Diel R (2015) Cost-effectiveness of incorporating bedaquiline into a treatment regimen for MDR/XDR-TB in Germany. Eur Respir J 46: 1826-1829 (ARCN) https://doi.org/10.1183/13993003.00811-2015 https://www.ncbi.nlm.nih.gov/pubmed/26493796

Wegmann M, Fehrenbach H, Krauss-Etschmann S (2015) Asthma Update 2015 – Was die zellbiologisch-pneumologische Grundlagenforschung dem Lungenarzt anbieten kann. Pneumologie 70: 103-109 (ARCN) https://doi.org/10.1055/s-0041-108313 https://www.ncbi.nlm.nih.gov/pubmed/26640964

Weber J, Illi S, Nowak D, Schierl R, Holst O, von Mutius E, Ege MJ (2015) Asthma and the Hygiene Hypothesis. Does Cleanliness Matter? American Journal of Respiratory and Critical Care Medicine 191: 522-529 (ARCN, CPC-M) https://doi.org/10.1164/rccm.201410-1899OC http://www.ncbi.nlm.nih.gov/pubmed/25584716

Watz H (2015) The Lungs and the Heart. American Journal of Respiratory and Critical Care Medicine 192: 7-8 (ARCN) https://doi.org/10.1164/rccm.201505-0888ED http://www.ncbi.nlm.nih.gov/pubmed/26131988

Watermann I, Schmitt B, Stellmacher F, Müller J, Gaber R, Kugler C, Reinmuth N, Huber RM, Thomas M, Zabel P, Rabe KF, Jonigk D, Warth A, Vollmer E, Reck M, Goldmann T (2015) Improved diagnostics targeting c-MET in non-small cell lung cancer: expression, amplification and activation? Diagn Pathol 10: 130 (ARCN, BREATH, CPC-M, TLRC) https://doi.org/10.1186/s13000-015-0362-5 http://www.ncbi.nlm.nih.gov/pubmed/26215852

Waschki B, Kirsten AM, Holz O, Mueller K-C, Schaper M, Sack A-L, Meyer T, Rabe KF, Magnussen H, Watz H (2015) Disease Progression and Changes in Physical Activity in Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine 192: 295-306 (ARCN, BREATH) https://doi.org/10.1164/rccm.201501-0081OC http://www.ncbi.nlm.nih.gov/pubmed/26020495

Warth A, Weichert W, Reck M, Reinmuth N (2015) ROS1-Translokationen im nicht-kleinzelligen Lungenkarzinom. Pneumologie 69: 477-482 (ARCN, TLRC) https://doi.org/10.1055/s-0034-1392446 https://www.ncbi.nlm.nih.gov/pubmed/26258422

Walker TM, Kohl TA, Omar SV, Hedge J, Del Ojo Elias C, Bradley P, Iqbal Z, Feuerriegel S, Niehaus KE, Wilson DJ, Clifton DA, Kapatai G, Ip CLC, Bowden R, Drobniewski FA, Allix-Béguec C, Gaudin C, Parkhill J, Diel R, Supply P, Crook DW, Smith EG, Walker AS, Ismail N, Niemann S, Peto TEA (2015) Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study. The Lancet Infectious Diseases 15: 1193-1202 (ARCN) https://doi.org/10.1016/s1473-3099(15)00062-6 https://www.ncbi.nlm.nih.gov/pubmed/26116186

Wagner W, Kolarova J, Ammerpohl O, Gutwein J, Welzel M, Baus I, Riepe FG, Eggermann T, Caliebe A, Holterhus P-M, Siebert R, Bens S (2015) In vivo Investigations of the Effect of Short- and Long-Term Recombinant Growth Hormone Treatment on DNA-Methylation in Humans. PLoS One 10: e0120463 (ARCN) https://doi.org/10.1371/journal.pone.0120463 https://www.ncbi.nlm.nih.gov/pubmed/25785847

Wagner C, Goldmann T, Rohmann K, Rupp J, Marwitz S, Rotta detto Loria J, Limmer S, Zabel P, Dalhoff K, Dr�mann D (2015) Budesonide Inhibits Intracellular Infection with Non-Typeable <b><i>Haemophilus influenzae</i></b> despite Its Anti-Inflammatory Effects in Respiratory Cells and Human Lung Tissue: A Role for p38 MAP Kinase. Respiration 90: 416-425 (ARCN) https://doi.org/10.1159/000439226 http://www.ncbi.nlm.nih.gov/pubmed/26452008

Voss M, Wolf L, Kamyschnikow A, Wonnenberg B, Honecker A, Herr C, Lepper PM, Wegmann M, Menger MD, Bals R, Beisswenger C (2015) Il-17A contributes to maintenance of pulmonary homeostasis in a murine model of cigarette smoke-induced emphysema. American Journal of Physiology-Lung Cellular and Molecular Physiology 309: L188-L195 (ARCN) https://doi.org/10.1152/ajplung.00388.2014 http://www.ncbi.nlm.nih.gov/pubmed/26024895

Vogelmeier C, Kardos P, Hofmann T, Canisius S, Scheuch G, Muellinger B, Nocker K, Menz G, Rabe KF (2015) Nebulised budesonide using a novel device in patients with oral steroid-dependent asthma. Eur Respir J 45: 1273-1282 (ARCN, UGMLC) https://doi.org/10.1183/09031936.00152014 http://www.ncbi.nlm.nih.gov/pubmed/25504995

Vock C, Yildirim AÖ, Wagner C, Schlick S, Lunding LP, Lee CG, Elias JA, Fehrenbach H, Wegmann M (2015) Distal airways are protected from goblet cell metaplasia by diminished expression of IL-13 signalling components. Clin Exp Allergy 45: 1447-1458 (ARCN, CPC-M) https://doi.org/10.1111/cea.12526 https://www.ncbi.nlm.nih.gov/pubmed/25772331

Vansteenkiste JF, Canon J-L, De Braud F, Grossi F, De Pas T, Gray JE, Su W-C, Felip E, Yoshioka H, Gridelli C, Dy GK, Thongprasert S, Reck M, Aimone P, Vidam GA, Roussou P, Wang YA, Di Tomaso E, Soria J-C (2015) Safety and Efficacy of Buparlisib (BKM120) in Patients with PI3K Pathway-Activated Non-Small Cell Lung Cancer. J Thorac Oncol 10: 1319-1327 (ARCN) https://doi.org/10.1097/jto.0000000000000607 http://www.ncbi.nlm.nih.gov/pubmed/26098748

Turska-Szewczuk A, Pietras H, Duda KA, Kozińska A, Pękala A, Holst O (2015) Structure of the O-specific polysaccharide from the lipopolysaccharide of Aeromonas sobria strain Pt312. Carbohydr Res 403: 142-148 (ARCN) https://doi.org/10.1016/j.carres.2014.06.011 http://www.ncbi.nlm.nih.gov/pubmed/25037826

Trog LM, Kahle B, Schindewolf M, Jappe U, Ludwig RJ (2015) Tolerance of Fondaparinux in Immediate-type Hypersensitivity to Heparins. The American Journal of Medicine 128: e21-e22 (ARCN) https://doi.org/10.1016/j.amjmed.2015.06.024 http://www.ncbi.nlm.nih.gov/pubmed/26169891

Thomas M, Fischer J, Andreas S, Kortsik C, Grah C, Serke M, von Eiff M, Witt C, Kollmeier J, Müller E, Schenk M, Schröder M, Villalobos M, Reinmuth N, Penzel R, Schnabel P, Acker T, Reuss A, Wolf M (2015) Erlotinib and bevacizumab versus cisplatin, gemcitabine and bevacizumab in unselected nonsquamous nonsmall cell lung cancer. Eur Respir J 46: 219-229 (ARCN, TLRC) https://doi.org/10.1183/09031936.00229014 http://www.ncbi.nlm.nih.gov/pubmed/25792638

Thatcher N, Hirsch FR, Luft AV, Szczesna A, Ciuleanu TE, Dediu M, Ramlau R, Galiulin RK, Bálint B, Losonczy G, Kazarnowicz A, Park K, Schumann C, Reck M, Depenbrock H, Nanda S, Kruljac-Letunic A, Kurek R, Paz-Ares L, Socinski MA (2015) Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial. The Lancet Oncology 16: 763-774 (ARCN) https://doi.org/10.1016/s1470-2045(15)00021-2 http://www.ncbi.nlm.nih.gov/pubmed/26045340

Stremnitzer C, Manzano-Szalai K, Willensdorfer A, Starkl P, Pieper M, König P, Mildner M, Tschachler E, Reichart U, Jensen-Jarolim E (2015) Papain Degrades Tight Junction Proteins of Human Keratinocytes In Vitro and Sensitizes C57BL/6 Mice via the Skin Independent of its Enzymatic Activity or TLR4 Activation. J Invest Dermatol 135: 1790-1800 (ARCN) https://doi.org/10.1038/jid.2015.58 http://www.ncbi.nlm.nih.gov/pubmed/25705851

Storbeck B, Schröder T, Oldigs M, Rabe K, Weber C (2015) Emphysema: Imaging for Endoscopic Lung Volume Reduction. RöFo – Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren 187: 543-554 (ARCN) https://doi.org/10.1055/s-0034-1399424 http://www.ncbi.nlm.nih.gov/pubmed/25962751

Spahr H, Hillmann D, Hain C, Pfäffle C, Sudkamp H, Franke G, Hüttmann G (2015) Imaging pulse wave propagation in human retinal vessels using full-field swept-source optical coherence tomography. Optics Letters 40: 4771 (ARCN) https://doi.org/10.1364/ol.40.004771 http://www.ncbi.nlm.nih.gov/pubmed/26469616

Schröder T, Storbeck B, Rabe K, Weber C (2015) The Aging Lung: Clinical and Imaging Findings and the Fringe of Physiological State. RöFo – Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren 187: 430-439 (ARCN) https://doi.org/10.1055/s-0034-1399227 http://www.ncbi.nlm.nih.gov/pubmed/25919194

Schmid-Bindert G, Engel-Riedel W, Reck M, Schuette W, Stöhlmacher J, Fischer JR, Mazières J, Chouaid C, Wolf M, Vinolas N, Soldatenkova V, Ripoche V, Nguyen T, Visseren-Grul C (2015) A randomized Phase 2 study of pemetrexed in combination with cisplatin or carboplatin as adjuvant chemotherapy in patients with completely resected stage IB or II Non-Small-Cell Lung Cancer. Lung Cancer 90: 397-404 (ARCN) https://doi.org/10.1016/j.lungcan.2015.11.007 http://www.ncbi.nlm.nih.gov/pubmed/26791798

Rossi A, Aisanov Z, Avdeev S, Di Maria G, Donner CF, Izquierdo JL, Roche N, Similowski T, Watz H, Worth H, Miravitlles M (2015) Mechanisms, assessment and therapeutic implications of lung hyperinflation in COPD. Respir Med 109: 785-802 (ARCN) https://doi.org/10.1016/j.rmed.2015.03.010 http://www.ncbi.nlm.nih.gov/pubmed/25892293

Rosenkranz E, Hilgers R-D, Uciechowski P, Petersen A, Plümäkers B, Rink L (2015) Zinc enhances the number of regulatory T cells in allergen-stimulated cells from atopic subjects. Eur J Nutr 56: 557-567 (ARCN) https://doi.org/10.1007/s00394-015-1100-1 https://www.ncbi.nlm.nih.gov/pubmed/26589301

Rose K, Kopp MV (2015) Pediatric investigation plans for specific immunotherapy: Questionable contributions to childhood health. Pediatr Allergy Immunol 26: 695-701 (ARCN) https://doi.org/10.1111/pai.12500 https://www.ncbi.nlm.nih.gov/pubmed/26495999

Roessler J, Ammerpohl O, Gutwein J, Steinemann D, Schlegelberger B, Weyer V, Sariyar M, Geffers R, Arnold N, Schmutzler R, Bartram CR, Heinrich T, Abbas M, Antonopoulos W, Schipper E, Hasemeier B, Kreipe H, Lehmann U (2015) The CpG island methylator phenotype in breast cancer is associated with the lobular subtype. Epigenomics 7: 187-199 (ARCN) https://doi.org/10.2217/epi.14.74 https://www.ncbi.nlm.nih.gov/pubmed/25347269

Ringshausen FC, de Roux A, Diel R, Hohmann D, Welte T, Rademacher J (2015) Bronchiectasis in Germany: a population-based estimation of disease prevalence. Eur Respir J 46: 1805-1807 (ARCN, BREATH) https://doi.org/10.1183/13993003.00954-2015 https://www.ncbi.nlm.nih.gov/pubmed/26293498

Rennard SI, Dale DC, Donohue JF, Kanniess F, Magnussen H, Sutherland ER, Watz H, Lu S, Stryszak P, Rosenberg E, Staudinger H (2015) CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine 191: 1001-1011 (ARCN) https://doi.org/10.1164/rccm.201405-0992OC http://www.ncbi.nlm.nih.gov/pubmed/25695403

Reinmuth N, Reck M (2015) Combinations Therapies. Prog Tumor Res 42: 79-94 (ARCN) https://doi.org/10.1159/000437186 https://www.ncbi.nlm.nih.gov/pubmed/26384009

Reinmuth N, Heigener D, Reck M (2015) Nicht-kleinzelliges Lungenkarzinom: Neues aus der Immuntherapie. DMW – Deutsche Medizinische Wochenschrift 140: 329-333 (ARCN) https://doi.org/10.1055/s-0041-100763 http://www.ncbi.nlm.nih.gov/pubmed/25734674

Reinmuth N, Heigener D, Reck M (2015) Novel angiogenesis inhibitors in nonsmall cell lung cancer. Curr Opin Oncol 27: 79-86 (ARCN) https://doi.org/10.1097/cco.0000000000000166 http://www.ncbi.nlm.nih.gov/pubmed/25602682

Recke A, Recke AL, Jappe U (2015) Periorbital contact dermatitis caused by octylisothiazolinone in a floor-cleaning agent. Contact Dermatitis 72: 339-341 (ARCN) https://doi.org/10.1111/cod.12351 http://www.ncbi.nlm.nih.gov/pubmed/25727641

Reck M, Paz-Ares L (2015) Immunologic Checkpoint Blockade in Lung Cancer. Semin Oncol 42: 402-417 (ARCN) https://doi.org/10.1053/j.seminoncol.2015.02.013 http://www.ncbi.nlm.nih.gov/pubmed/25965358

Reck M, Mellemgaard A, von Pawel J, Gottfried M, Bondarenko I, Cheng Y, Zarogoulidis K, Luft A, Bennouna J, Barrueco J, Aboshady H, Hocke J, Kaiser R, Douillard J-Y (2015) Anti-angiogenic-specific adverse events in patients with non-small cell lung cancer treated with nintedanib and docetaxel. Lung Cancer 90: 267-273 (ARCN) https://doi.org/10.1016/j.lungcan.2015.08.003 http://www.ncbi.nlm.nih.gov/pubmed/26415992

Reck M, Mellemgaard A (2015) Emerging treatments and combinations in the management of NSCLC: clinical potential of nintedanib. Biologics: Targets and Therapy 9: 47 (ARCN) https://doi.org/10.2147/btt.S57356 http://www.ncbi.nlm.nih.gov/pubmed/26170616

Reck M (2015) Nintedanib: examining the development and mechanism of action of a novel triple angiokinase inhibitor. Expert Rev Anticancer Ther 15: 579-594 (ARCN) https://doi.org/10.1586/14737140.2015.1031218 http://www.ncbi.nlm.nih.gov/pubmed/25831142

Raulf M, Bergmann KC, Kull S, Sander I, Hilger C, Brüning T, Jappe U, Müsken H, Sperl A, Vrtala S, Zahradnik E, Klimek L (2015) Mites and other indoor allergens — from exposure to sensitization and treatment. Allergo Journal International 24: 68-80 (ARCN) https://doi.org/10.1007/s40629-015-0049-1 http://www.ncbi.nlm.nih.gov/pubmed/26120549

Ramlau R, Thomas M, Novello S, Plummer R, Reck M, Kaneko T, Lau MR, Margetts J, Lunec J, Nutt J, Scagliotti GV (2015) Phase I Study of Lapatinib and Pemetrexed in the Second-Line Treatment of Advanced or Metastatic Non–Small-Cell Lung Cancer With Assessment of Circulating Cell Free Thymidylate Synthase RNA as a Potential Biomarker. Clin Lung Cancer 16: 348-357 (ARCN, TLRC) https://doi.org/10.1016/j.cllc.2015.01.004 http://www.ncbi.nlm.nih.gov/pubmed/25700774

Raedler D, Ballenberger N, Klucker E, Böck A, Otto R, Prazeres da Costa O, Holst O, Illig T, Buch T, von Mutius E, Schaub B (2015) Identification of novel immune phenotypes for allergic and nonallergic childhood asthma. Journal of Allergy and Clinical Immunology 135: 81-91 (ARCN, BREATH, CPC-M) https://doi.org/10.1016/j.jaci.2014.07.046 http://www.ncbi.nlm.nih.gov/pubmed/25226851

Rabe KF (2015) Lung cancer staging: a true story. The Lancet Respiratory Medicine 3: 258-259 (ARCN) https://doi.org/10.1016/s2213-2600(15)00030-2 http://www.ncbi.nlm.nih.gov/pubmed/25660224

Rabe KF (2015) Treatment of COPD and the TOnado trial: a tempest in a teapot? Eur Respir J 45: 869-871 (ARCN) https://doi.org/10.1183/09031936.00027915 http://www.ncbi.nlm.nih.gov/pubmed/25829428

Rabe KF (2015) Elastic Recoil Revisited. Chest 148: 297-298 (ARCN) https://doi.org/10.1378/chest.15-0786 http://www.ncbi.nlm.nih.gov/pubmed/26238824

Pujol J-L, Vansteenkiste JF, Pas TMD, Atanackovic D, Reck M, Thomeer M, Douillard J-Y, Fasola G, Potter V, Taylor P, Bosquée L, Scheubel R, Jarnjak S, Debois M, de Sousa Alves P, Louahed J, Brichard VG, Lehmann FF (2015) Safety and Immunogenicity of MAGE-A3 Cancer Immunotherapeutic with or without Adjuvant Chemotherapy in Patients with Resected Stage IB to III MAGE-A3-Positive Non-Small-Cell Lung Cancer. J Thorac Oncol 10: 1458-1467 (ARCN) https://doi.org/10.1097/jto.0000000000000653 http://www.ncbi.nlm.nih.gov/pubmed/26309191

Proost P, Heinbockel L, Marwitz S, Barcena Varela S, Ferrer-Espada R, Reiling N, Goldmann T, Gutsmann T, Mier W, Schürholz T, Drömann D, Brandenburg K, Martinez de Tejada G (2015) Therapeutical Administration of Peptide Pep19-2.5 and Ibuprofen Reduces Inflammation and Prevents Lethal Sepsis. PLoS One 10: e0133291 (ARCN) https://doi.org/10.1371/journal.pone.0133291 http://www.ncbi.nlm.nih.gov/pubmed/26197109

Postma DS, Drazen JM, Rabe KF (2015) The Asthma–COPD Overlap Syndrome. New England Journal of Medicine 373: 1241-1249 (ARCN) https://doi.org/10.1056/NEJMra1411863 http://www.ncbi.nlm.nih.gov/pubmed/26398072

Postma DS, Brightling C, Fabbri L, van der Molen T, Nicolini G, Papi A, Rabe KF, Siddiqui S, Singh D, van den Berge M, Kraft M (2015) Unmet needs for the assessment of small airways dysfunction in asthma: introduction to the ATLANTIS study. Eur Respir J 45: 1534-1538 (ARCN) https://doi.org/10.1183/09031936.00214314 http://www.ncbi.nlm.nih.gov/pubmed/26028618

Popat S, Mellemgaard A, Fahrbach K, Martin A, Rizzo M, Kaiser R, Griebsch I, Reck M (2015) Nintedanib plus docetaxel as second-line therapy in patients with non-small-cell lung cancer: a network meta-analysis. Future Oncology 11: 409-420 (ARCN) https://doi.org/10.2217/fon.14.290 http://www.ncbi.nlm.nih.gov/pubmed/25478720

Pirson C, Engel R, Jones GJ, Holder T, Holst O, Vordermeier HM, Burns DL (2015) Highly Purified Mycobacterial Phosphatidylinositol Mannosides Drive Cell-Mediated Responses and Activate NKT Cells in Cattle. Clin Vaccine Immunol 22: 178-184 (ARCN) https://doi.org/10.1128/cvi.00638-14 http://www.ncbi.nlm.nih.gov/pubmed/25499010

Pirson C, Engel R, Jones GJ, Holder T, Holst O, Vordermeier HM (2015) Erratum for Pirson et al., Highly Purified Mycobacterial Phosphatidylinositol Mannosides Drive Cell-Mediated Responses and Activate NKT Cells in Cattle. Clin Vaccine Immunol 22: 609-609 (ARCN) https://doi.org/10.1128/cvi.00139-15 http://www.ncbi.nlm.nih.gov/pubmed/25921470

Petersen A, Kull S, Rennert S, Becker W-M, Krause S, Ernst M, Gutsmann T, Bauer J, Lindner B, Jappe U (2015) Peanut defensins: Novel allergens isolated from lipophilic peanut extract. Journal of Allergy and Clinical Immunology 136: 1295-1301.e1295 (ARCN) https://doi.org/10.1016/j.jaci.2015.04.010 http://www.ncbi.nlm.nih.gov/pubmed/26037551

Pedersen F, Marwitz S, Holz O, Kirsten A, Bahmer T, Waschki B, Magnussen H, Rabe KF, Goldmann T, Uddin M, Watz H (2015) Neutrophil extracellular trap formation and extracellular DNA in sputum of stable COPD patients. Respir Med 109: 1360-1362 (ARCN, BREATH) https://doi.org/10.1016/j.rmed.2015.08.008 http://www.ncbi.nlm.nih.gov/pubmed/26321138

Pedersen F, Holz O, Lauer G, Quintini G, Kiwull-Schöne H, Kirsten A-M, Magnussen H, Rabe KF, Goldmann T, Watz H (2015) Multi-analyte profiling of inflammatory mediators in COPD sputum – The effects of processing. Cytokine 71: 401-404 (ARCN, BREATH) https://doi.org/10.1016/j.cyto.2014.10.008 http://www.ncbi.nlm.nih.gov/pubmed/25464927

Paz-Ares L, Mezger J, Ciuleanu TE, Fischer JR, von Pawel J, Provencio M, Kazarnowicz A, Losonczy G, de Castro G, Szczesna A, Crino L, Reck M, Ramlau R, Ulsperger E, Schumann C, Miziara JEA, Lessa ÁE, Dediu M, Bálint B, Depenbrock H, Soldatenkova V, Kurek R, Hirsch FR, Thatcher N, Socinski MA (2015) Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study. The Lancet Oncology 16: 328-337 (ARCN) https://doi.org/10.1016/s1470-2045(15)70046-x http://www.ncbi.nlm.nih.gov/pubmed/25701171

Okosun J, Wolfson RL, Wang J, Araf S, Wilkins L, Castellano BM, Escudero-Ibarz L, Al Seraihi AF, Richter J, Bernhart SH, Efeyan A, Iqbal S, Matthews J, Clear A, Guerra-Assunção JA, Bödör C, Quentmeier H, Mansbridge C, Johnson P, Davies A, Strefford JC, Packham G, Barrans S, Jack A, Du M-Q, Calaminici M, Lister TA, Auer R, Montoto S, Gribben JG, Siebert R, Chelala C, Zoncu R, Sabatini DM, Fitzgibbon J (2015) Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma. Nat Genet 48: 183-188 (ARCN) https://doi.org/10.1038/ng.3473 https://www.ncbi.nlm.nih.gov/pubmed/26691987

Oehrle B, Burgstaller G, Irmler M, Dehmel S, Grün J, Hwang T, Krauss-Etschmann S, Beckers J, Meiners S, Eickelberg O (2015) Validated prediction of pro-invasive growth factors using a transcriptome-wide invasion signature derived from a complex 3D invasion assay. Sci Rep 5: 12673 (ARCN, CPC-M) https://doi.org/10.1038/srep12673 http://www.ncbi.nlm.nih.gov/pubmed/26243655

Novello S, Kaiser R, Mellemgaard A, Douillard J-Y, Orlov S, Krzakowski M, von Pawel J, Gottfried M, Bondarenko I, Liao M, Barrueco J, Gaschler-Markefski B, Griebsch I, Palmer M, Reck M (2015) Analysis of patient-reported outcomes from the LUME-Lung 1 trial: A randomised, double-blind, placebo-controlled, Phase III study of second-line nintedanib in patients with advanced non-small cell lung cancer. Eur J Cancer 51: 317-326 (ARCN) https://doi.org/10.1016/j.ejca.2014.11.015 http://www.ncbi.nlm.nih.gov/pubmed/25534294

Noszczyńska M, Kasperkiewicz K, Duda KA, Podhorodecka J, Rabsztyn K, Gwizdała K, Świerzko AS, Radziejewska-Lebrecht J, Holst O, Skurnik M (2015) Serological characterization of the enterobacterial common antigen substitution of the lipopolysaccharide of Yersinia enterocolitica O : 3. Microbiology 161: 219-227 (ARCN) https://doi.org/10.1099/mic.0.083493-0 http://www.ncbi.nlm.nih.gov/pubmed/25406452

Molinaro A, Holst O, Di Lorenzo F, Callaghan M, Nurisso A, D’Errico G, Zamyatina A, Peri F, Berisio R, Jerala R, Jiménez-Barbero J, Silipo A, Martín-Santamaría S (2015) Chemistry of Lipid A: At the Heart of Innate Immunity. Chemistry – A European Journal 21: 500-519 (ARCN) https://doi.org/10.1002/chem.201403923 http://www.ncbi.nlm.nih.gov/pubmed/25353096

Miravitlles M, Price D, Rabe K, Schmidt H, Metzdorf N, Celli B (2015) Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 10: 549 (ARCN) https://doi.org/10.2147/copd.S71913 http://www.ncbi.nlm.nih.gov/pubmed/25834416

Meyer NH, Mayerhofer H, Tripsianes K, Blindow S, Barths D, Mewes A, Weimar T, Köhli T, Bade S, Madl T, Frey A, Haas H, Mueller-Dieckmann J, Sattler M, Schramm G (2015) A Crystallin Fold in the Interleukin-4-inducing Principle ofSchistosoma mansoniEggs (IPSE/α-1) Mediates IgE Binding for Antigen-independent Basophil Activation. J Biol Chem 290: 22111-22126 (ARCN) https://doi.org/10.1074/jbc.M115.675066 http://www.ncbi.nlm.nih.gov/pubmed/26163514

Merker M, Blin C, Mona S, Duforet-Frebourg N, Lecher S, Willery E, Blum MGB, Rüsch-Gerdes S, Mokrousov I, Aleksic E, Allix-Béguec C, Antierens A, Augustynowicz-Kopeć E, Ballif M, Barletta F, Beck HP, Barry CE, Bonnet M, Borroni E, Campos-Herrero I, Cirillo D, Cox H, Crowe S, Crudu V, Diel R, Drobniewski F, Fauville-Dufaux M, Gagneux S, Ghebremichael S, Hanekom M, Hoffner S, Jiao W-w, Kalon S, Kohl TA, Kontsevaya I, Lillebæk T, Maeda S, Nikolayevskyy V, Rasmussen M, Rastogi N, Samper S, Sanchez-Padilla E, Savic B, Shamputa IC, Shen A, Sng L-H, Stakenas P, Toit K, Varaine F, Vukovic D, Wahl C, Warren R, Supply P, Niemann S, Wirth T (2015) Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage. Nat Genet 47: 242-249 (ARCN) https://doi.org/10.1038/ng.3195 https://www.ncbi.nlm.nih.gov/pubmed/25599400

Mensel B, Heßelbarth L, Wenzel M, Kühn J-P, Dörr M, Völzke H, Lieb W, Hegenscheid K, Lorbeer R (2015) Thoracic and abdominal aortic diameters in a general population: MRI-based reference values and association with age and cardiovascular risk factors. Eur Radiol 26: 969-978 (ARCN) https://doi.org/10.1007/s00330-015-3926-6 https://www.ncbi.nlm.nih.gov/pubmed/26208859

Megson ZA, Pittenauer E, Duda KA, Engel R, Ortmayr K, Koellensperger G, Mach L, Allmaier G, Holst O, Messner P, Schäffer C (2015) Inositol-phosphodihydroceramides in the periodontal pathogen Tannerella forsythia: Structural analysis and incorporation of exogenous myo-inositol. Biochim Biophys Acta 1851: 1417-1427 (ARCN) https://doi.org/10.1016/j.bbalip.2015.08.004 http://www.ncbi.nlm.nih.gov/pubmed/26277409

Martinez FJ, Calverley PMA, Goehring U-M, Brose M, Fabbri LM, Rabe KF (2015) Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial. The Lancet 385: 857-866 (ARCN) https://doi.org/10.1016/s0140-6736(14)62410-7 http://www.ncbi.nlm.nih.gov/pubmed/25684586

Madurga A, Golec A, Pozarska A, Ishii I, Mižíková I, Nardiello C, Vadász I, Herold S, Mayer K, Reichenberger F, Fehrenbach H, Seeger W, Morty RE (2015) The H2S-generating enzymes cystathionine β-synthase and cystathionine γ-lyase play a role in vascular development during normal lung alveolarization. American Journal of Physiology-Lung Cellular and Molecular Physiology 309: L710-L724 (ARCN, CPC-M, UGMLC ) https://doi.org/10.1152/ajplung.00134.2015 http://www.ncbi.nlm.nih.gov/pubmed/26232299

Lunding LP, Webering S, Vock C, Behrends J, Wagner C, Hölscher C, Fehrenbach H, Wegmann M (2015) Poly(inosinic-cytidylic) Acid–Triggered Exacerbation of Experimental Asthma Depends on IL-17A Produced by NK Cells. The Journal of Immunology 194: 5615-5625 (ARCN) https://doi.org/10.4049/jimmunol.1402529 http://www.ncbi.nlm.nih.gov/pubmed/25972482

Lunding L, Wegmann M (2015) NK cells in asthma exacerbation. Oncotarget 6: 19932-19933 (ARCN) https://doi.org/10.18632/oncotarget.4841 http://www.ncbi.nlm.nih.gov/pubmed/26296976

Lunding L, Webering S, Vock C, Schröder A, Raedler D, Schaub B, Fehrenbach H, Wegmann M (2015) IL-37 requires IL-18Rα and SIGIRR/IL-1R8 to diminish allergic airway inflammation in mice. Allergy 70: 366-373 (ARCN, CPC-M) https://doi.org/10.1111/all.12566 http://www.ncbi.nlm.nih.gov/pubmed/25557042

Lunding L, Schröder A, Wegmann M (2015) Allergic airway inflammation: unravelling the relationship between IL-37, IL-18Rα and Tir8/SIGIRR. Expert Rev Respir Med 9: 739-750 (ARCN) https://doi.org/10.1586/17476348.2015.1109452 https://www.ncbi.nlm.nih.gov/pubmed/26561030

Lorenz J, Bals R, Ewert R, Heussel C, Kauczor H, Randerath W, Steinkamp G, Watz H, Worth H (2015) Expertentreffen obstruktive Atemwegserkrankungen: Messen und Bewerten der COPD. Pneumologie 69: 521-533 (ARCN, TLRC) https://doi.org/10.1055/s-0034-1392787 https://www.ncbi.nlm.nih.gov/pubmed/26335896

Lönnroth K, Migliori GB, Abubakar I, D’Ambrosio L, de Vries G, Diel R, Douglas P, Falzon D, Gaudreau M-A, Goletti D, González Ochoa ER, LoBue P, Matteelli A, Njoo H, Solovic I, Story A, Tayeb T, van der Werf MJ, Weil D, Zellweger J-P, Abdel Aziz M, Al Lawati MRM, Aliberti S, Arrazola de Oñate W, Barreira D, Bhatia V, Blasi F, Bloom A, Bruchfeld J, Castelli F, Centis R, Chemtob D, Cirillo DM, Colorado A, Dadu A, Dahle UR, De Paoli L, Dias HM, Duarte R, Fattorini L, Gaga M, Getahun H, Glaziou P, Goguadze L, del Granado M, Haas W, Järvinen A, Kwon G-Y, Mosca D, Nahid P, Nishikiori N, Noguer I, O’Donnell J, Pace-Asciak A, Pompa MG, Popescu GG, Robalo Cordeiro C, Rønning K, Ruhwald M, Sculier J-P, Simunović A, Smith-Palmer A, Sotgiu G, Sulis G, Torres-Duque CA, Umeki K, Uplekar M, van Weezenbeek C, Vasankari T, Vitillo RJ, Voniatis C, Wanlin M, Raviglione MC (2015) Towards tuberculosis elimination: an action framework for low-incidence countries. Eur Respir J 45: 928-952 (ARCN) https://doi.org/10.1183/09031936.00214014 https://www.ncbi.nlm.nih.gov/pubmed/25792630

Li Y, Fink C, El-Kholy S, Roeder T (2015) THE OCTOPAMINE RECEPTOR octß2R IS ESSENTIAL FOR OVULATION AND FERTILIZATION IN THE FRUIT FLYDrosophila melanogaster. Archives of Insect Biochemistry and Physiology 88: 168-178 (ARCN) https://doi.org/10.1002/arch.21211 https://www.ncbi.nlm.nih.gov/pubmed/25353988

Leidinger P, Treptow J, Hagens K, Eich J, Zehethofer N, Schwudke D, Oehlmann W, Lünsdorf H, Goldmann O, Schaible UE, Dittmar KEJ, Feldmann C (2015) Isoniazid@Fe2O3Nanocontainers and Their Antibacterial Effect on Tuberculosis Mycobacteria. Angewandte Chemie International Edition 54: 12597-12601 (ARCN) https://doi.org/10.1002/anie.201505493 https://www.ncbi.nlm.nih.gov/pubmed/26332072

Kuwana M, Hoeper MM, Behr J, Held M, Grunig E, Vizza CD, Vonk-Noordegraaf A, Lange TJ, Claussen M, Grohé C, Klose H, Olsson KM, Zelniker T, Neurohr C, Distler O, Wirtz H, Opitz C, Huscher D, Pittrow D, Gibbs JSR (2015) Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial Pneumonias. PLoS One 10: e0141911 (ARCN, BREATH, CPC-M, TLRC) https://doi.org/10.1371/journal.pone.0141911 http://www.ncbi.nlm.nih.gov/pubmed/26630396

Kunz LIZ, Postma DS, Klooster K, Lapperre TS, Vonk JM, Sont JK, Kerstjens HAM, Snoeck-Stroband JB, Hiemstra PS, Sterk PJ (2015) Relapse in FEV 1 Decline After Steroid Withdrawal in COPD. Chest 148: 389-396 (ARCN) https://doi.org/10.1378/chest.14-3091 http://www.ncbi.nlm.nih.gov/pubmed/25836351

Kulis M, Merkel A, Heath S, Queirós AC, Schuyler RP, Castellano G, Beekman R, Raineri E, Esteve A, Clot G, Verdaguer-Dot N, Duran-Ferrer M, Russiñol N, Vilarrasa-Blasi R, Ecker S, Pancaldi V, Rico D, Agueda L, Blanc J, Richardson D, Clarke L, Datta A, Pascual M, Agirre X, Prosper F, Alignani D, Paiva B, Caron G, Fest T, Muench MO, Fomin ME, Lee S-T, Wiemels JL, Valencia A, Gut M, Flicek P, Stunnenberg HG, Siebert R, Küppers R, Gut IG, Campo E, Martín-Subero JI (2015) Whole-genome fingerprint of the DNA methylome during human B cell differentiation. Nat Genet 47: 746-756 (ARCN) https://doi.org/10.1038/ng.3291 https://www.ncbi.nlm.nih.gov/pubmed/26053498

Krylov VB, Gerbst AG, Argunov DA, Dmitrenok AS, Shashkov AS, Kaczynski Z, Huebner J, Holst O, Nifantiev NE (2015) Definitive Structural Assessment of Enterococcal Diheteroglycan. Chemistry – A European Journal 21: 1749-1754 (ARCN) https://doi.org/10.1002/chem.201405857 http://www.ncbi.nlm.nih.gov/pubmed/25421964

Kriegsmann M, Muley T, Harms A, Tavernar L, Goldmann T, Dienemann H, Herpel E, Warth A (2015) Differential diagnostic value of CD5 and CD117 expression in thoracic tumors: A large scale study of 1465 non-small cell lung cancer cases. Diagn Pathol 10: 210 (ARCN, TLRC) https://doi.org/10.1186/s13000-015-0441-7 http://www.ncbi.nlm.nih.gov/pubmed/26643918

Kretzmer H, Bernhart SH, Wang W, Haake A, Weniger MA, Bergmann AK, Betts MJ, Carrillo-de-Santa-Pau E, Doose G, Gutwein J, Richter J, Hovestadt V, Huang B, Rico D, Jühling F, Kolarova J, Lu Q, Otto C, Wagener R, Arnolds J, Burkhardt B, Claviez A, Drexler HG, Eberth S, Eils R, Flicek P, Haas S, Hummel M, Karsch D, Kerstens HHD, Klapper W, Kreuz M, Lawerenz C, Lenze D, Loeffler M, López C, MacLeod RAF, Martens JHA, Kulis M, Martín-Subero JI, Möller P, Nagel I, Picelli S, Vater I, Rohde M, Rosenstiel P, Rosolowski M, Russell RB, Schilhabel M, Schlesner M, Stadler PF, Szczepanowski M, Trümper L, Stunnenberg HG, Küppers R, Ammerpohl O, Lichter P, Siebert R, Hoffmann S, Radlwimmer B (2015) DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control. Nat Genet 47: 1316-1325 (ARCN) https://doi.org/10.1038/ng.3413 https://www.ncbi.nlm.nih.gov/pubmed/26437030

Krauss-Etschmann S, Meyer KF, Dehmel S, Hylkema MN (2015) Inter- and transgenerational epigenetic inheritance: evidence in asthma and COPD? Clin Epigenetics 7: 53 (ARCN) https://doi.org/10.1186/s13148-015-0085-1 http://www.ncbi.nlm.nih.gov/pubmed/26052354

Kostikas K, Nussbaumer-Ochsner Y, Stolk J, Ferraz da Silva LF, van Schadewijk A, de Jeu RC, Prins FA, Mauad T, Rabe KF, Hiemstra PS (2015) Association of Lung Inflammatory Cells with Small Airways Function and Exhaled Breath Markers in Smokers – Is There a Specific Role for Mast Cells? PLoS One 10: e0129426 (ARCN) https://doi.org/10.1371/journal.pone.0129426 http://www.ncbi.nlm.nih.gov/pubmed/26069967

Kolarova J, Tangen I, Bens S, Gillessen-Kaesbach G, Gutwein J, Kautza M, Rydzanicz M, Stephani U, Siebert R, Ammerpohl O, Caliebe A (2015) Array-based DNA methylation analysis in individuals with developmental delay/intellectual disability and normal molecular karyotype. Eur J Med Genet 58: 419-425 (ARCN) https://doi.org/10.1016/j.ejmg.2015.05.001 https://www.ncbi.nlm.nih.gov/pubmed/26003415

Klinger A, Krapf L, Orzekowsky-Schroeder R, Koop N, Vogel A, Hüttmann G (2015) Intravital autofluorescence 2-photon microscopy of murine intestinal mucosa with ultra-broadband femtosecond laser pulse excitation: image quality, photodamage, and inflammation. J Biomed Opt 20: 116001 (ARCN) https://doi.org/10.1117/1.Jbo.20.11.116001 http://www.ncbi.nlm.nih.gov/pubmed/26524678

Kirsten AM, Förster K, Radeczky E, Linnhoff A, Balint B, Watz H, Wray H, Salkeld L, Cullberg M, Larsson B (2015) The safety and tolerability of oral AZD5069, a selective CXCR2 antagonist, in patients with moderate-to-severe COPD. Pulm Pharmacol Ther 31: 36-41 (ARCN) https://doi.org/10.1016/j.pupt.2015.02.001 http://www.ncbi.nlm.nih.gov/pubmed/25681277

Kirsten A-M, Watz H, Brindicci C, Piccinno A, Magnussen H (2015) Effects of beclomethason/formoterol and budesonide/formoterol fixed combinations on lung function and airway inflammation in patients with mild to moderate asthma – An exploratory study. Pulm Pharmacol Ther 31: 79-84 (ARCN) https://doi.org/10.1016/j.pupt.2014.08.007 http://www.ncbi.nlm.nih.gov/pubmed/25194884

Kemmer A, Bieber K, Abadpour A, Yu X, Mitschker N, Roth S, Kauderer C, Ludwig RJ, Seeger K, Köhl J, Zillikens D, Recke A (2015) A recombinant fusion protein derived from dog hookworm inhibits autoantibody-induced dermal-epidermal separationex vivo. Exp Dermatol 24: 872-878 (ARCN) https://doi.org/10.1111/exd.12804 https://www.ncbi.nlm.nih.gov/pubmed/26174039

Kasprick A, Yu X, Scholten J, Hartmann K, Pas HH, Zillikens D, Ludwig RJ, Petersen F (2015) Conditional depletion of mast cells has no impact on the severity of experimental epidermolysis bullosa acquisita. Eur J Immunol 45: 1462-1470 (ARCN) https://doi.org/10.1002/eji.201444769 http://www.ncbi.nlm.nih.gov/pubmed/25678008

 

Karsten CM, Laumonnier Y, Eurich B, Ender F, Bröker K, Roy S, Czabanska A, Vollbrandt T, Figge J, Köhl J (2015) Monitoring and Cell-Specific Deletion of C5aR1 Using a Novel Floxed GFP-C5aR1 Reporter Knock-in Mouse. The Journal of Immunology 194: 1841-1855 (ARCN) https://doi.org/10.4049/jimmunol.1401401 http://www.ncbi.nlm.nih.gov/pubmed/25589074

Karsten CM, Kohl J (2015) A bone to pick with Fc gamma receptors. Ann Transl Med 3: 218 (ARCN) https://doi.org/10.3978/j.issn.2305-5839.2015.07.11 http://www.ncbi.nlm.nih.gov/pubmed/26488014

Kallsen K, Zehethofer N, Abdelsadik A, Lindner B, Kabesch M, Heine H, Roeder T (2015) ORMDL deregulation increases stress responses and modulates repair pathways in Drosophila airways. Journal of Allergy and Clinical Immunology 136: 1105-1108 (ARCN, BREATH) https://doi.org/10.1016/j.jaci.2015.04.009 http://www.ncbi.nlm.nih.gov/pubmed/25979522

Jennings B, Hallier B, Hoffmann J, Roeder T, Tögel M, Meyer H, Paululat A (2015) The bHLH Transcription Factor Hand Regulates the Expression of Genes Critical to Heart and Muscle Function in Drosophila melanogaster. PLoS One 10: e0134204 (ARCN) https://doi.org/10.1371/journal.pone.0134204 http://www.ncbi.nlm.nih.gov/pubmed/26252215

Idzko M, Thijs W, Janssen K, van Schadewijk AM, Papapoulos SE, le Cessie S, Middeldorp S, Melissant CF, Rabe KF, Hiemstra PS (2015) Nasal Levels of Antimicrobial Peptides in Allergic Asthma Patients and Healthy Controls: Differences and Effect of a Short 1,25(OH)2 Vitamin D3 Treatment. PLoS One 10: e0140986 (ARCN) https://doi.org/10.1371/journal.pone.0140986 http://www.ncbi.nlm.nih.gov/pubmed/26545199

Homann A, Röckendorf N, Kromminga A, Frey A, Jappe U (2015) B cell epitopes on infliximab identified by oligopeptide microarray with unprocessed patient sera. J Transl Med 13: 339 (ARCN) https://doi.org/10.1186/s12967-015-0706-7 http://www.ncbi.nlm.nih.gov/pubmed/26511203

Holz O, Roepcke S, Watz H, Tegtbur U, Lahu G, Hohlfeld J (2015) Constant-load exercise decreases the serum concentration of myeloperoxidase in healthy smokers and smokers with COPD. Int J Chron Obstruct Pulmon Dis 10: 1393 (ARCN, BREATH) https://doi.org/10.2147/copd.S83269 http://www.ncbi.nlm.nih.gov/pubmed/26229458

Hoffmann J, Marsh LM, Pieper M, Stacher E, Ghanim B, Kovacs G, König P, Wilkens H, Haitchi HM, Hoefler G, Klepetko W, Olschewski H, Olschewski A, Kwapiszewska G (2015) Compartment-specific expression of collagens and their processing enzymes in intrapulmonary arteries of IPAH patients. American Journal of Physiology-Lung Cellular and Molecular Physiology 308: L1002-L1013 (ARCN) https://doi.org/10.1152/ajplung.00383.2014 http://www.ncbi.nlm.nih.gov/pubmed/25840998

Heigener DF, Reck M (2015) Immunotherapy: the third wave in lung cancer treatment. The Lancet Respiratory Medicine 3: 923-924 (ARCN) https://doi.org/10.1016/s2213-2600(15)00429-4 http://www.ncbi.nlm.nih.gov/pubmed/26679022

Heigener DF, Gandara DR, Reck M (2015) Targeting of MEK in lung cancer therapeutics. The Lancet Respiratory Medicine 3: 319-327 (ARCN) https://doi.org/10.1016/s2213-2600(15)00026-0 http://www.ncbi.nlm.nih.gov/pubmed/25801412

Groh M, Pagnoux C, Baldini C, Bel E, Bottero P, Cottin V, Dalhoff K, Dunogué B, Gross W, Holle J, Humbert M, Jayne D, Jennette JC, Lazor R, Mahr A, Merkel PA, Mouthon L, Sinico RA, Specks U, Vaglio A, Wechsler ME, Cordier J-F, Guillevin L (2015) Eosinophilic granulomatosis with polyangiitis (Churg–Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management. Eur J Intern Med 26: 545-553 (ARCN) https://doi.org/10.1016/j.ejim.2015.04.022 http://www.ncbi.nlm.nih.gov/pubmed/25971154

Gisch N, Schwudke D, Thomsen S, Heß N, Hakenbeck R, Denapaite D (2015) Lipoteichoic acid of Streptococcus oralis Uo5: a novel biochemical structure comprising an unusual phosphorylcholine substitution pattern compared to Streptococcus pneumoniae. Sci Rep 5: 16718 (ARCN) https://doi.org/10.1038/srep16718 http://www.ncbi.nlm.nih.gov/pubmed/26577602

Gehlsen U, Szaszák M, Gebert A, Koop N, Hüttmann G, Steven P (2015) Non-Invasive Multi-Dimensional Two-Photon Microscopy enables optical fingerprinting (TPOF) of immune cells. Journal of Biophotonics 8: 466-479 (ARCN) https://doi.org/10.1002/jbio.201400036 https://www.ncbi.nlm.nih.gov/pubmed/25186637

Fischer A, Ellinghaus D, Nutsua M, Hofmann S, Montgomery CG, Iannuzzi MC, Rybicki BA, Petrek M, Mrazek F, Pabst S, Grohé C, Grunewald J, Ronninger M, Eklund A, Padyukov L, Mihailovic-Vucinic V, Jovanovic D, Sterclova M, Homolka J, Nöthen MM, Herms S, Gieger C, Strauch K, Winkelmann J, Boehm BO, Brand S, Büning C, Schürmann M, Ellinghaus E, Baurecht H, Lieb W, Nebel A, Müller-Quernheim J, Franke A, Schreiber S (2015) Identification of Immune-Relevant Factors Conferring Sarcoidosis Genetic Risk. American Journal of Respiratory and Critical Care Medicine 192: 727-736 (ARCN) https://doi.org/10.1164/rccm.201503-0418OC http://www.ncbi.nlm.nih.gov/pubmed/26051272

Fink C, Hoffmann J, Knop M, Li Y, Isermann K, Roeder T (2015) Intestinal FoxO signaling is required to survive oral infection in Drosophila. Mucosal Immunol 9: 927-936 (ARCN) https://doi.org/10.1038/mi.2015.112 https://www.ncbi.nlm.nih.gov/pubmed/26627459

El-Kholy S, Stephano F, Li Y, Bhandari A, Fink C, Roeder T (2015) Expression analysis of octopamine and tyramine receptors in Drosophila. Cell and Tissue Research 361: 669-684 (ARCN) https://doi.org/10.1007/s00441-015-2137-4 http://www.ncbi.nlm.nih.gov/pubmed/25743690

Dyke SOM, Cheung WA, Joly Y, Ammerpohl O, Lutsik P, Rothstein MA, Caron M, Busche S, Bourque G, Rönnblom L, Flicek P, Beck S, Hirst M, Stunnenberg H, Siebert R, Walter J, Pastinen T (2015) Epigenome data release: a participant-centered approach to privacy protection. Genome Biol 16: 142 (ARCN) https://doi.org/10.1186/s13059-015-0723-0 https://www.ncbi.nlm.nih.gov/pubmed/26185018

Doose G, Haake A, Bernhart SH, López C, Duggimpudi S, Wojciech F, Bergmann AK, Borkhardt A, Burkhardt B, Claviez A, Dimitrova L, Haas S, Hoell JI, Hummel M, Karsch D, Klapper W, Kleo K, Kretzmer H, Kreuz M, Küppers R, Lawerenz C, Lenze D, Loeffler M, Mantovani-Löffler L, Möller P, Ott G, Richter J, Rohde M, Rosenstiel P, Rosenwald A, Schilhabel M, Schneider M, Scholz I, Stilgenbauer S, Stunnenberg HG, Szczepanowski M, Trümper L, Weniger MA, Hoffmann S, Siebert R, Iaccarino I (2015) MINCR is a MYC-induced lncRNA able to modulate MYC’s transcriptional network in Burkitt lymphoma cells. Proceedings of the National Academy of Sciences 112: E5261-E5270 (ARCN) https://doi.org/10.1073/pnas.1505753112 https://www.ncbi.nlm.nih.gov/pubmed/26351698

Doebele RC, Spigel D, Tehfe M, Thomas S, Reck M, Verma S, Eakle J, Bustin F, Goldschmidt J, Cao D, Alexandris E, Yurasov S, Camidge DR, Bonomi P (2015) Phase 2, randomized, open-label study of ramucirumab in combination with first-line pemetrexed and platinum chemotherapy in patients with nonsquamous, advanced/metastatic non-small cell lung cancer. Cancer 121: 883-892 (ARCN) https://doi.org/10.1002/cncr.29132 http://www.ncbi.nlm.nih.gov/pubmed/25377507

Diel R, Nienhaus A (2015) Aktuelle Fragestellungen zum Tuberkulose-Screening mit Interferon-Gamma-Release Assays (IGRAs). Pneumologie 69: 271-275 (ARCN) https://doi.org/10.1055/s-0034-1391919 https://www.ncbi.nlm.nih.gov/pubmed/25970120

Diel R, Lampenius N, Nienhaus A (2015) Cost Effectiveness of Preventive Treatment for Tuberculosis in Special High-Risk Populations. Pharmacoeconomics 33: 783-809 (ARCN) https://doi.org/10.1007/s40273-015-0267-x https://www.ncbi.nlm.nih.gov/pubmed/25774015

Diel R, Hittel N, Schaberg T (2015) Cost effectiveness of treating multi-drug resistant tuberculosis by adding Deltyba™ to background regimens in Germany. Respir Med 109: 632-641 (ARCN) https://doi.org/10.1016/j.rmed.2015.01.017 https://www.ncbi.nlm.nih.gov/pubmed/25862597

Dempke WC, Edvardsen K, Lu S, Reinmuth N, Reck M, Inoue A (2015) Brain Metastases in NSCLC – are TKIs Changing the Treatment Strategy? Anticancer Res 35: 5797-5806 (ARCN) https://www.ncbi.nlm.nih.gov/pubmed/26504000

de Tejada GM, Heinbockel L, Ferrer-Espada R, Heine H, Alexander C, Bárcena-Varela S, Goldmann T, Correa W, Wiesmüller K-H, Gisch N, Sánchez-Gómez S, Fukuoka S, Schürholz T, Gutsmann T, Brandenburg K (2015) Lipoproteins/peptides are sepsis-inducing toxins from bacteria that can be neutralized by synthetic anti-endotoxin peptides. Sci Rep 5: 14292 (ARCN) https://doi.org/10.1038/srep14292 http://www.ncbi.nlm.nih.gov/pubmed/26390973

Dalhoff K (2015) Pneumokokken-Impfung für Erwachsene unter 60 Jahren? Nein. DMW – Deutsche Medizinische Wochenschrift 140: 1774-1774 (ARCN) https://doi.org/10.1055/s-0041-107751 https://www.ncbi.nlm.nih.gov/pubmed/26529671

Collins JF, Wong YL, Lautenschläger I, Dombrowsky H, Zitta K, Bein B, Krause T, Goldmann T, Frerichs I, Steinfath M, Weiler N, Albrecht M (2015) Hydroxyethyl Starch (HES 130/0.4) Impairs Intestinal Barrier Integrity and Metabolic Function: Findings from a Mouse Model of the Isolated Perfused Small Intestine. PLoS One 10: e0121497 (ARCN) https://doi.org/10.1371/journal.pone.0121497 http://www.ncbi.nlm.nih.gov/pubmed/25799493

Chiappori AA, Kolevska T, Spigel DR, Hager S, Rarick M, Gadgeel S, Blais N, Von Pawel J, Hart L, Reck M, Bassett E, Burington B, Schiller JH (2015) A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer. Ann Oncol 26: 354-362 (ARCN) https://doi.org/10.1093/annonc/mdu550 http://www.ncbi.nlm.nih.gov/pubmed/25467017

Chardot T, Schwager C, Kull S, Krause S, Schocker F, Petersen A, Becker W-M, Jappe U (2015) Development of a Novel Strategy to Isolate Lipophilic Allergens (Oleosins) from Peanuts. PLoS One 10: e0123419 (ARCN) https://doi.org/10.1371/journal.pone.0123419 https://www.ncbi.nlm.nih.gov/pubmed/25860789

Celli BR, Decramer M, Wedzicha JA, Wilson KC, Agustí AA, Criner GJ, MacNee W, Make BJ, Rennard SI, Stockley RA, Vogelmeier C, Anzueto A, Au DH, Barnes PJ, Burgel P-R, Calverley PM, Casanova C, Clini EM, Cooper CB, Coxson HO, Dusser DJ, Fabbri LM, Fahy B, Ferguson GT, Fisher A, Fletcher MJ, Hayot M, Hurst JR, Jones PW, Mahler DA, Maltais F, Mannino DM, Martinez FJ, Miravitlles M, Meek PM, Papi A, Rabe KF, Roche N, Sciurba FC, Sethi S, Siafakas N, Sin DD, Soriano JB, Stoller JK, Tashkin DP, Troosters T, Verleden GM, Verschakelen J, Vestbo J, Walsh JW, Washko GR, Wise RA, Wouters EFM, ZuWallack RL (2015) An official American Thoracic Society/European Respiratory Society statement: research questions in COPD. European Respiratory Review 24: 159-172 (ARCN, UGMLC) https://doi.org/10.1183/16000617.00000315 http://www.ncbi.nlm.nih.gov/pubmed/26028628

Celli BR, Decramer M, Wedzicha JA, Wilson KC, Agustí A, Criner GJ, MacNee W, Make BJ, Rennard SI, Stockley RA, Vogelmeier C, Anzueto A, Au DH, Barnes PJ, Burgel P-R, Calverley PM, Casanova C, Clini EM, Cooper CB, Coxson HO, Dusser DJ, Fabbri LM, Fahy B, Ferguson GT, Fisher A, Fletcher MJ, Hayot M, Hurst JR, Jones PW, Mahler DA, Maltais F, Mannino DM, Martinez FJ, Miravitlles M, Meek PM, Papi A, Rabe KF, Roche N, Sciurba FC, Sethi S, Siafakas N, Sin DD, Soriano JB, Stoller JK, Tashkin DP, Troosters T, Verleden GM, Verschakelen J, Vestbo J, Walsh JW, Washko GR, Wise RA, Wouters EFM, ZuWallack RL (2015) An official American Thoracic Society/European Respiratory Society statement: research questions in COPD. Eur Respir J 45: 879-905 (ARCN, UGMLC) https://doi.org/10.1183/09031936.00009015 http://www.ncbi.nlm.nih.gov/pubmed/25829431

Celli BR, Decramer M, Wedzicha JA, Wilson KC, Agustí A, Criner GJ, MacNee W, Make BJ, Rennard SI, Stockley RA, Vogelmeier C, Anzueto A, Au DH, Barnes PJ, Burgel P-R, Calverley PM, Casanova C, Clini EM, Cooper CB, Coxson HO, Dusser DJ, Fabbri LM, Fahy B, Ferguson GT, Fisher A, Fletcher MJ, Hayot M, Hurst JR, Jones PW, Mahler DA, Maltais F, Mannino DM, Martinez FJ, Miravitlles M, Meek PM, Papi A, Rabe KF, Roche N, Sciurba FC, Sethi S, Siafakas N, Sin DD, Soriano JB, Stoller JK, Tashkin DP, Troosters T, Verleden GM, Verschakelen J, Vestbo J, Walsh JW, Washko GR, Wise RA, Wouters EFM, ZuWallack RL (2015) An Official American Thoracic Society/European Respiratory Society Statement: Research Questions in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine 191: e4-e27 (ARCN, UGMLC) https://doi.org/10.1164/rccm.201501-0044ST http://www.ncbi.nlm.nih.gov/pubmed/25830527

Cagnoni EF, Ferreira DS, Ferraz da Silva LF, Nicoletti Carvalho Petry AL, Gomes dos Santos AB, Rodrigues Medeiros MC, Dolhnikoff M, Rabe KF, Mauad T (2015) Bronchopulmonary lymph nodes and large airway cell trafficking in patients with fatal asthma. Journal of Allergy and Clinical Immunology 135: 1352-1357.e1359 (ARCN) https://doi.org/10.1016/j.jaci.2014.08.021 http://www.ncbi.nlm.nih.gov/pubmed/25262462

Buhl R, Maltais F, Abrahams R, Bjermer L, Derom E, Ferguson G, Flezar M, Hebert J, McGarvey L, Pizzichini E, Reid J, Veale A, Gronke L, Hamilton A, Korducki L, Tetzlaff K, Waitere-Wijker S, Watz H, Bateman E (2015) Author Correction. Eur Respir J 45: 1763.1762-1763 (ARCN) https://doi.org/10.1183/09031936.50136014 http://www.ncbi.nlm.nih.gov/pubmed/26028626

Buhl R, Maltais F, Abrahams R, Bjermer L, Derom E, Ferguson G, Fležar M, Hébert J, McGarvey L, Pizzichini E, Reid J, Veale A, Grönke L, Hamilton A, Korducki L, Tetzlaff K, Waitere-Wijker S, Watz H, Bateman E (2015) Tiotropium and olodaterol fixed-dose combinationversusmono-components in COPD (GOLD 2–4). Eur Respir J 45: 969-979 (ARCN) https://doi.org/10.1183/09031936.00136014 http://www.ncbi.nlm.nih.gov/pubmed/25573406

Brahmer J, Reckamp KL, Baas P, Crinò L, Eberhardt WEE, Poddubskaya E, Antonia S, Pluzanski A, Vokes EE, Holgado E, Waterhouse D, Ready N, Gainor J, Arén Frontera O, Havel L, Steins M, Garassino MC, Aerts JG, Domine M, Paz-Ares L, Reck M, Baudelet C, Harbison CT, Lestini B, Spigel DR (2015) Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer. New England Journal of Medicine 373: 123-135 (ARCN) https://doi.org/10.1056/NEJMoa1504627 http://www.ncbi.nlm.nih.gov/pubmed/26028407

Bradley P, Gordon NC, Walker TM, Dunn L, Heys S, Huang B, Earle S, Pankhurst LJ, Anson L, de Cesare M, Piazza P, Votintseva AA, Golubchik T, Wilson DJ, Wyllie DH, Diel R, Niemann S, Feuerriegel S, Kohl TA, Ismail N, Omar SV, Smith EG, Buck D, McVean G, Walker AS, Peto TEA, Crook DW, Iqbal Z (2015) Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis. Nature Communications 6: 10063 (ARCN) https://doi.org/10.1038/ncomms10063 https://www.ncbi.nlm.nih.gov/pubmed/26686880

Bousquet J, Schunemann HJ, Fonseca J, Samolinski B, Bachert C, Canonica GW, Casale T, Cruz AA, Demoly P, Hellings P, Valiulis A, Wickman M, Zuberbier T, Bosnic-Anticevitch S, Bedbrook A, Bergmann KC, Caimmi D, Dahl R, Fokkens WJ, Grisle I, Lodrup Carlsen K, Mullol J, Muraro A, Palkonen S, Papadopoulos N, Passalacqua G, Ryan D, Valovirta E, Yorgancioglu A, Aberer W, Agache I, Adachi M, Akdis CA, Akdis M, Annesi-Maesano I, Ansotegui IJ, Anto JM, Arnavielhe S, Arshad H, Baiardini I, Baigenzhin AK, Barbara C, Bateman ED, Beghé B, Bel EH, Ben Kheder A, Bennoor KS, Benson M, Bewick M, Bieber T, Bindslev-Jensen C, Bjermer L, Blain H, Boner AL, Boulet LP, Bonini M, Bonini S, Bosse I, Bourret R, Bousquet PJ, Braido F, Briggs AH, Brightling CE, Brozek J, Buhl R, Burney PG, Bush A, Caballero-Fonseca F, Calderon MA, Camargos PAM, Camuzat T, Carlsen KH, Carr W, Cepeda Sarabia AM, Chavannes NH, Chatzi L, Chen YZ, Chiron R, Chkhartishvili E, Chuchalin AG, Ciprandi G, Cirule I, Correia de Sousa J, Cox L, Crooks G, Costa DJ, Custovic A, Dahlen SE, Darsow U, De Carlo G, De Blay F, Dedeu T, Deleanu D, Denburg JA, Devillier P, Didier A, Dinh-Xuan AT, Dokic D, Douagui H, Dray G, Dubakiene R, Durham SR, Dykewicz MS, El-Gamal Y, Emuzyte R, Fink Wagner A, Fletcher M, Fiocchi A, Forastiere F, Gamkrelidze A, Gemicioğlu B, Gereda JE, González Diaz S, Gotua M, Grouse L, Guzmán MA, Haahtela T, Hellquist-Dahl B, Heinrich J, Horak F, Hourihane JOB, Howarth P, Humbert M, Hyland ME, Ivancevich JC, Jares EJ, Johnston SL, Joos G, Jonquet O, Jung KS, Just J, Kaidashev I, Kalayci O, Kalyoncu AF, Keil T, Keith PK, Khaltaev N, Klimek L, Koffi N’Goran B, Kolek V, Koppelman GH, Kowalski ML, Kull I, Kuna P, Kvedariene V, Lambrecht B, Lau S, Larenas-Linnemann D, Laune D, Le LTT, Lieberman P, Lipworth B, Li J, Louis R, Magard Y, Magnan A, Mahboub B, Majer I, Makela MJ, Manning P, De Manuel Keenoy E, Marshall GD, Masjedi MR, Maurer M, Mavale-Manuel S, Melén E, Melo-Gomes E, Meltzer EO, Merk H, Miculinic N, Mihaltan F, Milenkovic B, Mohammad Y, Molimard M, Momas I, Montilla-Santana A, Morais-Almeida M, Mösges R, Namazova-Baranova L, Naclerio R, Neou A, Neffen H, Nekam K, Niggemann B, Nyembue TD, O’Hehir RE, Ohta K, Okamoto Y, Okubo K, Ouedraogo S, Paggiaro P, Pali-Schöll I, Palmer S, Panzner P, Papi A, Park HS, Pavord I, Pawankar R, Pfaar O, Picard R, Pigearias B, Pin I, Plavec D, Pohl W, Popov TA, Portejoie F, Postma D, Potter P, Price D, Rabe KF, Raciborski F, Radier Pontal F, Repka-Ramirez S, Robalo-Cordeiro C, Rolland C, Rosado-Pinto J, Reitamo S, Rodenas F, Roman Rodriguez M, Romano A, Rosario N, Rosenwasser L, Rottem M, Sanchez-Borges M, Scadding GK, Serrano E, Schmid-Grendelmeier P, Sheikh A, Simons FER, Sisul JC, Skrindo I, Smit HA, Solé D, Sooronbaev T, Spranger O, Stelmach R, Strandberg T, Sunyer J, Thijs C, Todo-Bom A, Triggiani M, Valenta R, Valero AL, van Hage M, Vandenplas O, Vezzani G, Vichyanond P, Viegi G, Wagenmann M, Walker S, Wang DY, Wahn U, Williams DM, Wright J, Yawn BP, Yiallouros PK, Yusuf OM, Zar HJ, Zernotti ME, Zhang L, Zhong N, Zidarn M, Mercier J (2015) MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation. Allergy 70: 1372-1392 (ARCN, CPC-M) https://doi.org/10.1111/all.12686 http://onlinelibrary.wiley.com/store/10.1111/all.12686/asset/all12686.pdf?v=1&t=iye9jhxg&s=62f99260c0122a07bce5baa8804733425a27e703

Bousquet J, Kuh D, Bewick M, Standberg T, Farrell J, Pengelly R, Joel ME, Rodriguez Mañas L, Mercier J, Bringer J, Camuzat T, Bourret R, Bedbrook A, Kowalski ML, Samolinski B, Bonini S, Brayne C, Michel JP, Venne J, Viriot-Durandal P, Alonso J, Avignon A, Ben-Shlomo Y, Bousquet PJ, Combe B, Cooper R, Hardy R, Iaccarino G, Keil T, Kesse-Guyot E, Momas I, Ritchie K, Robine JM, Thijs C, Tischer C, Vellas B, Zaidi A, Alonso F, Andersen Ranberg K, Andreeva V, Ankri J, Arnavielhe S, Arshad H, Augé P, Berr C, Bertone P, Blain H, Blasimme A, Buijs GJ, Caimmi D, Carriazo A, Cesario A, Coletta J, Cosco T, Criton M, Cuisinier F, Demoly P, Fernandez-Nocelo S, Fougère B, Garcia-Aymerich J, Goldberg M, Guldemond N, Gutter Z, Harman D, Hendry A, Heve D, Illario M, Jeande C, Krauss-Etschmann S, Krys O, Kula D, Laune D, Lehmann S, Maier D, Malva J, Matignon P, Melen E, Mercier G, Moda G, Nizinkska A, Nogues M, O’Neill M, Pelissier JY, Poethig D, Porta D, Postma D, Puisieux F, Richards M, Robalo-Cordeiro C, Romano V, Roubille F, Schulz H, Scott A, Senesse P, Slagter S, Smit HA, Somekh D, Stafford M, Suanzes J, Todo-Bom A, Touchon J, Traver-Salcedo V, Van Beurden M, Varraso R, Vergara I, Villalba-Mora E, Wilson N, Wouters E, Zins M (2015) Operational definition of Active and Healthy Ageing (AHA): A conceptual framework. J Nutr Health Aging 19: 955-960 (ARCN, CPC-M) https://doi.org/10.1007/s12603-015-0589-6 https://www.ncbi.nlm.nih.gov/pubmed/26482699

Bousquet J, Anto JM, Berkouk K, Gergen P, Antunes JP, Augé P, Camuzat T, Bringer J, Mercier J, Best N, Bourret R, Akdis M, Arshad SH, Bedbrook A, Berr C, Bush A, Cavalli G, Charles MA, Clavel-Chapelon F, Gillman M, Gold DR, Goldberg M, Holloway JW, Iozzo P, Jacquemin S, Jeandel C, Kauffmann F, Keil T, Koppelman GH, Krauss-Etschmann S, Kuh D, Lehmann S, Carlsen KCL, Maier D, Méchali M, Melén E, Moatti JP, Momas I, Nérin P, Postma DS, Ritchie K, Robine JM, Samolinski B, Siroux V, Slagboom PE, Smit HA, Sunyer J, Valenta R, Van de Perre P, Verdier JM, Vrijheid M, Wickman M, Yiallouros P, Zins M (2015) Developmental determinants in non-communicable chronic diseases and ageing. Thorax 70: 595-597 (ARCN) https://doi.org/10.1136/thoraxjnl-2014-206304 http://www.ncbi.nlm.nih.gov/pubmed/25616486

Blachier F, Lautenschläger I, Frerichs I, Dombrowsky H, Sarau J, Goldmann T, Zitta K, Albrecht M, Weiler N, Uhlig S (2015) Quinidine, but Not Eicosanoid Antagonists or Dexamethasone, Protect the Gut from Platelet Activating Factor-Induced Vasoconstriction, Edema and Paralysis. PLoS One 10: e0120802 (ARCN) https://doi.org/10.1371/journal.pone.0120802 http://www.ncbi.nlm.nih.gov/pubmed/25793535

Betts MJ, Lu Q, Jiang Y, Drusko A, Wichmann O, Utz M, Valtierra-Gutiérrez IA, Schlesner M, Jaeger N, Jones DT, Pfister S, Lichter P, Eils R, Siebert R, Bork P, Apic G, Gavin A-C, Russell RB (2015) Mechismo: predicting the mechanistic impact of mutations and modifications on molecular interactions. Nucleic Acids Res 43: e10-e10 (ARCN, TLRC) https://doi.org/10.1093/nar/gku1094 https://www.ncbi.nlm.nih.gov/pubmed/25392414

Behr J, Kreuter M, Hoeper MM, Wirtz H, Klotsche J, Koschel D, Andreas S, Claussen M, Grohé C, Wilkens H, Randerath W, Skowasch D, Meyer FJ, Kirschner J, Gläser S, Herth FJF, Welte T, Huber RM, Neurohr C, Schwaiblmair M, Kohlhäufl M, Höffken G, Held M, Koch A, Bahmer T, Pittrow D (2015) Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry. Eur Respir J 46: 186-196 (ARCN, BREATH, CPC-M, TLRC) https://doi.org/10.1183/09031936.00217614 http://www.ncbi.nlm.nih.gov/pubmed/25837040

Bateman ED, O’Byrne PM, Buhl R, Rabe KF (2015) Roflumilast for asthma: Weighing the evidence. Pulm Pharmacol Ther 35: S1-S3 (ARCN) https://doi.org/10.1016/j.pupt.2015.08.001 http://www.ncbi.nlm.nih.gov/pubmed/26278190

Bardin P, Kanniess F, Gauvreau G, Bredenbröker D, Rabe KF (2015) Roflumilast for asthma: Efficacy findings in mechanism of action studies. Pulm Pharmacol Ther 35: S4-S10 (ARCN) https://doi.org/10.1016/j.pupt.2015.08.006 http://www.ncbi.nlm.nih.gov/pubmed/26296794

Ansari R, Buj C, Pieper M, König P, Schweikard A, Hüttmann G (2015) Micro-anatomical and functional assessment of ciliated epithelium in mouse trachea using optical coherence phase microscopy. Opt Express 23: 23217 (ARCN) https://doi.org/10.1364/oe.23.023217 http://www.ncbi.nlm.nih.gov/pubmed/26368424

Annoni R, Silva LFF, Nussbaumer-Ochsner Y, van Schadewijk A, Mauad T, Hiemstra PS, Rabe KF (2015) Increased expression of granzymes A and B in fatal asthma. Eur Respir J 45: 1485-1488 (ARCN) https://doi.org/10.1183/09031936.00213814 http://www.ncbi.nlm.nih.gov/pubmed/25745046

 

2014

Zheng J, Chen Y, Deng F, Huang R, Petersen F, Ibrahim S, Yu X (2014) mtDNA sequence, phylogeny and evolution of laboratory mice. Mitochondrion 17: 126-131 (ARCN) https://doi.org/10.1016/j.mito.2014.07.006 http://www.ncbi.nlm.nih.gov/pubmed/25038446

Zehethofer N, Bermbach S, Hagner S, Garn H, Müller J, Goldmann T, Lindner B, Schwudke D, König P (2014) Lipid Analysis of Airway Epithelial Cells for Studying Respiratory Diseases. Chromatographia 78: 403-413 (ARCN, UGMLC) https://doi.org/10.1007/s10337-014-2787-5 http://www.ncbi.nlm.nih.gov/pubmed/25750457

Yildirim AÖ, Lambermont VA, Schlepütz M, Dassow C, König P, Zimmermann LJ, Uhlig S, Kramer BW, Martin C (2014) Comparison of Airway Responses in Sheep of Different Age in Precision-Cut Lung Slices (PCLS). PLoS One 9: e97610 (ARCN, CPC-M) https://doi.org/10.1371/journal.pone.0097610 http://www.ncbi.nlm.nih.gov/pubmed/25229890

Yildirim AÖ, Bratu VA, Erpenbeck VJ, Fehrenbach A, Rausch T, Rittinghausen S, Krug N, Hohlfeld JM, Fehrenbach H (2014) Cell Counting in Human Endobronchial Biopsies – Disagreement of 2D versus 3D Morphometry. PLoS One 9: e92510 (ARCN, BREATH) https://doi.org/10.1371/journal.pone.0092510 http://www.ncbi.nlm.nih.gov/pubmed/24663339

Yáñez A, Cho S-H, Soriano JB, Rosenwasser LJ, Rodrigo GJ, Rabe KF, Peters S, Niimi A, Ledford DK, Katial R, Fabbri LM, Celedón JC, Canonica GW, Busse P, Boulet L-P, Baena-Cagnani CE, Hamid Q, Bachert C, Pawankar R, Holgate ST (2014) Asthma in the elderly: what we know and what we have yet to know. World Allergy Organization Journal 7: 8 (ARCN) https://doi.org/10.1186/1939-4551-7-8 http://www.ncbi.nlm.nih.gov/pubmed/25152804

Worm M, Jappe U, Kleine-Tebbe J, Schäfer C, Reese I, Saloga J, Treudler R, Zuberbier T, Waßmann A, Fuchs T, Dölle S, Raithel M, Ballmer-Weber B, Niggemann B, Werfel T (2014) Food allergies resulting from immunological cross-reactivity with inhalant allergens. Allergo Journal International 23: 1-16 (ARCN) https://doi.org/10.1007/s40629-014-0004-6 https://www.ncbi.nlm.nih.gov/pubmed/26120513

Wedzicha JA, Rabe KF, Martinez FJ, Bredenbröker D, Brose M, Goehring U-M, Calverley PMA (2014) Response. Chest 145: 428 (ARCN) https://doi.org/10.1378/chest.13-2535 http://www.ncbi.nlm.nih.gov/pubmed/24493539

Watz H, Pitta F, Rochester CL, Garcia-Aymerich J, ZuWallack R, Troosters T, Vaes AW, Puhan MA, Jehn M, Polkey MI, Vogiatzis I, Clini EM, Toth M, Gimeno-Santos E, Waschki B, Esteban C, Hayot M, Casaburi R, Porszasz J, McAuley E, Singh SJ, Langer D, Wouters EFM, Magnussen H, Spruit MA (2014) An official European Respiratory Society statement on physical activity in COPD. Eur Respir J 44: 1521-1537 (ARCN) https://doi.org/10.1183/09031936.00046814 http://www.ncbi.nlm.nih.gov/pubmed/25359358

Watz H, Krippner F, Kirsten A, Magnussen H, Vogelmeier C (2014) Indacaterol improves lung hyperinflation and physical activity in patients with moderate chronic obstructive pulmonary disease – a randomized, multicenter, double-blind, placebo-controlled study. BMC Pulm Med 14: 158 (ARCN, UGMLC) https://doi.org/10.1186/1471-2466-14-158 http://www.ncbi.nlm.nih.gov/pubmed/25280934

Watz H, Barnacle H, Hartley BF, Chan R (2014) Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial. The Lancet Respiratory Medicine 2: 63-72 (ARCN) https://doi.org/10.1016/s2213-2600(13)70200-5 http://www.ncbi.nlm.nih.gov/pubmed/24461903

Watz H, Arzt M (2014) COPD und Herzerkrankung. Herz 39: 53-57 (ARCN) https://doi.org/10.1007/s00059-014-4059-4 http://www.ncbi.nlm.nih.gov/pubmed/24509868

von Pawel J, Jotte R, Spigel DR, O’Brien MER, Socinski MA, Mezger J, Steins M, Bosquée L, Bubis J, Nackaerts K, Trigo JM, Clingan P, Schütte W, Lorigan P, Reck M, Domine M, Shepherd FA, Li S, Renschler MF (2014) Randomized Phase III Trial of Amrubicin Versus Topotecan As Second-Line Treatment for Patients With Small-Cell Lung Cancer. J Clin Oncol 32: 4012-4019 (ARCN) https://doi.org/10.1200/jco.2013.54.5392 http://www.ncbi.nlm.nih.gov/pubmed/25385727

von Pawel J, Harvey JH, Spigel DR, Dediu M, Reck M, Cebotaru CL, Humphreys RC, Gribbin MJ, Fox NL, Camidge DR (2014) Phase II Trial of Mapatumumab, a Fully Human Agonist Monoclonal Antibody to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor 1 (TRAIL-R1), in Combination With Paclitaxel and Carboplatin in Patients With Advanced Non–Small-Cell Lung Cancer. Clin Lung Cancer 15: 188-196.e182 (ARCN) https://doi.org/10.1016/j.cllc.2013.12.005 http://www.ncbi.nlm.nih.gov/pubmed/24560012

von Pawel J, Gorbounova V, Reck M, Kowalski DM, Allard A, Chadjaa M, Rey A, Bennouna J, Grossi F (2014) DISRUPT: A randomised phase 2 trial of ombrabulin (AVE8062) plus a taxane–platinum regimen as first-line therapy for metastatic non-small cell lung cancer. Lung Cancer 85: 224-229 (ARCN) https://doi.org/10.1016/j.lungcan.2014.05.013 http://www.ncbi.nlm.nih.gov/pubmed/24888230

Visser AW, de Mutsert R, Loef M, le Cessie S, den Heijer M, Bloem JL, Reijnierse M, Rosendaal FR, Kloppenburg M (2014) The role of fat mass and skeletal muscle mass in knee osteoarthritis is different for men and women: the NEO study. Osteoarthritis Cartilage 22: 197-202 (ARCN) https://doi.org/10.1016/j.joca.2013.12.002

Vansteenkiste J, Crinò L, Dooms C, Douillard JY, Faivre-Finn C, Lim E, Rocco G, Senan S, Van Schil P, Veronesi G, Stahel R, Peters S, Felip E, Stahel R, Felip E, Peters S, Kerr K, Besse B, Vansteenkiste J, Eberhardt W, Edelman M, Mok T, O’Byrne K, Novello S, Bubendorf L, Marchetti A, Baas P, Reck M, Syrigos K, Paz-Ares L, Smit EF, Meldgaard P, Adjei A, Nicolson M, Crinò L, Van Schil P, Senan S, Faivre-Finn C, Rocco G, Veronesi G, Douillard J-Y, Lim E, Dooms C, Weder W, De Ruysscher D, Le Pechoux C, De Leyn P, Westeel V (2014) 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up. Ann Oncol 25: 1462-1474 (ARCN) https://doi.org/10.1093/annonc/mdu089 http://www.ncbi.nlm.nih.gov/pubmed/24562446

van Zandbergen G, Yu X, Zheng J, Collin M, Schmidt E, Zillikens D, Petersen F (2014) EndoS Reduces the Pathogenicity of Anti-mCOL7 IgG through Reduced Binding of Immune Complexes to Neutrophils. PLoS One 9: e85317 (ARCN) https://doi.org/10.1371/journal.pone.0085317 http://www.ncbi.nlm.nih.gov/pubmed/24504190

Thijs W, Dehnavi RA, Hiemstra PS, de Roos A, Melissant CF, Janssen K, Tamsma JT, Rabe KF (2014) Association of lung function measurements and visceral fat in men with metabolic syndrome. Respir Med 108: 351-357 (ARCN) https://doi.org/10.1016/j.rmed.2013.10.003 http://www.ncbi.nlm.nih.gov/pubmed/24239315

Thijs W, de Mutsert R, le Cessie S, Hiemstra PS, Rosendaal FR, Middeldorp S, Rabe KF (2014) Reproducibility of exhaled nitric oxide measurements in overweight and obese adults. BMC Res Notes 7: 775 (ARCN) https://doi.org/10.1186/1756-0500-7-775 http://www.ncbi.nlm.nih.gov/pubmed/25366981

Suissa S, Rabe KF (2014) Rebuttal From Drs Suissa and Rabe. Chest 145: 942-943 (ARCN) https://doi.org/10.1378/chest.14-0113 http://www.ncbi.nlm.nih.gov/pubmed/24798832

Suissa S, Rabe KF (2014) Point: Were Industry-Sponsored Roflumilast Trials Appropriate? Yes. Chest 145: 937-939 (ARCN) https://doi.org/10.1378/chest.14-0112 http://www.ncbi.nlm.nih.gov/pubmed/24798830

Sinnecker H, Ramaker K, Frey A (2014) Coating with luminal gut-constituents alters adherence of nanoparticles to intestinal epithelial cells. Beilstein Journal of Nanotechnology 5: 2308-2315 (ARCN) https://doi.org/10.3762/bjnano.5.239 http://www.ncbi.nlm.nih.gov/pubmed/25551058

Sinnecker H, Krause T, Koelling S, Lautenschläger I, Frey A (2014) The gut wall provides an effective barrier against nanoparticle uptake. Beilstein Journal of Nanotechnology 5: 2092-2101 (ARCN) https://doi.org/10.3762/bjnano.5.218 http://www.ncbi.nlm.nih.gov/pubmed/25551037

Shevchuk O, Abidi N, Klawonn F, Wissing J, Nimtz M, Kugler C, Steinert M, Goldmann T, Jänsch L (2014) HOPE-Fixation of Lung Tissue Allows Retrospective Proteome and Phosphoproteome Studies. J Proteome Res 13: 5230-5239 (ARCN) https://doi.org/10.1021/pr500096a http://www.ncbi.nlm.nih.gov/pubmed/24702127

Sebastian M, Schmittel A, Reck M (2014) First-line treatment of EGFR-mutated nonsmall cell lung cancer: critical review on study methodology. European Respiratory Review 23: 92-105 (ARCN) https://doi.org/10.1183/09059180.00008413 http://www.ncbi.nlm.nih.gov/pubmed/24591666

Sebastian M, Niederle N, Thomas M, Reck M, Schmittel A, Fischer B, Overbeck T, Gröschel A, Deppermann M, Pirker R, Huber R, Eberhardt W, Griesinger F (2014) Molekulargenetische Untersuchungen bei fortgeschrittenem nicht-kleinzelligem Lungenkarzinom: praktische Relevanz. DMW – Deutsche Medizinische Wochenschrift 139: 2096-2100 (ARCN, TLRC, CPC-M) https://doi.org/10.1055/s-0034-1387294 http://www.ncbi.nlm.nih.gov/pubmed/25268213

Schreiber J, Kopp M, Korn S, Taube C, Buhl R (2014) Disease-Modifikation und Dauer einer Omalizumab-Therapie bei Patienten mit schwerem allergischen Asthma. Pneumologie 68: 187-192 (ARCN) https://doi.org/10.1055/s-0033-1359242 https://www.ncbi.nlm.nih.gov/pubmed/24477463

Schneider A, Faderl B, Schwarzbach J, Welker L, Karsch-Völk M, Jörres RA (2014) Prognostic value of bronchial provocation and FENO measurement for asthma diagnosis – Results of a delayed type of diagnostic study. Respir Med 108: 34-40 (ARCN, CPC-M) https://doi.org/10.1016/j.rmed.2013.11.008 http://www.ncbi.nlm.nih.gov/pubmed/24315470

Schmidt A, Belaaouaj A, Bissinger R, Koller G, Malleret L, D’Orazio C, Facchinelli M, Schulte-Hubbert B, Molinaro A, Holst O, Hammermann J, Schniederjans M, Meyer KC, Damkiaer S, Piacentini G, Assael B, Bruce K, Häußler S, LiPuma JJ, Seelig J, Worlitzsch D, Döring G (2014) Neutrophil elastase-mediated increase in airway temperature during inflammation. Journal of Cystic Fibrosis 13: 623-631 (ARCN) https://doi.org/10.1016/j.jcf.2014.03.004 http://www.ncbi.nlm.nih.gov/pubmed/24713593

Samakovlis C, Faisal MN, Hoffmann J, El-Kholy S, Kallsen K, Wagner C, Bruchhaus I, Fink C, Roeder T (2014) Transcriptional Regionalization of the Fruit Fly’s Airway Epithelium. PLoS One 9: e102534 (ARCN) https://doi.org/10.1371/journal.pone.0102534 http://www.ncbi.nlm.nih.gov/pubmed/25020150

Ryffel B, Jordakieva G, Wallmann J, Schmutz R, Lemell P, Wegmann M, Nittke T, Mittlböck M, Fehrenbach H, Godnic-Cvar J, Zieglmayer R, Jensen-Jarolim E (2014) Peripheral Erythrocytes Decrease upon Specific Respiratory Challenge with Grass Pollen Allergen in Sensitized Mice and in Human Subjects. PLoS One 9: e86701 (ARCN) https://doi.org/10.1371/journal.pone.0086701 http://www.ncbi.nlm.nih.gov/pubmed/24466205

Reinmuth N, Stumpf P, Stumpf A, Muley T, Kobinger S, Hoffmann H, Herth FJF, Schnabel PA, Bischoff H, Thomas M (2014) Characteristics of lung cancer after a previous malignancy. Respir Med 108: 910-917 (ARCN, TLRC) https://doi.org/10.1016/j.rmed.2014.02.015 http://www.ncbi.nlm.nih.gov/pubmed/24650574

Reinmuth N, Reck M, Grohé C (2014) Antiangiogenes Wirkprinzip – Konzepte der Therapieoptimierung des nicht-squamösen nicht-kleinzelligen Lungenkarzinoms. Pneumologie 68: 793-798 (ARCN) https://doi.org/10.1055/s-0034-1390807 http://www.ncbi.nlm.nih.gov/pubmed/25489867

Reinmuth N, Meyer A, Hartwigsen D, Schaeper C, Huebner G, Skock-Lober R, Bier A, Gerecke U, Held CP, Reck M (2014) Randomized, double-blind phase II study to compare nitroglycerin plus oral vinorelbine plus cisplatin with oral vinorelbine plus cisplatin alone in patients with stage IIIB/IV non-small cell lung cancer (NSCLC). Lung Cancer 83: 363-368 (ARCN) https://doi.org/10.1016/j.lungcan.2014.01.001 http://www.ncbi.nlm.nih.gov/pubmed/24462464

Reinmuth N, Kloos S, Warth A, Risch A, Muley T, Hoffmann H, Thomas M, Meister M (2014) Insulin-like growth factor 1 pathway mutations and protein expression in resected non–small cell lung cancer. Hum Pathol 45: 1162-1168 (ARCN, TLRC) https://doi.org/10.1016/j.humpath.2014.01.010 http://www.ncbi.nlm.nih.gov/pubmed/24745618

Reinmuth N, Heigener D, Goldmann T, Watermann I, Reck M (2014) Reduzierte Dosis von TKI führt nicht zu Wirkungsverlust bei Patienten mit aktivierender EGFR-Mutation. Pneumologie 68: 619-623 (ARCN) https://doi.org/10.1055/s-0034-1377927 http://www.ncbi.nlm.nih.gov/pubmed/25203821

Reck M, Popat S, Reinmuth N, De Ruysscher D, Kerr KM, Peters S (2014) Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 25: iii27-iii39 (ARCN) https://doi.org/10.1093/annonc/mdu199 http://www.ncbi.nlm.nih.gov/pubmed/25115305

Reck M, Paz-Ares LG, de Marinis F, Molinier O, Sahoo TP, Laack E, John W, Zimmermann AH, Visseren-Grul C, Gridelli C (2014) PARAMOUNT: Descriptive Subgroup Analyses of Final Overall Survival for the Phase III Study of Maintenance Pemetrexed versus Placebo Following Induction Treatment with Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non–Small-Cell Lung Cancer. J Thorac Oncol 9: 205-213 (ARCN) https://doi.org/10.1097/jto.0000000000000076 http://www.ncbi.nlm.nih.gov/pubmed/24419418

Reck M, Kaiser R, Mellemgaard A, Douillard J-Y, Orlov S, Krzakowski M, von Pawel J, Gottfried M, Bondarenko I, Liao M, Gann C-N, Barrueco J, Gaschler-Markefski B, Novello S (2014) Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial. The Lancet Oncology 15: 143-155 (ARCN) https://doi.org/10.1016/s1470-2045(13)70586-2 http://www.ncbi.nlm.nih.gov/pubmed/24411639

Reck M, Heigener D, Reinmuth N (2014) Nintedanib for the treatment of patients with advanced non-small-cell lung cancer. Expert Rev Clin Pharmacol 7: 579-590 (ARCN) https://doi.org/10.1586/17512433.2014.945430 http://www.ncbi.nlm.nih.gov/pubmed/25119062

Rabe KF, Fabbri LM, Israel E, Kögler H, Riemann K, Schmidt H, Glaab T, Vogelmeier CF (2014) Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial. The Lancet Respiratory Medicine 2: 44-53 (ARCN, UGMLC) https://doi.org/10.1016/s2213-2600(13)70248-0 http://www.ncbi.nlm.nih.gov/pubmed/24461901

Pfaar O, Bachert C, Bufe A, Buhl R, Ebner C, Eng P, Friedrichs F, Fuchs T, Hamelmann E, Hartwig-Bade D, Hering T, Huttegger I, Jung K, Klimek L, Kopp MV, Merk H, Rabe U, Saloga J, Schmid-Grendelmeier P, Schuster A, Schwerk N, Sitter H, Umpfenbach U, Wedi B, Wöhrl S, Worm M, Kleine-Tebbe J (2014) Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases. Allergo Journal International 23: 282-319 (ARCN) https://doi.org/10.1007/s40629-014-0032-2 http://www.ncbi.nlm.nih.gov/pubmed/26120539

Petersen A, Rennert S, Kull S, Becker W-M, Notbohm H, Goldmann T, Jappe U (2014) Roasting and lipid binding provide allergenic and proteolytic stability to the peanut allergen Ara h 8. Biol Chem 395: 239-250 (ARCN) https://doi.org/10.1515/hsz-2013-0206 http://www.ncbi.nlm.nih.gov/pubmed/24057594

Pallaud C, Reck M, Juhasz E, Szima B, Yu C-J, Burdaeva O, Orlov S, Hilton M, Archer V, Mok T (2014) Clinical genotyping and efficacy outcomes: Exploratory biomarker data from the phase II ABIGAIL study of first-line bevacizumab plus chemotherapy in non-squamous non-small-cell lung cancer. Lung Cancer 86: 67-72 (ARCN) https://doi.org/10.1016/j.lungcan.2014.07.019 http://www.ncbi.nlm.nih.gov/pubmed/25154982

Olsson KM, Delcroix M, Ghofrani HA, Tiede H, Huscher D, Speich R, Grünig E, Staehler G, Rosenkranz S, Halank M, Held M, Lange TJ, Behr J, Klose H, Claussen M, Ewert R, Opitz CF, Vizza CD, Scelsi L, Vonk-Noordegraaf A, Kaemmerer H, Gibbs JSR, Coghlan G, Pepke-Zaba J, Schulz U, Gorenflo M, Pittrow D, Hoeper MM (2014) Anticoagulation and Survival in Pulmonary Arterial Hypertension. Circulation 129: 57-65 (ARCN, BREATH, CPC-M, TLRC, UGMLC) https://doi.org/10.1161/circulationaha.113.004526 http://www.ncbi.nlm.nih.gov/pubmed/24081973

Novello S, Besse B, Felip E, Barlesi F, Mazieres J, Zalcman G, von Pawel J, Reck M, Cappuzzo F, Ferry D, Carcereny E, Santoro A, Garcia-Ribas I, Scagliotti G, Soria JC (2014) A phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small-cell lung cancer. Ann Oncol 25: 2156-2162 (ARCN) https://doi.org/10.1093/annonc/mdu384 http://www.ncbi.nlm.nih.gov/pubmed/25139550

Nikolic J, Mrkic I, Grozdanovic M, Popovic M, Petersen A, Jappe U, Gavrovic-Jankulovic M (2014) Protocol for simultaneous isolation of three important banana allergens. Journal of Chromatography B 962: 30-36 (ARCN) https://doi.org/10.1016/j.jchromb.2014.05.020 http://www.ncbi.nlm.nih.gov/pubmed/24887593

Neiwert O, Holst O, Duda KA (2014) Structural investigation of rhamnose-rich polysaccharides from Streptococcus dysgalactiae bovine mastitis isolate. Carbohydr Res 389: 192-195 (ARCN) https://doi.org/10.1016/j.carres.2013.12.018 http://www.ncbi.nlm.nih.gov/pubmed/24680507

Mok T, Gorbunova V, Juhasz E, Szima B, Burdaeva O, Orlov S, Yu C-J, Archer V, Hilton M, Delmar P, Pallaud C, Reck M (2014) A Correlative Biomarker Analysis of the Combination of Bevacizumab and Carboplatin-Based Chemotherapy for Advanced Nonsquamous Non–Small-Cell Lung Cancer: Results of the Phase II Randomized ABIGAIL Study (BO21015). J Thorac Oncol 9: 848-855 (ARCN) https://doi.org/10.1097/jto.0000000000000160 http://www.ncbi.nlm.nih.gov/pubmed/24807156

Migliori GB, Rabe KF, Bel E, Elliott M, Gaga M, Holgate ST, Joos G, Martin Burrieza F, Sax B, Sculier JP, Simonds AK, Blasi F, Barnes PJ (2014) The European Respiratory Society plans its future: the 2013-2018 strategic plan. Eur Respir J 43: 927-932 (ARCN) https://doi.org/10.1183/09031936.00221613 http://www.ncbi.nlm.nih.gov/pubmed/24687658

Marwitz S, Kolarova J, Reck M, Reinmuth N, Kugler C, Schädlich I, Haake A, Zabel P, Vollmer E, Siebert R, Goldmann T, Ammerpohl O (2014) The tissue is the issue: improved methylome analysis from paraffin-embedded tissues by application of the HOPE technique. Lab Invest 94: 927-933 (ARCN) https://doi.org/10.1038/labinvest.2014.79 https://www.ncbi.nlm.nih.gov/pubmed/24933424

Magnussen H, Watz H, Kirsten A, Decramer M, Dahl R, Calverley PMA, Towse L, Finnigan H, Tetzlaff K, Disse B (2014) Stepwise withdrawal of inhaled corticosteroids in COPD patients receiving dual bronchodilation: WISDOM study design and rationale. Respir Med 108: 593-599 (ARCN, TLRC, UGMLC) https://doi.org/10.1016/j.rmed.2014.01.002 http://www.ncbi.nlm.nih.gov/pubmed/24477080

Magnussen H, Disse B, Rodriguez-Roisin R, Kirsten A, Watz H, Tetzlaff K, Towse L, Finnigan H, Dahl R, Decramer M, Chanez P, Wouters EFM, Calverley PMA (2014) Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD. New England Journal of Medicine 371: 1285-1294 (ARCN, CPC-M, TLRC, UGMLC) https://doi.org/10.1056/NEJMoa1407154 http://www.ncbi.nlm.nih.gov/pubmed/25196117

Madurga A, Mižíková I, Ruiz-Camp J, Vadász I, Herold S, Mayer K, Fehrenbach H, Seeger W, Morty RE (2014) Systemic hydrogen sulfide administration partially restores normal alveolarization in an experimental animal model of bronchopulmonary dysplasia. American Journal of Physiology-Lung Cellular and Molecular Physiology 306: L684-L697 (ARCN, UGMLC) https://doi.org/10.1152/ajplung.00361.2013 http://www.ncbi.nlm.nih.gov/pubmed/24508731

Loeffler M, Kreuz M, Haake A, Hasenclever D, Trautmann H, Arnold C, Winter K, Koch K, Klapper W, Scholtysik R, Rosolowski M, Hoffmann S, Ammerpohl O, Szczepanowski M, Herrmann D, Küppers R, Pott C, Siebert R (2014) Genomic and epigenomic co-evolution in follicular lymphomas. Leukemia 29: 456-463 (ARCN) https://doi.org/10.1038/leu.2014.209 https://www.ncbi.nlm.nih.gov/pubmed/25027518

Lind M, Sipka AS, Schuberth H-J, Blutke A, Wanke R, Sauter-Louis C, Duda KA, Holst O, Rainard P, Germon P, Zerbe H, Petzl W (2014) Location-specific expression of chemokines, TNF-α and S100 proteins in a teat explant model. Innate Immun 21: 322-331 (ARCN) https://doi.org/10.1177/1753425914539820 http://www.ncbi.nlm.nih.gov/pubmed/25134520

Larenas-Linnemann D, Wahn U, Kopp M (2014) Use of omalizumab to improve desensitization safety in allergen immunotherapy. Journal of Allergy and Clinical Immunology 133: 937-937.e932 (ARCN) https://doi.org/10.1016/j.jaci.2013.12.1089 http://www.ncbi.nlm.nih.gov/pubmed/24581432

Lang DS, Marwitz S, Heilenkötter U, Schumm W, Behrens O, Simon R, Reck M, Vollmer E, Goldmann T (2014) Transforming Growth Factor-Beta Signaling Leads to uPA/PAI-1 Activation and Metastasis: A Study on Human Breast Cancer Tissues. Pathology & Oncology Research 20: 727-732 (ARCN) https://doi.org/10.1007/s12253-014-9753-2 https://www.ncbi.nlm.nih.gov/pubmed/24610082

Kreuter M, Vansteenkiste J, Herth FJF, Fischer JR, Eberhardt W, Zuna I, Reinmuth N, Griesinger F, Thomas M (2014) Impact and Safety of Adjuvant Chemotherapy on Pulmonary Function in Early Stage Non-Small Cell Lung Cancer. Respiration 87: 204-210 (ARCN, TLRC) https://doi.org/10.1159/000355361 http://www.ncbi.nlm.nih.gov/pubmed/24192055

Kornmann O, Watz H, Fuhr R, Krug N, Erpenbeck VJ, Kaiser G (2014) Omalizumab in patients with allergic (IgE-mediated) asthma and IgE/bodyweight combinations above those in the initially approved dosing table. Pulm Pharmacol Ther 28: 149-153 (ARCN, BREATH) https://doi.org/10.1016/j.pupt.2014.03.003 http://www.ncbi.nlm.nih.gov/pubmed/24657236

Kirsten AM, Watz H, Magnussen H (2014) Bronchodilatatorische Therapie der COPD. DMW – Deutsche Medizinische Wochenschrift 139: 264-267 (ARCN) https://doi.org/10.1055/s-0033-1360019 https://www.ncbi.nlm.nih.gov/pubmed/24473845

Kerr KM, Bubendorf L, Edelman MJ, Marchetti A, Mok T, Novello S, O’Byrne K, Stahel R, Peters S, Felip E, Stahel R, Felip E, Peters S, Kerr K, Besse B, Vansteenkiste J, Eberhardt W, Edelman M, Mok T, O’Byrne K, Novello S, Bubendorf L, Marchetti A, Baas P, Reck M, Syrigos K, Paz-Ares L, Smit EF, Meldgaard P, Adjei A, Nicolson M, Crinò L, Van Schil P, Senan S, Faivre-Finn C, Rocco G, Veronesi G, Douillard J-Y, Lim E, Dooms C, Weder W, De Ruysscher D, Le Pechoux C, De Leyn P, Westeel V (2014) Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer. Ann Oncol 25: 1681-1690 (ARCN) https://doi.org/10.1093/annonc/mdu145 http://www.ncbi.nlm.nih.gov/pubmed/24718890

Karsten J, Krabbe K, Heinze H, Dalhoff K, Meier T, Drömann D (2014) Bedside monitoring of ventilation distribution and alveolar inflammation in community-acquired pneumonia. J Clin Monit Comput 28: 403-408 (ARCN) https://doi.org/10.1007/s10877-014-9549-7 http://www.ncbi.nlm.nih.gov/pubmed/24435618

Karsten CM, Laumonnier Y, Köhl J (2014) Functional Analysis of C5a Effector Responses In Vitro and In Vivo. Methods Mol Biol 1100: 291-304 (ARCN) https://doi.org/10.1007/978-1-62703-724-2_23 http://www.ncbi.nlm.nih.gov/pubmed/24218268

Jäger J, Marwitz S, Tiefenau J, Rasch J, Shevchuk O, Kugler C, Goldmann T, Steinert M, Flynn JL (2014) Human Lung Tissue Explants Reveal Novel Interactions during Legionella pneumophila Infections. Infection and Immunity 82: 275-285 (ARCN) https://doi.org/10.1128/iai.00703-13 http://www.ncbi.nlm.nih.gov/pubmed/24166955

Holz O, Waschki B, Roepcke S, Watz H, Lauer G, Faulenbach C, Hohlfeld JM (2014) Potential prognostic value of biomarkers in lavage, sputum and serum in a five year clinical follow-up of smokers with and without COPD. BMC Pulm Med 14: 30 (ARCN, BREATH) https://doi.org/10.1186/1471-2466-14-30 http://www.ncbi.nlm.nih.gov/pubmed/24581181

Hensel M, Claes A-K, Steck N, Schultz D, Zähringer U, Lipinski S, Rosenstiel P, Geddes K, Philpott DJ, Heine H, Grassl GA (2014) Salmonella enterica serovar Typhimurium ΔmsbB Triggers Exacerbated Inflammation in Nod2 Deficient Mice. PLoS One 9: e113645 (ARCN) https://doi.org/10.1371/journal.pone.0113645 http://www.ncbi.nlm.nih.gov/pubmed/25423082

Heigener DF, Reck M (2014) Crizotinib. Recent Results Cancer Res 201: 197-205 (ARCN) https://doi.org/10.1007/978-3-642-54490-3_11 https://www.ncbi.nlm.nih.gov/pubmed/24756793

Heigener DF, Deppermann KM, Pawel Jv, Fischer JR, Kortsik C, Bohnet S, Eiff Mv, Koester W, Thomas M, Schnabel PA, Reck M (2014) Open, randomized, multi-center phase II study comparing efficacy and tolerability of Erlotinib vs. Carboplatin/Vinorelbin in elderly patients (>70 years of age) with untreated non-small cell lung cancer. Lung Cancer 84: 62-66 (ARCN, TLRC) https://doi.org/10.1016/j.lungcan.2014.01.024 http://www.ncbi.nlm.nih.gov/pubmed/24560332

Heigener D, Reck M (2014) Exploring the potential of immuno-oncology-based treatment for patients with non-small cell lung cancer. Expert Rev Anticancer Ther 15: 69-83 (ARCN) https://doi.org/10.1586/14737140.2015.957187 http://www.ncbi.nlm.nih.gov/pubmed/25199617

Hassan R, Kindler HL, Jahan T, Bazhenova L, Reck M, Thomas A, Pastan I, Parno J, O’Shannessy DJ, Fatato P, Maltzman JD, Wallin BA (2014) Phase II Clinical Trial of Amatuximab, a Chimeric Antimesothelin Antibody with Pemetrexed and Cisplatin in Advanced Unresectable Pleural Mesothelioma. Clinical Cancer Research 20: 5927-5936 (ARCN) https://doi.org/10.1158/1078-0432.Ccr-14-0804 http://www.ncbi.nlm.nih.gov/pubmed/25231400

Gronbach K, Flade I, Holst O, Lindner B, Ruscheweyh HJ, Wittmann A, Menz S, Schwiertz A, Adam P, Stecher B, Josenhans C, Suerbaum S, Gruber AD, Kulik A, Huson D, Autenrieth IB, Frick J-S (2014) Endotoxicity of Lipopolysaccharide as a Determinant of T-Cell−Mediated Colitis Induction in Mice. Gastroenterology 146: 765-775 (ARCN) https://doi.org/10.1053/j.gastro.2013.11.033 http://www.ncbi.nlm.nih.gov/pubmed/24269927

Grether M, Eickelberg O, Mall MA, Rabe KF, Welte T, Seeger W (2014) New metrics for translational research. The Lancet Respiratory Medicine 2: e13-e14 (ARCN, BREATH, CPC-M, TLRC, UGMLC) https://doi.org/10.1016/s2213-2600(14)70150-x http://www.ncbi.nlm.nih.gov/pubmed/25100195

Garon EB, Ciuleanu T-E, Arrieta O, Prabhash K, Syrigos KN, Goksel T, Park K, Gorbunova V, Kowalyszyn RD, Pikiel J, Czyzewicz G, Orlov SV, Lewanski CR, Thomas M, Bidoli P, Dakhil S, Gans S, Kim J-H, Grigorescu A, Karaseva N, Reck M, Cappuzzo F, Alexandris E, Sashegyi A, Yurasov S, Pérol M (2014) Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial. The Lancet 384: 665-673 (ARCN, TLRC) https://doi.org/10.1016/s0140-6736(14)60845-x http://www.ncbi.nlm.nih.gov/pubmed/24933332

Garate JA, Stöckl J, del Carmen Fernández-Alonso M, Artner D, Haegman M, Oostenbrink C, Jiménez-Barbero J, Beyaert R, Heine H, Kosma P, Zamyatina A (2014) Anti-endotoxic activity and structural basis for human MD-2·TLR4 antagonism of tetraacylated lipid A mimetics based on βGlcN(1↔1)αGlcN scaffold. Innate Immun 21: 490-503 (ARCN) https://doi.org/10.1177/1753425914550426 http://www.ncbi.nlm.nih.gov/pubmed/25394365

Gaber R, Watermann I, Kugler C, Reinmuth N, Huber RM, Schnabel PA, Vollmer E, Reck M, Goldmann T (2014) Correlation of EGFR expression, gene copy number and clinicopathological status in NSCLC. Diagn Pathol 9: 165 (ARCN, TLRC) https://doi.org/10.1186/s13000-014-0165-0 http://www.ncbi.nlm.nih.gov/pubmed/25227424

Foligne B, Bang C, Weidenbach K, Gutsmann T, Heine H, Schmitz RA (2014) The Intestinal Archaea Methanosphaera stadtmanae and Methanobrevibacter smithii Activate Human Dendritic Cells. PLoS One 9: e99411 (ARCN) https://doi.org/10.1371/journal.pone.0099411 http://www.ncbi.nlm.nih.gov/pubmed/24915454

Engelke C, Wiese AV, Schmudde I, Ender F, Ströver HA, Vollbrandt T, König P, Laumonnier Y, Köhl J (2014) Distinct Roles of the Anaphylatoxins C3a and C5a in Dendritic Cell–Mediated Allergic Asthma. The Journal of Immunology 193: 5387-5401 (ARCN) https://doi.org/10.4049/jimmunol.1400080 http://www.ncbi.nlm.nih.gov/pubmed/25355927

Dimitrijevic J, Krapf L, Wolter C, Schmidtke C, Merkl J-P, Jochum T, Kornowski A, Schüth A, Gebert A, Hüttmann G, Vossmeyer T, Weller H (2014) CdSe/CdS-quantum rods: fluorescent probes for in vivo two-photon laser scanning microscopy. Nanoscale 6: 10413-10422 (ARCN) https://doi.org/10.1039/c4nr02702g http://www.ncbi.nlm.nih.gov/pubmed/25080095

Diel R, Nienhaus A, Lampenius N, Rüsch-Gerdes S, Richter E (2014) Cost of multi drug resistance tuberculosis in Germany. Respir Med 108: 1677-1687 (ARCN) https://doi.org/10.1016/j.rmed.2014.09.021 https://www.ncbi.nlm.nih.gov/pubmed/25443398

Butts C, Socinski MA, Mitchell PL, Thatcher N, Havel L, Krzakowski M, Nawrocki S, Ciuleanu T-E, Bosquée L, Trigo JM, Spira A, Tremblay L, Nyman J, Ramlau R, Wickart-Johansson G, Ellis P, Gladkov O, Pereira JR, Eberhardt WEE, Helwig C, Schröder A, Shepherd FA (2014) Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial. The Lancet Oncology 15: 59-68 (ARCN, TLRC, CPC-M) https://doi.org/10.1016/s1470-2045(13)70510-2 http://www.ncbi.nlm.nih.gov/pubmed/24331154

Bousquet J, Addis A, Adcock I, Agache I, Agusti A, Alonso A, Annesi-Maesano I, Anto JM, Bachert C, Baena-Cagnani CE, Bai C, Baigenzhin A, Barbara C, Barnes PJ, Bateman ED, Beck L, Bedbrook A, Bel EH, Benezet O, Bennoor KS, Benson M, Bernabeu-Wittel M, Bewick M, Bindslev-Jensen C, Blain H, Blasi F, Bonini M, Bonini S, Boulet LP, Bourdin A, Bourret R, Bousquet PJ, Brightling CE, Briggs A, Brozek J, Buhl R, Bush A, Caimmi D, Calderon M, Calverley P, Camargos PA, Camuzat T, Canonica GW, Carlsen KH, Casale TB, Cazzola M, Cepeda Sarabia AM, Cesario A, Chen YZ, Chkhartishvili E, Chavannes NH, Chiron R, Chuchalin A, Chung KF, Cox L, Crooks G, Crooks MG, Cruz AA, Custovic A, Dahl R, Dahlen SE, De Blay F, Dedeu T, Deleanu D, Demoly P, Devillier P, Didier A, Dinh-Xuan AT, Djukanovic R, Dokic D, Douagui H, Dubakiene R, Eglin S, Elliot F, Emuzyte R, Fabbri L, Fink Wagner A, Fletcher M, Fokkens WJ, Fonseca J, Franco A, Frith P, Furber A, Gaga M, Garces J, Garcia-Aymerich J, Gamkrelidze A, Gonzales-Diaz S, Gouzi F, Guzman MA, Haahtela T, Harrison D, Hayot M, Heaney LG, Heinrich J, Hellings PW, Hooper J, Humbert M, Hyland M, Iaccarino G, Jakovenko D, Jardim JR, Jeandel C, Jenkins C, Johnston SL, Jonquet O, Joos G, Jung KS, Kalayci O, Karunanithi S, Keil T, Khaltaev N, Kolek V, Kowalski ML, Kull I, Kuna P, Kvedariene V, Le LT, Lodrup Carlsen KC, Louis R, MacNee W, Mair A, Majer I, Manning P, de Manuel Keenoy E, Masjedi MR, Melen E, Melo-Gomes E, Menzies-Gow A, Mercier G, Mercier J, Michel JP, Miculinic N, Mihaltan F, Milenkovic B, Molimard M, Momas I, Montilla-Santana A, Morais-Almeida M, Morgan M, N’Diaye M, Nafti S, Nekam K, Neou A, Nicod L, O’Hehir R, Ohta K, Paggiaro P, Palkonen S, Palmer S, Papadopoulos NG, Papi A, Passalacqua G, Pavord I, Pigearias B, Plavec D, Postma DS, Price D, Rabe KF, Radier Pontal F, Redon J, Rennard S, Roberts J, Robine JM, Roca J, Roche N, Rodenas F, Roggeri A, Rolland C, Rosado-Pinto J, Ryan D, Samolinski B, Sanchez-Borges M, Schunemann HJ, Sheikh A, Shields M, Siafakas N, Sibille Y, Similowski T, Small I, Sola-Morales O, Sooronbaev T, Stelmach R, Sterk PJ, Stiris T, Sud P, Tellier V, To T, Todo-Bom A, Triggiani M, Valenta R, Valero AL, Valiulis A, Valovirta E, Van Ganse E, Vandenplas O, Vasankari T, Vestbo J, Vezzani G, Viegi G, Visier L, Vogelmeier C, Vontetsianos T, Wagstaff R, Wahn U, Wallaert B, Whalley B, Wickman M, Williams DM, Wilson N, Yawn BP, Yiallouros PK, Yorgancioglu A, Yusuf OM, Zar HJ, Zhong N, Zidarn M, Zuberbier T (2014) Integrated care pathways for airway diseases (AIRWAYS-ICPs). Eur Respir J 44: 304-323 (ARCN, UGMLC) https://doi.org/10.1183/09031936.00014614 http://www.ncbi.nlm.nih.gov/pubmed/24925919

Bölke T, Krapf L, Orzekowsky-Schroeder R, Vossmeyer T, Dimitrijevic J, Weller H, Schüth A, Klinger A, Hüttmann G, Gebert A (2014) Data-adaptive image-denoising for detecting and quantifying nanoparticle entry in mucosal tissues through intravital 2-photon microscopy. Beilstein Journal of Nanotechnology 5: 2016-2025 (ARCN) https://doi.org/10.3762/bjnano.5.210 http://www.ncbi.nlm.nih.gov/pubmed/25551029

Besse B, Reck M (2014) Pharmacogenomics in NSCLC: mostly unsexy but desperately needed. Ann Oncol 25: 2099-2100 (ARCN) https://doi.org/10.1093/annonc/mdu289 http://www.ncbi.nlm.nih.gov/pubmed/25096605

Besse B, Adjei A, Baas P, Meldgaard P, Nicolson M, Paz-Ares L, Reck M, Smit EF, Syrigos K, Stahel R, Felip E, Peters S, Stahel R, Felip E, Peters S, Kerr K, Besse B, Vansteenkiste J, Eberhardt W, Edelman M, Mok T, O’Byrne K, Novello S, Bubendorf L, Marchetti A, Baas P, Reck M, Syrigos K, Paz-Ares L, Smit EF, Meldgaard P, Adjei A, Nicolson M, Crinò L, Van Schil P, Senan S, Faivre-Finn C, Rocco G, Veronesi G, Douillard J-Y, Lim E, Dooms C, Weder W, De Ruysscher D, Le Pechoux C, De Leyn P, Westeel V (2014) 2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease. Ann Oncol 25: 1475-1484 (ARCN) https://doi.org/10.1093/annonc/mdu123 http://www.ncbi.nlm.nih.gov/pubmed/24669016

Berti C, Cetin I, Agostoni C, Desoye G, Devlieger R, Emmett PM, Ensenauer R, Hauner H, Herrera E, Hoesli I, Krauss-Etschmann S, Olsen SF, Schaefer-Graf U, Schiessl B, Symonds ME, Koletzko B (2014) Pregnancy and Infants’ Outcome: Nutritional and Metabolic Implications. Critical Reviews in Food Science and Nutrition 56: 82-91 (ARCN) https://doi.org/10.1080/10408398.2012.745477 https://www.ncbi.nlm.nih.gov/pubmed/24628089

Bermbach S, Weinhold K, Roeder T, Petersen F, Kugler C, Goldmann T, Rupp J, König P (2014) Mechanisms of Cilia-Driven Transport in the Airways in the Absence of Mucus. Am J Respir Cell Mol Biol 51: 56-67 (ARCN) https://doi.org/10.1165/rcmb.2012-0530OC http://www.ncbi.nlm.nih.gov/pubmed/24467665

Beeh KM, Watz H, Puente-Maestu L, de Teresa L, Jarreta D, Caracta C, Gil EG, Magnussen H (2014) Aclidinium improves exercise endurance, dyspnea, lung hyperinflation, and physical activity in patients with COPD: a randomized, placebo-controlled, crossover trial. BMC Pulm Med 14: 209 (ARCN) https://doi.org/10.1186/1471-2466-14-209 http://www.ncbi.nlm.nih.gov/pubmed/25539654

Becker W-M, Jappe U (2014) Peanut Allergens. Chem Immunol Allergy 100: 256-267 (ARCN) https://doi.org/10.1159/000359916 http://www.ncbi.nlm.nih.gov/pubmed/24925406

Bauer B, Siebert R, Traulsen A (2014) Cancer initiation with epistatic interactions between driver and passenger mutations. J Theor Biol 358: 52-60 (ARCN) https://doi.org/10.1016/j.jtbi.2014.05.018 https://www.ncbi.nlm.nih.gov/pubmed/24859427

Basma H, Gunji Y, Iwasawa S, Nelson A, Farid M, Ikari J, Liu X, Wang X, Michalski J, Smith L, Iqbal J, Behery RE, West W, Yelamanchili S, Rennard D, Holz O, Mueller K-C, Magnussen H, Rabe K, Castaldi PJ, Rennard SI (2014) Reprogramming of COPD lung fibroblasts through formation of induced pluripotent stem cells. American Journal of Physiology-Lung Cellular and Molecular Physiology 306: L552-L565 (ARCN, BREATH ) https://doi.org/10.1152/ajplung.00255.2013 http://www.ncbi.nlm.nih.gov/pubmed/24487392

Barnes NC, Saetta M, Rabe KF (2014) Implementing lessons learned from previous bronchial biopsy trials in a new randomized controlled COPD biopsy trial with roflumilast. BMC Pulm Med 14: 9 (ARCN) https://doi.org/10.1186/1471-2466-14-9 http://www.ncbi.nlm.nih.gov/pubmed/24484726

Barlesi F, Scherpereel A, Gorbunova V, Gervais R, Vikström A, Chouaid C, Chella A, Kim JH, Ahn MJ, Reck M, Pazzola A, Kim HT, Aerts JG, Morando C, Loundou A, Groen HJM, Rittmeyer A (2014) Maintenance bevacizumab–pemetrexed after first-line cisplatin–pemetrexed–bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trial. Ann Oncol 25: 1044-1052 (ARCN) https://doi.org/10.1093/annonc/mdu098 http://www.ncbi.nlm.nih.gov/pubmed/24585722

Ballmann M, Hubert D, Assael BM, Kronfeld K, Honer M, Holl RW (2014) Open randomised prospective comparative multi-centre intervention study of patients with cystic fibrosis and early diagnosed diabetes mellitus. BMC Pediatr 14: 70 (ARCN, BREATH) https://doi.org/10.1186/1471-2431-14-70 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975280/pdf/1471-2431-14-70.pdf

 

2013

Wygrecka M, Dahal BK, Kosanovic D, Petersen F, Taborski B, von Gerlach S, Didiasova M, Zakrzewicz D, Preissner KT, Schermuly RT, Markart P (2013) Mast Cells and Fibroblasts Work in Concert to Aggravate Pulmonary Fibrosis. The American Journal of Pathology 182: 2094-2108 (ARCN, UGMLC) https://doi.org/10.1016/j.ajpath.2013.02.013 http://www.ncbi.nlm.nih.gov/pubmed/23562441

White WB, Cooke GE, Kowey PR, Calverley PMA, Bredenbröker D, Goehring U-M, Zhu H, Lakkis H, Mosberg H, Rowe P, Rabe KF (2013) Cardiovascular Safety in Patients Receiving Roflumilast for the Treatment of COPD. Chest 144: 758-765 (ARCN) https://doi.org/10.1378/chest.12-2332 http://www.ncbi.nlm.nih.gov/pubmed/23412642

Wedzicha JA, Rabe KF, Martinez FJ, Bredenbröker D, Brose M, Goehring U-M, Calverley PMA (2013) Efficacy of Roflumilast in the COPD Frequent Exacerbator Phenotype. Chest 143: 1302-1311 (ARCN) https://doi.org/10.1378/chest.12-1489 http://www.ncbi.nlm.nih.gov/pubmed/23117188

Watz H, Mistry SJ, Lazaar AL (2013) Safety and tolerability of the inhaled phosphodiesterase 4 inhibitor GSK256066 in moderate COPD. Pulm Pharmacol Ther 26: 588-595 (ARCN) https://doi.org/10.1016/j.pupt.2013.05.004 http://www.ncbi.nlm.nih.gov/pubmed/23701917

Watz H, Bock D, Meyer M, Schierhorn K, Vollhardt K, Woischwill C, Pedersen F, Kirsten A, Beeh K-M, Meyer-Sabellek W, Magnussen H, Beier J (2013) Inhaled pan-selectin antagonist Bimosiamose attenuates airway inflammation in COPD. Pulm Pharmacol Ther 26: 265-270 (ARCN) https://doi.org/10.1016/j.pupt.2012.12.003 http://www.ncbi.nlm.nih.gov/pubmed/23257347

Warmbold C, Uliczka K, Rus F, Suck R, Petersen A, Silverman N, Ulmer AJ, Heine H, Roeder T (2013) Dermatophagoides pteronyssinus Major Allergen 1 Activates the Innate Immune Response of the Fruit Fly Drosophila melanogaster. The Journal of Immunology 190: 366-371 (ARCN) https://doi.org/10.4049/jimmunol.1201347 http://www.ncbi.nlm.nih.gov/pubmed/23203927

von Bartheld MB, Dekkers OM, Szlubowski A, Eberhardt R, Herth FJ, in ‘t Veen JCCM, de Jong YP, van der Heijden EHFM, Tournoy KG, Claussen M, van den Blink B, Shah PL, Zoumot Z, Clementsen P, Porsbjerg C, Mauad T, Bernardi FD, van Zwet EW, Rabe KF, Annema JT (2013) Endosonography vs Conventional Bronchoscopy for the Diagnosis of Sarcoidosis. JAMA 309: 2457 (ARCN, TLRC) https://doi.org/10.1001/jama.2013.5823 http://www.ncbi.nlm.nih.gov/pubmed/23780458

Vogelmeier C, Fabbri LM, Rabe KF, Beeh K-M, Schmidt H, Metzdorf N, Glaab T (2013) Effect of tiotropium vs. salmeterol on exacerbations: GOLD II and maintenance therapy naïve patients. Respir Med 107: 75-83 (ARCN, UGMLC) https://doi.org/10.1016/j.rmed.2012.09.015 http://www.ncbi.nlm.nih.gov/pubmed/23102611

van Gaalen JL, Beerthuizen T, van der Meer V, van Reisen P, Redelijkheid GW, Snoeck-Stroband JB, Sont JK (2013) Long-Term Outcomes of Internet-Based Self-Management Support in Adults With Asthma: Randomized Controlled Trial. J Med Internet Res 15: e188 (ARCN) https://doi.org/10.2196/jmir.2640 https://www.ncbi.nlm.nih.gov/pubmed/24028826

van Bremen T, Drömann D, Luitjens K, Dodt C, Dalhoff K, Goldmann T, Schaaf B (2013) Triggering receptor expressed on myeloid cells − 1 (Trem-1) on blood neutrophils is associated with cytokine inducibility in human E. coli sepsis. Diagn Pathol 8: 24 (ARCN) https://doi.org/10.1186/1746-1596-8-24 http://www.ncbi.nlm.nih.gov/pubmed/23414215

Taube C, Kunz LIZ, Strebus J, Budulac SE, Lapperre TS, Sterk PJ, Postma DS, Mauad T, Timens W, Hiemstra PS (2013) Inhaled Steroids Modulate Extracellular Matrix Composition in Bronchial Biopsies of COPD Patients: A Randomized, Controlled Trial. PLoS One 8: e63430 (ARCN) https://doi.org/10.1371/journal.pone.0063430 http://www.ncbi.nlm.nih.gov/pubmed/23667615

Szecsi PB, Faiz A, Tjin G, Harkness L, Weckmann M, Bao S, Black JL, Oliver BGG, Burgess JK (2013) The Expression and Activity of Cathepsins D, H and K in Asthmatic Airways. PLoS One 8: e57245 (ARCN) https://doi.org/10.1371/journal.pone.0057245 http://www.ncbi.nlm.nih.gov/pubmed/23483898

Stemerding AM, Köhl J, Pandey MK, Kuipers A, Leusen JH, Boross P, Nederend M, Vidarsson G, Weersink AYL, van de Winkel JGJ, van Kessel KPM, van Strijp JAG (2013) Staphylococcus aureus Formyl Peptide Receptor–like 1 Inhibitor (FLIPr) and Its Homologue FLIPr-like Are Potent FcγR Antagonists That Inhibit IgG-Mediated Effector Functions. The Journal of Immunology 191: 353-362 (ARCN) https://doi.org/10.4049/jimmunol.1203243 http://www.ncbi.nlm.nih.gov/pubmed/23740955

Soria JC, Mauguen A, Reck M, Sandler AB, Saijo N, Johnson DH, Burcoveanu D, Fukuoka M, Besse B, Pignon JP (2013) Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer. Ann Oncol 24: 20-30 (ARCN) https://doi.org/10.1093/annonc/mds590 http://www.ncbi.nlm.nih.gov/pubmed/23180113

Schuette WHW, Gröschel A, Sebastian M, Andreas S, Müller T, Schneller F, Guetz S, Eschbach C, Bohnet S, Leschinger MI, Reck M (2013) A Randomized Phase II Study of Pemetrexed in Combination With Cisplatin or Carboplatin as First-Line Therapy for Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer. Clin Lung Cancer 14: 215-223 (ARCN) https://doi.org/10.1016/j.cllc.2012.10.001 http://www.ncbi.nlm.nih.gov/pubmed/23332288

Schraufnagel DE, Blasi F, Kraft M, Gaga M, Finn PW, Rabe KF (2013) An Official American Thoracic Society/European Respiratory Society Policy Statement: Disparities in Respiratory Health. American Journal of Respiratory and Critical Care Medicine 188: 865-871 (ARCN) https://doi.org/10.1164/rccm.201308-1509ST http://www.ncbi.nlm.nih.gov/pubmed/24083859

Schraufnagel DE, Blasi F, Kraft M, Gaga M, Finn P, Rabe KF (2013) An official American Thoracic Society and European Respiratory Society policy statement: disparities in respiratory health. Eur Respir J 42: 906-915 (ARCN) https://doi.org/10.1183/09031936.00062113 http://www.ncbi.nlm.nih.gov/pubmed/24081761

Schönfeld N, Haas W, Richter E, Bauer T, Bös L, Castell S, Hauer B, Magdorf K, Matthiessen W, Mauch H, Reuß A, Rüsch-Gerdes S, Zabel P, Dalhoff K, Schaberg T, Loddenkemper R (2013) Empfehlungen zur Diagnostik und Therapie nichttuberkulöser Mykobakteriosen des Deutschen Zentralkomitees zur Bekämpfung der Tuberkulose (DZK) und der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DGP). Pneumologie 67: 605-633 (ARCN) https://doi.org/10.1055/s-0033-1344790 http://www.ncbi.nlm.nih.gov/pubmed/24198237

Schneider A, Schwarzbach J, Faderl B, Welker L, Karsch-Völk M, Jörres RA (2013) FENO measurement and sputum analysis for diagnosing asthma in clinical practice. Respir Med 107: 209-216 (ARCN, CPC-M) https://doi.org/10.1016/j.rmed.2012.10.003 http://www.ncbi.nlm.nih.gov/pubmed/23107283

Schmudde I, Laumonnier Y, Köhl J (2013) Anaphylatoxins coordinate innate and adaptive immune responses in allergic asthma. Semin Immunol 25: 2-11 (ARCN) https://doi.org/10.1016/j.smim.2013.04.009 http://www.ncbi.nlm.nih.gov/pubmed/23694705

Scagliotti GV, Felip E, Besse B, von Pawel J, Mellemgaard A, Reck M, Bosquee L, Chouaid C, Lianes-Barragán P, Paul EM, Ruiz-Soto R, Sigal E, Ottesen LH, LeChevalier T (2013) An Open-Label, Multicenter, Randomized, Phase II Study of Pazopanib in Combination with Pemetrexed in First-Line Treatment of Patients with Advanced-Stage Non–Small-Cell Lung Cancer. J Thorac Oncol 8: 1529-1537 (ARCN) https://doi.org/10.1097/jto.0000000000000005 http://www.ncbi.nlm.nih.gov/pubmed/24389434

Rennard S, LeVan, Wang X, Nelson, Weiler, Sato, Kanaji, Nakanishi M, Michalski, Farid, Basma, Miller L, Wieslander, Muller, Holz, Magnussen H, Rabe K, Liu X, Patil A (2013) Anti-inflammatory effects of budesonide in human lung fibroblasts are independent of histone deacetylase 2. Journal of Inflammation Research 6: 109 (ARCN) https://doi.org/10.2147/jir.S43736 http://www.ncbi.nlm.nih.gov/pubmed/24062615

Reinmuth N, Stumpf A, Stumpf P, Muley T, Kobinger S, Hoffmann H, Herth FJF, Schnabel PA, Warth A, Bischoff H, Thomas M (2013) Characteristics and outcome of patients with second primary lung cancer. Eur Respir J 42: 1668-1676 (ARCN, TLRC) https://doi.org/10.1183/09031936.00022512 http://www.ncbi.nlm.nih.gov/pubmed/23060634

Reinmuth N, Payer N, Muley T, Hoffmann H, Herth FJF, Villalobos M, Thomas M (2013) Treatment and outcome of patients with metastatic NSCLC: a retrospective institution analysis of 493 patients. Respir Res 14: 139 (ARCN, TLRC) https://doi.org/10.1186/1465-9921-14-139 http://www.ncbi.nlm.nih.gov/pubmed/24351122

Reinmuth N, Gröschel A, Reck M (2013) Aktuelle Entwicklungen in der Therapie des nicht-kleinzelligen Lungenkarzinoms. Pneumologie 67: 634-638 (ARCN) https://doi.org/10.1055/s-0033-1344793 http://www.ncbi.nlm.nih.gov/pubmed/24198238

Reck M, Krzakowski M, Chmielowska E, Sebastian M, Hadler D, Fox T, Wang Q, Greenberg J, Beckman RA, von Pawel J (2013) A randomized, double-blind, placebo-controlled phase 2 study of tigatuzumab (CS-1008) in combination with carboplatin/paclitaxel in patients with chemotherapy-naïve metastatic/unresectable non-small cell lung cancer. Lung Cancer 82: 441-448 (ARCN) https://doi.org/10.1016/j.lungcan.2013.09.014 http://www.ncbi.nlm.nih.gov/pubmed/24148258

Reck M, Heigener DF, Mok T, Soria J-C, Rabe KF (2013) Management of non-small-cell lung cancer: recent developments. The Lancet 382: 709-719 (ARCN) https://doi.org/10.1016/s0140-6736(13)61502-0 http://www.ncbi.nlm.nih.gov/pubmed/23972814

Reck M, Bondarenko I, Luft A, Serwatowski P, Barlesi F, Chacko R, Sebastian M, Lu H, Cuillerot JM, Lynch TJ (2013) Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensive-disease-small-cell lung cancer: results from a randomized, double-blind, multicenter phase 2 trial. Ann Oncol 24: 75-83 (ARCN) https://doi.org/10.1093/annonc/mds213 http://www.ncbi.nlm.nih.gov/pubmed/22858559

Ravensberg AJ, Slats AM, van Wetering S, Janssen K, van Wijngaarden S, de Jeu R, Rabe KF, Sterk PJ, Hiemstra PS (2013) CD8+ T cells characterize early smoking-related airway pathology in patients with asthma. Respir Med 107: 959-966 (ARCN) https://doi.org/10.1016/j.rmed.2013.03.018 http://www.ncbi.nlm.nih.gov/pubmed/23639272

Rabe KF, Fabbri LM, Vogelmeier C, Kögler H, Schmidt H, Beeh KM, Glaab T (2013) Seasonal Distribution of COPD Exacerbations in the Prevention of Exacerbations With Tiotropium in COPD Trial. Chest 143: 711-719 (ARCN, UGMLC) https://doi.org/10.1378/chest.12-1277 http://www.ncbi.nlm.nih.gov/pubmed/23188489

Rabe KF, Cooper CB (2013) Global Initiative on Obstructive Lung Disease Revised. What Constitutes a Guideline? American Journal of Respiratory and Critical Care Medicine 187: 1035-1036 (ARCN) https://doi.org/10.1164/rccm.201210-1873ED http://www.ncbi.nlm.nih.gov/pubmed/23675707

Pfefferle PI, Prescott SL, Kopp M (2013) Microbial influence on tolerance and opportunities for intervention with prebiotics/probiotics and bacterial lysates. Journal of Allergy and Clinical Immunology 131: 1453-1463 (ARCN, UGMLC) https://doi.org/10.1016/j.jaci.2013.03.020 http://www.ncbi.nlm.nih.gov/pubmed/23643095

Pedersen F, Marwitz S, Seehase S, Kirsten A-M, Zabel P, Vollmer E, Rabe KF, Magnussen H, Watz H, Goldmann T (2013) HOPE-preservation of paraffin-embedded sputum samples–A new way of bioprofiling in COPD. Respir Med 107: 587-595 (ARCN) https://doi.org/10.1016/j.rmed.2012.12.006 http://www.ncbi.nlm.nih.gov/pubmed/23312618

Paz-Ares LG, de Marinis F, Dediu M, Thomas M, Pujol J-L, Bidoli P, Molinier O, Sahoo TP, Laack E, Reck M, Corral J, Melemed S, John W, Chouaki N, Zimmermann AH, Visseren-Grul C, Gridelli C (2013) PARAMOUNT: Final Overall Survival Results of the Phase III Study of Maintenance Pemetrexed Versus Placebo Immediately After Induction Treatment With Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non–Small-Cell Lung Cancer. J Clin Oncol 31: 2895-2902 (ARCN, TLRC) https://doi.org/10.1200/jco.2012.47.1102 http://www.ncbi.nlm.nih.gov/pubmed/23835707

Papi A, Corradi M, Pigeon-Francisco C, Baronio R, Siergiejko Z, Petruzzelli S, Fabbri LM, Rabe KF (2013) Beclometasone–formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial. The Lancet Respiratory Medicine 1: 23-31 (ARCN) https://doi.org/10.1016/s2213-2600(13)70012-2 http://www.ncbi.nlm.nih.gov/pubmed/24321801

http://www.thelancet.com/journals/lanres/article/PIIS2213-2600(13)70012-2/abstract

Ojcius DM, Rotta detto Loria J, Rohmann K, Droemann D, Kujath P, Rupp J, Goldmann T, Dalhoff K (2013) Nontypeable Haemophilus Influenzae Infection Upregulates the NLRP3 Inflammasome and Leads to Caspase-1-Dependent Secretion of Interleukin-1β — A Possible Pathway of Exacerbations in COPD. PLoS One 8: e66818 (ARCN) https://doi.org/10.1371/journal.pone.0066818 http://www.ncbi.nlm.nih.gov/pubmed/23840534

Mrkic I, Abughren M, Nikolic J, Andjelkovic U, Vassilopoulou E, Sinaniotis A, Petersen A, Papadopoulos NG, Gavrovic-Jankulovic M (2013) Molecular Characterization of Recombinant Mus a 5 Allergen from Banana Fruit. Mol Biotechnol 56: 498-506 (ARCN) https://doi.org/10.1007/s12033-013-9719-8 http://www.ncbi.nlm.nih.gov/pubmed/24198217

Miyaji EN, Neuhaus V, Schwarz K, Klee A, Seehase S, Förster C, Pfennig O, Jonigk D, Fieguth H-G, Koch W, Warnecke G, Yusibov V, Sewald K, Braun A (2013) Functional Testing of an Inhalable Nanoparticle Based Influenza Vaccine Using a Human Precision Cut Lung Slice Technique. PLoS One 8: e71728 (ARCN, BREATH) https://doi.org/10.1371/journal.pone.0071728 http://www.ncbi.nlm.nih.gov/pubmed/23967238

Leßmann N, Drömann D, Schlaefer A (2013) Feasibility of respiratory motion-compensated stereoscopic X-ray tracking for bronchoscopy. Int J Comput Assist Radiol Surg 9: 199-209 (ARCN) https://doi.org/10.1007/s11548-013-0920-9 https://www.ncbi.nlm.nih.gov/pubmed/23888315

Le Friec G, Köhl J, Kemper C (2013) A complement a day keeps the Fox(p3) away. Nat Immunol 14: 110-112 (ARCN) https://doi.org/10.1038/ni.2515 http://www.ncbi.nlm.nih.gov/pubmed/23334823

Lang DS, Heilenkötter U, Schumm W, Behrens O, Simon R, Vollmer E, Goldmann T (2013) Optimized immunohistochemistry in combination with image analysis: A reliable alternative to quantitative ELISA determination of uPA and PAI-1 for routine risk group discrimination in breast cancer. The Breast 22: 736-743 (ARCN) https://doi.org/10.1016/j.breast.2012.12.011 http://www.ncbi.nlm.nih.gov/pubmed/23332148

Kupczyk M, Haque S, Sterk PJ, Niżankowska-Mogilnicka E, Papi A, Bel EH, Chanez P, Dahlén B, Gaga M, Gjomarkaj M, Howarth PH, Johnston SL, Joos GF, Kanniess F, Tzortzaki E, James A, Middelveld RJM, Dahlén S-E (2013) Detection of exacerbations in asthma based on electronic diary data: results from the 1-year prospective BIOAIR study. Thorax 68: 611-618 (ARCN) https://doi.org/10.1136/thoraxjnl-2012-201815 http://www.ncbi.nlm.nih.gov/pubmed/23564399

Kreuter M, Vansteenkiste J, Fischer JR, Eberhardt W, Zabeck H, Kollmeier J, Serke M, Frickhofen N, Reck M, Engel-Riedel W, Neumann S, Thomeer M, Schumann C, De Leyn P, Graeter T, Stamatis G, Zuna I, Griesinger F, Thomas M (2013) Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT study. Ann Oncol 24: 986-992 (ARCN, TLRC) https://doi.org/10.1093/annonc/mds578 http://www.ncbi.nlm.nih.gov/pubmed/23161898

Kretschmer S, Dethlefsen I, Hagner-Benes S, Marsh LM, Garn H, König P (2013) Visualization of Intrapulmonary Lymph Vessels in Healthy and Inflamed Murine Lung Using CD90/Thy-1 as a Marker. PLoS One 8: e55201 (ARCN, UGMLC) https://doi.org/10.1371/journal.pone.0055201 http://www.ncbi.nlm.nih.gov/pubmed/23408960

Kopp MV, Hamelmann E, Bendiks M, Zielen S, Kamin W, Bergmann K-C, Klein C, Wahn U (2013) Transient impact of omalizumab in pollen allergic patients undergoing specific immunotherapy. Pediatr Allergy Immunol 24: 427-433 (ARCN) https://doi.org/10.1111/pai.12098 https://www.ncbi.nlm.nih.gov/pubmed/23799935

Kirsten A-M, Watz H, Kirsten D (2013) Sarcoidosis with involvement of the paranasal sinuses – a retrospective analysis of 12 biopsy-proven cases. BMC Pulm Med 13: 59 (ARCN) https://doi.org/10.1186/1471-2466-13-59 http://www.ncbi.nlm.nih.gov/pubmed/24070015

Kemper C, Köhl J (2013) Novel roles for complement receptors in T cell regulation and beyond. Mol Immunol 56: 181-190 (ARCN) https://doi.org/10.1016/j.molimm.2013.05.223 http://www.ncbi.nlm.nih.gov/pubmed/23796748

Janssen O, Schaumann F, Holz O, Lavae-Mokhtari B, Welker L, Winkler C, Biller H, Krug N, Hohlfeld JM (2013) Low-dose endotoxin inhalation in healthy volunteers – a challenge model for early clinical drug development. BMC Pulm Med 13: 19 (ARCN, BREATH) https://doi.org/10.1186/1471-2466-13-19 http://www.ncbi.nlm.nih.gov/pubmed/23537365

Huber RM, Reck M, Thomas M (2013) Current status of and future strategies for multimodality treatment of unresectable stage III nonsmall cell lung cancer. Eur Respir J 42: 1119-1133 (ARCN, TLRC, CPC-M) https://doi.org/10.1183/09031936.00143112 http://www.ncbi.nlm.nih.gov/pubmed/23429914

Hotta K, Suzuki E, Di Maio M, Chiodini P, Fujiwara Y, Takigawa N, Ichihara E, Reck M, Manegold C, Pilz L, Hisamoto-Sato A, Tabata M, Tanimoto M, Shepherd FA, Kiura K (2013) Progression-free survival and overall survival in phase III trials of molecular-targeted agents in advanced non-small-cell lung cancer. Lung Cancer 79: 20-26 (ARCN) https://doi.org/10.1016/j.lungcan.2012.10.007 http://www.ncbi.nlm.nih.gov/pubmed/23164554

Hoffmann J, Romey R, Fink C, Yong L, Roeder T (2013) Overexpression of Sir2 in the adult fat body is sufficient to extend lifespan of male and female Drosophila. Aging (Albany NY) 5: 315-327 (ARCN) http://www.ncbi.nlm.nih.gov/pubmed/23765091

Hess C, Winkler A, Lorenz AK, Holecska V, Blanchard V, Eiglmeier S, Schoen A-L, Bitterling J, Stoehr AD, Petzold D, Schommartz T, Mertes MMM, Schoen CT, Tiburzy B, Herrmann A, Köhl J, Manz RA, Madaio MP, Berger M, Wardemann H, Ehlers M (2013) T cell–independent B cell activation induces immunosuppressive sialylated IgG antibodies. J Clin Invest 123: 3788-3796 (ARCN) https://doi.org/10.1172/jci65938 http://www.ncbi.nlm.nih.gov/pubmed/23979161

Heinbockel L, Sánchez-Gómez S, Martinez de Tejada G, Dömming S, Brandenburg J, Kaconis Y, Hornef M, Dupont A, Marwitz S, Goldmann T, Ernst M, Gutsmann T, Schürholz T, Brandenburg K (2013) Preclinical Investigations Reveal the Broad-Spectrum Neutralizing Activity of Peptide Pep19-2.5 on Bacterial Pathogenicity Factors. Antimicrob Agents Chemother 57: 1480-1487 (ARCN) https://doi.org/10.1128/aac.02066-12 http://www.ncbi.nlm.nih.gov/pubmed/23318793

Heigener DF, von Pawel J, Eschbach C, Brune A, Schmittel A, Schmelter T, Reck M, Fischer JR (2013) Prospective, multicenter, randomized, independent-group, open-label phase II study to investigate the efficacy and safety of three regimens with two doses of sagopilone as second-line therapy in patients with stage IIIB or IV non-small-cell lung cancer. Lung Cancer 80: 319-325 (ARCN) https://doi.org/10.1016/j.lungcan.2013.02.007 http://www.ncbi.nlm.nih.gov/pubmed/23522488

Hagner S, Harb H, Zhao M, Stein K, Holst O, Ege MJ, Mayer M, Matthes J, Bauer J, von Mutius E, Renz H, Heine H, Pfefferle PI, Garn H (2013) Farm-derived Gram-positive bacteriumStaphylococcus sciuriW620 prevents asthma phenotype in HDM- and OVA-exposed mice. Allergy 68: 322-329 (ARCN, CPC-M, UGMLC ) https://doi.org/10.1111/all.12094 http://www.ncbi.nlm.nih.gov/pubmed/23369007

Gröschel A, Warth A, Reinmuth N (2013) Crizotinib – Molekulare Therapie des Lungenkarzinoms. Pneumologie 67: 205-208 (ARCN) https://doi.org/10.1055/s-0032-1326365 http://www.ncbi.nlm.nih.gov/pubmed/23576200

Griese M, Kappler M, Eismann C, Ballmann M, Junge S, Rietschel E, van Koningsbruggen-Rietschel S, Staab D, Rolinck-Werninghaus C, Mellies U, Köhnlein T, Wagner T, König S, Teschler H, Heuer H-E, Kopp M, Heyder S, Hammermann J, Küster P, Honer M, Mansmann U, Beck-Speier I, Hartl D, Fuchs C, Hector A (2013) Inhalation Treatment with Glutathione in Patients with Cystic Fibrosis. A Randomized Clinical Trial. American Journal of Respiratory and Critical Care Medicine 188: 83-89 (ARCN, CPC-M) https://doi.org/10.1164/rccm.201303-0427OC http://www.ncbi.nlm.nih.gov/pubmed/23631796

Goldmann T, Vollmer E (2013) Comment on Nietner et al. [Virchows Arch (s2012) 461:259–269]. Virchows Archiv 463: 609-609 (ARCN) https://doi.org/10.1007/s00428-013-1451-z http://www.ncbi.nlm.nih.gov/pubmed/23873525

Goldmann T, Pedersen F, Seehase S, Marwitz S, Lang DS, Kirsten A-M, Zabel P, Vollmer E, Magnussen H, Rabe KF, Watz H (2013) The Effect of Dithiothreitol on the Transcriptome of Induced Sputum Cells. Respiration 86: 262-263 (ARCN) https://doi.org/10.1159/000348392 http://www.ncbi.nlm.nih.gov/pubmed/23594515

Gaga M, Sculier J-P, Rabe KF (2013) Pulmonologists and lung cancer: pivotal role in multidisciplinary approach. Eur Respir J 42: 1183-1185 (ARCN) https://doi.org/10.1183/09031936.00145813 http://www.ncbi.nlm.nih.gov/pubmed/24178934

Gaga M, Powell CA, Schraufnagel DE, Schönfeld N, Rabe K, Hill NS, Sculier J-P (2013) An Official American Thoracic Society/European Respiratory Society Statement: The Role of the Pulmonologist in the Diagnosis and Management of Lung Cancer. American Journal of Respiratory and Critical Care Medicine 188: 503-507 (ARCN) https://doi.org/10.1164/rccm.201307-1269ST http://www.ncbi.nlm.nih.gov/pubmed/23947517

Fritzsche A, Watz H, Magnussen H, Tuinmann G, Löwe B, von Leupoldt A (2013) Cognitive biases in patients with chronic obstructive pulmonary disease and depression – a pilot study. Br J Health Psychol 18: 827-843 (ARCN) https://doi.org/10.1111/bjhp.12025 https://www.ncbi.nlm.nih.gov/pubmed/23351008

Flesch BK, Wesche J, Berthold T, Goldmann T, Hundt M, Greinacher A, Bux J (2013) Expression of the CTL2 transcript variants in human peripheral blood cells and human tissues. Transfusion 53: 3217-3223 (ARCN) https://doi.org/10.1111/trf.12160 http://www.ncbi.nlm.nih.gov/pubmed/23480595

Fink C, Staubach F, Kuenzel S, Baines JF, Roeder T (2013) Noninvasive Analysis of Microbiome Dynamics in the Fruit Fly Drosophila melanogaster. Applied and Environmental Microbiology 79: 6984-6988 (ARCN) https://doi.org/10.1128/aem.01903-13 http://www.ncbi.nlm.nih.gov/pubmed/24014528

Edelman MJ, Schneider C-P, Tsai C-M, Kim H-T, Quoix E, Luft AV, Kaleta R, Mukhopadhyay P, Trifan OC, Whitaker L, Reck M (2013) Randomized Phase II Study of Ixabepilone or Paclitaxel Plus Carboplatin in Patients With Non–Small-Cell Lung Cancer Prospectively Stratified by Beta-3 Tubulin Status. J Clin Oncol 31: 1990-1996 (ARCN) https://doi.org/10.1200/jco.2012.45.3282 http://www.ncbi.nlm.nih.gov/pubmed/23589560

dos Santos ABG, Binoki D, Silva LFF, de Araujo BB, Otter ID, Annoni R, Tsokos M, Stein RT, Hiemstra PS, Rabe KF, Debertin A, Tschernig T, Mauad T (2013) Immune cell profile in infants’ lung tissue. Annals of Anatomy – Anatomischer Anzeiger 195: 596-604 (ARCN) https://doi.org/10.1016/j.aanat.2013.05.003 http://www.ncbi.nlm.nih.gov/pubmed/23856415

Diel R, Loddenkemper R, Zellweger J-P, Sotgiu G, D’Ambrosio L, Centis R, van der Werf MJ, Dara M, Detjen A, Gondrie P, Reichman L, Blasi F, Migliori GB (2013) Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination. Eur Respir J 42: 785-801 (ARCN) https://doi.org/10.1183/09031936.00205512 https://www.ncbi.nlm.nih.gov/pubmed/23397299

Darwiche K, Zabel P, Teschler H (2013) Pleuraerkrankungen: Neue Erkenntnisse und Entwicklungen. DMW – Deutsche Medizinische Wochenschrift 138: 199-201 (ARCN) https://doi.org/10.1055/s-0032-1327345 https://www.ncbi.nlm.nih.gov/pubmed/23340940

Dalhoff K, Santiago E (2013) Adult Patients With Nosocomial Pneumonia. Deutsches Aerzteblatt Online 110: 634-640 (ARCN, BREATH) https://doi.org/10.3238/arztebl.2013.0634 http://www.ncbi.nlm.nih.gov/pubmed/24133545

Cordier J-F, Cottin V, Guillevin L, Bel E, Bottero P, Dalhoff K, Humbert M, Lazor R, Sinico RA, Sivasothy P, Wechsler ME (2013) L5. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss). La Presse Médicale 42: 507-510 (ARCN) https://doi.org/10.1016/j.lpm.2013.02.308 http://www.ncbi.nlm.nih.gov/pubmed/23490637

Cheng DT, Kim DK, Cockayne DA, Belousov A, Bitter H, Cho MH, Duvoix A, Edwards LD, Lomas DA, Miller BE, Reynaert N, Tal-Singer R, Wouters EFM, Agustí A, Fabbri LM, Rames A, Visvanathan S, Rennard SI, Jones P, Parmar H, MacNee W, Wolff G, Silverman EK, Mayer RJ, Pillai SG (2013) Systemic Soluble Receptor for Advanced Glycation Endproducts Is a Biomarker of Emphysema and Associated with AGER Genetic Variants in Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine 188: 948-957 (ARCN) https://doi.org/10.1164/rccm.201302-0247OC http://www.ncbi.nlm.nih.gov/pubmed/23947473

Brehler R, Klimek L, Kopp MV, Virchow JC (2013) Specific Immunotherapy. Deutsches Aerzteblatt Online 110: 148-158 (ARCN) https://doi.org/10.3238/arztebl.2013.0148 http://www.ncbi.nlm.nih.gov/pubmed/23533561

Bierbaum S, Forster J, Berner R, Rücker G, Rohde G, Neumann-Haefelin D, Panning M (2013) Detection of respiratory viruses using a multiplex real-time PCR assay in Germany, 2009/10. Arch Virol 159: 669-676 (ARCN, BREATH) https://doi.org/10.1007/s00705-013-1876-3 http://www.ncbi.nlm.nih.gov/pubmed/24126621

Bendiks M, Kopp MV (2013) The Relationship Between Advances in Understanding the Microbiome and the Maturing Hygiene Hypothesis. Curr Allergy Asthma Rep 13: 487-494 (ARCN) https://doi.org/10.1007/s11882-013-0382-8 https://www.ncbi.nlm.nih.gov/pubmed/23934550

Behr J, Günther A, Ammenwerth W, Bittmann I, Bonnet R, Buhl R, Eickelberg O, Ewert R, Gläser S, Gottlieb J, Grohé C, Kreuter M, Kroegel C, Markart P, Neurohr C, Pfeifer M, Prasse A, Schönfeld N, Schreiber J, Sitter H, Theegarten D, Theile A, Wilke A, Wirtz H, Witt C, Worth H, Zabel P, Müller-Quernheim J, Costabel U (2013) S2K-Leitlinie zur Diagnostik und Therapie der idiopathischen Lungenfibrose. Pneumologie 67: 81-111 (ARCN, CPC-M, TLRC) https://doi.org/10.1055/s-0032-1326009 http://www.ncbi.nlm.nih.gov/pubmed/23325398

Beghè B, Rabe KF, Fabbri LM (2013) Phosphodiesterase-4 Inhibitor Therapy for Lung Diseases. American Journal of Respiratory and Critical Care Medicine 188: 271-278 (ARCN) https://doi.org/10.1164/rccm.201301-0021PP http://www.ncbi.nlm.nih.gov/pubmed/23656508

Beeh KM, Glaab T, Stowasser S, Schmidt H, Fabbri LM, Rabe KF, Vogelmeier CF (2013) Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial. Respir Res 14: 116 (ARCN, UGMLC) https://doi.org/10.1186/1465-9921-14-116 http://www.ncbi.nlm.nih.gov/pubmed/24168767

Beczała A, Ovchinnikova OG, Datta N, Mattinen L, Knapska K, Radziejewska-Lebrecht J, Holst O, Skurnik M (2013) Structure and genetic basis of Yersinia similis serotype O:9 O-specific polysaccharide. Innate Immun 21: 3-16 (ARCN) https://doi.org/10.1177/1753425913514783 http://www.ncbi.nlm.nih.gov/pubmed/24361587

Barnes PJ, Blasi F, Ward B, Reeves E, Rabe KF (2013) Respiratory diseases in the world: one voice “united for lung health”. Eur Respir J 43: 3-5 (ARCN) https://doi.org/10.1183/09031936.00202613 http://www.ncbi.nlm.nih.gov/pubmed/24381315

Barnes N, Calverley PMA, Kaplan A, Rabe KF (2013) Chronic obstructive pulmonary disease and exacerbations: clinician insights from the global Hidden Depths of COPD survey. Curr Med Res Opin 30: 667-684 (ARCN) https://doi.org/10.1185/03007995.2013.867842 http://www.ncbi.nlm.nih.gov/pubmed/24256026

Barnes N, Calverley PMA, Kaplan A, Rabe KF (2013) Chronic obstructive pulmonary disease and exacerbations: Patient insights from the global Hidden Depths of COPD survey. BMC Pulm Med 13: 54 (ARCN) https://doi.org/10.1186/1471-2466-13-54 http://www.ncbi.nlm.nih.gov/pubmed/23971625

Asgari E, Le Friec G, Yamamoto H, Perucha E, Sacks SS, Köhl J, Cook HT, Kemper C (2013) C3a modulates IL-1β secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation. Blood 122: 3473-3481 (ARCN) https://doi.org/10.1182/blood-2013-05-502229 http://www.ncbi.nlm.nih.gov/pubmed/23878142

Ansari R, Myrtus C, Aherrahrou R, Erdmann J, Schweikard A, Hüttmann G (2013) Ultrahigh-resolution, high-speed spectral domain optical coherence phase microscopy. Optics Letters 39: 45 (ARCN) https://doi.org/10.1364/ol.39.000045 http://www.ncbi.nlm.nih.gov/pubmed/24365818

 

2012

Ziegler-Heitbrock L, Frankenberger M, Heimbeck I, Burggraf D, Wjst M, Häussinger K, Brightling C, Gupta S, Parr D, Subramanian D, Singh D, Kolsum U, Boschetto P, Potena A, Gorecka D, Nowinski A, Barta I, Döme B, Strausz J, Greulich T, Vogelmeier C, Bals R, Hohlfeld JM, Welte T, Venge P, Gut I, Boland A, Olaso R, Hager J, Hiemstra P, Rabe KF, Unmüßig M, Müller-Quernheim J, Prasse A (2012) The EvA study: aims and strategy. Eur Respir J 40: 823-829 (ARCN, BREATH, UGMLC) https://doi.org/10.1183/09031936.00142811 http://www.ncbi.nlm.nih.gov/pubmed/22441733

Wouters EFM, Bredenbröker D, Teichmann P, Brose M, Rabe KF, Fabbri LM, Göke B (2012) Effect of the Phosphodiesterase 4 Inhibitor Roflumilast on Glucose Metabolism in Patients with Treatment-Naive, Newly Diagnosed Type 2 Diabetes Mellitus. The Journal of Clinical Endocrinology & Metabolism 97: E1720-E1725 (ARCN) https://doi.org/10.1210/jc.2011-2886 http://www.ncbi.nlm.nih.gov/pubmed/22723325

Wilson KC, Irwin RS, File TM, Schünemann HJ, Guyatt GH, Rabe KF (2012) Reporting and Publishing Guidelines. Proc Am Thorac Soc 9: 293-297 (ARCN) https://doi.org/10.1513/pats.201208-065ST http://www.ncbi.nlm.nih.gov/pubmed/23256173

Wegmann M, Lunding L, Orinska Z, Wong DM, Manz RA, Fehrenbach H (2012) Long-Term Bortezomib Treatment Reduces Allergen-Specific IgE but Fails to Ameliorate Chronic Asthma in Mice. International Archives of Allergy and Immunology 158: 43-53 (ARCN) https://doi.org/10.1159/000330103 http://www.ncbi.nlm.nih.gov/pubmed/22212634

Weckmann M, Moir LM, Heckman CA, Black JL, Oliver BG, Burgess JK (2012) Lamstatin – a novel inhibitor of lymphangiogenesis derived from collagen IV. Journal of Cellular and Molecular Medicine 16: 3062-3073 (ARCN) https://doi.org/10.1111/j.1582-4934.2012.01648.x http://www.ncbi.nlm.nih.gov/pubmed/22998238

Waschki B, Spruit MA, Watz H, Albert PS, Shrikrishna D, Groenen M, Smith C, Man WDC, Tal-Singer R, Edwards LD, Calverley PMA, Magnussen H, Polkey MI, Wouters EFM (2012) Physical activity monitoring in COPD: Compliance and associations with clinical characteristics in a multicenter study. Respir Med 106: 522-530 (ARCN) https://doi.org/10.1016/j.rmed.2011.10.022 http://www.ncbi.nlm.nih.gov/pubmed/22118987

Vogt B, Pulletz S, Elke G, Zhao Z, Zabel P, Weiler N, Frerichs I (2012) Spatial and temporal heterogeneity of regional lung ventilation determined by electrical impedance tomography during pulmonary function testing. J Appl Physiol 113: 1154-1161 (ARCN) https://doi.org/10.1152/japplphysiol.01630.2011 http://www.ncbi.nlm.nih.gov/pubmed/22898553

Vansteenkiste J, Ramlau R, von Pawel J, San Antonio B, Eschbach C, Szczesna A, Kennedy L, Visseren-Grul C, Chouaki N, Reck M (2012) A Phase II Randomized Study of Cisplatin-Pemetrexed plus either Enzastaurin or Placebo in Chemonaive Patients with Advanced Non-Small Cell Lung Cancer. Oncology 82: 25-29 (ARCN) https://doi.org/10.1159/000335268 http://www.ncbi.nlm.nih.gov/pubmed/22269428

Thatcher TH, Cockayne DA, Cheng DT, Waschki B, Sridhar S, Ravindran P, Hilton H, Kourteva G, Bitter H, Pillai SG, Visvanathan S, Müller K-C, Holz O, Magnussen H, Watz H, Fine JS (2012) Systemic Biomarkers of Neutrophilic Inflammation, Tissue Injury and Repair in COPD Patients with Differing Levels of Disease Severity. PLoS One 7: e38629 (ARCN, BREATH) https://doi.org/10.1371/journal.pone.0038629 http://www.ncbi.nlm.nih.gov/pubmed/22701684

Szymanski KV, Toennies M, Becher A, Fatykhova D, N’Guessan PD, Gutbier B, Klauschen F, Neuschaefer-Rube F, Schneider P, Rueckert J, Neudecker J, Bauer TT, Dalhoff K, Drömann D, Gruber AD, Kershaw O, Temmesfeld-Wollbrueck B, Suttorp N, Hippenstiel S, Hocke AC (2012) Streptococcus pneumoniae-induced regulation of cyclooxygenase-2 in human lung tissue. Eur Respir J 40: 1458-1467 (ARCN) https://doi.org/10.1183/09031936.00186911 http://www.ncbi.nlm.nih.gov/pubmed/22441740

Smit EF, Socinski MA, Mullaney BP, Myrand SP, Scagliotti GV, Lorigan P, Reck M, Ciuleanu T, von Pawel J, Karaseva NA, Szczesna A, Ohannesian D, Powell E, Hozak RR, Hong S, Guba SC, Thatcher N (2012) Biomarker analysis in a phase III study of pemetrexed–carboplatin versus etoposide–carboplatin in chemonaive patients with extensive-stage small-cell lung cancer. Ann Oncol 23: 1723-1729 (ARCN) https://doi.org/10.1093/annonc/mdr563 http://www.ncbi.nlm.nih.gov/pubmed/22186609

Seeger W, Welte T, Eickelberg O, Mall M, Rabe K, Keller B, Winkler S, Koller U (2012) Das Deutsche Zentrum für Lungenforschung – Translationale Forschung für Prävention, Diagnose und Therapie von Atemwegserkrankungen. Pneumologie 66: 464-469 (ARCN, BREATH, CPC-M, TLRC, UGMLC) https://doi.org/10.1055/s-0032-1310086 http://www.ncbi.nlm.nih.gov/pubmed/22875729

Schünemann HJ, Woodhead M, Anzueto A, Buist AS, MacNee W, Rabe KF, Heffner J (2012) A Guide to Guidelines for Professional Societies and Other Developers of Recommendations. Proc Am Thorac Soc 9: 215-218 (ARCN) https://doi.org/10.1513/pats.201208-053ST https://www.ncbi.nlm.nih.gov/pubmed/23256161

Schmudde I, Ströver HA, Vollbrandt T, König P, Karsten CM, Laumonnier Y, Köhl J (2012) C5a receptor signalling in dendritic cells controls the development of maladaptive Th2 and Th17 immunity in experimental allergic asthma. Mucosal Immunol 6: 807-825 (ARCN) https://doi.org/10.1038/mi.2012.119 http://www.ncbi.nlm.nih.gov/pubmed/23212198

Schaberg T, Bauer T, Castell S, Dalhoff K, Detjen A, Diel R, Greinert U, Hauer B, Lange C, Magdorf K, Loddenkemper R (2012) Empfehlungen zur Therapie, Chemoprävention und Chemoprophylaxe der Tuberkulose im Erwachsenen- und Kindesalter. Pneumologie 66: 133-171 (ARCN) https://doi.org/10.1055/s-0031-1291619 https://www.thieme-connect.com/products/ejournals/pdf/10.1055/s-0031-1291619.pdf

Scagliotti GV, Krzakowski M, Szczesna A, Strausz J, Makhson A, Reck M, Wierzbicki RF, Albert I, Thomas M, Miziara JEA, Papai ZS, Karaseva N, Thongprasert S, Portulas ED, von Pawel J, Zhang K, Selaru P, Tye L, Chao RC, Govindan R (2012) Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer: A Phase III Trial. J Clin Oncol 30: 2070-2078 (ARCN, TLRC) https://doi.org/10.1200/jco.2011.39.2993 http://www.ncbi.nlm.nih.gov/pubmed/22564989

Scagliotti GV, Ilaria R, Novello S, von Pawel J, Fischer JR, Ermisch S, de Alwis DP, Andrews J, Reck M, Crino L, Eschbach C, Manegold C (2012) Tasisulam Sodium (LY573636 Sodium) as Third-Line Treatment in Patients With Unresectable, Metastatic Non–Small-Cell Lung Cancer: A Phase-II Study. J Thorac Oncol 7: 1053-1057 (ARCN) https://doi.org/10.1097/JTO.0b013e3182519d79 http://www.ncbi.nlm.nih.gov/pubmed/22588156

Sandler A, Hirsh V, Reck M, von Pawel J, Akerley W, Johnson DH (2012) An evidence-based review of the incidence of CNS bleeding with anti-VEGF therapy in non-small cell lung cancer patients with brain metastases. Lung Cancer 78: 1-7 (ARCN) https://doi.org/10.1016/j.lungcan.2012.07.004 http://www.ncbi.nlm.nih.gov/pubmed/22877947

Röschmann KIL, van Kuijen AM, Luiten S, Jonker MJ, Breit TM, Fokkens WJ, Petersen A, van Drunen CM (2012) Purified Timothy grass pollen major allergen Phl p 1 may contribute to the modulation of allergic responses through a pleiotropic induction of cytokines and chemokines from airway epithelial cells. Clin Exp Immunol 167: 413-421 (ARCN) https://doi.org/10.1111/j.1365-2249.2011.04522.x http://www.ncbi.nlm.nih.gov/pubmed/22288584

Röschmann KIL, van Kuijen AM, Luiten S, Jonker MJ, Breit TM, Fokkens WJ, Petersen A, van Drunen CM (2012) Comparison of Timothy grass pollen extract- and single major allergen-induced gene expression and mediator release in airway epithelial cells: a meta-analysis. Clin Exp Allergy 42: 1479-1490 (ARCN) https://doi.org/10.1111/j.1365-2222.2012.04033.x https://www.ncbi.nlm.nih.gov/pubmed/22994345

Roeder T, Isermann K, Kallsen K, Uliczka K, Wagner C (2012) A Drosophila Asthma Model – What the Fly Tells Us About Inflammatory Diseases of the Lung. Adv Exp Med Biol 710: 37-47 (ARCN) https://doi.org/10.1007/978-1-4419-5638-5_5 https://www.ncbi.nlm.nih.gov/pubmed/22127884

Reck M, Thatcher N, Smit EF, Lorigan P, Szutowicz-Zielinska E, Liepa AM, Winfree KB, Peterson P, Guba SC, Socinski MA (2012) Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin. Lung Cancer 78: 276-281 (ARCN) https://doi.org/10.1016/j.lungcan.2012.09.002 http://www.ncbi.nlm.nih.gov/pubmed/23043970

Reck M, Rosell R, Tiemann M (2012) Therapiestandards und Perspektiven beim nichtkleinzelligen Lungenkarzinom im Stadium IV. Onkologie 35: 10-13 (ARCN) https://doi.org/10.1159/000338986 http://www.ncbi.nlm.nih.gov/pubmed/22678019

Reck M, Barlesi F, Crinò L, Henschke CI, Isla D, Stiebeler S, Spigel DR (2012) Predicting and managing the risk of pulmonary haemorrhage in patients with NSCLC treated with bevacizumab: a consensus report from a panel of experts. Ann Oncol 23: 1111-1120 (ARCN) https://doi.org/10.1093/annonc/mdr463 http://www.ncbi.nlm.nih.gov/pubmed/22056855

Reck M (2012) What future opportunities may immuno-oncology provide for improving the treatment of patients with lung cancer? Ann Oncol 23: viii28-viii34 (ARCN) https://doi.org/10.1093/annonc/mds260 http://www.ncbi.nlm.nih.gov/pubmed/22918925

Raith M, Schaal K, Koslowski R, Fehrenbach H, Poets CF, Schleicher E, Bernhard W (2012) Effects of recombinant human keratinocyte growth factor on surfactant, plasma, and liver phospholipid homeostasis in hyperoxic neonatal rats. J Appl Physiol 112: 1317-1328 (ARCN) https://doi.org/10.1152/japplphysiol.00887.2011 http://www.ncbi.nlm.nih.gov/pubmed/22323656

Rabe KF, Ward B (2012) Uncovering and tackling Europe’s hidden respiratory illness. The Lancet 380: 623-624 (ARCN) https://doi.org/10.1016/s0140-6736(12)61306-3 http://www.ncbi.nlm.nih.gov/pubmed/22901869

Rabe KF, Gratziou C, Ward B, Berteletti F (2012) Towards a total ban on links with the tobacco industry: new rules for the ERS. Eur Respir J 40: 809-810 (ARCN) https://doi.org/10.1183/09031936.00117012 http://www.ncbi.nlm.nih.gov/pubmed/23024325

Rabe KF (2012) Drug Safety in COPD Revisited. Chest 142: 271-274 (ARCN) https://doi.org/10.1378/chest.12-1395 http://www.ncbi.nlm.nih.gov/pubmed/22871745

Peters S, Adjei AA, Gridelli C, Reck M, Kerr K, Felip E (2012) Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 23: vii56-vii64 (ARCN) https://doi.org/10.1093/annonc/mds226 http://www.ncbi.nlm.nih.gov/pubmed/22997455

Paz-Ares L, de Marinis F, Dediu M, Thomas M, Pujol J-L, Bidoli P, Molinier O, Sahoo TP, Laack E, Reck M, Corral J, Melemed S, John W, Chouaki N, Zimmermann AH, Visseren-Grul C, Gridelli C (2012) Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial. The Lancet Oncology 13: 247-255 (ARCN) https://doi.org/10.1016/s1470-2045(12)70063-3 http://www.ncbi.nlm.nih.gov/pubmed/22341744

Ohlendorff S, Martinez, Fabbri, Goehring, Rabe K, Calverley P (2012) Does roflumilast decrease exacerbations in severe COPD patients not controlled by inhaled combination therapy? the REACT study protocol. Int J Chron Obstruct Pulmon Dis 7: 375 (ARCN) https://doi.org/10.2147/copd.S31100 http://www.ncbi.nlm.nih.gov/pubmed/22791991

Ofran Y, Röckendorf N, Borschbach M, Frey A (2012) Molecular Evolution of Peptide Ligands with Custom-Tailored Characteristics for Targeting of Glycostructures. PLoS Computational Biology 8: e1002800 (ARCN) https://doi.org/10.1371/journal.pcbi.1002800 http://www.ncbi.nlm.nih.gov/pubmed/23271960

Oefner CM, Winkler A, Hess C, Lorenz AK, Holecska V, Huxdorf M, Schommartz T, Petzold D, Bitterling J, Schoen A-L, Stoehr AD, Vu Van D, Darcan-Nikolaisen Y, Blanchard V, Schmudde I, Laumonnier Y, Ströver HA, Hegazy AN, Eiglmeier S, Schoen CT, Mertes MMM, Loddenkemper C, Löhning M, König P, Petersen A, Luger EO, Collin M, Köhl J, Hutloff A, Hamelmann E, Berger M, Wardemann H, Ehlers M (2012) Tolerance induction with T cell–dependent protein antigens induces regulatory sialylated IgGs. Journal of Allergy and Clinical Immunology 129: 1647-1655.e1613 (ARCN) https://doi.org/10.1016/j.jaci.2012.02.037 http://www.ncbi.nlm.nih.gov/pubmed/22502800

Möbs C, Ipsen H, Mayer L, Slotosch C, Petersen A, Würtzen PA, Hertl M, Pfützner W (2012) Birch pollen immunotherapy results in long-term loss of Bet v 1–specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies. Journal of Allergy and Clinical Immunology 130: 1108-1116.e1106 (ARCN) https://doi.org/10.1016/j.jaci.2012.07.056 http://www.ncbi.nlm.nih.gov/pubmed/23021882

Michalski J, Kanaji N, Liu X, Nogel S, Wang X, Basma H, Nakanishi M, Sato T, Gunji Y, Fahrid M, Nelson A, Muller K-C, Holz O, Magnussen H, Rabe KF, Toews ML, Rennard SI (2012) Attenuation of Inhibitory Prostaglandin E2 Signaling in Human Lung Fibroblasts Is Mediated by Phosphodiesterase 4. Am J Respir Cell Mol Biol 47: 729-737 (ARCN, BREATH) https://doi.org/10.1165/rcmb.2012-0057OC http://www.ncbi.nlm.nih.gov/pubmed/23043089

Merimsky O, Cheng C-K, Au JS-K, Von Pawel J, Reck M (2012) Efficacy and safety of first-line erlotinib in elderly patients with advanced non-small cell lung cancer. Oncol Rep 28: 721-727 (ARCN) https://doi.org/10.3892/or.2012.1824 http://www.ncbi.nlm.nih.gov/pubmed/22614912

Lynch TJ, Bondarenko I, Luft A, Serwatowski P, Barlesi F, Chacko R, Sebastian M, Neal J, Lu H, Cuillerot J-M, Reck M (2012) Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study. J Clin Oncol 30: 2046-2054 (ARCN) https://doi.org/10.1200/jco.2011.38.4032 http://www.ncbi.nlm.nih.gov/pubmed/22547592

Laskin J, Crinò L, Felip E, Franke F, Gorbunova V, Groen H, Jiang G-l, Reck M, Schneider C-P (2012) Safety and Efficacy of First-Line Bevacizumab Plus Chemotherapy in Elderly Patients with Advanced or Recurrent Nonsquamous Non-small Cell Lung Cancer: Safety of Avastin in Lung trial (MO19390). J Thorac Oncol 7: 203-211 (ARCN) https://doi.org/10.1097/JTO.0b013e3182370e02 http://www.ncbi.nlm.nih.gov/pubmed/22173662

Klaenhammer TR, Kleerebezem M, Kopp MV, Rescigno M (2012) The impact of probiotics and prebiotics on the immune system. Nature Reviews Immunology 12: 728-734 (ARCN) https://doi.org/10.1038/nri3312 http://www.ncbi.nlm.nih.gov/pubmed/23007572

Kirsten A, Watz H, Pedersen F, Holz O, Smith R, Bruin G, Koehne-Voss S, Magnussen H, Waltz DA (2012) The anti-IL-17A antibody secukinumab does not attenuate ozone-induced airway neutrophilia in healthy volunteers. Eur Respir J 41: 239-241 (ARCN, BREATH) https://doi.org/10.1183/09031936.00123612 http://www.ncbi.nlm.nih.gov/pubmed/23277522

Jappe U (2012) Allergie auf Säugetierfleisch. Der Hautarzt 63: 299-306 (ARCN) https://doi.org/10.1007/s00105-011-2266-y http://www.ncbi.nlm.nih.gov/pubmed/22418768

Heydenreich B, Bellinghausen I, König B, Becker WM, Grabbe S, Petersen A, Saloga J (2012) Gram-positive bacteria on grass pollen exhibit adjuvant activity inducing inflammatory T cell responses. Clin Exp Allergy 42: 76-84 (ARCN) https://doi.org/10.1111/j.1365-2222.2011.03888.x https://www.ncbi.nlm.nih.gov/pubmed/22092824

Hermes A, Waschki B, Reck M (2012) Hyponatremia as prognostic factor in small cell lung cancer – A retrospective single institution analysis. Respir Med 106: 900-904 (ARCN) https://doi.org/10.1016/j.rmed.2012.02.010 http://www.ncbi.nlm.nih.gov/pubmed/22405607

Hermes A, Heigener D, Gatzemeier U, Schatz J, Reck M (2012) Efficacy and safety of bronchoscopic laser therapy in patients with tracheal and bronchial obstruction: a retrospective single institution report. The Clinical Respiratory Journal 6: 67-71 (ARCN) https://doi.org/10.1111/j.1752-699X.2011.00247.x http://www.ncbi.nlm.nih.gov/pubmed/21801329

Hattar K, Savai R, Subtil FSB, Wilhelm J, Schmall A, Lang DS, Goldmann T, Eul B, Dahlem G, Fink L, Schermuly R-T, Banat G-A, Sibelius U, Grimminger F, Vollmer E, Seeger W, Grandel U (2012) Endotoxin induces proliferation of NSCLC in vitro and in vivo: role of COX-2 and EGFR activation. Cancer Immunology, Immunotherapy 62: 309-320 (ARCN, UGMLC) https://doi.org/10.1007/s00262-012-1341-2 http://www.ncbi.nlm.nih.gov/pubmed/22923191

Grozdanovic M, Popovic M, Polovic N, Burazer L, Vuckovic O, Atanaskovic-Markovic M, Lindner B, Petersen A, Gavrovic-Jankulovic M (2012) Evaluation of IgE reactivity of active and thermally inactivated actinidin, a biomarker of kiwifruit allergy. Food and Chemical Toxicology 50: 1013-1018 (ARCN) https://doi.org/10.1016/j.fct.2011.12.030 http://www.ncbi.nlm.nih.gov/pubmed/22227218

Gridelli C, de Marinis F, Pujol J-L, Reck M, Ramlau R, Parente B, Pieters T, Middleton G, Corral J, Winfree K, Melemed S, Zimmermann A, John W, Beyrer J, Chouaki N, Visseren-Grul C, Paz-Ares LG (2012) Safety, Resource Use, and Quality of Life in Paramount: A Phase III Study of Maintenance Pemetrexed Versus Placebo after Induction Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non–Small-Cell Lung Cancer. J Thorac Oncol 7: 1713-1721 (ARCN) https://doi.org/10.1097/JTO.0b013e318267cf84 http://www.ncbi.nlm.nih.gov/pubmed/23059776

Fabbri LM, Boyd C, Boschetto P, Rabe KF, Buist AS, Yawn B, Leff B, Kent DM, Schünemann HJ (2012) How to Integrate Multiple Comorbidities in Guideline Development. Proc Am Thorac Soc 9: 274-281 (ARCN) https://doi.org/10.1513/pats.201208-063ST http://www.ncbi.nlm.nih.gov/pubmed/23256171

Doherty TM, Budulac SE, Boezen HM, Hiemstra PS, Lapperre TS, Vonk JM, Timens W, Postma DS (2012) Toll-Like Receptor (TLR2 and TLR4) Polymorphisms and Chronic Obstructive Pulmonary Disease. PLoS One 7: e43124 (ARCN) https://doi.org/10.1371/journal.pone.0043124 http://www.ncbi.nlm.nih.gov/pubmed/22952638

de Carvalho-Pinto RM, Cukier A, Angelini L, Antonangelo L, Mauad T, Dolhnikoff M, Rabe KF, Stelmach R (2012) Clinical characteristics and possible phenotypes of an adult severe asthma population. Respir Med 106: 47-56 (ARCN) https://doi.org/10.1016/j.rmed.2011.08.013 http://www.ncbi.nlm.nih.gov/pubmed/21890336

Contoli M, Kraft M, Hamid Q, Bousquet J, Rabe KF, Fabbri LM, Papi A (2012) Do small airway abnormalities characterize asthma phenotypes? In search of proof. Clin Exp Allergy 42: 1150-1160 (ARCN) https://doi.org/10.1111/j.1365-2222.2012.03963.x http://www.ncbi.nlm.nih.gov/pubmed/22805462

Calderon MA, Gerth van Wijk R, Eichler I, Matricardi PM, Varga EM, Kopp MV, Eng P, Niggemann B, Nieto A, Valovirta E, Eigenmann PA, Pajno G, Bufe A, Halken S, Beyer K, Wahn U (2012) Perspectives on allergen-specific immunotherapy in childhood: An EAACI position statement. Pediatr Allergy Immunol 23: 300-306 (ARCN) https://doi.org/10.1111/j.1399-3038.2012.01313.x http://www.ncbi.nlm.nih.gov/pubmed/22594930

Burgess JK, Weckmann M (2012) Matrikines and the lungs. Pharmacol Ther 134: 317-337 (ARCN) https://doi.org/10.1016/j.pharmthera.2012.02.002 http://www.ncbi.nlm.nih.gov/pubmed/22366287

Buhl R, Kuna P, Peters MJ, Andersson TLG, Naya IP, Peterson S, Rabe KF (2012) The effect of budesonide/formoterol maintenance and reliever therapy on the risk of severe asthma exacerbations following episodes of high reliever use: an exploratory analysis of two randomised, controlled studies with comparisons to standard therapy. Respir Res 13: 59 (ARCN) https://doi.org/10.1186/1465-9921-13-59 http://www.ncbi.nlm.nih.gov/pubmed/22816878

Bousquet J, Schünemann HJ, Samolinski B, Demoly P, Baena-Cagnani CE, Bachert C, Bonini S, Boulet LP, Bousquet PJ, Brozek JL, Canonica GW, Casale TB, Cruz AA, Fokkens WJ, Fonseca JA, van Wijk RG, Grouse L, Haahtela T, Khaltaev N, Kuna P, Lockey RF, Lodrup Carlsen KC, Mullol J, Naclerio R, O’Hehir RE, Ohta K, Palkonen S, Papadopoulos NG, Passalacqua G, Pawankar R, Price D, Ryan D, Simons FER, Togias A, Williams D, Yorgancioglu A, Yusuf OM, Aberer W, Adachi M, Agache I, Aït-Khaled N, Akdis CA, Andrianarisoa A, Annesi-Maesano I, Ansotegui IJ, Baiardini I, Bateman ED, Bedbrook A, Beghé B, Beji M, Bel EH, Ben Kheder A, Bennoor KS, Bergmann KC, Berrissoul F, Bieber T, Bindslev Jensen C, Blaiss MS, Boner AL, Bouchard J, Braido F, Brightling CE, Bush A, Caballero F, Calderon MA, Calvo MA, Camargos PAM, Caraballo LR, Carlsen KH, Carr W, Cepeda AM, Cesario A, Chavannes NH, Chen YZ, Chiriac AM, Chivato Pérez T, Chkhartishvili E, Ciprandi G, Costa DJ, Cox L, Custovic A, Dahl R, Darsow U, De Blay F, Deleanu D, Denburg JA, Devillier P, Didi T, Dokic D, Dolen WK, Douagui H, Dubakiene R, Durham SR, Dykewicz MS, El-Gamal Y, El-Meziane A, Emuzyte R, Fiocchi A, Fletcher M, Fukuda T, Gamkrelidze A, Gereda JE, González Diaz S, Gotua M, Guzmán MA, Hellings PW, Hellquist-Dahl B, Horak F, Hourihane JOB, Howarth P, Humbert M, Ivancevich JC, Jackson C, Just J, Kalayci O, Kaliner MA, Kalyoncu AF, Keil T, Keith PK, Khayat G, Kim YY, Koffi N’Goran B, Koppelman GH, Kowalski ML, Kull I, Kvedariene V, Larenas-Linnemann D, Le LT, Lemière C, Li J, Lieberman P, Lipworth B, Mahboub B, Makela MJ, Martin F, Marshall GD, Martinez FD, Masjedi MR, Maurer M, Mavale-Manuel S, Mazon A, Melen E, Meltzer EO, Mendez NH, Merk H, Mihaltan F, Mohammad Y, Morais-Almeida M, Muraro A, Nafti S, Namazova-Baranova L, Nekam K, Neou A, Niggemann B, Nizankowska-Mogilnicka E, Nyembue TD, Okamoto Y, Okubo K, Orru MP, Ouedraogo S, Ozdemir C, Panzner P, Pali-Schöll I, Park HS, Pigearias B, Pohl W, Popov TA, Postma DS, Potter P, Rabe KF, Ratomaharo J, Reitamo S, Ring J, Roberts R, Rogala B, Romano A, Roman Rodriguez M, Rosado-Pinto J, Rosenwasser L, Rottem M, Sanchez-Borges M, Scadding GK, Schmid-Grendelmeier P, Sheikh A, Sisul JC, Solé D, Sooronbaev T, Spicak V, Spranger O, Stein RT, Stoloff SW, Sunyer J, Szczeklik A, Todo-Bom A, Toskala E, Tremblay Y, Valenta R, Valero AL, Valeyre D, Valiulis A, Valovirta E, Van Cauwenberge P, Vandenplas O, van Weel C, Vichyanond P, Viegi G, Wang DY, Wickman M, Wöhrl S, Wright J, Yawn BP, Yiallouros PK, Zar HJ, Zernotti ME, Zhong N, Zidarn M, Zuberbier T (2012) Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs. Journal of Allergy and Clinical Immunology 130: 1049-1062 (ARCN) https://doi.org/10.1016/j.jaci.2012.07.053 http://www.ncbi.nlm.nih.gov/pubmed/23040884

Asthma WHOCCf, Rhinitis, Bousquet J, Anto JM, Demoly P, Schunemann HJ, Togias A, Akdis M, Auffray C, Bachert C, Bieber T, Bousquet PJ, Carlsen KH, Casale TB, Cruz AA, Keil T, Lodrup Carlsen KC, Maurer M, Ohta K, Papadopoulos NG, Roman Rodriguez M, Samolinski B, Agache I, Andrianarisoa A, Ang CS, Annesi-Maesano I, Ballester F, Baena-Cagnani CE, Basagana X, Bateman ED, Bel EH, Bedbrook A, Beghe B, Beji M, Ben Kheder A, Benet M, Bennoor KS, Bergmann KC, Berrissoul F, Bindslev Jensen C, Bleecker ER, Bonini S, Boner AL, Boulet LP, Brightling CE, Brozek JL, Bush A, Busse WW, Camargos PA, Canonica GW, Carr W, Cesario A, Chen YZ, Chiriac AM, Costa DJ, Cox L, Custovic A, Dahl R, Darsow U, Didi T, Dolen WK, Douagui H, Dubakiene R, El-Meziane A, Fonseca JA, Fokkens WJ, Fthenou E, Gamkrelidze A, Garcia-Aymerich J, Gerth van Wijk R, Gimeno-Santos E, Guerra S, Haahtela T, Haddad H, Hellings PW, Hellquist-Dahl B, Hohmann C, Howarth P, Hourihane JO, Humbert M, Jacquemin B, Just J, Kalayci O, Kaliner MA, Kauffmann F, Kerkhof M, Khayat G, Koffi N’Goran B, Kogevinas M, Koppelman GH, Kowalski ML, Kull I, Kuna P, Larenas D, Lavi I, Le LT, Lieberman P, Lipworth B, Mahboub B, Makela MJ, Martin F, Martinez FD, Marshall GD, Mazon A, Melen E, Meltzer EO, Mihaltan F, Mohammad Y, Mohammadi A, Momas I, Morais-Almeida M, Mullol J, Muraro A, Naclerio R, Nafti S, Namazova-Baranova L, Nawijn MC, Nyembue TD, Oddie S, O’Hehir RE, Okamoto Y, Orru MP, Ozdemir C, Ouedraogo GS, Palkonen S, Panzner P, Passalacqua G, Pawankar R, Pigearias B, Pin I, Pinart M, Pison C, Popov TA, Porta D, Postma DS, Price D, Rabe KF, Ratomaharo J, Reitamo S, Rezagui D, Ring J, Roberts R, Roca J, Rogala B, Romano A, Rosado-Pinto J, Ryan D, Sanchez-Borges M, Scadding GK, Sheikh A, Simons FE, Siroux V, Schmid-Grendelmeier PD, Smit HA, Sooronbaev T, Stein RT, Sterk PJ, Sunyer J, Terreehorst I, Toskala E, Tremblay Y, Valenta R, Valeyre D, Vandenplas O, van Weel C, Vassilaki M, Varraso R, Viegi G, Wang DY, Wickman M, Williams D, Wohrl S, Wright J, Yorgancioglu A, Yusuf OM, Zar HJ, Zernotti ME, Zidarn M, Zhong N, Zuberbier T (2012) Severe Chronic Allergic (and Related) Diseases: A Uniform Approach – A MeDALL – GA2LEN – ARIA Position Paper. International Archives of Allergy and Immunology 158: 216-231 (ARCN) https://doi.org/10.1159/000332924 http://www.ncbi.nlm.nih.gov/pubmed/22382913

Annoni R, Lanças T, Yukimatsu Tanigawa R, de Medeiros Matsushita M, de Morais Fernezlian S, Bruno A, Fernando Ferraz da Silva L, Roughley PJ, Battaglia S, Dolhnikoff M, Hiemstra PS, Sterk PJ, Rabe KF, Mauad T (2012) Extracellular matrix composition in COPD. Eur Respir J 40: 1362-1373 (ARCN) https://doi.org/10.1183/09031936.00192611 http://www.ncbi.nlm.nih.gov/pubmed/22496324

Aleksic I, Popovic M, Dimitrijevic R, Andjelkovic U, Vassilopoulou E, Sinaniotis A, Atanaskovic-Markovic M, Lindner B, Petersen A, Papadopoulos NG, Gavrovic-Jankulovic M (2012) Molecular and immunological characterization of Mus a 5 allergen from banana fruit. Mol Nutr Food Res 56: 446-453 (ARCN) https://doi.org/10.1002/mnfr.201100541 http://www.ncbi.nlm.nih.gov/pubmed/22162266

Abdullah M, Kähler D, Vock C, Reiling N, Kugler C, Drömann D, Rupp J, Hauber HP, Fehrenbach H, Zabel P, Vollmer E, Dalhoff K, Goldmann T (2012) Pulmonary Haptoglobin and CD163 Are Functional Immunoregulatory Elements in the Human Lung. Respiration 83: 61-73 (ARCN) https://doi.org/10.1159/000329868 https://www.ncbi.nlm.nih.gov/pubmed/21860221

Abdullah M, Goldmann T (2012) Pulmonary haptoglobin (pHp) is part of the surfactant system in the human lung. Diagn Pathol 7: 158 (ARCN) https://doi.org/10.1186/1746-1596-7-158 http://www.ncbi.nlm.nih.gov/pubmed/23164167

 

2011

Stahel R, Thatcher N, Früh M, Le Péchoux C, Postmus PE, Sorensen JB, Felip E (2011) 1st ESMO Consensus Conference in lung cancer; Lugano 2010: Small-cell lung cancer. Ann Oncol 22: 1973-1980 (ARCN) https://doi.org/10.1093/annonc/mdr313 http://www.ncbi.nlm.nih.gov/pubmed/21727198

Rabe KF (2011) Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease. Br J Pharmacol 163: 53-67 (ARCN) https://doi.org/10.1111/j.1476-5381.2011.01218.x http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085868/pdf/bph0163-0053.pdf

Felip E, Gridelli C, Baas P, Rosell R, Stahel R (2011) Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy. Ann Oncol 22: 1507-1519 (ARCN) https://doi.org/10.1093/annonc/mdr150 http://www.ncbi.nlm.nih.gov/pubmed/21536661

Bousquet J, Anto JM, Sterk PJ, Adcock IM, Chung K, Roca J, Agusti A, Brightling C, Cambon-Thomsen A, Cesario A, Abdelhak S, Antonarakis SE, Avignon A, Ballabio A, Baraldi E, Baranov A, Bieber T, Bockaert J, Brahmachari S, Brambilla C, Bringer J, Dauzat M, Ernberg I, Fabbri L, Froguel P, Galas D, Gojobori T, Hunter P, Jorgensen C, Kauffmann F, Kourilsky P, Kowalski ML, Lancet D, Pen C, Mallet J, Mayosi B, Mercier J, Metspalu A, Nadeau JH, Ninot G, Noble D, Öztürk M, Palkonen S, Préfaut C, Rabe K, Renard E, Roberts RG, Samolinski B, Schünemann HJ, Simon H-U, Soares M, Superti-Furga G, Tegner J, Verjovski-Almeida S, Wellstead P, Wolkenhauer O, Wouters E, Balling R, Brookes AJ, Charron D, Pison C, Chen Z, Hood L, Auffray C (2011) Systems medicine and integrated care to combat chronic noncommunicable diseases. Genome Med 3: 43 (ARCN) https://doi.org/10.1186/gm259 http://www.ncbi.nlm.nih.gov/pubmed/21745417